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Abstract 
Replication of the genome is a central process in cellular life, which must be 
tightly regulated at the risk of genomic instability. DNA replication has been 
extensively studied in bacteria and eukaryotes, and recently, in archaea. 
Universally, DNA replication is started at specific genomic sites termed origins of 
replication, which are recognised by an initiator factor. While in both bacteria 
and archaea the initiator factor is a single protein, it is assumed that this role is 
performed in eukaryotes by a highly conserved six-subunit origin recognition 
complex (ORC). Recent phylogenetic studies, however, suggest that the 
presence of a six-subunit ORC might not be as conserved as initially believed.  
Trypanosoma brucei is a protozoan parasite in which little is known about 
nuclear DNA replication. To date, initiation of T. brucei DNA replication has 
been associated with a single factor, TbORC1/CDC6, though highly diverged 
interacting partners have been identified. To elucidate whether T. brucei 
possesses a diverged ORC-like complex, TbORC1/CDC6 and its known interacting 
partners, TbORC1B, TbORC4, Tb7980, Tb3120, and a novel factor, Tb1120, were 
analysed. First, the protein sequences of these factors were re-analysed, 
revealing varying degrees of conservation and divergence with other eukaryotes’ 
ORC proteins. Second, expression silencing by inducible-RNA interference (RNAi) 
of TbORC1/CDC6, TbORC1B, TbORC4, and Tb3120, in procyclic form (PCF) and 
bloodstream form (BSF) cells, confirmed their involvement in DNA replication. 
Third, subcellular localisation and dynamics of TbORC1/CDC6 and its interacting 
partners during the cell cycle of PCF and BSF cells was investigated by 
immunofluorescence, revealing TbORC1B to be the sole factor to display an 
apparent cell cycle-dependent localisation pattern, perhaps suggesting that it 
might be a DNA replication regulatory factor. Finally, immunoprecipitation and 
gel filtration assays support the existence of an ORC-like complex, apparently 
large enough to be composed of TbORC1/CDC6 and known interacting partners, 
and potentially, additional factors.  
TbORC1/CDC6-binding sites and origins of replication in T. brucei have been 
mapped in PCF cells. Like most eukaryotes, no specific sequence elements were 
found to define TbORC1/CDC6-binding sites or origins of replication, and the 
TbORC1/CDC6-binding sites outnumbered the mapped origins, which appeared to 
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be activated at different times during S phase. It has been reported in other 
eukaryotes that different cell types activate different origins or the activation 
timing differs. Here, origins of replication were mapped in T. brucei PCF and BSF 
cells, revealing a pronounced inflexibility in origin usage in these two life cycle 
stages. Only one, notable genome-wide difference was found: in BSF cells, the 
single active variant surface glycoprotein (VSG) expression site was found to be 
early replicating, whereas all other silent VSG expression sites were late 
replicating; in PCF cells however, where all VSG expression sites are silenced, 
these were all late replicating. These data reveal a locus-specific link between 
DNA replication and transcription in T. brucei, which may relate to immune 
evasion.  
The genomes of T. brucei and related kinetoplastids are highly syntenic. Since 
most eukaryotic origins of replication are not defined by consensus DNA 
sequences, but appear instead to be defined by, among other features, 
chromatin context and status, origins were here mapped in both L. major and L. 
mexicana promastigotes in order to ask if common features could be found 
relative to T. brucei. Surprisingly, only a single origin could be found per 
Leishmania chromosome, in contrast with all eukaryotes examined to date, 
where each chromosome is replicated from multiple detectable origins. Origin-
active loci in Leishmania were found to be distinguishable from related non-
origin loci in terms of size, a characteristic not observed in T. brucei, although 
around 40% of the mapped origins are conserved in location relative to T. brucei. 
These data reveal pronounced differences in replication dynamics between the 
two genera, despite the considerable overlap in genome organisation. 
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1.1 Trypanosoma brucei and related kinetoplastids 
1.1.1 The kinetoplastids 
Recent taxonomic studies divide the Eukarya domain into five supergroups (Adl 
et al., 2012; Lukes et al., 2014), as shown in Figure 1.1. In these classifications, 
kinetoplastid protists are included into the Excavata supergroup, group Discoba, 
subgroup Discicristata, phylum Euglenozoa, and class Kinetoplastea (Lukes et al., 
2014; Moreira et al., 2004; Adl et al., 2012) (Figure 1.1). As the name suggests, 
this class owes its name to the presence of a specific cellular structure, the 
kinetoplast (Moreira et al., 2004; Vickerman, 1976), which is the cell’s single 
mitochondrion DNA, organised as a mass of concatenated DNA circles (reviewed 
in Jensen and Englund, 2012; Liu et al., 2005). This early-branching group (Dacks 
et al., 2008) appears to be evolutionarily more ancestral than other major 
groups of protozoan parasites (Lukes et al., 2014), such as the apicomplexans 
(which incorporates clinically important genera such as Plasmodium and 
Toxoplasma), and includes a wide range of ubiquitous organisms, from free-
living species to obligatory parasites, and pathogens of invertebrates, 
vertebrates and plants (reviewed in Simpson et al., 2006; Lukes et al., 2014). 
Generally, kinetoplastids are seen as highly diverged eukaryotes, as they show 
unusual aspects of core biological processes, such as mitochondrial RNA editing, 
genomic organisation, mRNA trans-splicing, and compartmentalisation of 
glycolysis (reviewed in Simpson et al., 2006), when compared to the canonical or 
model eukaryotes (e.g. yeasts, domestic fly, mice, and human), which belong to 
the Opisthokonta supergroup. The class Kinetoplastea has been divided into two 
subclasses (Moreira et al., 2004), the early-branching Prokinetoplastina, and the 
Metakinetoplastina, which incorporates the order Trypanosomatida, containing 
exclusively parasitic and uniflagellate organisms (Adl et al., 2012; Moreira et al., 
2004). It is within the order Trypanosomatida that disease-causing parasites from 
the dixeneous (have a vertebrate/plant host and an invertebrate host) genera 
Trypanosoma and Leishmania are placed (Adl et al., 2012; Lukes et al., 2014; 
Moreira et al., 2004). These include pathogenic species of humans and other 
mammals that are of clinical and veterinary importance, and impose a great 
economic burden on the affected countries: Trypanosoma brucei (sleeping 
sickness disease in sub-Saharan Africa), Trypanosoma cruzi (Chagas disease in 
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South America) and the various Leishmania spp. (cutaneous and visceral 
leishmaniasis, affecting countries worldwide). 
 
Figure 1.1. The phylogeny of the Eukarya domain.  
Diagram showing a general overview of the eukaryote phylogeny based on the recent classification 
of the Eukarya domain by (Adl et al., 2012). In this case, the taxonomic positions of the class 
Kinetoplastea, order Trypanosomatida, and the Trypanosoma and Leishmania genera are 
highlighted. Distances are not to scale. (…) represents the other genera within the order 
Trypanosomatida, but that are not relevant for the present work. SAR refers to the group containing 
the Stramenopiles, Alveolates, and Rhizaria groups, previously classified differently (Adl et al., 
2005). The groups in grey refer to organism presently classified as incertae sedis, as their inclusion 
into the other groups is not clear (Adl et al., 2012). Figure adapted from (Lukes et al., 2014), 
reproduced with permission (license number 3586570624161). 
 
1.1.2 Human African Trypanosomiasis: past, present and future 
Sleeping sickness disease, or human African trypanosomiasis (HAT), is caused by 
two subspecies of Trypanosoma brucei: T. b. gambiense and T. b. rhodesiense. 
Although generally called HAT, the two subspecies of T. brucei are considered to 
cause different diseases (Franco et al., 2014), as the clinical pattern (see below) 
and epidemiology of the infections are distinct. T. b. gambiense causes a chronic 
form of HAT (gambiense HAT) in western and central Africa (Figure 1.2, A), 
accounting for 98% of the HAT cases reported in the last 10 years (Franco et al., 
2014). In contrast, T. b. rhodesiense is responsible for an acute form of the 
disease (rhodesiense HAT) in eastern and southern Africa (Figure 1.2, B), where 
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it occasionally infects humans; it is considered a zoonotic disease, infecting 
livestock and wildlife animals. Both subspecies of the parasite are transmitted to 
the mammalian host (see life cycle below) by infected tsetse flies, of the genus 
Glossina (reviewed in Fevre et al., 2006), when taking a blood meal. The 
distribution of HAT reflects the regions of the African continent that are 
inhabited by the tsetse fly, which is delimited to most of mid-continental Africa, 
between the Sahara and Kalahari deserts (tsetse belt) (Figure 1.2) (Franco et al., 
2014; Simarro et al., 2010), where it is estimated that around 70 million people 
are at risk (Simarro et al., 2012; Franco et al., 2014). Generally, working-age 
adults and young adults of rural areas are at higher risk of HAT, as many work in 
environments colonised by tsetse flies such as forests, savannah, and plantations 
(Franco et al., 2014). Together with the highly morbidity due to the 
incapacitating and chronic nature of the disease, HAT has a devastating impact 
on the income-generating capacity of families, social acceptance and, overall, is 
responsible for a significant socio-economic burden on the affected countries 
(Franco et al., 2014; Simarro et al., 2010; Steverding, 2008; Fevre et al., 2006). 
A third T. brucei subspecies, T. b. brucei, as well as the distinct species T. 
congolense and T. vivax, are not infective to humans, but infective to both wild 
and domestic animals, being responsible for veterinary trypanosomiasis, also 
known as nagana. While in wild animals nagana displays relatively mild 
symptoms, in domestic animals it results in severe and debilitating disease that 
is often fatal, rendering stock farming impractical in countries within the tsetse 
belt, thus adding substantially to the economic impact already caused by HAT 
(reviewed in Brun et al., 2010; Steverding, 2008; Franco et al., 2014).  
It is thought that trypanosomes have been infecting humans since hominids first 
appeared in Africa, having most likely contributed to early hominid evolution 
(Steverding, 2008). Indeed, there are several reports throughout human history 
documenting HAT and nagana (Steverding, 2008). Although HAT epidemics during 
the early 20th century were devastating, implementation of successful control 
measures and adequate surveillance programs led to a highly efficient reduction 
in the cases of HAT by the 1960’s where the landmark of <5,000 cases was 
reached (reviewed in Steverding, 2008; Franco et al., 2014). However, 
subsequent socio-political instability in a large number of the affected countries 
led to the abandonment of these measures, and the consequent resurgent of 
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HAT in the 1980’s, with an alarming increase in the number of estimated cases 
(>300,000) by the late 1990’s (Steverding, 2008; Franco et al., 2014; Brun et al., 
2010). Since 2000, joint efforts led and coordinated by the World Health 
Organisation (WHO) have been successful in reversing this trend: epidemiological 
data shows that in 2013 there were 6,228 new declared cases of gambiense HAT 
(although around 20,000 new cases were estimated) (Figure 1.2, A), and 98 
reported cases of rhodesiense HAT (Figure 1.2, B), a reduction of 75% and 88%, 
respectively, since 2000 (Franco et al., 2014). These results are encouraging, 
and gambiense HAT has been targeted for elimination by 2020 (WHO, 2012).  
 
Figure 1.2. Epidemiological distribution of HAT as of 2013.  
A) Distribution of gambiense HAT (caused by T. b. gambiense) in 2013. B) Distribution of 
rhodesiense HAT (caused by T. b. rhodesiense) in 2013. Adapted from the worldwide distributions 
of human African trypanosomiasis maps available from WHO on 
http://gamapserver.who.int/mapLibrary/Files/Maps/HAT_ga_ 2013.png (T. b. gambiense) and 
http://gamapserver.who.int/mapLibrary/Files/Maps/HAT_rh_ 2013.png (T. b. rhodesiense), 
accessed in March 2015. © WHO 2014. All rights reserved. 
 
HAT consists of two clinical stages. The first, early, or hemo-lymphatic stage, 
takes place when the parasite resides and multiplies in the bloodstream and 
lymphatic system, causing general symptoms such as intermittent fever, 
headache, weakness, anaemia and musculoskeletal pains, commonly 
misdiagnosed as other fever-causing diseases (reviewed in Franco et al., 2014; 
Brun et al., 2010). If not treated, HAT develops to the second, late, or meningo-
encephalitic stage, in which the parasites cross the blood-brain barrier, invading 
the central nervous system and progressively causing serious neurological 
damage. It is during this stage that common sleeping sickness-associated 
A) B) 
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symptoms such as sleep disturbances and neuropsychiatric symptoms are 
noticeable and, if not treated, eventually result in coma and subsequent death 
(reviewed in Franco et al., 2014; Brun et al., 2010). During both stages, the 
parasite is exclusively extracellular, with the levels of the parasite in the blood 
(parasitemia) fluctuating throughout the infection, partly as a result of the 
infected-host immune response and the parasite’s evasion strategy, termed 
antigenic variation (see below). In rhodesiense HAT, the first stage of the 
disease is much shorter than in gambiense HAT, resulting in death within 6-8 
months of infection. On the other hand, individuals suffering from gambiense 
HAT remain mildly symptomatic for years, although the chronic meningo-
encephalic stage is seen, if untreated, within an average of 3 years (reviewed in 
Franco et al., 2014; Fevre et al., 2006; Brun et al., 2010). Diagnosis is not easy, 
and new improved methods are necessary, as the present ones based on 
microscopic analysis of blood and cerebrospinal fluid, or serologic and 
polymerase chain reaction (PCR)-based assays, appear to be insufficient (Brun et 
al., 2010). 
Treatment of HAT is performed according to the stage of the disease using a 
very small range of drugs: first stage gambiense HAT is treated with 
pentamidine; second stage gambiense HAT can be treated with either 
eflornithine or melarsoprol; first stage rhodesiense HAT is treated with suramin; 
and second stage rhodesiense HAT is treated with melarsoprol (Brun et al., 2010; 
Steverding, 2010). Melarsoprol and eflornithine have been also used in 
combination with nifurtimox (oral drug used to treat Chagas disease), for the 
treatment of second stage gambiense HAT, with better results than monotherapy 
(reviewed in Brun et al., 2010). In all cases, the treatment regimens require 
either intramuscular (pentamidine) or intravenous (eflornithine, melarsoprol, 
and suramin) injections, given in various doses over, sometimes, long periods of 
time, making the treatments cumbersome and not always feasible in the most 
affected areas (Brun et al., 2010; Fevre et al., 2006). In addition, these drugs 
are highly toxic, and result in mild to severe, and sometimes life threatening (in 
the case of melarsoprol), side effects (Brun et al., 2010; Steverding, 2010). For 
these reasons, and considering that most of these drugs were developed in the 
first half of the 20th century, it is imperative that new, safer drugs are 
developed in the near future. 
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1.1.3 The life cycle of Trypanosoma brucei 
T. brucei parasites are transmitted to their mammalian hosts through the bite of 
an infected tsetse fly (Glossina spp.) (reviewed in Fevre et al., 2006). While 
probing its blood meal, the fly inoculates the host with the non-replicating, cell 
cycle arrested, mammal infective life cycle stage of the parasite, the metacyclic 
trypomastigote form, which is found in the fly’s salivary glands (see below), and 
injected into the mammalian host with the fly’s saliva (reviewed in Franco et 
al., 2014). Once in the mammalian host bloodstream, the metacyclic form cells 
re-enter the cell cycle. Associated with the onset of replication, the cells 
undergo morphological changes, differentiating into the proliferative long 
slender bloodstream forms (BSF) that actively divide (Figure 1.3), establishing 
and maintaining an extracellular infection in the bloodstream and lymphatic 
system. BSF stage cells express variant surface glycoproteins (VSGs) on their 
surface membrane, which form a dense coat that is recognised by the host 
immune system. The parasite is able to evade the host’s anti-VSG immune 
response by sequentially expressing distinct VSGs on its surface (via antigenic 
variation). As each new VSG is not immediately recognised by the host, such 
switching allows continued immune evasion (reviewed in McCulloch et al., 2014; 
Glover et al., 2013b), which contributes to the intermittent waves of 
parasitemia characteristic of trypanosomiasis (reviewed in MacGregor et al., 
2012). As long slender BSF numbers increase in the bloodstream, quorum 
sensing-like mechanisms are activated, and the parasite differentiates into a 
non-proliferative, cell cycle arrested stage pre-adapted for transmission to the 
fly, the short stumpy form (Figure 1.3) (Vassella et al., 1997; Reuner et al., 
1997; MacGregor et al., 2011; Dean et al., 2009; Mony et al., 2014). This 
differentiation allows the parasite to limit its numbers in the bloodstream, 
prolonging host survival and increasing the chances of transmission, as well as 
providing pre-adaptation to the fly’s gut environment (reviewed in MacGregor et 
al., 2012).  
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Figure 1.3. T. brucei life cycle.  
Simplified diagram of the life cycle of T. brucei parasites. Detailed description in the main text. CNS 
refers to the central nervous system. Reproduced from (Langousis and Hill, 2014), with permission 
(license number 3586570870008).  
 
When a tsetse fly probes its blood meal from an infected mammal, short stumpy 
forms are ingested and, in the fly’s midgut, differentiate into replicative 
trypomastigote procyclic forms (PCF) (Figure 1.3) (Jones et al., 2014; Szoor et 
al., 2006; Szoor et al., 2010; Matthews and Gull, 1997), thus establishing the 
next stage of the life cycle (reviewed in Dyer et al., 2013; Ooi and Bastin, 2013). 
From here, the parasites migrate to the proventriculus, where they undergo 
extensive morphological changes into long trypomastigotes that then divide 
asymmetrically to generate one long and one short epimastigote (Figure 1.3) 
(reviewed in Dyer et al., 2013; Ooi and Bastin, 2013). This latter form of the 
parasite then migrates to the salivary gland, where it attaches to the epithelial 
cells (Figure 1.3) and proliferates, colonising the salivary glands (Rotureau et 
al., 2012). Eventually, this epimastigote form divides asymmetrically (Rotureau 
et al., 2012) to generate non-proliferative metacyclic trypomastigote forms 
(Figure 1.3) (reviewed in Dyer et al., 2013; Ooi and Bastin, 2013). Virtually all 
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fly stages of the parasite do not express VSG on their surface: procyclin is 
expressed in PCF cells (Acosta-Serrano et al., 2001; Vassella et al., 2001; 
Urwyler et al., 2005) and BARP in epimastigotes (Urwyler et al., 2007). However, 
metacyclic form cells express a single metacyclic VSG (MVSG) on their surface, 
selected from the MVSG repertoire (Ginger et al., 2002; Vickerman, 1985; Barry 
et al., 1998). A number of different MVSG-coated metacyclic cells are 
generated, providing a heterogeneous metacyclic population (Tetley et al., 
1987; Barry et al., 1998). Together with other biological features (e.g. rate of 
endocytosis) (Natesan et al., 2007), VSG expression renders the metacyclic 
forms adapted to infect the mammalian host (Vickerman, 1985; Barry et al., 
1998). Metacyclic forms are released into the salivary gland lumen (Tetley and 
Vickerman, 1985) and subsequently inoculated into the mammalian host, starting 
the life cycle again (Figure 1.3).  
 
1.2 Trypanosoma brucei in more detail 
1.2.1 Cell structure 
Being a parasite with a complex life cycle in which it must survive and develop 
in two different hosts, T. brucei undergoes extensive biological modifications 
during the life cycle, including discernible morphological changes (Figure 1.3 and 
Figure 1.4). One morphological difference between the epimastigote and the 
trypomastigote cell types is the position of kinetoplast localisation relative to 
the nucleus: in epimastigotes, the kinetoplast is localised anteriorly to the 
nucleus, while in trypomastigotes it is positioned posteriorly (Figure 1.4, A) 
(Wheeler et al., 2013a). Moreover, there are also considerable morphological 
differences between the various trypomastigote stages of the parasite (BSF, 
stumpy forms, PCF and metacyclic forms) (Figure 1.3). However, despite 
assuming various morphologies, the general cellular ultrastructure of the 
parasite is largely conserved (Wheeler et al., 2013a). T. brucei cells have an 
elongated shape, with a single flagellum that is laterally attached to most of the 
length of the cell body (juxtaform morphology; only the distal tip is free of the 
cell body) (Wheeler et al., 2013a). The length and lateral attachment of the 
flagellum controls the body length of the cell (Wheeler et al., 2013a), besides 
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also playing an important role in cell motility and cell division (reviewed in 
Langousis and Hill, 2014; Field and Carrington, 2009). The flagellum has a 
canonical 9 + 2 axoneme structure with an associated paraflagellar rod, and 
protrudes from the posterior end of the cell, emerging from the flagellar pocket, 
the only site where endocytosis and exocytosis take place (reviewed in Overath 
and Engstler, 2004). Here, the flagellum originates from the basal body, which is 
linked to the kinetoplast through the mitochondrial membrane (reviewed in 
Langousis and Hill, 2014; Field and Carrington, 2009). The cell’s shape is defined 
by a highly polarised sub-pellicular microtubule cytoskeleton, an array of 
uniformly distributed microtubules under the plasma membrane, which remains 
intact during all stages of the cell cycle (reviewed in Matthews, 2005). Cellular 
structures and organelles, such as the flagellar pocket, the flagellum, the Golgi 
complex, the mitochondrion, the kinetoplast, and the nucleus, are present in 
single copy, and are specifically positioned (with the exception of the 
mitochondrion that runs the length of the cell) between the posterior end and 
the centre of the cell (Figure 1.4, B), forming a highly reproducible and 
organised cell structure (reviewed in Matthews, 2005).  
 
Figure 1.4. T. brucei general cell structure.  
Simplified representations of T. brucei cells. A) Representation of a trypomastigote cell (top) and an 
epimastigote cell (bottom). Legend within the insert box: basal body (BB); flagellar pocket (FP); 
axoneme (Ax); paraflagellar rod (PFR); nucleus-posterior distance (NP); kinetoplast-posterior 
distance (KP). B) Trypomastigote general internal cellular structure in more detail. Legend is shown 
below the diagram. A) Reproduced from (Wheeler et al., 2013a), PLoS ONE, with permission, © 
2013 Wheeler et al. all rights reserved. B) Reproduced from (Matthews, 2005), with permission, © 
Company of Biologists Ltd., all rights reserved. 
 
A) B) 
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1.2.2 Cell cycle 
Overall, T. brucei BSF and PCF proliferative trypomastigote forms follow the 
general lines of a typical eukaryotic cell cycle, although containing some unique 
features (reviewed in Matthews, 2005; Vaughan and Gull, 2008) and perhaps 
diverged regulatory mechanisms (reviewed in Hammarton, 2007; Li, 2012). 
During G1 phase, the first morphologic event of cell division is the duplication of 
the basal body and the beginning of the synthesis of a new flagellum (Woodward 
and Gull, 1990; Wheeler et al., 2013b) (Figure 1.5, A, second row), which is 
immediately followed by the duplication of the Golgi complex (Ho et al., 2006). 
In T. brucei the single-copy organelles are apparently duplicated by a template-
based mechanism where a new organelle is generated just beside the old one 
(reviewed in Vaughan and Gull, 2008). One aspect in which T. brucei’s cell cycle 
differs from the canonical eukaryotic cell cycle is the S phase, as the parasite 
has two distinct, although highly coordinated, S phases: the kinetoplast S phase, 
where the kinetoplast DNA (kDNA) is replicated; and the nuclear S phase, when 
the nuclear chromosomal DNA is replicated (Figure 1.5, B). kDNA replication is 
initiated by factors (reviewed in Liu et al., 2005; Jensen and Englund, 2012) 
distinct from the ones involved in nuclear DNA replication (reviewed in Tiengwe 
et al., 2013). Kinetoplast S phase is started immediately before nuclear S phase, 
and it is considerably shorter (Woodward and Gull, 1990), meaning that the 
kinetoplast and nuclear cell cycle phases are not synchronised. During nuclear S 
phase, the kinetoplast G2 phase starts, culminating in the segregation of the old 
and newly formed kinetoplast networks (when the basal bodies are separated by 
a microtubule-mediated event) during nuclear G2 phase (reviewed in Liu et al., 
2005; Jensen and Englund, 2012) (Figure 1.5, A, third row). Alongside, the Golgi 
complex is also segregated (Hall et al., 2006). Until the onset of nuclear mitosis, 
these cells possess one nucleus (N) and two kinetoplasts (K) (1N2K) (Woodward 
and Gull, 1990). Next, mitosis occurs as a closed process (Figure 1.5, A, third 
row): the nuclear envelope is not disrupted, and an intra-nuclear spindle 
mediates chromosomes segregation, resulting in a cell with two nuclei and two 
kinetoplasts (2N2K) (Ogbadoyi et al., 2000). During all the previous phases, the 
new flagellum is continuously formed.  
 
Chapter 1  32 
 
 
Figure 1.5. Cell cycle of T. brucei PCF and BSF cells.  
A) Schematic representation of the different cell morphologies of the PCF cells (left) and BSF cells 
(right) during the cell cycle. On the far left, the cell type refers to the nucleus (N) and kinetoplast (K) 
configurations characteristic of each cell cycle stage shown for both PCF and BSF cells. In both 
representations of PCF and BSF cells, the new flagellum is represented in red, and the old 
flagellum is shown in green. Each major occurrence is described for each cell cycle stage. B) 
Simplified representation of the nuclear (N) and kinetoplast (K) S phases timing in relation to each 
other. M refers to nuclear mitosis, C to cytokinesis, D to kinetoplast division, and A to kinetoplast 
anaphase (segregation). The cell types according to their nucleus and kinetoplast conformations 
are shown above. A) Figure adapted from (Wheeler et al., 2013b), © 2013 Wheeler et al. all rights 
reserved. B) Diagram generated based on the descriptions and schematics from (Woodward and 
Gull, 1990; McKean, 2003; Ploubidou et al., 1999; Hammarton, 2007).  
 
A) 
B) 
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The non-synchronisation but tight coordination of the kinetoplast and nuclear S 
phases allow the classification of individual cells in an asynchronous cellular 
population into the cell cycle stages they are in: cells with 1N1K morphology are 
in nuclear G1; cells with one nucleus but one “elongated” (e) kinetoplast 
(1N1eK) are in nuclear late G1 or S phase; cells with 1N2K are in nuclear G2; 
while cells with 2N2K are post-mitotic but have not undergone complete 
cytokinesis (Woodward and Gull, 1990; Siegel et al., 2008) (Figure 1.5, B).  
Upon cytokinesis, which starts immediately after mitosis, a unidirectional 
cleavage furrow is formed (Figure 1.5, A, rows 4 and 5), anterior-posteriorly 
along the longitudinal axis of the parasite, passing between the two flagella of 
the dividing cell (Wheeler et al., 2013b). This allows the division of the two 
cells, which remain connected by a discrete “cytoplasmic bridge” (thin section 
of the membrane) (Figure 1.5, A, sixth row) prior to abscission (Wheeler et al., 
2013b). After abscission the two daughter cells are released, each with a single 
set of organelles (Figure 1.5, A, seventh row). 
Overall, the cell cycles of PCF and BSF cells are similar (Figure 1.5, A), though 
several morphological differences are seen (Wheeler et al., 2013b), and 
functional studies have shown that the molecular mechanisms involved in cell 
cycle regulation might differ between these two life cycle stages (reviewed in 
Hammarton, 2007; Li, 2012). In nuclear G1 phase (1N1K cells), the morphology 
of BSF and PCF cells is similar, although the latter is longer and wider, with the 
kinetoplast localised further from the posterior end, and with a shorter 
protruding portion of the flagellum (Wheeler et al., 2013b) (Figure 1.5, A, top 
row). The major morphological differences arise after mitosis, most likely due to 
the way the new flagellum is displayed in the cell during its synthesis and 
cytokinesis in the two cell types (Wheeler et al., 2013b). A key difference lies in 
the presence of a flagella connector in PCF cells that attaches the distal tip of 
the growing new flagellum to the old flagellum until it reaches a “stop point”, 
from where the new flagellum tip does not move forward relative to the old one, 
though its growth continues and it is maintained completely attached to the cell 
body (reviewed in Langousis and Hill, 2014) (Figure 1.5, A, rows 2 to 4). The 
flagella connector is absent from BSF cells and the new flagellum grows with the 
distal tip located in the cell-body groove (Hughes et al., 2013) until it reaches 
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the end of the cell body, continuing to grow unattached to the cell body during 
cytokinesis (Wheeler et al., 2013b) (Figure 1.5, A, rows 2 to 4). The new 
flagellum growth coincides with the movement of the base of the flagellum, the 
flagellar pocket and consequently the kinetoplast, resulting in the differing 
placement of the nuclei and kinetoplasts in post-mitotic 2N2K cells, with a 
conformation of 1K1N1K1N in PCF cells but 1K1K1N1N in BSF cells (Wheeler et 
al., 2013b) (Figure 1.5, A, rows 4 and 5). Differences between the cell cycle 
controls of these two stages of the parasite are, however, more profound. 
Various functional studies investigating the cell cycle effects resulting from the 
depletion of certain factors by RNA interference (RNAi) or from blocking certain 
cell cycle stages with drugs have revealed different phenotype outcomes in PCF 
and BSF cells. For example, chemical inhibition of DNA replication and mitosis 
revealed that PCF cells still progress through cytokinesis, suggesting that this life 
cycle stage does not possess the mitosis to cytokinesis cell cycle checkpoint 
(Ploubidou et al., 1999). This was supported by RNAi studies investigating the 
role of TbCYC6, a mitotic cyclin (Hammarton et al., 2003), the mitotic cyclin-
dependent kinase TbCRK3 (Tu and Wang, 2004), and the aurora-like kinase 
TbAUK1 (Li and Wang, 2006). However, the depletion of any of these factors in 
BSF cells resulted in the blocking of cytokinesis, suggesting that this life cycle 
stage, in contrast to PCF cells, possesses the mitosis to cytokinesis checkpoint 
(Hammarton, 2007; Li, 2012). A similar disparity in phenotypes was also obtained 
with the depletion of the DNA replication initiator factor TbORC1/CDC6 (see 
below) (Benmerzouga et al., 2013; Tiengwe et al., 2012b).  
1.2.3 Unusual genome organisation and unconventional 
transcription 
The nuclear genome of T. brucei is composed of eleven diploid megabase-sized 
chromosomes (0.9 to 6 Mbp), one to five aneuploid intermediate chromosomes 
(150 to 900 Kbp), and around 100 minichromosomes (50 to 150 Kbp) (Berriman et 
al., 2005; Melville et al., 1998; Turner et al., 1997) (Figure 1.6). All the three 
types of chromosome possess telomeric repeats (TTAGGG) with the same base 
composition as mammals (reviewed in Dreesen et al., 2007). The megabase 
chromosomes (Figure 1.6) display a portioned organisation, with a core region 
containing all the RNA polymerase II (RNA Pol II)-transcribed housekeeping genes 
(~7,500) flanked by large hemizygous subtelomeres (between the telomere and 
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the first housekeeping gene) containing arrays of VSG genes and VSG 
pseudogenes (~1,500) (Marcello and Barry, 2007; Cross et al., 2014). Mammalian 
VSGs are exclusively expressed from telomeric bloodstream expression sites 
(BES), found on the megabase and intermediate chromosomes and where the 
VSG and expression site associated genes (ESAGs) are co-expressed by RNA Pol I 
(reviewed in McCulloch et al., 2014; Glover et al., 2013b; Daniels et al., 2010; 
Ersfeld, 2011). Each BSF cell expresses only one BES, a process termed 
monoallelic expression (reviewed in Gunzl et al., 2014). T. brucei is the only 
known organism that uses RNA Pol I to transcribe not only rRNA genes, but also 
protein-coding genes (Gunzl et al., 2003): this is not limited to the VSGs, but 
also and the procyclin genes, encoding the surface proteins on PCF cells (Haenni 
et al., 2006; Haenni et al., 2009). To date, the centromeres of only megabase 
chromosomes 1 to 8 have been mapped (Obado et al., 2007), and were recently 
shown to localise with some protein components of the highly diverged, putative 
T. brucei kinetochore (Akiyoshi and Gull, 2014). The role of both the 
intermediate and minichromosomes appears to be entirely dedicated to 
antigenic variation. These chromosomes encode intact and functional VSGs or 
VSG pseudogenes (that can recombine to generate functional new “mosaic” 
VSGs), contributing to the parasite’s VSG archive, and providing the parasite 
with a repertoire of transcriptionally silent VSGs that can be activated (reviewed 
in McCulloch et al., 2014; Glover et al., 2013a). Structurally, the 
minichromosomes consist of a central uninterrupted repetitive palindromic core 
region (20-80 Kbp per chromosome, with a single inversion point in the centre) 
of 177 bp repeats, flanked by short subtelomeric regions containing non-
repetitive DNA, and the telomeres (Wickstead et al., 2004). The stretches of 177 
bp repeats are also present in the intermediate chromosomes, though at the 
subtelomeres, flanking a non-repetitive core region (Wickstead et al., 2004). 
These intermediate chromosomes also contain BESs (Hertz-Fowler et al., 2008) 
that can be activated upon antigenic variation (reviewed in McCulloch et al., 
2014; Glover et al., 2013b). Overall, around 20% of the T. brucei genome is 
dedicated to the VSG archive and antigenic variation (Berriman et al., 2005). 
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Figure 1.6. T. brucei megabase, intermediate and minichromosome structures.  
Simplified representation of chromosome structure and organisation of the three types of 
chromosomes composing the genome of T. brucei. The megabase chromosomes contain a core 
region harbouring all the parasite’s housekeeping genes, arranged in large directional gene 
clusters (DGCs) or large polycistronic transcription units (shown in red and blue, the transcription 
orientation highlighted by an arrow). Two DGCs are separated by a region called the strand switch 
region (SSR), which can be divergent, convergent or head-to-tail, depending on the orientation of 
the DGCs, as shown and described in the main text. The subtelomeric region, containing part of 
the VSG archive, flanks this core section of the chromosomes. At the extremities are the telomeres, 
where the bloodstream expression sites (BESs) are localised. Only one BES is active per cell at a 
given time (represented in orange). The telomeres of the megabase, intermediate and 
minichromosomes are made up by TTAGGG (T2AG3)-repeats. The intermediate and 
minichromosomes harbour the remaining of the VSG archive, with some of the BES localising to 
the intermediate chromosomes. The core region of the minichromosomes consists of palindromic 
177 bp repeats. Not to scale. Diagram adapted from (Glover et al., 2013b), © 2013 Glover et al. all 
rights reserved, and descriptions from (Ersfeld, 2011; Daniels et al., 2010).  
 
Sequencing of the T. brucei, T. cruzi and L. major (also known as TriTryps) 
genomes 10 years ago (El-Sayed et al., 2005b; El-Sayed et al., 2005a; Berriman 
et al., 2005; Ivens et al., 2005) showed that these parasites share a conserved 
core proteome (~6200 genes; T. brucei and T. cruzi genomes share an average of 
57% identify, while T. brucei and L. major share about 44%), encoded in highly 
syntenic (i.e. the order of the genes is conserved) gene blocks within the 
chromosome cores, with, for example, ~68% of T. brucei and ~75% of L. major 
genes being found in the same genomic context (El-Sayed et al., 2005b). The 
organisation of the core genome into 11 large megabase chromosomes contrasts 
with the more fragmented genomes of T. cruzi (41 chromosomes) (Weatherly et 
al., 2009), and L. major (36 chromosomes) (Ivens et al., 2005). Due to the high 
levels of synteny, it has been suggested that the T. brucei genome derived from 
the fusion of a more fragmented ancestral genome (El-Sayed et al., 2005b). The 
main difference between these genomes lays in the non-syntenic subtelomeric 
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regions, which are short in L. major, but large in both T. cruzi and T. brucei (El-
Sayed et al., 2005b). These contain species-specific features associated with 
disease mechanisms, such as antigenic variation in T. brucei (reviewed in 
McCulloch et al., 2014; Glover et al., 2013b). A characteristic of the 
trypanosomatids genomes is their unconventional gene organisation into large 
polycistronic gene clusters, also known as polycistronic transcription units or 
directional gene clusters (DGCs), in which the genes are arranged in a head-to-
tail orientation (reviewed in Daniels et al., 2010; Jackson, 2014; Stuart and 
Myler, 2006; Ersfeld, 2011). The various DGCs are separated by regions named 
strand switch regions (SSRs) (Figure 1.6), which can be divergent (dSSR; the 
genes in the two DGCs are oriented away from the SSR in opposing directions), 
convergent (cSSRs; the transcription the genes in the two DGCs are oriented 
towards the SSR in opposing directions), or head-to-tail (h-t SSR; two DGCs are 
oriented in the same direction) (reviewed in Daniels et al., 2010). Each DGC is 
transcribed from a single RNA Pol II transcription initiation site, though no 
typical RNA Pol II promoters are found, generating polycistronic mRNAs 
(reviewed in Daniels et al., 2010; Ersfeld, 2011). These polycistronic mRNAs are 
then processed into monocistronic mRNAs by co-transcriptional trans-splicing of 
a capped short spliced-leader (SL) RNA exon to the 5’ untranslated region (5’ 
UTR), coupled with polyadenylation of the upstream gene, producing mature 
mRNAs (reviewed in Daniels et al., 2010; Clayton, 2002; Michaeli, 2011). 
Transcription is initiated at dSSRs and h-t SSRs sites enriched in modified or 
variant histones, such as histone H4 acetylated at lysine 10 (H4K10ac), histone 
H3 trimethylated at lysine 4 (H3K4me3) (Wright et al., 2010) and histone H2 
variants H2AZ and H2BZ (Siegel et al., 2009) in T. brucei, and acetylated histone 
H3 in L. major (Thomas et al., 2009). Transcription termination is still not 
completely understood (reviewed in Ersfeld, 2011), but transcription appears to 
terminate at cSSRs and h-t SSRs that are enriched in histone variants H3V and 
H4V in T. brucei (Siegel et al., 2009), and base J (an hypermodified thymidine 
base in kinetoplastids) (reviewed in Borst and Sabatini, 2008) in L. major 
(Reynolds et al., 2014). As a consequence of transcription into large 
polycistronic mRNAs, gene expression in trypanosomatids is mainly controlled at 
the post-transcriptional level (reviewed in Clayton, 2002; Siegel et al., 2011; 
Kramer, 2012). 
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1.3 Initiation of nuclear DNA replication as we know it 
Throughout evolution, cellular life has diverged into what is now classified as the 
three domains of life: Bacteria, Archaea and Eukarya (reviewed in Pace et al., 
2012). Despite their extreme differences, basic molecular mechanisms 
underlying vital processes, such as gene transcription (reviewed in Werner and 
Grohmann, 2011) and DNA replication (reviewed in O'Donnell et al., 2013), have 
been kept considerably functionally conserved. However, the molecular 
machineries and associated regulatory processes involved in these core processes 
present different degrees of complexity between the three domains, being 
apparently simpler in bacterial and archaeal organisms than in eukaryotic ones 
(reviewed in Masai et al., 2010; O'Donnell et al., 2013).  
The complete faithful duplication of the genome before cellular division is 
central to the propagation of life, and one of the most complex and tightly 
regulated processes in the cell. Normally, the genomic DNA is replicated once, 
and only once, per cell cycle (reviewed in O'Donnell et al., 2013; Masai et al., 
2010). A key step in this is, therefore, the initiation of the process, which 
involves the tightly controlled and timely recruitment and activation of various 
factors. Simplistically, initiation of DNA replication consists in the recruitment 
and binding of the initiator factor(s) to the replication starting sites (termed 
origins of replication), which leads to the recruitment and loading of the 
replicative helicase, that is necessary for opening of the DNA helix during 
replication (Figure 1.7) (reviewed in Masai et al., 2010; O'Donnell et al., 2013). 
After the helicase is loaded, the components of the replication machinery, 
including the replicative DNA polymerases, are then recruited to the origin and 
consequently, start of DNA synthesis.  
In the next sections, the molecular machineries involved in the initiation of DNA 
replication, the origins of replication and how they are defined, and the 
regulation of the initiation steps of DNA replication in the three domains of life, 
are explored.  
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Figure 1.7. Initiation of DNA replication.  
Simplified diagram representing the steps of initiation of DNA replication. An initiator factor 
recognises and binds the origin of replication. This allows the further recruitment of the replicative 
helicase to the origin, either through a helicase loader or directly. The helicase is then activated, 
and melts the dsDNA, allowing the recruitment of the remaining components of the replication 
machinery (not shown), and thus the beginning of DNA synthesis. Note than in bacteria the origin is 
not melted by the helicase but by the initiator factor. Details of the machineries and process in 
bacteria, archaea and eukaryotes are detailed in the main text. Diagram based on the descriptions 
made in various review articles (Costa et al., 2013; Masai et al., 2010). 
 
1.3.1 Initiation molecular machineries 
Recognition of the origins of replication by the initiator factors is the first step 
in DNA replication (reviewed in O'Donnell et al., 2013; Masai et al., 2010; Costa 
et al., 2013). The replication initiator factors found in bacteria, archaea and 
eukaryotes belong to the AAA+ superfamily of ATPases, more specifically, to the 
DnaA/CDC6/ORC clade, which encompasses two sequence-divergent families: 
the bacterial DnaA family and the archaeo-eukaryotic CDC6/ORC family 
(reviewed in Iyer et al., 2004; Davey et al., 2002b; Erzberger and Berger, 2006; 
Kawakami and Katayama, 2010). Nevertheless, these AAA+ ATPase factors are 
molecularly conserved and perform analogous roles in replication, working both 
in the identification and binding of replication origins (through their DNA 
recognition domains) and as molecular switches, in which ADP/ATP are used as 
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driving forces of initiator factor assembly and helicase loading onto the origins 
(reviewed in Robinson and Bell, 2005; Wigley, 2009; Duncker et al., 2009; 
Kawakami and Katayama, 2010).  
1.3.1.1 General structure of AAA+ ATPases 
The amino acid ATP-binding (AAA+) domain’s basic structure is shown in Figure 
1.8. Motifs within domain I (Figure 1.8) are also found in other P-loop NTPases, 
while motifs in domain II define the AAA+ ATPase family (reviewed in Davey et 
al., 2002b). In domain I, the signature Walker A and Walker B motifs, 
fundamental parts of the AAA+ ATP-binding site, are found (Figure 1.8). The 
Walker A (the phosphate-binding loop, or P-loop) is usually conserved as 
GX4GK[S/T]
a, and forms a distinctive loop that interacts directly with the 
phosphates of the ATP molecule (for which the lysine (K) residue is crucial). The 
Walker B motif is typically defined by hhhhDEb, in which the hydrophobic amino 
acids are essential for ATPase activity, the aspartate (D) co-ordinates the 
magnesium ions (Mg2+) needed for ATP hydrolysis, and the glutamate (E) 
residue’s role is to prime a water molecule for the ATP hydrolysis reaction 
(reviewed in Iyer et al., 2004; Davey et al., 2002b; Erzberger and Berger, 2006; 
Matte and Delbaere, 2010; Hanson and Whiteheart, 2005). Though it is now 
recognised, as more protein structures are analysed, that the canonical 
sequences of the Walker motifs are not as conserved as previously thought 
(reviewed in Matte and Delbaere, 2010), some specific modifications to the 
Walker A and B motifs are known to render the proteins unable to bind ATP (e.g. 
the replacement of the lysine – K, in the Walker A by an alanine – A) and devoid 
of ATPase activity (change from the glutamate – E , to glutamine – Q, in the 
Walker B motif) (reviewed in Iyer et al., 2004; Hanson and Whiteheart, 2005). A 
distinguishable characteristic of the initiator factors clade is the insertion of an 
additional α-helix between the helix α2 and strand β2 (thus between the Walker 
A and Walker B motifs). This insertion is called the initiator-specific motif (ISM), 
and is known to be important for oligomerisation of the initiator factor as well as 
origin recognition (Iyer et al., 2004; Erzberger and Berger, 2006; Duderstadt and 
Berger, 2008). Still within domain I, is the sensor 1 motif (Figure 1.8). This motif 
                                         
a
 X refers to any amino acid.  
b
 h refers to an hydrophobic amino acid. 
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has a conserved polar residue (usually asparagine – N, though it can also be 
serine – S, threonine – T, or aspartate – D), which is important for ATP hydrolysis 
(reviewed in Iyer et al., 2004; Erzberger and Berger, 2006). Physically, this polar 
residue is placed between the Walker A and Walker B motifs, where it interacts 
with the second acidic residue of the Walker B motif to properly orient the 
water molecule for ATP hydrolysis (reviewed in Hanson and Whiteheart, 2005; 
Erzberger and Berger, 2006). Next to the sensor 1 motif, localising to Box VII or 
SRC, is the conserved arginine finger (Figure 1.8), which is involved in ATP 
hydrolysis not of the molecule it is part of, but of the adjacent AAA+ ATPase 
subunit in the complex they are both part of (see example of Orc1 and Orc4, 
below). This is achieved because, structurally, the arginine of one subunit is 
docked into the ATP-containing active site of the adjacent subunit in the 
complex, where it interacts directly with the ATP there bound (reviewed in Iyer 
et al., 2004; Hanson and Whiteheart, 2005). Finally, in the C-terminal region of 
the AAA+ domain (domain II) is the sensor 2 motif (Figure 1.8) (reviewed in 
Davey et al., 2002b; Hanson and Whiteheart, 2005), containing a frequently 
conserved arginine residue that interacts directly with ATP (reviewed in Iyer et 
al., 2004; Erzberger and Berger, 2006). This element is involved in both ATP-
binding and hydrolysis, and undergoes conformational changes whether the 
protein is bound to ATP or ADP (reviewed in Hanson and Whiteheart, 2005; Iyer 
et al., 2004). 
 
Figure 1.8. AAA+ ATPase domain: characteristic motifs and elements.  
Simplified representation of the AAA+ domain. The signature motifs and elements are shown: 
domain I, enclosing the Walker A, Walker B, Sensor 1, and Box VII or SRC (containing the arginine 
finger), and domain 2, encompassing Sensor 2. The canonical sequences of Walker A and Walker 
B are shown below. Diagram reproduced and adapted from (Davey et al., 2002b), with permission 
(license number 3591430587500). 
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1.3.1.2 Bacterial DnaA 
DnaA is the replication initiator factor present, typically as a single copy gene, 
in all known bacteria (reviewed in Iyer et al., 2004; Messer, 2002). DnaA is 
structurally arranged in four functionally distinct domains (Figure 1.9) (reviewed 
in Mott and Berger, 2007; Messer et al., 1999). The amino-terminal domain 
(domain I) is involved in the oligomerisation of DnaA (Simmons et al., 2003) as 
well as in the interaction of DnaA with the bacterial replicative helicase, DnaB 
(see below) (Seitz et al., 2000). Adjacent is a flexible and poorly conserved 
linker element (domain II), whose length and sequence content diverges 
between different bacterial species (Messer et al., 1999), or can even be absent, 
as in Aquifex aeolicus (Erzberger et al., 2002). Downstream is the signature 
AAA+ domain (domain III), containing the binding site for ATP and ADP, and is 
responsible for the protein’s ATPase function, which is critical for the initiation 
of DNA replication (Messer et al., 1999). Both ATP-bound (ATP-DnaA) and ADP-
bound (ADP-DnaA) forms of DnaA are present in the cell and are involved in the 
initiation of DNA replication, although only the ATP-DnaA oligomers are able to 
effectively initiate DNA replication from the bacterial origin (oriC) (Sekimizu et 
al., 1987). Moreover, domain III also contains another DnaB interaction site 
(Messer et al., 1999). At the carboxy-terminus is domain IV, which includes a 
helix-turn-helix (HTH) DNA-binding motif, the DnaA signature sequence that 
mediates the specific recognition of the DnaA box sequences (DnaA sequence-
specific binding sites, see below) in oriC, and a basic loop that is essential for 
DNA binding (Blaesing et al., 2000). 
 
Figure 1.9. Bacterial DnaA protein domains.  
Schematic representation of the four protein domains of the bacterial DnaA. The sequences shown 
for the basic loop and the DnaA signature sequence are the ones from E. coli DnaA. Detailed 
description in the main text. Diagram reproduced from (Mott and Berger, 2007), with permission 
(license number 3590960451859).  
 
Chapter 1  43 
 
1.3.1.3 Archaeal Orc1/Cdc6 
In archaea, the identified initiator factors are distinct from DnaA, and are 
instead related to the Orc1 subunit of the eukaryotic ORC (see below), as well as 
one of the eukaryotic ORC-MCM mediators, Cdc6 (reviewed in Kelman and 
Kelman, 2014). Eukaryotic Orc1 and Cdc6 appear to be paralogues (see below), 
and archaeal homologues are commonly referred to as the Orc1/Cdc6 proteins 
(reviewed in Robinson and Bell, 2005). In archaea, the machinery involved in 
initiation of DNA replication appears to differ greatly amongst the various 
archaeal lineages, where different groups of organisms may use various 
combinations of key players in the process. For instance, with the exception the 
analysed Methanococcales and Methanopyrales species, in which no homologue 
of Orc1/Cdc6 could be found, meaning a non-orthologous protein is used as the 
initiator factor (Raymann et al., 2014), all archaeal genomes studied to date 
contain at least one orc1/cdc6 gene, with most lineages containing two or three 
genes encoding Orc1/Cdc6 (Barry and Bell, 2006; Raymann et al., 2014). Indeed, 
some Halobacteriales species possess large numbers of orc1/cdc6 genes 
(Raymann et al., 2014), with as many as 14 in Haloferax volcanii (Norais et al., 
2007). Because of its homology with eukaryotic Orc1 and Cdc6 proteins, it is 
generally considered that the archaeal initiation machinery is a simplified 
version of the eukaryotic one (see below), and it has been hypothesised that the 
archaeal Orc1/Cdc6 proteins are involved in both origin recognition (a role that 
has been established) and replicative helicase loading, though how this is 
achieved remains unclear (reviewed in Kelman and Kelman, 2014). 
Studies developed in two of the three Orc1/Cdc6 proteins found in Sulfolobus 
solfataricus, Orc1/Cdc6-1 and Orc1/Cdc6-3 (Dueber et al., 2007; Dueber et al., 
2011), and one of the two from Aeropyrum pernix, Orc1/Cdc6-1 (Gaudier et al., 
2007), revealed that archaeal Orc1/Cdc6 protein structure comprises two 
domains: an amino-terminal AAA+ ATPase domain, which is where sequence 
homology is found with bacterial DnaA, and a carboxyl-terminal DNA-binding 
domain of the winged helix domain (WHD) family. The WHD domain, which 
allows the direct interaction between Orc1/Cdc6 with the replicative helicase, is 
the primary DNA-binding element of these proteins, recognising and binding 
specifically to the origin recognition box (ORB) elements present at the origins 
(below) (Dueber et al., 2007; Gaudier et al., 2007). However, it has been shown 
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that DNA interaction is achieved through relatively few base-specific contacts, 
suggesting that the binding of Orc1/Cdc6 proteins to ORBs may rely on sequence 
specificity as well as DNA structure (Dueber et al., 2007; Dueber et al., 2011; 
Gaudier et al., 2007). Surprisingly, these studies have also revealed that the 
AAA+ domain acts beyond its canonical activity as an ATPase and mediator of the 
further higher-ordered assembly of initiator factors to the origin: when in its 
ADP-bound form, the Orc1/Cdc6 AAA+ domain interacts directly with DNA via the 
ISM in an apparently sequence-independent fashion. This event was shown to 
cause a bend in the DNA and, together with the WHD domain, to be able to 
significantly deform and unwind the DNA target (Dueber et al., 2007; Dueber et 
al., 2011; Gaudier et al., 2007). These observations reinforce the idea that 
origin recognition by archaeal Orc1/Cdc6 proteins is not solely dependent on 
specific sequence recognition, as observed in bacteria DnaA interaction with 
DnaA boxes in oriC, but is also influenced by the DNA shape and deformation. 
This may be analogous to origin binding by ORC in eukaryotes, where there is no 
evidence for sequence specific DNA binding in any organism other than 
Saccharomyces cerevisiae (see below), placing archaea Orc1/Cdc6 as a possible 
evolutionary link between the origin binders of bacteria and eukaryotes (Dueber 
et al., 2011).  
1.3.1.4 The Eukaryotic machine: the Origin Recognition Complex 
In eukaryotes, it has been assumed that a six-subunit complex, named the origin 
recognition complex (ORC), first identified in the budding yeast Saccharomyces 
cerevisiae (Bell and Stillman, 1992), acts universally as the replication initiator 
factor (reviewed in Duncker et al., 2009; Costa et al., 2013). This is mainly 
because most of the present knowledge of eukaryotic DNA replication has been 
obtained from studies in model organism such as S. cerevisiae, 
Schizosaccharomyces pombe, Drosophila melanogaster, Xenopus laevis, mouse 
and human, all members of the Opisthokonta supergroup (Figure 1.1) (Costa et 
al., 2013). Recently, however, the fast growing availability of sequenced 
genomes from organisms across the six eukaryotic supergroups (Figure 1.1) has 
allowed a more representative analysis of the diversity of the eukaryotic 
replication machineries (Aves et al., 2012; Tiengwe et al., 2012b). Analysis of 36 
genomes has revealed that although the six subunits of ORC (Orc1 to Orc6) were 
found across the six eukaryotic supergroups, there was not a single ORC subunit 
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that was present in every single eukaryote species analysed (Aves et al., 2012). 
More surprisingly, two of these (Orc3 and Orc6), were not found in all the 
eukaryotic supergroups (Aves et al., 2012). This suggests that there may be 
variability in the composition of ORC between eukaryotes, or at least greater 
sequence flexibility that previously appreciated in the six-subunit complex 
constituted of Orc1 to Orc6 (see below). Nevertheless, because available studies 
focus almost exclusively on organisms possessing the conserved six-subunit ORC, 
this is described here in detail. 
Five of the ORC subunits, Orc1 to Orc5, appear to be structurally similar, each 
having a predicted AAA+ ATPase domain, as well as at least one WHD domain 
(Figure 1.10) (reviewed in Duncker et al., 2009; Costa et al., 2013). However, 
while the AAA+ ATPase domains in the Orc1, Orc4 and Orc5 subunits are usually 
conserved and closely related with the one found in the bacterial DnaA, Orc2 
and Orc3 appear to have highly divergent AAA+ folds, possessing non-canonical 
Walker A and Walker B motifs (Figure 1.10, insert box) that are somewhat 
conserved between the Orc2 and Orc3 subunits of the various species that have 
been analysed (Speck et al., 2005; Clarey et al., 2006). An insertion has recently 
been identified in Orc3 (Figure 1.10, only shown in the D. melanogaster 
diagram), between the protein’s AAA+ fold and WHD domain, and this was shown 
to interact with Orc6 within ORC (Bleichert et al., 2013). Orc1, the largest 
subunit of ORC, possesses an extra domain, absent from all the other Orc 
proteins, as well as from Cdc6 and the archaeal Orc1/Cdc6 proteins: the bromo-
adjacent homology (BAH) domain (reviewed in Li and Stillman, 2012). Though 
considered a universal feature of all eukaryotic Orc1 subunits (reviewed in Costa 
et al., 2013; Duncker et al., 2009), where it plays roles in gene silencing and 
potentially origin recognition (see below), it is now known that this domain is 
absent from Orc1-like proteins in kinetoplastids (reviewed in Tiengwe et al., 
2013), and thus it might not be as universal among eukaryotes as initially 
thought. Interestingly, Orc1 is more closely related in terms of sequence to the 
conserved replication factor cell division cycle 6, Cdc6, than to the other Orc 
proteins, and phylogenetic analysis suggests that the two genes may be 
paralogues that evolved from an ancestral archaeal-like Orc1/Cdc6 protein 
(Giraldo, 2003). Like Orc1, Orc4, and Orc5, Cdc6 has a predicted AAA+ ATPase 
domain as well as a WHD domain (Figure 1.10) (reviewed in Duncker et al., 
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2009), and plays an important role in the initiation process of DNA replication 
(see below). In contrast, Orc6, the least conserved of the Orc proteins in both 
sequence and function (Chesnokov et al., 2003; Prasanth et al., 2002; Semple et 
al., 2006; Balasov et al., 2007; Chen and Bell, 2011; Liu et al., 2011; Takara and 
Bell, 2011) does not possess any of these domains, nor shows any evidence of a 
common evolution with Orc1-5 (reviewed in Duncker et al., 2009). Despite this 
divergence, Orc6 is central to DNA replication and ORC function (see below). 
 
Figure 1.10. ORC subunits.  
Top left, schematic representation of Orc1-Orc5 and Cdc6 subunits of S. cerevisiae. Below, 
diagrams representing the domains present in the Orc1-Orc6 subunits of D. melanogaster. Next, 
Orc4 subunit of S. pombe, highlighting the 9 AT-hook motifs at its N-terminus. Below, a schematic 
representation of S. cerevisiae Orc6 is shown. Within the insert dashed line box, the sequence 
conservation within the Walker A and Walker B motifs from various species (S. cerevisiae, S. 
pombe, Homo sapiens, Mus musculus, D. melanogaster, and X. laevis) are shown as a sequence 
logo format (Speck et al., 2005). Note that Orc1, Orc4, and Orc5 sequences coincide with the 
canonical sequences of these motifs, while Orc2 and Orc3 show highly divergent motifs, though 
these differences are conserved between the Orc2 and Orc3 sequences analysed (Speck et al., 
2005). S. cerevisiae Orc1 to Orc5, and Cdc6 diagram reproduced from (Duncker et al., 2009), with 
permission, © Duncker et al., 2009 BioMed Central Ltd. Sequence conservation diagram 
reproduced from (Speck et al., 2005) with permission (license number 3592720894270). D. 
melanogaster Orc1 to Orc6 schematics, reproduced from (Bleichert et al., 2015), with permission 
(license number 3592670461587). S. pombe Orc4 diagram reproduced from (Chuang and Kelly, 
1999), with permission, © by the National Academy of Sciences. S. cerevisiae Orc6 schematics 
reproduced from (Chen and Bell, 2011), with permission, © Chen and Bell, 2011 by Cold Spring 
Harbor Laboratory Press.  
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The most well characterised ORCs are those from S. cerevisiae, S. pombe, D. 
melanogaster and human, in which all are composed of the canonical six Orc 
subunits (reviewed in Li and Stillman, 2012), with the Orc proteins of S. 
cerevisiae being usually used to portrait the general structure of the eukaryotic 
Orc proteins, as shown in Figure 1.10 (reviewed in Duncker et al., 2009). 
However, there is some diversity in function, regulation and even protein 
domains between the homologues of these species (reviewed in Li and Stillman, 
2012). For instance, the S. pombe Orc4 subunit is unique among the Orc4 
subunits studied so far: it has an N-terminal extension harbouring nine AT-hook 
motifs (Figure 1.10), which are responsible for the binding of ORC to the DNA 
(Chuang and Kelly, 1999; Lee et al., 2001; Gaczynska et al., 2004). The human 
and D. melanogaster Orc6 subunits are structurally related with the transcription 
factor TFIIB, possessing a TFIIB-like domain (containing a conserved helix-turn-
helix motif) at their N-terminal regions (Figure 1.10), potentially acting as a 
DNA-binding domain (Liu et al., 2011; Balasov et al., 2007; Chesnokov et al., 
2003), while its C-terminal domain (CTD) is responsible for interactions with 
other factors, e.g. Orc3 (Bleichert et al., 2013) and Pnut (Chesnokov et al., 
2003) in D. melanogaster. In turn, though S. cerevisiae Orc6 also appears to have 
TFIIB-like domains (Bleichert et al., 2013), it does not bind to DNA, but 
possesses two Cdt1 (helicase loader, see below) binding domains, and a C-
terminal region that mediates its association with the other ORC subunits (Figure 
1.10) (Chen and Bell, 2011; Takara and Bell, 2011). 
Recently, the crystal structure of D. melanogaster ORC has been solved 
(Bleichert et al., 2015), showing that the Orc proteins organise within ORC as 
follows: Orc1-Orc4-Orc5-Orc3-Orc2 (Figure 1.11, B), with Orc6 bound by its C-
terminus to the insertion domain of Orc3 (Bleichert et al., 2015; Bleichert et al., 
2013). In human cells Orc6 has also been shown to interact with ORC via Orc3 
(Siddiqui and Stillman, 2007), while in budding yeast it is thought that Orc6 
interacts with both Orc3 and Orc2 (Bleichert et al., 2013; Sun et al., 2012). This 
new structural model reorganises Orc2 and Orc3 within the complex, which was 
previously predicted, by electron microscopy-based techniques, to be Orc1-Orc4-
Orc5-Orc2-Orc3 in D. melanogaster (Bleichert et al., 2013) as well as in S. 
cerevisiae (Sun et al., 2012), which had suggested a structural similarity 
between yeast and metazoan ORC complexes (Figure 1.11, A). In the latest 
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model (Figure 1.11, B), the AAA+ ATPase and the WHD domains co-associate, 
with the WHD domain of one subunit being packed against the AAA+ ATPase 
domain of its adjoining partner within the ORC body (the Orc1 WHD is packed 
into Orc4 AAA+ domain; Orc4 WHD is packed into Orc5 AAA+ domain; Orc5 WHD 
into Orc3 AAA+ domain; and Orc3 WHD packed into Orc2 AAA+ domain), forming 
a ‘collar’ of WHD domains that is rotationally offset from the AAA+ ATPase 
domains, containing a central channel (Figure 1.11, C) (Bleichert et al., 2015). It 
has been suggested that this WHD collar of the Orc1-5 proteins interacts with 
the replicative helicase once this is loaded onto the origin (Figure 1.11, C) 
(Bleichert et al., 2015), in contrast with the observations made in S. cerevisiae 
where the AAA+ ATPase domains of the Orc proteins latch onto the C-terminal 
AAA+ motor domains of the MCM2-7 helicase (Sun et al., 2013). Though Orc1, 
Orc4 and Orc5 are known to bind to ATP in various organisms, Orc1 is the main 
source of ATPase activity of the complex, and requires the conserved arginine 
finger of Orc4, which is inserted into Orc1 ATP-binding cleft within its AAA+ 
ATPase domain, for its catalytic activity (Randell et al., 2006; Bowers et al., 
2004; Siddiqui and Stillman, 2007; Klemm et al., 1997; Chesnokov et al., 2001). 
Similar to what has been reported in yeast (Sun et al., 2012), the D. 
melanogaster ORC structure shows that the arginine finger of Orc4 and the ATP-
binding site of Orc1 are too far away from each other to allow co-operative ATP-
hydrolysis, suggesting that ORC must undergo conformational changes in order to 
bring these two regions together and consequently allow Orc1 ATPase activity 
(Sun et al., 2012; Bleichert et al., 2015). Indeed, the latest model (Figure 1.11, 
C) (Bleichert et al., 2015) suggests that ORC is first assembled as an auto-
inactive/inhibited ATP-bound form that is limited in its capabilities to bind DNA 
within its central channel or to bind Cdc6 to its ring. Upon activation (possibly 
through the recognition of origin DNA by Orc6, via its TFIIB-like domains), it is 
proposed that ORC undergoes conformational changes, including the block 
movement of the Orc1 AAA+ ATPase domain. This would allow interaction of 
Orc1 with the Orc4 arginine finger and unlatching of the Orc2 WHD domain, 
opening a gap in the Orc1-5 ring, and consequent loading of ORC onto the DNA. 
Cdc6 would then dock between Orc1 and Orc2, closing the gap and trapping the 
origin DNA within the complex central channel (Bleichert et al., 2015). It has 
been shown that ORC binding to origin DNA is enhanced by the binding of Cdc6 
to Orc1: Cdc6 induces conformational changes on ORC, and its ATPase activity 
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stabilises the further interaction of ORC specifically with origin DNA, allowing 
only initiation of replication from these sites (Speck and Stillman, 2007).  
 
Figure 1.11. ORC models.  
A) Comparison of the ORC structures of S. cerevisiae (top) (data originally from Speck et al., 2005) 
and D. melanogaster (bottom) (Bleichert et al., 2013) obtained by electron microscopy techniques. 
Next are shown the models of the different Orc subunits distribution within the ORC complex. Note 
that the most recent model has shown that, at least in D. melanogaster (Bleichert et al., 2015), 
Orc2 and Orc3 are swapped. B) Crystal structure of D. melanogaster ORC, outlined by the electron 
microscopy image shown in A). C) Model proposed in (Bleichert et al., 2015) for the ORC complex 
loading in D. melanogaster: a) ORC, in its auto-inhibited form, is recruited to the origin DNA, which 
is potentially recognised by Orc6’s TFIIB-like domains; b) ORC is activated, changing its 
conformation; this repositions Orc2’s WHD domain, exposing a gap in the ORC ring; c) the open 
ring encloses the origin DNA; d) Cdc6 is recruited to the origin where it binds ORC between Orc1 
and Orc2, trapping the origin DNA within the complex; e) Cdt1-bound to the replicative helicase 
MCM2-7 is recruited and loads the helicase onto the origin DNA, using the exposed WHD of the 
ORC subunits. A) Reproduced from (Bleichert et al., 2013), with permission, © 2013, Bleichert et 
al. B) and C) Reproduced from (Bleichert et al., 2015), with permission (license number 
3593200048352). 
 
1.3.1.5 The replicative helicases 
In the three domains of life, the replicative helicase is a six-subunit ring-shaped 
complex with a central channel through which it unwinds the parental duplex 
DNA during replication and upon which the replication fork machineries are 
assembled. The replicative helicase is the first component of the replication fork 
to be recruited to initiator-bound origins of replication, and its recruitment as 
A) 
B) 
C) 
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an inactive complex and eventual activation are two of the most tightly 
regulated events in DNA replication.  
In bacteria, the best-studied replicative helicase is the homohexameric DnaB 
from E. coli, and all other bacteria examined so far possess DnaB-like 
orthologues (reviewed in Li and Araki, 2013; Kaguni, 2011). DnaB monomers have 
an N-terminal region containing a primase-binding domain, a linker region, and a 
C-terminal RecA-like ATPase domain (Leipe et al., 2000), enclosing Walker A and 
Walker B motifs, as well as an arginine finger, which is responsible for ATP 
binding and association of DnaB with the helicase loader DnaC (see below) 
(reviewed in Li and Araki, 2013; Kaguni, 2011). The DnaB helicase consists of a 
ring shaped structure of six DnaB subunits (Bailey et al., 2007; Wang et al., 
2008; Lo et al., 2009), oriented in the same direction and aligned side-by-side, 
through which the single-stranded DNA (ssDNA) passes (Jezewska et al., 1998; 
Kaplan and O'Donnell, 2002; Gupta et al., 2010). Unlike the archaeal and 
eukaryotic replicative helicases, the DnaB helicase travels in the 5’-to-3’ 
direction, with the C-terminal regions of each subunit oriented toward the 
duplex side of the fork, meaning that it unwinds the DNA by translocating along 
the parental DNA lagging-strand (reviewed in Li and Araki, 2013; Kaguni, 2011).  
In archaea, the homohexameric minichromosome maintenance complex (MCM) 
acts as the replicative helicase (reviewed in Kelman and Kelman, 2014). Like the 
initiator factors, the archaeal MCM proteins are also AAA+ ATPases, but together 
with the eukaryotic helicase, MCM2-7 (below), are classified into the Helix-2 
insert clade, NtrC/MCM group (Iyer et al., 2004; Erzberger and Berger, 2006). 
The similarities between the archaeal and eukaryotic MCM subunits suggest that 
these have most likely evolved from a common ancestor, though eukaryotes have 
evolved greater complexity, with six distinct MCM subunits (MCM2-7) compared 
with a single archaeal MCM subunit making up the homohexameric MCM complex 
(reviewed in Slaymaker and Chen, 2012). All archaeal species studied to date 
encode for at least one member of the MCM family, but certain archaeal groups, 
such as the Methanococcales, contain 2 to 8 MCM genes (Walters and Chong, 
2010), though only one of these appears to be essential and to encode the MCM 
helicase subunit that acts on DNA replication (Pan et al., 2011; Ishino et al., 
2011; Raymann et al., 2014). MCM proteins have a N-terminus domain (NTD) 
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connected to a C-terminus domain (CTD) by an N-C linker (reviewed in 
Slaymaker and Chen, 2012; Barry and Bell, 2006; Kelman and Kelman, 2014). The 
NTD is poorly conserved between MCM proteins in terms of primary sequence, 
but appears to be structurally and functionally conserved (Fletcher et al., 2003), 
and plays a role in higher-order structure assembly (reviewed in Slaymaker and 
Chen, 2012; Bell and Botchan, 2013). The NTD domain is divided into three 
subdomains: A, which plays a role in regulating the MCM complex (Miller et al., 
2014); subdomain B contains a zinc-binding domain, and is involved in DNA 
binding and in the helicase activity of the MCM complex; and subdomain C that is 
connected to the AAA+ domain via the N-C linker (reviewed in Slaymaker and 
Chen, 2012; Bell and Botchan, 2013; Barry and Bell, 2006; Costa and Onesti, 
2009). The CTD, also known as the motor domain, as it is responsible for the 
chemo-mechanical motion of the MCM complex, encompasses the AAA+ ATPase 
domain and a small subdomain containing a predicted degenerate WHD fold. The 
AAA+ ATPase domain harbours conserved Walker A (though with minor variations 
from the canonical sequence, 1.3.1.1) (Iyer et al., 2004) and Walker B motifs, an 
arginine finger, as well as sensor 1 and 2 motifs (reviewed in Slaymaker and 
Chen, 2012; Costa and Onesti, 2009). The arginine finger appears to be crucial, 
as its mutation results in the MCM complex being unable to unwind DNA and 
hydrolyse ATP (Moreau et al., 2007). In addition, the AAA+ domain harbours 
DNA-interacting β-hairpin motifs (reviewed in Bell and Botchan, 2013; Costa and 
Onesti, 2009; Slaymaker and Chen, 2012), including the H2I motif that places the 
MCM proteins into the Helix-2 insert clade of AAA+ proteins (Iyer et al., 2004). As 
a complex, the six MCM subunits are organised into a two-tiered ring-shaped 
structure, with a positively charged central channel wide enough to 
accommodate either ssDNA or dsDNA. One tier of the structure is made up of the 
NTDs of the subunits, and the other tier by the AAA+ ATPase domains (reviewed 
in Costa and Onesti, 2009; Costa et al., 2006). The MCM helicase uses the energy 
from ATP hydrolysis to translocate over the DNA in the 3’-to-’5 direction 
(McGeoch et al., 2005; Rothenberg et al., 2007; Graham et al., 2011), and thus 
translocates along the parental DNA leading strand, displacing the other, and 
therefore melting the DNA (there are four models on MCM unwinding of the DNA, 
but they are not discussed here) (reviewed in Bochman and Schwacha, 2009; 
Slaymaker and Chen, 2012). Presently it is thought that the AAA+ ATPase 
domains of the six MCM subunits face the DNA duplex junction, with the NTDs 
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trailing behind (McGeoch et al., 2005). Most of the archaeal MCM complexes 
appear to exist as single hexamers, though it has been shown that they can exist 
as head-to-head double-hexamers (like MCM2-7, see below), or even as 
heptamers and filaments (reviewed in Kelman and Kelman, 2014; Bell and 
Botchan, 2013; Slaymaker and Chen, 2012).  
In contrast with the bacterial and archaeal systems, the core of the eukaryotic 
replicative helicase is a heterohexameric complex (MCM2-7) composed of six 
distinct, though evolutionarily related, MCM subunits: MCM2, MCM3, MCM4, 
MCM5, MCM6 and MCM7 (reviewed in Bochman and Schwacha, 2009; Bell and 
Botchan, 2013; Costa et al., 2013). Analysis of genomes across the six subgroups 
of the eukaryotic tree (Figure 1.1) showed that all the six MCM subunits are 
present in every analysed species, which is consistent with MCM2-7 indispensable 
role as the eukaryotic replicative helicase (Aves et al., 2012). In terms of protein 
domains, the eukaryotic MCM2-7 subunits have the basic domain structure as the 
archaeal MCM counterparts, with conserved AAA+ ATPase domains, but subunit-
characteristic N- or C-terminal extensions that are important for the regulation 
and recruitment of MCM2-7 in eukaryotes (reviewed in Bochman and Schwacha, 
2009; Bell and Botchan, 2013), allowing the readily identification of homologues 
in all eukaryotic species studied to date (Aves et al., 2012). Studies suggest that 
the MCM2-7 subunits interact in a defined conformation – MCM5-MCM3-MCM7-
MCM4-MCM6-MCM2 (Figure 1.12, A) (Davey et al., 2003; Bochman et al., 2008) – 
either to form a closed or a gapped ring structure (opened between MCM5 and 
MCM2), with a positively charged central channel (Costa et al., 2011; Costa et 
al., 2014). As in archaea, the MCM2-7 complex is a two-tier structure, 
corresponding to the subunits NTDs and the AAA+ ATPase domains (Figure 1.12, 
B) (Costa et al., 2011). However, MCM2-7 is only the catalytic core of the larger 
complex that is the active eukaryotic replicative helicase, the CMG complex, 
which also contains the accessory activating/stimulatory proteins Cdc45 and the 
four members of the GINS complex (Sld5, Psf1, Psf2 and Psf3) (Moyer et al., 
2006; Ilves et al., 2010). Like other ATPases, the ATPase activity of one of the 
MCM2-7 subunits is dependent on the donation of the arginine finger of the 
adjacent subunit to its active site (reviewed in Vijayraghavan and Schwacha, 
2012). It is thought that Cdc45 and GINS binding to the gapped-ring conformation 
of MCM2-7 (Figure 1.12, C) (Costa et al., 2011) results in the latter undergoing 
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conformational changes that enable the combination of the ATP-binding sites 
and the arginine fingers of the different adjacent subunits to form the active 
sites, and thus allow ATP-hydrolysis (reviewed in Bell and Botchan, 2013; 
Vijayraghavan and Schwacha, 2012). Nevertheless, the MCM2-7 complex is first 
loaded onto ORC-bound origin dsDNA as an inactive head-to-head double-
hexamer (Evrin et al., 2013a; Sun et al., 2013; Evrin et al., 2009; Remus et al., 
2009) by the helicase loader Cdt1 (Takara and Bell, 2011), and only later does it 
interact with the remaining members of the CMG complex to initiate DNA 
replication (see below). Though it is initially bound to dsDNA, after activation by 
kinases (see below), the origin dsDNA is melted, and the two CMG complexes 
split apart in opposite directions (Yardimci et al., 2010), where each 
translocates along ssDNA in the 3’-to-5’ direction (meaning along the DNA 
template leading strand, with the AAA+ ATPase domains of the MCM2-7 subunits 
facing the DNA duplex) (Figure 1.12, D) as the replication fork progresses (Costa 
et al., 2014; Fu et al., 2011; Froelich et al., 2014), unwinding the DNA like the 
archaeal MCM helicase. 
 
Figure 1.12. The MCM2-7. helicase. 
A) Diagram showing the organisation of the MCM subunits within the MCM2-7 complex. Both 
closed (left) and gaped (right) ring conformations are represented. B) Schematic representation of 
A) 
B) 
C) 
D) 
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the MCM2-7 complex. Circles represent the NTD, while elipses represent the CTD of each subunit 
containing the AAA+ ATPase domain. Below, diagram representing the directionality of the MCM2-
7 complex movement along ssDNA, with the AAA+ ATPase domains facing the DNA helix, and the 
NTD domains trailing behind. C) CMG structure obtained by electron microscopy, view from the 
NTD domains of MCM2-7. Cdc45 binds to MCM2, while the GINS complex interacts with MCM5 
and MCM3. D) Model of the double-hexamers of MCM2-7 assembly onto dsDNA. The gaped ring 
conformation is assembled onto the dsDNA as an inactive double-hexamer (accessory proteins are 
not shown), where each MCM2-7 complex assumes the closed conformation. Upon binding of 
Cdc45 and the GINS complex, and activation by cell cycle kinases (not shown), the dsDNA melts, 
and the two CMG complexes split in opposite directions, unwiding the DNA in the bi-directional 
replication forks. A) reproduced from (Froelich et al., 2014), with permission, © 2013, Froelich et al, 
all rights reserved. B) reproduced from (Bell and Kaguni, 2013), with permission, © Bell and 
Kaguni, 2013 by Cold Spring Harbor Laboratory Press, all rights reserved. C) and D) reproduced 
from (Costa et al., 2014), © 2014 Costa et al., all rights reserved.  
 
1.3.1.6 Initiator factors: more than replication factors 
Besides playing essential roles in the initiation steps of DNA replication, several 
studies have suggested that initiator factors do not act exclusively on DNA 
replication, and can contribute to further cellular events, such as gene 
expression, cell cycle progression, chromosome segregation and cytokinesis 
(reviewed in Scholefield et al., 2011). Before considering the action of origin 
binding factors in replication initiation, this section addresses some of these 
further functions.  
In Bacteria, DnaA has been shown to be an important transcription regulator by 
binding to specific DnaA binding sites found upstream, or within, the promoter 
regions of numerous genes (Goranov et al., 2005). One of these genes is dnaA 
itself, where DnaA acts as a transcription repressor, auto-regulating its 
expression and thus initiation of replication (Braun et al., 1985; Ogura et al., 
2001). DnaA was also demonstrated to regulate, both by activation and 
repression, the nrdAB operon (Olliver et al., 2010) that encodes the 
ribonucleotide reductase (RNR) enzyme. RNR catalyses the final step in the 
deoxyribonucleotides (dNTPs) synthesis, and is thus necessary for DNA 
replication (reviewed in Nordlund and Reichard, 2006), demonstrating that DnaA 
is involved in the coordination between initiation of replication and nucleotide 
synthesis. Furthermore, DnaA appears to play a role in the coordination between 
DNA replication and cell division: DnaA was shown to repress ftsL gene 
transcription upon DNA replication disturbance (Goranov et al., 2005), 
effectively blocking cell division, a process dependent on FstL (reviewed in 
Errington et al., 2003).  
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In Eukaryotes, ORC subunits have been extensively associated with other 
functions besides DNA replication initiation (reviewed in Duncker et al., 2009; 
Sasaki and Gilbert, 2007; Scholefield et al., 2011). For example, in human cells 
Orc1 is involved in the control of centriole and centrosome copy number 
(Hemerly et al., 2009). Moreover, Orc1 has also been associated with gene 
silencing through the formation of heterochromatin in diverse organisms. In S. 
cerevisiae, Orc1 interacts with the silent chromatin protein Sir1, recruiting it to 
the transcriptionally silent mating type loci, HMR and HML, whose silencing is 
essential for proper haploid cell identity (Hou et al., 2005; Ozaydin and Rine, 
2010). Similarly, in D. melanogaster, Xenopous sp. and mammalian cells, Orc1 
interacts with heterochromatin protein 1 (HP1) to promote the spreading of 
heterochromatin (Pak et al., 1997; Auth et al., 2006). It has also been shown in 
mammals that a number of ORC subunits (most likely, ORC as a complex) form a 
complex with the telomere repeat binding factors TRF1 and TRF2 (as well as HP1 
and other factors), and bind telomeres via an RNA intermediate, TERRA, 
influencing heterochromatin formation and telomere capping by the shelterin 
complex (Deng et al., 2009; Flynn et al., 2011). Orc1 does not solely contribute 
to transcriptional silencing, however, since Arabidopsis thaliana Orc1 (perhaps 
uniquely amongst eukaryotes) possesses a homeodomain that binds histone H3 
trimethylated on lysine residue 4 (H3K4me3) at a number of genes, activating 
transcription (de la Paz Sanchez and Gutierrez, 2009). Orc6 has been shown to 
be important in human and D. melanogaster cytokinesis, where it appears to 
coordinate this process with DNA replication: Orc6 depletion by RNA 
interference (RNAi) leads to a reduction in DNA synthesis and an increase in 
multinucleated cells that have completed mitosis without cytokinesis (Prasanth 
et al., 2002). Studies showed that by the end of mitosis, Orc6 localises to the 
cytokinetic furrow, and directly interacts with the septin protein Pnut, a 
filament-forming GTPase essential for a successful cytokinesis (Huijbregts et al., 
2009). Other subunits of ORC, such as Orc5 or even the whole ORC complex, 
have also been associated with other cellular events, namely chromosome 
organisation and segregation (reviewed in Scholefield et al., 2011). 
 
Chapter 1  56 
 
1.3.2 Origins of Replication – where to start? 
DNA replication starts at specific genomic sites called origins of replication, and 
it is to these sites that the initiator factors bind to (reviewed in Leonard and 
Mechali, 2013). As discussed above, initiator factors are functionally conserved 
and possess both ATPase and DNA binding domains that are essential for 
recognition and binding to origins of replication. However, bacterial, archaeal 
and eukaryotic origins of replication are considerably different: while bacterial 
and archaeal origins are defined by specific DNA sequences, eukaryotic origins 
(with the exception of S. cerevisiae) are not, and therefore binding of ORC 
appears to be dependent on other, poorly defined factors, such as chromatin 
status and structure (reviewed in Leonard and Mechali, 2013; Masai et al., 2010; 
Mechali, 2010; Mott and Berger, 2007; Costa et al., 2013).  
1.3.2.1 The single origin in Bacteria 
In all studied bacteria, a single origin of replication, oriC, is present per 
chromosome (reviewed in Messer, 2002; Robinson and Bell, 2005; Mott and 
Berger, 2007), often adjacent to the dnaA gene (Mackiewicz et al., 2004). 
Typically, oriC comprises multiple, repetitive non-palindromic 9 bp sequences – 
the DnaA boxes, to which DnaA specifically binds. In addition, there is an AT-rich 
DNA-unwinding element (DUE) (Figure 1.13), whose melting is a key event in the 
initiation of replication, by facilitating the opening of the dsDNA (Mackiewicz et 
al., 2004). The oriC regions can vary considerably between bacteria: the oriC 
size can fluctuate from 200 bp up to 1,000 bp; the consensus sequence, number 
and arrangement of DnaA boxes, as well as of repeats present in the AT-rich 
region, may be quite different; and other DnaA binding sites (e.g. I-sites) may be 
present, as well as specific binding sites for other regulatory factors (reviewed in 
Zawilak-Pawlik et al., 2005; Leonard and Mechali, 2013; Costa et al., 2013; Mott 
and Berger, 2007; Messer, 2002). For example, the E. coli oriC is approximately 
250 bp and contains five DnaA boxes (Figure 1.13), while Mycobacterium 
tuberculosis and Streptomyces coelicolor have, respectively, 550 bp and 930 bp-
sized oriCs comprising 13 and 19 DnaA boxes, respectively, with completely 
different spatial arrangements (Zawilak-Pawlik et al., 2005). Interestingly, the 
differences in DnaA box numbers and distribution along the oriC have been 
demonstrated to be optimally adjusted to their equivalent DnaA proteins, with a 
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specific DnaA being only able to act on the cognate origin, thus suggesting that 
both the oriC and the initiator factor have evolved towards optimal interaction 
(Zawilak-Pawlik et al., 2005).  
 
Figure 1.13. Bacterial oriC.  
Schematic representation of the E. coli oriC. The main features such as the DUE, R boxes, I-sites, 
and ATP-DnaA boxes are shown, and are described in the main text. The τ-sites are not shown. 
Adapted from (Mott and Berger, 2007), with permission (license number 3594771446008). 
 
In more detail, E. coli oriC (Figure 1.13), which has been extensively studied as 
a model, contains five DnaA boxes (R1-R5) defined by the consensus sequence 
5’-TT(A/T)TNCACA-3’ (Schaper and Messer, 1995). Of these, R1, R2 and R4 show 
high affinity for both ATP- and ADP-DnaA forms (Schaper and Messer, 1995), 
while R3 and R5 show preferentially affinity to ATP-DnaA (Kawakami et al., 
2005; Keyamura et al., 2007). In addition, other weaker DnaA binding sites such 
as the three 9 bp I-sites and the τ-sites, interspersed between the DnaA-boxes 
(McGarry et al., 2004), and the six 6 bp ATP-DnaA boxes, localised within the 
AT-rich region (DUE) of oriC, are also preferably recognised by ATP-DnaA (Speck 
and Messer, 2001). Furthermore, E. coli oriC also contains recognition sites for 
initiation of replication regulatory proteins such as Fis (repressor) and IHF 
(stimulator), which upon binding change the origin DNA conformation, thus 
affecting DnaA binding (Ryan et al., 2004). 
1.3.2.2 A single or multiple origins in Archaea 
It is becoming apparent that DNA replication in archaeal organisms possesses a 
blend of attributes found in bacteria and eukaryotes, and the origins of 
replication are an example of this variability: although most archaeal circular 
genomes contain a single origin, several genera have now been shown to 
replicate their genome from multiple origins of replication (reviewed in Barry 
and Bell, 2006; Kelman and Kelman, 2014; Leonard and Mechali, 2013). For 
example, the first origin of replication in archaea was identified in Pyrococcus 
abyssi, and termed oriC (Myllykallio et al., 2000). Like in bacteria, P. abyssi 
possesses a single origin containing several repeated sequences (see below) and 
an AT-rich region, from where replication is initiated (Matsunaga et al., 2001) 
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and proceeds at a similar rate to that of bacteria (Myllykallio et al., 2000). 
Moreover, the origin is localised immediately upstream of P. abyssi's single 
orc1/cdc6 gene (Matsunaga et al., 2001), analogous to the co-localisation of the 
bacterial oriC and dnaA. This would suggest that DNA replication in archaea 
might be similar to the process in bacteria. However, this view was challenged 
by studies in Sulfolobus solfataricus and Sulfolobus acidocaldarius (Robinson et 
al., 2004; Lundgren et al., 2004), where three origins of replication, named 
oriC1, oriC2, and oriC3, where identified in their single circular chromosomes. In 
these archaeal species, three orc1/cdc6 genes are found, cdc6-1, cdc6-2, and 
cdc6-3 (She et al., 2001). Like in P. abyssi, in these Sulfolobus species two of 
the origins are located immediately adjacent to a cdc6 gene, although the third 
origin was not associated with a cdc6 gene, and the cdc6-2 gene does not co-
localise with any origin (Robinson et al., 2004; Lundgren et al., 2004). In 
addition, it was shown that the replication rate in these Sulfolobus species is 
more similar to rates described in eukaryotic organisms, and slower than that of 
E. coli (Lundgren et al., 2004). Other archaea were also found to possess 
multiple origins, such as Aeropyrum pernix, which has two (Robinson and Bell, 
2007), and Haloferax volcanii, which has three to five (Norais et al., 2007; 
Hawkins et al., 2013). It has been proposed that the development of origin 
multiplicity in archaea might have occurred via the acquisition of 
extrachromosomal elements, by horizontal gene transfer (Robinson and Bell, 
2007). 
 
Figure 1.14. Archaeal origins of replication.  
Schematic representation of the origin of replication of P. furiosus and one of the origins of A. 
pernix. The DUE, ORBs and mini-ORBs (mORB) are shown. Reproduced from (Leonard and 
Mechali, 2013), with adaptations, © Leonard and Mechali, 2013 by Cold Spring Harbor Laboratory 
Press, all rights reserved. 
 
Generically, archaeal origins localise to intergenic regions (frequently near 
genes of proteins involved in DNA replication, in most cases upstream of a 
orc1/cdc6 gene). They are composed of one or more AT-rich sections acting as 
DUEs, flanked by a variable number (species-specific) of inverted repeated 
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motifs, named origin recognition box (ORB) elements, which are specifically 
recognised by the Orc1/Cdc6 proteins and are essential for DNA replication 
initiation (Figure 1.14) (Myllykallio et al., 2000; Robinson et al., 2004; Berquist 
and DasSarma, 2003; Grainge et al., 2006). Additional sites have also been found 
in Sulfolobus spp. origins: mini-ORBs (motifs that correspond only to the minimal 
ORB sequence and are recognised with lower affinity by the Cdc6-1 factor), and 
C2 and C3 sites (whose sequence is distinct from that of the ORB elements, and 
are binding sites for the Cdc6-2 and Cdc6-3 factors) (Robinson et al., 2004). 
Overall, the presence of specific sequences that are recognised by Orc1/Cdc6 
proteins, as well as of a DUE, resemble the origins of replication in bacteria, 
while origin multiplicity in several archaeal genera resemble the eukaryotic 
systems (see below). 
1.3.2.3 The amazing repertoire and plasticity of Eukaryotic origins 
In contrast with bacteria and archaea, DNA replication of the eukaryotic large 
linear chromosomes is initiated from hundreds, and even thousands, of potential 
origins that, so far, were rarely shown to possess any characteristic sequence 
elements (reviewed in Leonard and Mechali, 2013; Mechali, 2010; Masai et al., 
2010). Origins in S. cerevisiae and its close yeast relatives are rare exceptions 
among eukaryotes: S. cerevisiae origins contain specific sequence elements, 
named autonomous replication sequences (ARS). These contain a specific 11 bp 
consensus sequence (5’-[A/T]TTTA[T/C][A/G]TTT[A/T]-3’) known as the 
autonomous consensus sequence (ACS), to which ORC specifically binds (Bell and 
Stillman, 1992), besides other elements close to the ACS that contribute to its 
activity (reviewed in Leonard and Mechali, 2013). In contrast, in all other 
eukaryotes studied so far, no consensus sequence elements have been identified 
that define origins or ORC-binding sites, and the rules that drive specification of 
initiation sites, as well as the determinants of origin activation timing, are still 
poorly understood (reviewed in Leonard and Mechali, 2013; Mechali, 2010; Masai 
et al., 2010; Rhind and Gilbert, 2013). Indeed, though it is clear that ORC 
binding is needed to designate a sequence as a potential origin, it is insufficient 
to ensure its activation: only a subset of the ORC binding sites, and thus 
potential origins, is used per cell cycle to replicate the whole genome. It 
appears that at the beginning of S phase potential origins are present in large 
excess, organised in groups that define replicons. Within such groups about one 
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in five origins is activated per cell cycle in an apparently stochastic manner 
(Cayrou et al., 2011), providing origin flexibility within each replicon (reviewed 
in McIntosh and Blow, 2012) and thus adaptation to possible perturbations of the 
normal cell cycle (see below). Another characteristic of eukaryote replication is 
that the genome is replicated in a defined temporal sequence, as origins are 
activated asynchronously during S phase, with some being fired early in S phase 
and others later (Figure 1.15, A), following a replication timing programme 
(reviewed in Rhind and Gilbert, 2013) that appears to be specific to different 
cell types (Ryba et al., 2010). Finally, origin activation follows a tightly 
regulated temporal plan (reviewed in Jackson et al., 2012), stretching from ORC 
binding during the G1 phase, to replication initiation in S phase (see below). 
Overall, many factors appear to contribute to this complex picture, including 
chromatin structure and status, transcriptional activity, and epigenetic factors 
such as histone acetylation (Figure 1.15, C) (reviewed in Aladjem, 2007; Masai et 
al., 2010; Mechali, 2010; Leonard and Mechali, 2013). 
 
Figure 1.15. Eukaryotic origins of replication.  
A) Origins of replication in eukaryotes are activated at different times during S phase. Though all 
four origins are recognised by the ORC complex, and the pre-replication complex (pre-RC) is 
established, the origins are activated at different times, with origins 1 and 2 being early firing, while 
3 and 4 are late firing origins. The activation of the four origins allows the complete replication of 
the shown genome segment. B) Only a subset of origins are activated per cell cycle. Though six 
potential origins are shown (bound by the pre-RC), only some are activated (green rectangles). The 
different types of origins are depicted: constitutive origins, flexible origins, and dormant/inactive 
origins. Detailed description in the main text. C) Simplified representation of the different features 
thought to have a role in defining a DNA region as an origin: sequence features; chromatin 
structure cues; chromatin status environment; active transcription elements. Description in the main 
text. All reproduced from (Mechali, 2010), with permission (license number 3595050459007).  
A) B) 
C) 
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DNA replication in eukaryotes presents a high level of plasticity in which origin 
selection and timing allows the cell to respond to internal and external factors 
in order to maintain genomic stability. This is possible because not all the 
potential origins are activated in each cell cycle, or simultaneously. Therefore, 
depending on their usage, origins of replication can be classified as follows 
(Figure 1.15, B): constitutive origins, which are consistently used in every cell 
cycle; flexible origins, which can be used stochastically in different cell cycles; 
and dormant or inactive origins, which are barely used in normal growth 
conditions, but can be activated during cell stress conditions, such as replication 
fork blockage and stalling, or specific development programmes (reviewed in 
McIntosh and Blow, 2012; Masai et al., 2010; Mechali, 2010). In normal growth 
conditions, replication forks formed from nearby activated origins passively 
replicate the origins that have not been activated in that cell cycle (Woodward 
et al., 2006; Ge et al., 2007).  
Although no origin or ORC-binding specific sequences have been found, some 
features appear to be present at eukaryotic origins (Figure 1.15, C). For 
instance, in S. pombe and D. melanogaster, origins localise in intergenic regions 
and appear to possess characteristic AT-rich islands to where ORC binds 
(Segurado et al., 2003; MacAlpine et al., 2004; Chuang and Kelly, 1999). 
Interestingly, studies in S. pombe revealed that the origin AT-rich regions are 
over-represented between divergent transcription units (Segurado et al., 2003), 
while in D. melanogaster two-thirds of ORC-binding sites are present in promoter 
regions, and some overlap with a subset of RNA polymerase II-binding sites 
(MacAlpine et al., 2010; MacAlpine et al., 2004). Studies in mouse (Delgado et 
al., 1998; Sequeira-Mendes et al., 2009) and human cells (Delgado et al., 1998; 
Cadoret et al., 2008) have also reported origins to localise within or near CpG 
islands, GC-rich unmethylated regions (where G and C are bound by a 
phosphodiester (p) bond) that enclose promoters of many mammalian genes 
(Larsen et al., 1992). Indeed, studies have shown that origins present in or near 
CpG islands replicate more efficiently than origins situated in GC-poor regions 
(Sequeira-Mendes et al., 2009; Watanabe et al., 2002). Together, these 
observations suggest a link between DNA replication initiation and gene 
transcription. However, this relationship is frequently contradictory, and 
perhaps more complex than initially thought (reviewed in Helmrich et al., 2013): 
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in some cases transcription appears to enhance origin activation, while in others 
seems to inhibit it, or even do not show correlation at all, like in S. cerevisiae 
(Raghuraman et al., 2001; Saha et al., 2004; Norio et al., 2005). Whether the 
effect of transcription on replication involves protein-protein interaction 
between transcription and replication factors remains elusive, and some studies 
suggest that transcription induces alterations in the DNA topology and chromatin 
status, which may allow replication machinery access to the origin and further 
activation (reviewed in Aladjem, 2007; Masai et al., 2010; Mechali, 2010; 
Leonard and Mechali, 2013; Sequeira-Mendes and Gomez, 2012). For instance, in 
D. melanogaster the topology of the DNA appears to influence ORC binding, as it 
shows a higher affinity for negatively supercoiled DNA (Remus et al., 2004), 
known to be induced by transcription (Dayn et al., 1992). 
Potential origin localisation and activation appears to be greatly influenced by 
chromatin structure and status. For example, in S. cerevisiae, origins are 
localised in intergenic regions that have an open, nucleosome-free chromatin 
structure (Yuan et al., 2005) and, when nucleosomes are forcedly positioned 
over the ACS, origin function can be inhibited (Simpson, 1990). Histone post-
translational modifications, such as acetylation, have also been associated with 
replication origins, influencing the timing of activation (reviewed in Masai et al., 
2010). It has also been reported that acetylation of histones H3 and H4 enhances 
origin activation (Unnikrishnan et al., 2010), while Sir2, a histone deacetylase, 
was shown to inhibit origin activation from five different origins (Crampton et 
al., 2008). Similarly, in human cells the histone acetyltransferase HBO1 was 
shown to be essential for the loading of the replicative helicase to the chromatin 
(Iizuka et al., 2006; Miotto and Struhl, 2010). Interestingly, it has also been 
suggested that nuclear positioning of origins during G1 phase may play a crucial 
role in the determination of the replication timing (Jackson et al., 2012; 
Aladjem, 2007; Mechali, 2010). In S. cerevisiae cells, for instance, origins that 
are activated late in S phase localise preferentially at the nuclear periphery, 
while the ones that are activated early localise randomly (Heun et al., 2001). 
Ultimately, eukaryotic origins appear, unlike origins in bacteria and archaea, not 
to be clearly defined by sequence elements, but instead to depend on the 
combination of a variety of less defined features for ORC binding and activation. 
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1.3.3 Initiation of DNA replication – helicase loading and origin 
melting 
Chromosomal DNA replication must occur strictly once per cell cycle; otherwise, 
under- or over-replication of genomic DNA will result in genomic instability 
(reviewed in Abbas et al., 2013), with deleterious effects to the cell. Therefore, 
DNA replication is a tightly regulated process (reviewed in Siddiqui et al., 2013; 
Masai et al., 2010; Mott and Berger, 2007), mainly due to the activation and 
inactivation of the initiator factors and assembly of the pre-replication 
complexes (pre-RCs). It must also be coordinated with other major cell cycle 
events in order to ensure complete replication of the genome. As depicted in 
Figure 1.7, initiation of DNA replication generally refers to the steps from origin 
recognition to helicase activation. These steps are summarised in the next few 
sections for the three domains of life.  
1.3.3.1 Initiation of DNA replication in Bacteria 
Throughout the cell cycle, DnaA is bound to the high affinity R1, R2 and R4 DnaA 
boxes at oriC, and only binds to the remaining DnaA boxes, I-sites and ATP-DnaA 
boxes within the DUE, immediately before the initiation of DNA replication 
(Cassler et al., 1995; Speck et al., 1999), when the ATP-DnaA levels increase 
abruptly, after remaining low for most part of the cell cycle (Kurokawa et al., 
1999). Regulation of initiation of replication in bacteria is rather complex, 
involving multiple intricate mechanisms, from regulation of dnaA gene 
expression, proteins that regulate DnaA activity, oriC sequestration by SeqA, 
methylation of oriC DNA, as well as active transcription at oriC (not further 
explored here, but recently extensively reviewed in Skarstad and Katayama, 
2013). The cooperative assembly of the DnaA molecules to oriC leads to the 
formation of a large nucleoprotein initiation complex (a helical oligomer capable 
of ATP-hydrolysis as DnaA molecules donate their arginine fingers to the active 
site of adjacent DnaA subunits) (Mott et al., 2008; Duderstadt et al., 2010) that 
promotes the melting of the AT-rich DUE region by destabilizing it (Figure 1.16), 
generating an open strand-separated complex that is stabilised by the additional 
binding of ATP-DnaA to the ATP-DnaA boxes therein present (Speck et al., 1999). 
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After DNA melting, two DnaB hexamers are recruited to the ssDNA in the opened 
region of oriC (Figure 1.16) to allow the formation of bidirectional replication 
forks (reviewed in Bell and Kaguni, 2013; Robinson and Bell, 2005; Costa et al., 
2013). Although DnaA interacts physically with DnaB (Seitz et al., 2000), helicase 
loading requires the action of DnaC, the helicase loader that, alongside DnaA, 
belongs to the DnaA/CDC6/ORC clade of the AAA+ superfamily of ATPases (Iyer 
et al., 2004). Briefly, ATP-DnaC inhibits DnaB helicase activity (Mott et al., 
2008; Davey et al., 2002a) and has a high affinity for ssDNA, playing an 
important role in the loading of DnaB to the melted AT-rich DUE and subsequent 
expansion of the ssDNA region at the oriC. Afterwards, both DnaB and ssDNA 
presence lead to ATP hydrolysis by DnaC, that in the ADP-DnaC form releases 
DnaB, relieving the inhibition from the helicase (Davey et al., 2002a; Makowska-
Grzyska and Kaguni, 2010). Next, other replication-fork factors, such as the 
DnaG primase and the DNA polymerase III holoenzyme, are placed on the ssDNA 
region, starting the bidirectional polymerization of the DNA around the circular 
genome of E. coli (reviewed in Johnson and O'Donnell, 2005).  
 
Figure 1.16. Origin melting and helicase loading in bacteria.  
Schematic representation of oriC melting and helicase loading. Various DnaA molecules are 
loaded onto the oriC, leading to the melting of the DUE (left). DnaB is loaded onto the ssDNA at the 
melted DUE by DnaC (middle): in (1), DnaB is loaded onto the “bottom” strand where it interacts 
directly with DnaA; in (2), DnaB is loaded onto the “top” strand via interaction of DnaC with DnaA. 
DnaC is released, and the DnaB hexamers migrate to their positions in the DUE to allow the 
assembly of the replication forks (right). Below is represented the colour-coded legend; dashed 
lines highlight the interactions between the different factors domains. Reproduced from (Mott et al., 
2008), with permission (license number 3595340631956). 
 
1.3.3.2 Initiation of DNA replication in Archaea  
In archaea, the mechanisms underlying origin binding and helicase recruitment 
are still being established, and may differ between the various archaeal 
taxonomic groups, perhaps reflecting differences in the number of encoded 
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Orc1/Cdc6 factors and origins per chromosome. Studies in Pyrococcus furiosus 
have shown that Orc1/Cdc6 binds to the ORB and mini-ORB elements (Matsunaga 
et al., 2007), where it induces alterations in the topological structure of the DNA 
that leads to the melting of the AT-rich region of oriC, which is required for the 
further loading of the MCM helicase (Matsunaga et al., 2010). Furthermore, it 
was also shown that the recruitment of MCM is dependent on Orc1/Cdc6 (Akita 
et al., 2010), suggesting that in P. furiosus helicase loading might be 
independent from a loading factor, such as DnaC in bacteria, or Cdc6 and Cdt1 
(see below) in eukaryotes. Conversely, studies in multi-origin archaea have 
revealed a more complex process. For instance, in S. solfataricus, replication 
initiation appears to be extremely complex, with interplay between the three 
Orc1/Cdc6 proteins with the three origins, each having different and even 
overlapping binding sites (Robinson et al., 2004; Lundgren et al., 2004; Dueber 
et al., 2007). Orc1/Cdc6 binding to overlapping ORB sites results in contacts 
between the ATPase domains of the two different initiator proteins, which is 
reminiscent of the multimeric interactions seen in eukaryotic ORC (Dueber et 
al., 2007). In addition, the binding causes DNA distortions, though whether this 
aids MCM loading is unclear. The overall process, however, appears to be simpler 
in A. pernix, where the AT-rich region is flanked by two pairs of ORBs, to each of 
which Orc1/Cdc6-1 binds (Gaudier et al., 2007). When the four sites have been 
bound by Orc1/Cdc6-1, a higher-order assembly of Orc1/Cdc6 is thought to occur 
at the origin and initiates unwinding of the DUE, allowing further MCM loading 
(Grainge et al., 2006).  
Despite the fact that there is evidence for direct Orc1/Cdc6-MCM interactions in 
some archaea, an interesting gene has been identified adjacent of one of the 
origins of both A. pernix and S. solfataricus. This gene encodes a protein with 
distant sequence homology to the eukaryotic helicase loader Cdt1. The product 
of this gene was name winged-helix initiator protein (WhiP), as it has two 
winged helix-turn-helix domains, like Ctd1 (Robinson and Bell, 2007). The 
presence of a putative helicase loader in these organisms may place them once 
again as potential evolutionary links between bacteria and eukaryotes. However, 
despite the intriguing location of its gene, and evidence that WhiP binds to 
origins (Robinson and Bell, 2007), functional evidence that it acts as a helicase 
loader is currently lacking (reviewed in Kelman and Kelman, 2014).  
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Archaeal MCM has also been shown to interact with a chromatin protein, Alba, 
which in its deacetylated form strongly inhibits MCM activity (Marsh et al., 
2006). Depending on its acetylation state, Alba is able to influence the degree of 
chromatin packaging (Wardleworth et al., 2002), an additional observation that 
may reinforce the idea that archaeal origin activation may be susceptible to 
other factors, such as chromatin structure, like in eukaryotes.  
Besides the clear homology with the eukaryotic Orc1 and Cdc6 subunits as well 
as with the MCM subunits of the helicase, homologues of other eukaryotic 
replication-associated factors have also been found in archaea, strengthening 
the idea that the archaeal replication machinery involved in the initial steps of 
DNA replication might be a simplified version of the eukaryotic one. These 
factors include orthologues of some subunits of the eukaryotic GINS complex and 
Cdc45, which in eukaryotes form the active replicative helicase together with 
MCM2-7 (see below) (reviewed in Kelman and Kelman, 2014). Reflecting the 
heterogeneity of the archaeal group, some species appear to possess a single 
orthologue of GINS, labelled GINS15 (or GINS51) due to its similarity with the 
Psf1 and Sld5 subunits of the eukaryotic GINS, while others also possess another 
orthologue, GINS23, which shows similarity with both Psf2 and Psf3 subunits of 
the eukaryotic complex (Raymann et al., 2014; Marinsek et al., 2006). 
Nevertheless, independently of the presence of one or two GINS homologues, in 
all cases studied to date, the archaeal GINS proteins form tetrameric complexes 
(either an homotetramer of GINS15, or a heterotetramer of 2:2 ratio of GINS15 
and GINS23) (Ogino et al., 2011; Marinsek et al., 2006), mimicking the 
tetrameric complex in eukaryotes. In addition, these GINS complexes have been 
shown to interact with the MCM helicase (Marinsek et al., 2006; MacNeill, 2011; 
Li et al., 2010) and the orthologue of the eukaryotic Cdc45 and the bacterial 
RecJ (the GINS associated nuclease – GAN) (Yuan et al., 2013; Krastanova et al., 
2012; Li et al., 2011b), among other replication-related factors (reviewed in 
Kelman and Kelman, 2014; MacNeill, 2010). To date, all analysed species of 
archaea appear to have a protein with some similarity to Cdc45 (Makarova et 
al., 2012). However, the role of the Cdc45-like factor is not clear, since gene 
deletion studies suggest it is not essential for archaeal DNA replication (reviewed 
in Kelman and Kelman, 2014).  
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1.3.3.3 Initiation of DNA replication in Eukaryotes and its regulation  
When compared to bacteria and archaea, initiation of DNA replication in 
eukaryotes is a much more complex process: not only are the molecular 
machineries involved more complex (sections 1.3.1.4 and 1.3.1.5), but there are 
hundreds to thousands of origins of replication per genome that are not defined 
by a specific sequence, and the number of players and overall regulation of the 
process is more intricate (Bell and Kaguni, 2013; McIntosh and Blow, 2012; 
Jackson et al., 2012; Rhind and Gilbert, 2013; Siddiqui et al., 2013; O'Donnell et 
al., 2013). Very simplistically, initiation of replication in eukaryotes is regulated 
at three levels: though all potential origins are recognised by ORC (“where”), 
only a subset of these is activated (“which”) in each individual cell per cell cycle 
during S phase (“when”) (reviewed in Masai et al., 2010). The main events in 
replication initiation in eukaryotes are the loading and then the activation of the 
MCM2-7 helicase. In order to guarantee that the genome is replicated once and 
only once per cell cycle, these two events are tightly regulated and are mutually 
exclusive, taking place in different stages of the cell cycle: helicase loading is 
restricted to G1 phase (referred to as pre-RC assembly and origin licensing), 
while helicase activation and subsequent replication fork assembly take place 
exclusively during the S phase. Helicase loading requires three factors: ORC, 
Cdc6 and the helicase loader Cdt1, and these are the steps described below. 
The first step is the recognition of all potential origins by ORC (with Orc1 bound 
to ATP) (Klemm et al., 1997), from late mitosis to the end of G1 phase (Figure 
1.17, A). In S. pombe, ORC binding to origins occurs in an ATP-independent 
fashion through its Orc4 AT-hook motif, which recognises AT-rich DNA, and it is 
to date the only eukaryote where ORC binding does not occur in the ATP-bound 
form (Chuang and Kelly, 1999; Lee et al., 2001; Kong and DePamphilis, 2001). At 
least in human cells, ORC assembly and recruitment to the nucleus is a dynamic 
process: Orc1, Orc6 and an ORC subcomplex comprising Orc2-5 are transported 
independently to the nucleus of the cell, and only then do they interact at the 
origins, in an ATP-dependent fashion (Ghosh et al., 2011). Once ORC is bound to 
the origin, and upon entry into G1 phase, Cdc6 is recruited to the origin (Figure 
1.17, A). Cdc6, in its ATP-bound form, binds to the Orc1 subunit (Wang et al., 
1999), stabilising the ORC-DNA interaction (Speck and Stillman, 2007), and 
leading to conformational changes in ORC (Sun et al., 2012). In at least S. 
Chapter 1  68 
 
cerevisiae, the Cdc6-ORC conformational changes result in the exposure of two 
Cdt1-binding domains in Orc6 that allow the recruitment and subsequent loading 
of the MCM2-7 helicase to the origin (Figure 1.17, A) (Takara and Bell, 2011; 
Chen et al., 2007; Chen and Bell, 2011). Cdt1 is the MCM2-7 helicase loader, and 
though it is poorly conserved among eukaryotes (Aves et al., 2012), it possesses 
two characteristic WHD domains at the centre and in the C-terminus (reviewed 
in Caillat and Perrakis, 2012; Bell and Kaguni, 2013). It is the most C-terminal 
WHD domain of Cdt1 that interacts with the MCM2-7 helicase (via MCM6, at least 
in human and mouse cells) (Wei et al., 2010; Zhang et al., 2010; Yanagi et al., 
2002). At least in S. cerevisiae, Cdt1 and MCM2-7 are only recruited to the origin 
as a complex (Tanaka and Diffley, 2002), where it binds to ORC via interaction 
between Cdt1 and Orc6 (Takara and Bell, 2011). It appears that the helicase is 
loaded onto the origin in pairs, as an inactive head-to-head double-hexamer 
(Figure 1.17, A), with each MCM2-7 complex being loaded by Cdt1 in a concerted 
fashion (Remus et al., 2009; Takara and Bell, 2011; Evrin et al., 2009; 
Fernandez-Cid et al., 2013; Evrin et al., 2013a; Gambus et al., 2011). The 
assembly at the origin composed of ORC, Cdc6, Cdt1 and the MCM2-7 helicase is 
the pre-replication complex (pre-RC) (reviewed in Costa et al., 2013). 
ATP-binding by Cdc6, as well as its further hydrolysis (stimulated by the binding 
of Cdc6 to ORC and origin DNA) (Randell et al., 2006; Evrin et al., 2013b) not 
only induces structural changes in the origin-bound ORC and Cdc6 complex, but 
also in the structure of the MCM2-7 ring itself: though it is not known when, the 
MCM2-7 ring must be opened at the MCM2/MCM5 interface in order to encircle 
origin DNA (Figure 1.17, A) (reviewed in Bell and Kaguni, 2013). A proposed 
scenario is that when Cdt1 interacts with ORC, it leads to the opening of the 
MCM2/MCM5 gate in the two MCM2-7 complexes, forming a single 
channel/opening gate (Figure 1.17, A); subsequently, ATP-hydrolysis by Cdc6 
leads to the release of Cdt1 from the pre-RC and consequently, the deposit of 
the two closed inactive MCM2-7 hexamers around dsDNA (reviewed in Bell and 
Kaguni, 2013). Next, ATP bound to Orc1 is hydrolysed, resulting in the release of 
the loaded MCM2-7 double-hexamers from ORC (Figure 1.17, A), and allowing the 
subsequent loading of more MCM2-7 double-hexamers (repeated loading) 
(Bowers et al., 2004) to the origin after ADP to ATP exchange. In S. cerevisiae, 
the MCM3 subunit (specially its C-terminus) appears to have a role in the ATP 
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hydrolysis by Cdc6 and ORC, and is essential for the recruitment of all MCM2-7 
subunits to the ORC-binding site (Frigola et al., 2013). Nevertheless, in all 
eukaryotes, once the helicase has been loaded, the origin is considered licensed, 
and ready to be activated/fired. As already discussed in section 1.3.2.3, though 
all potential origins are licensed, only a subset of these are activated during S 
phase, following a specific activation timing programme, with the non-activated 
origin pool working as dormant origins that can be activated during S phase if 
needed. However, the cell must ensure that enough potential origins are 
licensed by the end of G1 phase before entering S phase (reviewed in McIntosh 
and Blow, 2012). For instance, in human cells, it appears that the licensing 
checkpoint delays or even inhibits progression into S phase if an insufficient 
number of origins have been licensed by the end of G1 phase (Shreeram et al., 
2002; Blow and Gillespie, 2008). It is thus crucial that the cell has enough 
licensed origins to completely replicate its genome, even in cases of replication 
perturbation.  
Next, the helicase must be activated. This is achieved via the recruitment of 
additional replicative factors to the origin that assemble to form the pre-
initiation complex (pre-IC), and is dependent on the levels and functions of two 
protein kinases, the cyclin-dependent kinase (CDK) and the Dbf4-dependent 
kinase (DDK, which consists in the catalytic Cdc7 subunit and the regulatory Dbf4 
subunit) (Figure 1.17, B) (reviewed in Tanaka and Araki, 2013; Costa et al., 
2013). The pre-IC components include the remaining factors that, together with 
MCM2-7, constitute the replicative helicase (the CMG complex): Cdc45 and the 
GINS complex (Moyer et al., 2006; Ilves et al., 2010). This stage in the initiation 
of DNA replication has been extensively studied in S. cerevisiae, and it appears 
to be functionally conserved in metazoans, and potentially in other eukaryotic 
groups, though the factors and regulatory mechanisms involved might differ 
(reviewed in Tanaka and Araki, 2013). Taking S. cerevisiae as the current best 
understood model, at the G1 to S phase transition, the levels of Dbf4 increase 
(and are kept high during S phase before decreasing in late mitosis) (Cheng et 
al., 1999; Oshiro et al., 1999; Ferreira et al., 2000), and thus DDK activity 
(Figure 1.17, B). DDK then phosphorylates MCM2-7 (Randell et al., 2010; Bruck 
and Kaplan, 2009; Ramer et al., 2013; Yeeles et al., 2015), promoting the 
subsequent interaction of MCM2-7 with Sld3, Sld7 and Cdc45 at the origins 
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(Figure 1.17, A) (Heller et al., 2011; Tanaka et al., 2011). At the onset of S 
phase, CDK is activated (Figure 1.17, B), and recruits the GINS complex (Figure 
1.17, A), via the interplay with other factors such as Sld2, Dpb11 and DNA 
Polymerase ε (Muramatsu et al., 2010), to origin-bound MCM2-7 associated with 
Sld3, Sld7, and Cdc45, by phosphorylating Sld2 and Sld3 (Zegerman and Diffley, 
2007; Tanaka et al., 2007). MCM10 is also recruited to the origin (Figure 1.17, 
A), and appears to be necessary for the unwinding of the origin (van Deursen et 
al., 2012; Kanke et al., 2012), but its actual role or timing is not clear. The 
complete replicative helicase (CMG complex) is then activated – most likely via 
MCM2-7 undergoing conformational changes triggered by the binding of Cdc45 
and GINS (Costa et al., 2011; Ilves et al., 2010) – leading to the unwinding of the 
origin DNA (Figure 1.17, A), separation of the MCM2-7 double-hexamers initially 
loaded onto the origin (Yardimci et al., 2010; Kang et al., 2012; Costa et al., 
2011), and establishment of the bidirectional replication forks (Figure 1.17, A). A 
key step in the initiation of DNA replication is the switch of the MCM2-7 helicase 
from encircling dsDNA in the pre-RC to enclosing leading strand ssDNA at the 
replication fork. However, how this is achieved is presently not clear (reviewed 
in Costa et al., 2013; Tanaka and Araki, 2013). 
It is imperative that any region of the genome is replicated only once per cell 
cycle, meaning that each origin is activated only once during S phase, and that 
the whole genome must be completely replicated by the end of S phase, by 
activating enough origins (reviewed in Diffley, 2011). As detailed above, 
initiation of DNA replication is separated into two major, non-overlapping, 
events: helicase loading and helicase activation. In order to ensure that these 
two steps do not occur simultaneously, thus preventing re-replication, 
eukaryotes have developed various redundant regulatory mechanisms (reviewed 
in Diffley, 2010), with different degrees of complexity, depending on the 
organism. These involve the cell cycle-dependent interplay of various protein 
kinases and the anaphase–promoting complex/cyclosome (APC/C), an E3 
ubiquitin ligase that targets multiple factors for degradation by the proteasome, 
as well as nuclear exclusion of members of the pre-RC during specific stages of 
the cell cycle, or their cell cycle-dependent expression (reviewed in Arias and 
Walter, 2007; Costa et al., 2013; Tanaka and Araki, 2013). In higher eukaryotes, 
Cdt1 is regulated by another, and additional, type of mechanism: it is 
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sequestered/inhibited by geminin in S and G2 phases, which prevents MCM2-7 
loading to the origins (Wohlschlegel et al., 2000; Lee et al., 2004), and thus re-
licensing and re-replication of the origins during S phase. Some of these 
mechanisms are explored in the discussion of Chapter 3, as they relate directly 
to the potential function of one T. brucei replication factor, TbORC1B.  
 
Figure 1.17. Initiation of DNA replication in eukaryotes.  
A) Diagram depicting the two crucial events in initiation of DNA replication in eukaryotes (using S. 
cerevisiae as a model): helicase loading (left panel) and helicase activation (right panel). On the left 
panel, the origin is recognised and bound by ORC from late mitosis to the end of G1 phase. Next, 
Cdc6 is recruited and binds to ORC, leading to conformational changes in the complex. This 
exposes Orc6, and Cdt1-binding sites within. Next, the MCM2-7 helicase bound to Cdt1 is recruited 
to the origin (forming the pre-RC complex with ORC and Cdc6), and loaded onto the origin, in an 
ATP-dependent fashion, and by opening the gate between the MCM2 and MCM5 subunits. Once 
the helicase is loaded, the origin is considered licensed. The licensed origin (right panel, dashed 
arrow) is then activated at the onset (or during) S phase. The MCM2-7 helicase is phosphorylated 
A) 
B) 
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by DDK, leading to the recruitment and binding of Cdc45, Sld3 and Sld7 to the helicase (1). The 
action of CDK then recruits another factors including the GINS complex that together with Cdc45 
and MCM2-7 forms the CMG complex, which is the active replicative helicase (2). Once active, the 
helicase unwinds the origin DNA, allowing the assembly of the replicative fork components and 
initiation of DNA synthesis (3). B) Diagram depicting the fluctuating levels of CDK and DDK (y-axis) 
throughout the cell cycle (x-axis). The gaps within which the different replication complexes can be 
formed are shown. In A) the diagram on the left was reproduced from (Bell and Kaguni, 2013) with 
permission, © Bell and Kaguni, 2013 by Cold Spring Harbor Laboratory Press, all rights reserved. 
Diagram on the right was reproduced, with adaptations, from (Heller et al., 2011), Copyright © 2011 
Elsevier Inc. All rights reserved. B) Diagram reproduced from (O'Donnell et al., 2013) with 
permission, © O’Donnel et al., 2013 by Cold Spring Harbor Laboratory Press, all rights reserved.  
 
1.4 DNA replication in Trypanosoma brucei and related 
kinetoplastids – still a field to explore 
As evident in the previous sections, present knowledge of DNA replication 
initiation events in eukaryotes is largely derived from research based on model 
organisms, all members of the Opisthokonta supergroup (Figure 1.1). Although it 
has been long assumed that all eukaryotes possess a conserved six-subunit ORC, 
recent evidence from studies analysing large numbers of organisms from across 
the different eukaryotic supergroups (Aves et al., 2012), as well as studies on 
DNA replication in protists such as Tetrahymena thermophila (Mohammad et al., 
2007; Mohammad et al., 2003; Lee et al., 2015), Plasmodium falciparum (Gupta 
et al., 2008; Gupta et al., 2009), and various kinetoplastids (reviewed in 
Tiengwe et al., 2013), suggest that the six-subunit ORC might not be as 
conserved across the eukaryotic tree as initially thought.  
One organism that appears to lack a conventional six-subunit ORC is T. brucei, 
where only recently has the process of initiation of DNA replication become the 
focus of research interest (reviewed in Calderano et al., 2011a; Tiengwe et al., 
2013). The next few sections report the present knowledge of how nuclear DNA 
replication is initiated in T. brucei and related kinetoplastids. 
1.4.1.1 Do kinetoplastids have an unconventional and divergent ORC? 
Until quite recently, virtually nothing was known about how nuclear DNA 
replication is initiated in T. brucei and related kinetoplastids (reviewed in 
Tiengwe et al., 2013). Upon sequencing of the TriTryp genomes (T. brucei, T. 
cruzi, and L. major) (Berriman et al., 2005; El-Sayed et al., 2005a; Ivens et al., 
2005; El-Sayed et al., 2005b), it became clear that in these parasites the process 
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of initiation of DNA replication might be different from model eukaryotes. 
Although an initial genome-wide bioinformatic analysis of these genomes 
suggested that the molecular machinery involved in replication fork assembly 
and DNA synthesis resembled that found in model eukaryotes, with orthologues 
of the MCM2-7 helicase, Cdc45 and the sliding clamp proliferating cell nuclear 
antigen (PCNA) identified (El-Sayed et al., 2005a), only one potential ORC 
subunit, a putative orthologue of Orc1 (which, like in other eukaryotes, also 
shows homology with Cdc6), was identified (El-Sayed et al., 2005a). This protein 
was subsequently named TbORC1/CDC6 in T. brucei and TcORC1/CDC6 in T. 
cruzi (Godoy et al., 2009), and Orc1 in Leishmania spp. (Kumar et al., 2008). 
Together with the lack of identifiable orthologues of key factors such as Cdc6, 
Cdt1, the GINS complex, MCM10, and the DDK kinase, these observations lead to 
the hypothesis that initiation of DNA replication in these three kinetoplastids 
could be more similar to the process found in archaeal organisms rather than the 
one found in model eukaryotes (El-Sayed et al., 2005a; Godoy et al., 2009).  
This hypothesis has sparked research interest, not just because the molecular 
machinery might be divergent and make the evolutionary link between archaea 
and eukaryotes, but also because the process of initiation of DNA replication 
might be a potential target for drug development against these pathogenic 
parasites (reviewed in Calderano et al., 2011a; Tiengwe et al., 2013). 
Consequently, in the last few years, orthologues of several factors involved in 
the late steps of the initiation of DNA replication have been identified and 
experimentally validated in T. brucei (reviewed in Tiengwe et al., 2013). 
Interaction and functional analysis has been reported for the MCM2-7 complex 
(Tiengwe et al., 2012b; Dang and Li, 2011), Cdc45 (Oyola et al., 2009; Dang and 
Li, 2011) and the four members of the GINS complex (Dang and Li, 2011). 
Localisation of PCNA has been described (Kaufmann et al., 2012), and sequence 
analysis of MCM10 and MCM9 reported (Liu et al., 2009). Finally, analysis of 
MCM2-7 supplementary factors, MCM8 and the MCM-binding protein (MCM-BP), 
has been described in the context of antigenic variation (Kim et al., 2013) and a 
recent study has identified the highly diverged components of the T. brucei 
kinetochores (Akiyoshi and Gull, 2014). 
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Identification of the earliest acting ORC components, as well as how MCM2-7 is 
recruited to the pre-RC, and thus testing if TbORC1/CDC6 alone provides ORC 
function, has proved challenging. Sequence-based searches have failed to 
identify clear kinetoplastid orthologues for many members of the putative pre-
RC, as no orthologues for Cdc6 and Cdt1, as well as Orc2, Orc3, Orc4, Orc5 and 
Orc6, were detectable. Instead, four putative ORC-like factors have been 
identified in T. brucei and shown to interact with TbORC1/CDC6 in PCF cells 
(Tiengwe et al., 2012b; Dang and Li, 2011). One such factor was initially 
identified through a search of the T. brucei genome using both human and yeast 
ORC proteins as queries, revealing a gene encoding a protein with very low level 
homology to Orc1; this was suggested to be a divergent, second Orc1-like factor, 
and was named TbORC1B (Dang and Li, 2011). Identification of TbORC1/CDC6 
interacting partners by immunoprecipitation-based assays revealed one protein 
that displays low level homology with D. melanogaster Orc4 subunit, suggesting 
it may be an Orc4 orthologue, leading to its naming as TbORC4. The same 
interaction analysis also revealed two apparently kinetoplastid-specific factors, 
Tb7980 and Tb3120 (Tiengwe et al., 2012b). Orthologues of these four 
TbORC1/CDC6 interacting factors are also found in both T. cruzi and L. major 
(Tiengwe et al., 2012b; Dang and Li, 2011).  
Protein sequence analysis of these factors revealed that both TbORC1/CDC6 and 
TbORC1B lack the Orc1-typical BAH domain, although both appear to possess an 
AAA+ ATPase domain, containing well conserved Walker A and Walker B motifs, 
though TbORC1B appears to lack the characteristic arginine finger motif (Figure 
1.18) (Godoy et al., 2009; Dang and Li, 2011). Experimental data using 
recombinant protein was able to confirm that TbORC1/CDC6 and TcORC1/CDC6 
are ATPases (Godoy et al., 2009), while TbORC1B did not display such activity 
(Dang and Li, 2011). In addition, a NLS motif was found in TbORC1/CDC6’s N-
terminus, while a WHD domain has also been predicted in its C-terminus (Figure 
1.18) (Godoy et al., 2009), though such motif and domain have not been found 
in TbORC1B or any of the other putative ORC-like factors (reviewed in Tiengwe 
et al., 2013). Furthermore, in the case of TbORC1/CDC6 and TcORC1/CDC6, both 
were shown, through a yeast phenotypic complementation assay, to be able to 
replace Cdc6’s function in S. cerevisiae, but were not able to replace Orc1 
(perhaps because S. cerevisiae Orc1 recognises specific sequences at the origins 
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of replication that the kinetoplastid ORC1/CDC6 protein cannot). This result was 
taken as evidence that TbORC1/CDC6 and TcORC1/CDC6 might have a dual role 
(of both Orc1 and Cdc6) in DNA replication (Godoy et al., 2009). TbORC4 also 
appears to have an AAA+ ATPase domain, although both Walker A and Walker B 
motifs appear degenerate (Figure 1.18) (Tiengwe et al., 2012b). Nevertheless, 
TbORC4 seems to possess a conserved arginine finger motif commonly found in 
other organisms’ Orc4 subunits (Tiengwe et al., 2012b). Although never tested, 
these observations suggest that TbORC4 does not possess ATPase activity, and 
might instead stimulate TbORC1/CDC6 ATPase activity, similarly to what has 
been observed for the Orc4 subunits of other eukaryotes (reviewed in Davey et 
al., 2002b; Duncker et al., 2009). Analysis of Tb7980 and Tb3120 protein 
sequences did not reveal significant homology with any ORC factors (the 
detection of non-significant Orc5 and Orc2 motifs, respectively, is discussed in 
detail in Chapter 3), though Tb7980 appears to have a putative AAA+ ATPase 
domain with relatively conserved Walker A and Walker B motifs (Figure 1.18) 
(Tiengwe et al., 2012b; Tiengwe et al., 2013). From the available data, it is 
clear that TbORC1/CDC6 is the most conserved Orc-like protein identified to 
date in T. brucei, and might explain why the remaining Orc-like factors have not 
been identified by bioinformatic analysis performed in earlier studies (El-Sayed 
et al., 2005a).  
 
Figure 1.18. TbORC1/CDC6 and interacting factors putative domains.  
Schematic representation of the different putative domains that have been identified to date in 
TbORC1/CDC6, TbORC1B, TbORC4, Tb7980 and Tb3120. Domains or motifs highlighted with (*) 
were identified as being non-significant. Within the insert box is a simplified diagram of the domains 
found in model eukaryotes ORC proteins, as in (Duncker et al., 2009). Reproduced from (Tiengwe 
et al., 2013), © 2013 Elsevier Ltd. All rights reserved. 
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Individual RNAi targeting TbORC1/CDC6 (Godoy et al., 2009; Tiengwe et al., 
2012b; Benmerzouga et al., 2013), TbORC4, Tb7980 or Tb3120 (Tiengwe et al., 
2012b), using tetracycline-inducible RNA interference (RNAi) systems (detailed in 
Chapters 3 and 4) in both T. brucei PCF and BSF cell types resulted in similar cell 
cycle and growth defects. However, TbORC1/CDC6 is presently the only factor 
that has been directly shown to be involved in the process of nuclear DNA 
replication (Benmerzouga et al., 2013), and it will be essential to assess whether 
TbORC1B, TbORC4, Tb7980 and Tb3120 also have roles in DNA replication. Two 
aspects of the observed RNAi phenotypes are noteworthy. First, the effects seen 
after RNAi in PCF T. brucei are remarkably mild, with slowing of growth seen 
after around 4 days (Tiengwe et al., 2012b; Godoy et al., 2009), which is 
surprising, as replication factors would be predicted to be essential. Second, the 
phenotypes observed in PCF cells are distinct in severity and form to those 
reported for BSF cells (Tiengwe et al., 2012b; Benmerzouga et al., 2013). While 
in the former stage of the parasite’s life cycle silencing of TbORC1/CDC6, 
TbORC4, Tb7980 and Tb3120 consistently results in the accumulation of 
enucleated cells (0N1K, termed zoids) (Godoy et al., 2009; Tiengwe et al., 
2012b; Benmerzouga et al., 2013), in BSF cells impairment of TbORC1/CDC6, 
TbORC4 and Tb7980 expression leads to the accumulation of cells with multiple 
nuclei and kinetoplasts (Tiengwe et al., 2012b; Benmerzouga et al., 2013). This 
disparity might result from differences between the two life cycle stages cell 
cycle checkpoints, as already discussed in section 1.2.2 (reviewed in 
Hammarton, 2007; Li, 2012), and are exhaustively discussed in Chapters 3 and 4. 
To date, the role of TbORC1B in DNA replication or the effects of its depletion 
have not been investigated.  
Very little is known about these proteins’ expression and dynamics throughout 
the cell cycle. Presently, sub-cellular localisation studies have been mostly 
limited to TbORC1/CDC6 in T. brucei PCF cells (Godoy et al., 2009), 
TcORC1/CDC6 in T. cruzi epimastigote cells (Godoy et al., 2009), and L. major 
Orc1 (herein referred to as LmORC1/CDC6) in promastigote cells (Kumar et al., 
2008), all replicative cell types in the insect host. Immunolocalisation of 
TbORC1/CDC6 has shown that, like TcOrc1/Cdc6 in T. cruzi, it is expressed 
throughout the cell cycle, during which it localises exclusively to the nucleus, 
where it is bound to chromatin (Godoy et al., 2009). Likewise, LmORC1/CDC6 
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has been shown to localise to the nucleus of the cell throughout the cell cycle, 
but whether it is constantly bound to chromatin is presently unknown (Kumar et 
al., 2008). More recent work, however, has shown that TcORC1/CDC6 
localisation in the nucleus of T. cruzi epimastigotes is not static: during S phase 
TcORC1/CDC6 accumulates at the nuclear periphery, while throughout the other 
cellular phases is dispersed in the nucleus (Calderano et al., 2011b). Whether 
this is also observed in both L. major and T. brucei counterparts requires further 
investigation, as this phenomenon has not been reported in microscopic 
observations of LmORC1/CDC6 and TbORC1/CDC6 made so far (Kumar et al., 
2008; Godoy et al., 2009). This may suggest that TbORC1/CDC6 regulation, as 
well as its counterparts in T. cruzi and L. major, if existent, is not being 
controlled by proteosome-mediated degradation or nuclear exclusion, as it is 
observed in other eukaryotes (reviewed in Costa et al., 2013; Arias and Walter, 
2007; Siddiqui et al., 2013), and therefore, other factors might be involved in 
the activation/repression of origin firing. Recently, TcORC1/CDC6 has also been 
localised in different life cycle stages of T. cruzi: whereas it is nuclear in 
replicative stages, it is absent from the nucleus in non-replicating cell types 
(Calderano et al., 2014). Presently, there is no cellular localisation data for any 
of the remaining ORC-like factors, and it is unknown whether any of them might 
be performing a regulatory role. Nevertheless, evidence from T. brucei factors 
acting in the late steps and upstream of the pre-RC assembly might shed some 
light on the regulation of DNA replication in T. brucei (see below).  
It has been proposed that TbORC1B, TbORC4, Tb7980 and Tb3120 interact with 
TbORC1/CDC6 (Tiengwe et al., 2012b; Dang and Li, 2011) and form a diverged, 
potentially 5-subunit ORC-like complex (Li, 2012). However, to date, such 
putative ORC-like complex has not been isolated in T. brucei, and neither have 
TbORC1B, TbORC4, Tb7980 and Tb3120 been shown to interact between each 
other. Therefore, it remains possible that these factors provide distinct, non-
ORC functions (Tiengwe et al., 2013).  
1.4.1.2 The T. brucei replicative helicase and other members of the pre-IC 
complex  
As already mentioned, with the exception of ORC, Cdc6 and Cdt1, most of the 
factors involved in steps downstream of ORC recognition and binding to the 
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origin of replication have been identified in T. brucei. Consequently, the 
orthologues in both T. cruzi and L. major were also identified, suggesting that 
the main difference between kinetoplastids and other eukaryotes relies on the 
early acting components of the initiation of DNA replication. Below is a 
description of the present knowledge available on the kinetoplastid orthologues 
of the pre-IC and few early recruited members of the replication fork.  
Orthologues of the six subunits of the MCM2-7 helicase were readily identified in 
an initial in silico analysis (El-Sayed et al., 2005a), and were later 
experimentally confirmed by two independent studies (Tiengwe et al., 2012b; 
Dang and Li, 2011). Together, these suggest that T. brucei has a typical 
eukaryotic replicative helicase, with the six subunits (TbMCM2 to TbMCM7) 
appearing to possess conserved AAA+ ATPase domains, as well as the signature 
arginine finger (Tiengwe et al., 2012b; Dang and Li, 2011). As discussed in 
section 1.3.1.5, the MCM2-7 hexamer is organised in a highly defined geometry: 
MCM5-MCM3-MCM7-MCM4-MCM6-MCM2, and that it can exist in both closed or 
open ring conformations, with a gate between the MCM2 and MCM5 subunits 
(Davey et al., 2003; Costa et al., 2011; Costa et al., 2014; Bochman et al., 
2008). Therefore, it would be predicted that T. brucei TbMCM2-7 subunits 
interact in a similar fashion. Using both immunoprecipitation (IP) assays in PCF 
cells and yeast-2-hybrid techniques, which have been used in previous studies to 
understand the interactions between the MCM2-7 subunits within the hexameric 
complex in other eukaryotes (Yu et al., 2004; Crevel et al., 2001), the two 
aforementioned studies were able to map the interactions between the T. brucei 
TbMCM2-7 subunits (Tiengwe et al., 2012b; Dang and Li, 2011), which overall 
appear to match the ones mapped in other eukaryotes (reviewed in Bochman 
and Schwacha, 2009). However, the interaction patterns obtained in the two 
studies were not completely coincident (Tiengwe et al., 2012b; Dang and Li, 
2011), and therefore, at present, the interacting network within the TbMCM2-7 
complex is not completely clear. For instance, in both studies, there were at 
least two adjacent subunits in the MCM2-7 ring that did not interact in one 
study, namely TbMCM3 and TbMCM7 (Tiengwe et al., 2012b), and TbMCM7 and 
TbMCM4 (Dang and Li, 2011), but were shown to interact in the other, perhaps 
simply due to technical differences between the two studies, rather than 
biological differences (Figure 1.19, A and C) (Tiengwe et al., 2012b; Dang and Li, 
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2011). A detailed network of the interactions mapped in both studies (Tiengwe 
et al., 2012b; Dang and Li, 2011) is shown in (Figure 1.19, A and C), and is not 
further discussed here in detail.  
Because to date no homologues of Cdt1 have been found in T. brucei, T. cruzi or 
L. major, it is possible that, like in some archaeal organisms, ORC may interact 
directly with the helicase, recruiting it to the origin independently of a loading 
factor. Besides mapping the interactions within the TbMCM2-7 complex, these 
studies have also mapped the interactions of TbORC1/CDC6 and TbORC1B with 
the TbMCM2-7 complex in T. brucei PCF cells via co-immunoprecipitation (co-IP) 
assays (Tiengwe et al., 2012b; Dang and Li, 2011). Again, the results presented 
by both works are not congruent. In (Tiengwe et al., 2012b), no interactions 
were observed between TbORC1/CDC6 and TbMCM3, TbMCM6 or TbMCM7, 
possibly suggesting that an unknown factor, functionally similar to Cdt1 but 
highly divergent in terms of protein sequence, may be mediating the interaction 
between the initiator factor at the origin and the core replicative helicase. On 
the other hand, both TbORC1/CDC6 and TbORC1B were shown to interact with 
TbMCM3 in (Dang and Li, 2011). It is, however, not known if either TbORC1/CDC6 
or TbORC1B interact with other subunits of MCM2-7, as this was not tested (Dang 
and Li, 2011). Nonetheless, whether the interactions between initiator factors 
and the helicase occur already at the origin or if TbORC1/CDC6 or TbORC1B act 
as the helicase loader, it is not known. Again, the discrepancies between the 
two studies are most likely due to technical differences, but still, require further 
investigation for consistency. It is not known if other TbORC1/CDC6 interacting 
partners (TbORC4, Tb7980 and Tb3120) also interact with the helicase, or 
whether any of these has the potential to act as a helicase loader, and thus 
functionally replace Cdt1.  
In addition to the six MCM2-7 subunits, orthologues of the four member of the 
GINS complex (Sld5, Psf1, Psf2 and Psf3), as well as Cdc45 have also been 
identified, and their interactions within the CMG complex mapped in T. brucei 
(Dang and Li, 2011). Via a yeast-2-hybrid assay, it was possible to infer the 
following interactions: TbMCM5 interacts with the four subunits of TbGINS; all 
four TbGINS subunits interact with each other, perhaps forming a tight complex; 
TbSLD5 interacts with the six subunits of TbMCM2-7; and TbPSF1 interacts only 
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with TbMCM3, TbMCM5 and TbMCM6 (Figure 1.19, C) (Dang and Li, 2011). This 
complex network of protein-protein interactions may suggest that both TbMCM5 
and TbSLD5 are possibly located in the interface between the two complexes 
(Dang and Li, 2011). Indeed, it has been shown in D. melanogaster that the GINS 
complex binds to MCM2-7 via MCM3 and MCM5 (Costa et al., 2011). TbCDC45 
interactions with TbMCM2-7 and TbGINS were further inferred through a GST-
pulldown assay (Dang and Li, 2011). This showed that TbCDC45 interacts with all 
the four subunits of TbGINS, as well as TbMCM2, TbMCM4 and TbMCM5 (Figure 
1.19, C), analogous to what was reported in D. melanogaster (Costa et al., 2011; 
Costa et al., 2014), where Cdc45 has been described as being the bridge 
between the MCM2-7 and GINS complexes within the CMG complex, thus closing 
the MCM2-MCM5 gate. Furthermore, using recombinant proteins, the T. brucei 
CMG complex was shown, in contrast to TbMCM2-7 alone, to possess helicase 
activity, suggesting that association of both TbGINS and TbCDC45 with TbMCM2-7 
is required to activate the latter’s helicase activity, at least in vitro (Dang and 
Li, 2011).  
 
Figure 1.19. Protein-protein interactions within TbMCM2-7 and the TbCMG replicative 
helicase.  
A) Interactions within the TbMCM2-7 complex as described in (Tiengwe et al., 2012b); filled lines 
represent interactions mapped by IP, while grey dashed lines represent interactions mapped via 
yeast-2-hybrid assays. B) Representation of the interactions within the D. melanogaster CMG 
complex. Reproduced from (Costa et al., 2011), with permission (license number 3597820018916). 
C) Schematic representation of the interactions within the T. brucei CMG complex as mapped in 
(Dang and Li, 2011). Legend of the interactions in A) and C) is shown within the insert box. 
A) B) 
C) 
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In addition to mapping the interactions between the T. brucei CMG subunits, the 
effects of RNAi, as well as their localisation throughout the cell cycle were also 
investigated (Dang and Li, 2011). Induction of RNAi targeting, individually, 
TbMCM2, TbMCM3, TbMCM5, TbMCM7, TbSLD5, TbPSF2, TbPSF3 and TbCDC45 in 
PCF cells resulted in a growth defect, accompanied by an increase in number of 
enucleated cells (0N1K, or zoids) and a reduction in replicating cells (Dang and 
Li, 2011), similarly to what has been observed for TbORC1/CDC6 (Benmerzouga 
et al., 2013), and thus supporting their role in DNA replication in T. brucei. 
Despite a reduction in ~90% of the targeted mRNA, no growth defects were 
observed for TbMCM4, TbMCM6 or TbSLD5 (Dang and Li, 2011). Like 
TbORC1/CDC6 (Godoy et al., 2009), all members of the TbMCM2-7 and TbGINS 
complexes localise to the nucleus of PCF cells throughout the cell cycle (Dang 
and Li, 2011), in contrast to what has been observed in other organisms such as 
yeast, where MCM2-7 export to the cytoplasm after DNA replication acts as a 
mechanism to impede re-replication of already duplicated DNA (Nguyen et al., 
2000; Braun and Breeden, 2007). TbCDC45, the remaining member of the CMG 
complex, however, shows a dynamic localisation: it is nuclear from G1 to G2 
phases (with an expression peak at S phase), but is then excluded from the 
nucleus upon mitosis, apparently through the CRM1/exportin-1 mediated 
pathway (Dang and Li, 2011). This is not observed in yeast, where Cdc45 
localises to the nucleus throughout the cell cycle (Hopwood and Dalton, 1996). It 
is then possible that exclusion of TbCDC45 from the nucleus might be used as a 
regulatory mechanism in T. brucei to prevent the re-assembly of the CMG 
complex, and thus avoid activation of assembled pre-RCs at the origins, and 
therefore, re-replication.  
In addition to the putative ORC-like and CMC complexes, another replication 
factors, involved in the early stages of DNA replication, have also been explored 
experimentally in T. brucei. These include PCNA. In eukaryotes, PCNA is 
typically the DNA sliding clamp responsible for tethering the replicative DNA 
polymerases to DNA, although it is also involved in multiple cellular processes, 
including DNA repair (reviewed in Moldovan et al., 2007; De Biasio and Blanco, 
2013). In T. brucei PCF cells, analysis of TbPCNA revealed that its expression is 
cell cycle-regulated, localising in distinct foci throughout the nucleus of the cells 
mainly during late G1 and S phase cells, while it is virtually absent from G2 
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phase or post-mitotic cells (Kaufmann et al., 2012). Perhaps surprisingly, this 
phenotype is rather different from the one observed for PCNA orthologues in 
Leishmania donovani (LdPCNA) (Kumar et al., 2009; Minocha et al., 2011), and 
Trypanosoma cruzi (TcPCNA) (Calderano et al., 2011b): both LdPCNA and 
TcPCNA localise to the nucleus throughout the cell cycle (though with different 
sub-nuclear dynamics). It is therefore possible that some aspects of DNA 
replication control and regulation might differ between T. brucei, T. cruzi and 
Leishmania. Another replication-associated factor already analysed in T. brucei 
is the orthologue of the MCM-binding protein (MCM-BP), which in model 
eukaryotes has been shown to form alternative replication complexes with the 
MCM3-7 subunits in a cell cycle-dependent fashion (Sakwe et al., 2007; Li et al., 
2011a; Nguyen et al., 2012). Moreover, some evidence appears to indicate that 
MCM-BP might also be acting as an unloader of the replicative helicase from the 
chromatin at the end of the S phase (Nishiyama et al., 2011). Like in other 
organisms, the T. brucei orthologue of MCM-BP (TbMCM-BP) was shown to 
interact with TbMCM4-7 and, conversely to other eukaryotes, with TbMCM8 as 
well (Kim et al., 2013). Using a conditional knock-out (KO) system, it was shown 
that TbMCM-BP is essential for BSF cells viability, resulting in the de-repression 
of silent VSGs, and cell cycle arrest in G2 phase with the consequent generation 
of zoids, a phenotype that has never been reported in BSF cells before (Kim et 
al., 2013).  
1.4.1.3 Origins of replication – not as many as expected 
Like most eukaryotes, to date no specific sequence elements defining origins of 
replication have been found in T. brucei (Tiengwe et al., 2012a). Moreover, 
TbORC1/CDC6-binding sites, and thus potential origins of replication, surpass the 
number of detectable active origins, which appear to be activated during S 
phase following a defined replication timing programme (Tiengwe et al., 2012a), 
suggesting that as far as origins of replication are concerned, T. brucei appears 
to possess what has been embraced as universal eukaryotic DNA replication 
features (reviewed in Masai et al., 2010; O'Donnell et al., 2013).  
TbORC1/CDC6-binding sites were mapped across the 11-megabase chromosomes 
of T. brucei PCF cells by chromatin immunoprecipitation coupled with 
microarray hybridisation (ChIP-chip) (Tiengwe et al., 2012a). This revealed ~953 
Chapter 1  83 
 
TbORC1/CDC6-binding sites, and thus potential origins of replication, which 
displayed sparse binding in the core regions of the 11-megabase chromosomes, 
and dense binding at the subtelomeric regions. Within the chromosome core 
(~362 binding sites), TbORC1/CDC6 accumulated at the SSR boundaries of the 
polycistronic transcription units: 38% at dSSRs, 54% at h-t SSRs, and 7% at cSSRs, 
with an average spacing between TbORC1/CDC6-binding sites of ~130 Kbp 
(Tiengwe et al., 2012a). As mentioned in section 1.2.3, while cSSRs are assumed 
to be transcription termination sites, the dSSRs and h-tail SSRs are transcription 
start sites, marked by histone H4K10ac accumulation (Siegel et al., 2009). 
TbORC1/CDC6-binding sites localised just upstream of the H4K10ac-binding sites 
(Tiengwe et al., 2012a). Analysis of the TbORC1/CDC6-binding sites did not 
retrieve any common sequence element, and it is presently not known if any 
specific chromatin or epigenetic markers are involved in TbORC1/CDC6 binding 
to these specific genomic sites.  
 
Figure 1.20. TbORC1/CDC6-binging sites and active origins of replication.  
Schematic representation of T. brucei chromosome 8 (size in Mbp), with the different directional 
gene clusters shown in dark blue, and their transcription direction highlighted by dark blue arrows. 
TbORC1/CDC6 binding sites are represented in red, and the activated origins as open circles, 
where the size of the circles aims to reflect the different timing of origin activation – larger circles 
are earlier firing origins than smaller circles. Below is a representation of the chromosome regions: 
subtelomere and core. The centromere is highlighted in green. Reproduced from (Tiengwe et al., 
2013), © 2013 Elsevier Ltd. All rights reserved. 
 
In order to map the origins of replication that are activated during early-mid S 
phase at the population level, marker frequency analysis (MFA; detailed in 
Chapter 4) coupled with deep sequencing (MFA-seq) was used (Tiengwe et al., 
2012a). From this analysis, 42 MFA-seq peaks (activated origins) were identified, 
all within the core region of the chromosomes. The number of origins per 
chromosome correlated with chromosome size, and the sites of the origins co-
localised with TbORC1/CDC6-binding sites (~4.4% of the TbORC1/CDC6-binding 
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sites), thus confirming TbORC1/CDC6 as an initiator factor (or a member of an 
initiator complex) (Tiengwe et al., 2012a). However, not all identified peaks had 
the same height, suggesting that the various origins are activated at different 
times during S phase, most likely following a replication timing programme, like 
in other eukaryotes (reviewed in Rhind and Gilbert, 2013). For instance, the 
most predominant peak in chromosomes 1 to 8 corresponds to the loci previously 
mapped as centromeres (Obado et al., 2007), suggesting that these regions are 
replicated early, reflecting what has been observed in model eukaryotes such as 
yeast (Kim et al., 2003). Nevertheless, these results suggest a low density of 
active origins, with one origin per 600 Kbp, which is much more dispersed than 
in other eukaryotes (estimated to have an origin per 50-150 Kbp) (Yamazaki et 
al., 2013). Recently, the replication fork rate has been estimated for both T. 
brucei PCF and BSF cells to be of 3.7 Kbp.min-1 and 4.4 Kbp.min-1, respectively 
(Calderano et al., 2015), which is slightly faster than what has been reported in 
other eukaryotes (2 Kbp.min-1) (reviewed in Mechali, 2010), but is theoretically 
enough to allow the complete replication of the T. brucei genome from the 42 
mapped origins.  
By overlapping with a subset of the TbORC1/CDC6-binding sites in the 
chromosomes’ core region, the MFA-seq mapped origins overlapped with SSRs, 
thus suggesting a potential correlation between DNA replication and 
transcription (Tiengwe et al., 2012a), as seen in other eukaryotes (reviewed in 
Barlow and Nussenzweig, 2014; Leonard and Mechali, 2013; Helmrich et al., 
2013). Indeed, this appears to be the case in T. brucei: depletion of 
TbORC1/CDC6 by RNAi results not only in the impairment of DNA replication 
(Benmerzouga et al., 2013), but also in a widespread effect on transcription 
(Tiengwe et al., 2012a), including the de-repression of silent metacyclic VSGs in 
PCF cells and silent VSGs in BSF cells (Tiengwe et al., 2012a; Benmerzouga et 
al., 2013). In the case of the silent VSG de-repression, it is possible that this is a 
result of the depletion of TbORC1/CDC6 densely accumulated at the 
subtelomeric regions of the chromosomes, which might, similarly to other 
eukaryotic Orc1 subunits (Sasaki and Gilbert, 2007; Duncker et al., 2009), act in 
chromatin silencing, and thus be somehow involved in antigenic variation, 
supported by the report that TbORC1/CDC6 RNAi induction also results in an 
increase in VSG switching in BSF cells (Benmerzouga et al., 2013).  
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1.5 Aims and Objectives 
As detailed above, not much is known about how DNA replication is initiated in 
T. brucei and related kinetoplastids. However, it is now clear that though the 
replication fork and DNA synthesis molecular machineries appear to be 
conserved, the factors involved in the earliest stages of the process appear to be 
highly divergent. If this is verified, these diverged factors could be consequently 
used, in the long term run, as potential targets for drug development against T. 
brucei, T. cruzi and L. major. 
The main aim of the work shown here was focused ultimately on testing whether 
T. brucei possesses a diverged ORC-like complex, or whether TbORC1/CDC6 
assumes the role of the initiator factor alone, as previously suggested (Godoy et 
al., 2009). To achieve this, the published TbORC1/CDC6-interacting factors 
TbORC1B, TbORC4, Tb7980 and Tb3120, as well as Tb1120, which has not been 
published, were analysed for homology with other eukaryotic factors, tested for 
a role in DNA replication, their subcellular localisation during the cell cycle 
analysed, and interactions with TbORC1/CDC6 in PCF cells examined. These 
results are shown and discussed in Chapter 3. 
Due to the morphological and biological differences between PCF and BSF cells, 
the present work also aimed to investigate the role of the TbORC1/CDC6-
interacting factors in BSF cells. Therefore, Chapter 4 explores the involvement 
of these factors in DNA replication, as well as their subcellular localisation 
throughout the cell cycle. Furthermore, the origins of replication were also 
mapped in BSF cells and compared with the ones identified in PCF cells.  
Finally, Chapter 5 aimed to investigate origin conservation between two related 
organisms that share highly syntenic genomes, T. brucei and L. major, and thus 
explore which features define an origin of replication in kinetoplastids.  
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2 Materials and Methods 
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2.1 Bioinformatics 
2.1.1 Gene and protein sequence retrieval 
Gene and protein sequences were retrieved from the TriTrypDB online database 
(http://tritrypdb.org/tritrypdb/) (Aslett et al., 2010), as FASTA format files. All 
gene IDs shown relate to TriTrypDB version 8.1. Whole genome sequences of T. 
brucei TREU 927, L. major Friedlin, and L. mexicana U1103 were retrieved from 
TriTrypDB version 6.0, while the T. brucei Lister 427 genome sequence was 
retrieved from TriTrypDB version 8.0. 
2.1.2 Gene and protein sequence analysis and manipulation 
Gene and protein sequence analysis, primer design, and plasmid cloning 
planning, were performed using CLC genomics Workbench, version 7.5.1 (QIAGEN 
Aarhus A/S), and are described in more detail in other sections when necessary. 
2.1.3 Protein homology search and protein sequence alignments 
For protein homology searches, protein sequences were analysed using the 
standard (default settings) protein-protein Basic Local Alignment Search Tool 
(BLAST) (blastp) (http://blast.ncbi.nlm.nih. gov/Blast.cgi) (Altschul et al., 
1990), with the non-redundant protein sequences database (nr) (Li et al., 2013). 
For protein structure and function prediction, RaptorX (Källberg et al., 2012) 
and I-TASSER (Zhang, 2008a; Roy et al., 2010) online servers were used. Protein 
alignments were performed using CLC genomics Workbench, with a gap open 
cost of 10.0, gap extension cost of 1.0, end gap cost of “as any other”, and the 
very accurate (slow) option for alignment.  
2.1.4 Protein domain and motif search 
Protein domain and motif searches were performed using Pfam, version 27.0 
(http://pfam.xfam.org/) (Finn et al., 2014), InterPro, version 49.0 
(http://www.ebi.ac.uk/interpro/) (Hunter et al., 2012), GenomeNet Motif 
search tool (http://www.genome.jp/tools/motif/) (Kyoto University 
Bioinformatics Center), MyHits© Motif Scan tool (http://myhits.isb-sib.ch/) 
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(Pagni et al., 2007), and ScanProsite online tool 
(http://prosite.expasy.org/scanprosite/) (Sigrist et al., 2013). 
2.2 General Molecular Biology Techniques 
2.2.1 Plasmid cloning  
2.2.1.1 Primer design 
Primers were designed using CLC genomics Workbench, and ordered from 
Eurofins Genomics (Ebersber, Germany). For amplification of gene fragments to 
be cloned into vectors for endogenous tagging, gene deletion (labelled as KO 
plasmids), and RNAi in PCF cells (pLew RNAi plasmids), primers were designed to 
include the sequences for the restriction enzymes to be used for cloning, and are 
shown in Table 2-1. Primers designed for use in gateway cloning are described in 
section, 2.2.1.10.  
2.2.1.2 Genomic DNA extraction and purification 
Genomic DNA (gDNA) was extracted from approximately 3 x 106 PCF or BSF cells 
using the Blood and Tissue DNA extraction kit (Qiagen), according to the 
manufacturer’s instructions. The gDNA was eluted in 50 μl of Buffer AE, and 
stored at 4°C until use. 
2.2.1.3 Polymerase Chain Reaction (PCR) of products used for cloning 
For PCR amplification of fragments to be used for cloning, Phusion® High-
Fidelity DNA Polymerase (New England Biolabs), a high fidelity proofreading 
polymerase was used, according to the manufacturer’s instructions. Reactions 
were set as follows: 10 μl of 5x Buffer HF, 1 μl of 10 mM dNTP mix (Promega), 
2.5 μl of forward primer (10 pmol stock), 2.5 μl of reverse primer (10 pmol 
stock), 0.5 μl of Phusion®, 1 μl of gDNA, and 32.5 μl of MilliQ water, to a final 
volume of 50 μl per reaction. The basic PCR program was performed as follows: 
98°C for 30 sec; 35 cycles of 98°C for 10 sec, 54-64°C for 30 sec (depending on 
the melting temperature of each pair of primers), and 72°C for 45 sec to 1 min 
30 sec (depending on the size of the fragment to be amplified, 1 min per 1 Kb); 
and a final extension step of 72°C for 5 min. The resulting PCR products were 
then analysed by agarose gel electrophoresis (section 2.2.1.4). 
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Table 2-1. Primers used for cloning.  
List of primer sequences used for cloning plasmids for endogenous tagging, gene deletions (KO) and pLew RNAi plasmids. 5’ UTR and 3’UTR refer to the gene’s 
intergenic regions at the 5’ and 3’ ends, respectively. The restriction site sequences are underlined and in red. 
Number Gene Gene ID Sense Sequence 
Restriction 
Sites 
Purpose 
CTOL
c
_65 
TbORC4 Tb927.10.13380 
Fwd CCCAAGCTTCGTTTCTGCTGTCTTTGGGG HindIII 
C-terminus tag 
CTOL_66 Rev CCCTCTAGACACGAGGCTGCGTAATC XbaI 
CTOL_69 
Tb7890 Tb927.10.7980 
Fwd CCCAAGCTTCGAGCAAGTATCGTCACACAGGA HindIII 
C-terminus tag C 103 Fwd ATGGCGAGAGCTCTCGTCATCGGTCG SacI 
CTOL_70 Rev CCCTCTAGATCGTGGAATGAGGTCGT XbaI 
C 120 
Tb3120 Tb927.9.4530 
Fwd CCCAAGCTTAGTGCATGGTATAGACGAAC HindIII 
C-terminus tag 
C 121 Rev CCCTCTAGATGCCTCCACTGGAGCTCCAC XbaI 
C 3 
Tb1120 Tb927.6.1120 
Fwd GCATAAGCTTCTTCTGTTGCTTTCTGCGAG HindIII 
C-terminus tag 
C 4 Rev CCCTCTAGAGCTAAGCGCAAGCAAGGAGG XbaI 
C 5 
TbORC1B Tb927.9.2030 
Fwd GCATAAGCTTACAACGAGACAGTCAAATCG HindIII 
C-terminus tag 
C 6 Rev GCATTCTAGACAGGGATAAAATGCCCTTGA XbaI 
C 1 
TbMCM10 Tb927.9.1730 
Fwd GACATGGCGCGCCCACATTACACGAGGATTCTG AscI 
C-terminus tag 
C 2 Rev GCATTCTAGACGCATCCTCTCGAAGGCTAA XbaI 
C 184 
Tb7890 Tb927.10.7980 
Rev GCATGGATCCACGACGGGGAAACAGAACG BamHI N-terminus tag 
(5’intergenic region) C 185 Fwd GCATGGTACCGACATGCCGTGACGAACTC KpnI 
C 186 Fwd GCATACTAGTGCAGCCCAAACACCACGCA SpeI N-terminus tag (ORF 
5’ region) C 187 Rev GCATGGTACCCACGACGAAGTGAAGCTCA KpnI 
C 189 
TbORC4 Tb927.10.13380 
Fwd GCATAAGCTTGCGGCCGCTACCCTCCTTTCTTCTAGT HindIII/NotI 
KO (5’UTR region) 
C 190 Rev GCATTCTAGACCACGCCTCGCAACCTCAAGAA XbaI 
C 191 Fwd GCATGAGCTCACCAAGGAGGTGGCGCGATT SacI 
KO (3’UTR region) 
C 192 Rev GCATATCGATGCGGCCGCGTTCTTCACATCATTAGCG ClaI/NotI 
C 193 
Tb7890 Tb927.10.7980 
Fwd GCATAAGCTTGCGGCCGCCGCCAGGAATCGTTTTAGTA HindIII/NotI 
KO (5’UTR region) 
C 194 Rev GCATTCTAGAAAGATGGAGATGTAACCGGA XbaI 
C 195 Fwd GCATGAGCTCCCACAGCACAAAGGGTTA SacI 
KO (3’UTR region) 
C 196 Rev GCATATCGATGCGGCCGCGACTTCTTCCACACTCAGTT ClaI/NotI 
C 197 
Tb3120 Tb927.9.4530 
Fwd GCATAAGCTTGCGGCCGCTCATCTCTTGGTGGTTCCTC HindIII/NotI 
KO (5’UTR region) 
C 198 Rev GCATTCTAGACATAACACCGAGCGCAAA XbaI 
                                         
c
 Primers labelled as CTOL and CT were designed by Dr Calvin Tiengwe during the course of his PhD, and most can be found in Tiengwe et al., 2012b, as well as in 
his thesis Tiengwe, 2010. 
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C 199 Fwd GCATGGAGCTCCAGTGGAGGCATAGGTTGA SacI 
KO (3’UTR region) 
C 200 Rev GCATATCGATGCGGCCGCCTCTCACCAGAAATGTACCC ClaI/NotI 
C 205 
Tb1120 Tb927.6.1120 
Fwd GCATAAGCTTGCGGCCGCAGTTGACTGTATGAGAGCG HindIII/NotI 
KO (5’UTR region) 
C 206 Rev GCATTCTAGATAGTGCATTGATTCCTTCGG XbaI 
C 207 Fwd GCATGGTACCAGAGTTTAAAGCGAGGTCC KpnI 
KO (3’UTR region) 
C 208 Rev GCATATCGATGCGGCCGCGTGCAGATGGGATTGAGGA ClaI/NotI 
C 201 
TbORC1B Tb927.9.2030 
Fwd GCATAAGCTTGCGGCCGCGCACAACTCATTCGGTAAAA HindIII/NotI 
KO (5’UTR region) 
C 202 Rev GCATTCTAGACGTTATATTCTTGTTCCCGT XbaI 
C 203 Fwd GCATGAGCTCGGGAACTCAAGGGCATTTTA SacI 
KO (3’UTR region) 
C 204 Rev GCATATCGATGCGGCCGCAGTTTCTTTCAGTCTGCTCA ClaI/NotI 
CT 1 
TbORC1/ 
CDC6 
Tb927.11.7216 
Fwd CCCCAAGCTTGAAGCCCACAGCTGTCTTTC HindIII 
pLew- RNAi 
CT 2 Rev CCCCCTCGAGTTCTCCGGCAACTTGTAACC XhoI 
CT 3 Fwd CCCCGGATCCGAAGCCCACAGCTGTCTTTC BamHI 
CT 4 Rev CCCCCTTAAGTTCTCCGGCAACTTGTAACC AflII 
CT 5 
TbORC4 Tb927.10.13380 
Fwd CCCCAAGCTTCACGTTGTATCCCCTTGCTT HindIII 
pLew- RNAi 
CT 6 Rev CCCCCTCGAGTTCAGTTTCGGCGAAGTTCT XhoI 
CT 7 Fwd CCCCGGATCCCACGTTGTATCCCCTTGCTT BamHI 
CT 8 Rev CCCCCTTAAGTTCAGTTTCGGCGAAGTTCT AflII 
C 65 
Tb7890 Tb927.10.7980 
Fwd GCATAAGCTTCTTCCCATGCGAGCAAGTAT HindIII 
pLew- RNAi 
C 66 Rev GCATCTCGAGTTCAGCAGGGACCGATAAAC XhoI 
C 69 Fwd GCATGGATCCCTTCCCATGCGAGCAAGTAT BamHI 
C 70 Rev GCATCTTAAGTTCAGCAGGGACCGATAAAC AflII 
CT 9 
Tb3120 Tb927.9.4530 
Fwd CCCCAAGCTTCTAACGGCTCAGTTTCTCGG HindIII 
pLew- RNAi 
CT 10 Rev CCCCCTCGAGTTGGCAAAAGATTCCTCACC XhoI 
CT 11 Fwd CCCCGGATCCCTAACGGCTCAGTTTCTCGG BamHI 
CT 12 Rev CCCCCTTAAGTTGGCAAAAGATTCCTCACC AflII 
C 104 
Tb1120 Tb927.6.1120 
Fwd CCCAAGCTTGGAGGATGGGAAAGAAGGAG  HindIII 
pLew- RNAi 
C 105 Rev CCCCTCGAGCCGGGAGCAGAAGTACAGAG XhoI 
C 106 Fwd CCCGGATCCGGAGGATGGGAAAGAAGGAG  BamHI 
C 107 Rev CCCCTTAAGCCGGGAGCAGAAGTACAGAG AflII 
CT 13 
TbORC1B Tb927.9.2030 
Fwd CCCCAAGCTTCTATCGGCTGAGTACGCCTC HindIII 
pLew- RNAi 
CT 14 Rev CCCCCTCGAGTTTGCGATTTGACTGTCTCG XhoI 
CT 15 Fwd CCCCGGATCCCTATCGGCTGAGTACGCCTC BamHI 
CT 16 Rev CCCCCTTAAGTTTGCGATTTGACTGTCTCG AflII 
Chapter 2  91 
 
 
2.2.1.4 Agarose Gel Electrophoresis 
For PCR product analysis, 1% (w/v) UltraPure™ Agarose (Life Technologies) gels, 
diluted in 1x TAE buffer (40 mM Tris base, 19 mM acetic acid, 1mM EDTA) were 
prepared. To allow DNA detection by ultraviolet light, SYBR® Safe DNA Gel Stain 
(Life Technologies) was diluted 1:20000 into the warm melted agarose. To the 
PCR products, 6x type III DNA Gel-loading Buffer (Sambrook and Russell, 2001) 
was added to a final concentration of 1x, before these were loaded onto the gel, 
alongside the 1 Kb Plus ladder (Invitrogen™, Life Technologies). The gels were 
ran at 40-100 v in 1x TAE buffer, on Mini-Sub® Cell GT Cell tanks (Bio Rad). For 
visualisation, gels were imaged using a Gel Doc™ XR+ System (Bio Rad), equipped 
with the Quantity One 1-D v 4.6 Analysis Software (Bio Rad). 
2.2.1.5 PCR products purification 
PCR products were purified using one of two methods: either directly from the 
PCR reaction, using the QIAquick PCR purification kit (Qiagen), or from an 
agarose fragment containing the PCR product, using the QIAquick Gel 
purification kit (Qiagen), both according to the manufacturer’s instructions. In 
the latter case, the gels were imaged under a Dark Reader blue Transilluminator 
(Clare Chemical Research), and the appropriate bands excised using a sterile 
scalpel blade.  
2.2.1.6 Restriction Enzyme digestion 
With the exception of cloning performed using the gateway system (below), all 
PCR products used for cloning were digested with the corresponding restriction 
enzymes (Table 2-1). All enzymes were from New England Biolabs (NEB), and 
used according to the manufacturer’s instructions, with consultation of the 
Double Digest Finder application (https://www.neb.com/tools-and-
resources/interactive-tools/double-digest-finder) for the planning of double 
enzyme digestion reactions. Reactions were set up as follows: 5 μl of the 
appropriate 10x buffer, 1 μl of each of the two restriction enzymes, 20 μl of the 
PCR product, and 23 μl of MilliQ water. The reactions were incubated for 1 h at 
the temperature recommended by NEB. The plasmids used as backbone vectors 
for the PCR product cloning were likewise digested using the same pairs of 
enzymes, as mentioned above. Both digested PCR products and plasmid vectors 
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were then separated on 1% (w/v) agarose gels (section 2.2.1.4), and purified 
with a QIAquick Gel purification kit (Qiagen), as aforementioned. The 
concentration of the purified products was then assessed by a NanoDrop 1000™ 
Spectrophotometer (Thermo Scientific), before ligation (below). 
2.2.1.7 Ligation 
Ligation of digested PCR products and plasmid vector was performed using the 
T4 DNA Ligase (NEB), according to the manufacturer’s instructions. In order to 
assess the amount of PCR product to use, Equation 1 was used, considering 50 ng 
of plasmid vector. Two ligation reactions were prepared in parallel, using a 1:5 
and 1:10 plasmid vector:PCR product ratios, each with a total volume of 20 μl, 
containing 1x Ligation Buffer and 1 μl of T4 DNA Ligase (NEB). The reactions 
were incubated at room temperature (21-25°C) for 30 min, and then 
transformed into competent bacteria (below). 
Equation 1. Ligation components formula. 
 
𝑃𝑙𝑎𝑠𝑚𝑖𝑑 𝑤𝑒𝑖𝑔ℎ𝑡 (𝜇𝑔)  ×  𝑃𝐶𝑅 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑠𝑖𝑧𝑒 (𝑏𝑝)
𝑃𝑙𝑎𝑠𝑚𝑖𝑑 𝑠𝑖𝑧𝑒 (𝑏𝑝)
= 𝑃𝐶𝑅 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 (𝜇𝑔) 
2.2.1.8 Transformation of competent bacteria  
Chemically competent Escherichia coli strain DH5α bacteria (prepared by Mr 
Craig Lapsley) were used. Aliquots stored at - 80°C were allowed to thaw on ice 
for 30 min. Next, 50 μl of bacteria were added to 10 μl of the ligation product, 
and left on ice for 30 min. Then, the cells were incubated at 42°C for 30 sec, 
and immediately placed on ice for 2 min. Next, 250 μl of liquid lysogeny broth 
(LB) medium (10 g.L-1 of Tryptone, 5 g.L-1 of yeast extract, and 10 g.L-1 of NaCl) 
were added to the cells, and these incubated for 1 h at 37°C, with agitation. 
Around 100-200 μl of cells were then plated on LB agar (10 g.L-1 of Tryptone, 5 
g.L-1 of yeast extract, 10 g.L-1 of NaCl, and 15 10 g.L-1 of agarose) supplemented 
with 100 μg.ml-1 of Ampicillin (Sigma Aldrich), and incubated overnight at 37°C. 
Plates were inspected for colonies, which were then transferred onto 5 ml of 
liquid LB supplemented with 100 μg.ml-1 of Ampicillin, and incubated overnight 
at 37°C, with agitation. The overnight culture was then centrifuged for 3 min at 
6000 g, and used for plasmid purification (below). 
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2.2.1.9 Plasmid purification, and further confirmation by enzymatic 
digestion and sequencing 
In order to purify the plasmids from the pellets of overnight grown liquid 
cultures of transformed E. coli DH5α bacteria, the QIAprep Spin Miniprep Kit 
(Qiagen) was used, according to the manufacturer’s instructions. The 
concentration of the plasmids was then assessed by photospectrometry using a 
NanoDrop 1000™ Spectrophotometer (Thermo Scientific). Approximately 5 μl of 
plasmid was then digested with the appropriate restriction enzymes for 
confirmation (section 2.2.1.6), and separated on a 1% (w/v) agarose gel, as 
abovementioned (section 2.2.1.4). If correct, according to the sizes of the 
resulting fragments, the plasmids were then sent for sequencing either at the 
DNA Sequencing & Services™ University of Dundee, UK (www.dnaseq.co.uk), or 
Eurofins Genomics (Ebersber, Germany). Primers used are shown in Table 2-2. 
The resulting chromatogram files containing the sequence peak data (.ab1) were 
then analysed using CLC genomics Workbench, version 7.5.1 (QIAGEN Aarhus 
A/S), by assembling the sequence peak data to the reference file (the plasmid 
map) using the “Assemble Sequences to Reference” function.  
Table 2-2. Primers used for sequencing of plasmids, for confirmation of the inserts.  
(*) Primers provided by Eurofins sequencing services. (MP) primers designed by Dr Marko 
Prorocic; (AT) primers designed by Dr Anna Trenaman. The numbers refer to their individual 
primer lists. 
Number Name Sequence Plasmids seq. 
MP 15 HA/myc Fwd CGTTGGCCGATTCATTAATGC C-terminal 12-myc and 6-HA tag  
MP 16 HA/myc Rev TAATGACGAACGGGAAATGC C-terminal 12-myc and 6-HA tag  
* M13 uni (-43) AGGGTTTTCCCAGTCACGACGTT KO plasmids 
* M13 rev (-49) GAGCGGATAACAATTTCACACAGG KO plasmids 
AT 120 N-tag Fwd GTATACCAACAAGCCCGAAAAC N-terminal 12-myc tag 
AT 121 N-tag Rev CCTTTCCACGGAAAAGACAC N-terminal 12-myc tag 
 
2.2.1.10 The specific case of Gateway® Cloning 
Constructs designed for RNAi in bloodstream form cells (BSF) were generated 
using a derivation of the gateway® cloning technology (described in Jones et al., 
2014). Gene specific primers were designed to include the attB sites (Table 2-4), 
and the PCRs were performed using Phusion® High-Fidelity DNA Polymerase 
(NEB), as described above (section 2.2.1.3). The PCR products were separated 
on 1% (w/v) agarose gels and the bands extracted as described in previous 
sections (2.2.1.4 and 2.2.1.5). The BP reaction was then performed using the 
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Gateway® BP Clonase® II Enzyme mix kit (Life Technologies), as follows: 5 μl of 
purified PCR product, 1 μl of pGL2084 vector (Jones et al., 2014), 3.75 μl of TE 
buffer, and 0.25 μl of BP Clonase® II, incubated for 1 h at room temperature 
(20-25°C). Next, 1 μl of Proteinase K solution (2 μg.μl-1) was added to the mix, 
and incubated at 37°C for 1 h. The 10 μl of reaction was then added to 50 μl of 
E. coli MAX Efficiency® DH5α™ competent cells (Life Technologies), which were 
transformed as described in the previous section 2.2.1.8, using S.O.C medium 
(2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM 
MgSO4, and 20 mM glucose), instead of LB medium, for the bacteria recovery 
step. The plasmids resultant from the bacteria transfections were purified as 
described before (section 2.2.1.9), and digested with the following restriction 
enzymes: BamHI and XbaI to excise both inserts; StuI to excise the sense insert; 
ClaI to excise the anti-sense insert; and AscI to test the linearization sites. 
Reactions were prepared in a total of 20 μl as follows: 2 μl of Buffer 4 with BSA 
or CutSmart™ buffer (NEB), 0.25 μl of restriction enzyme (NEB), 3 μl of plasmid, 
and 14.75 μl of MilliQ water; and incubated for 1 h at 37°C. The resulting 
digested products were then separated on an agarose gel and analyse as 
described previously. 
2.2.1.11 Preparation of plasmids for procyclic form and bloodstream 
form cells transfection 
Prior to transfection into either PCF or BSF cells, 10 μg of plasmid were digested 
with the appropriate restriction enzyme overnight (as described above; the 
restriction enzyme used is mentioned in Table 2-3), for linearization. The 
digested sample was then purified by ethanol precipitation, as follows: the 
digestion reaction was centrifuged at maximum speed for 20 min at 4°C, and the 
supernatant discarded; 100 μl of 70% Ethanol were added to the pellet, and 
centrifuged at maximum speed for 2 min at room temperature; the supernatant 
was then removed, and the pellet was allowed to dry; the pellet was then re-
suspended in 11 μl of MilliQ water. From this, 1 μl was separated, alongside the 
un-digested sample, on a 1% (w/v) agarose gel, as mentioned above, for 
confirmation. If correct, the remaining 10 μl were used for transfection as 
described in sections 2.3.4 and 2.3.5.
Chapter 2  95 
 
 
Table 2-3. Restriction sites used for plasmid linearization prior to transfection into PCF or 
BSF T. brucei cells. 
 
Plasmid Linearization restriction site (s) 
TbORC1/CDC6-12mycBSD XhoI 
TbORC1B-12mycBSD ClaI 
TbORC4-12mycBSD SmaI 
Tb3120-12mycBSD NsiI 
Tb1120-12mycBSD NsiI 
TbORC1B-6HABLE ClaI 
Tb1120-6HABLE NsiI 
pLew RNAi (all plasmids) NotI 
pGL2084 RNAi (all plasmids) AscI 
 
2.2.2 Routine PCR for cell line confirmation 
For routine PCR, Taq DNA Polymerase with ThermoPol® Buffer (NEB) was used. 
Primers were designed to confirm integration of the different plasmids, either 
KO or endogenous tag, into the T. brucei genome (Table 2-5). In more detail, 
reactions were set as follows: 2 μl of 10x ThermoPol® Buffer, 0.5 μl of 10 mM 
dNTP mix (Promega), 0.5 μl of forward primer (10 pmol stock), 0.5 μl of reverse 
primer (10 pmol stock), 0.125 μl of Taq DNA Polymerase, 4 μl of gDNA, and 12.4 
μl of MilliQ water, to a final volume of 20 μl per reaction. The basic PCR 
program was performed as follows: 95°C for 5 min; 35 cycles of 95°C for 1 min, 
53-57°C for 30 sec (depending on the melting temperature of each pair of 
primers), and 68°C for 1 min to 2 min and 30 sec (depending on the size of the 
fragment to be amplified, 1 min per 1 Kb); and final extension step of 68°C for 
10 min. The resulting PCR products were then analysed by agarose gel 
electrophoresis as in section 2.2.1.4.  
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Table 2-4. Primers used for Gateway cloning.  
The attB sites are highlighted in red. 
Number Gene Gene ID Sense Sequence 
C 108 
TbORC1/CDC6 Tb927.11.7216 
Fwd GGGGACAAGTTTGTACAAAAAAGCAGGCTGAAGCCCACAGCTGTCTTTC 
C 109 Rev GGGGACCACTTTGTACAAGAAAGCTGGGTTTCTCCGGCAACTTGTAACC 
C 114 
TbORC4 Tb927.10.13380 
Fwd GGGGACAAGTTTGTACAAAAAAGCAGGCTCACGTTGTATCCCCTTGCTT 
C 115 Rev GGGGACCACTTTGTACAAGAAAGCTGGGTTTCAGTTTCGCCGAAGTTCT 
C 116 
Tb7890 Tb927.10.7980 
Fwd GGGGACAAGTTTGTACAAAAAAGCAGGCTAGTGTGGCTCCGGTTACATC 
C 117 Rev GGGGACCACTTTGTACAAGAAAGCTGGGTTTGTTGCAAAGAGCGTGTTC 
C 110 
Tb3120 Tb927.9.4530 
Fwd GGGGACCACTTTGTACAAGAAAGCTGGGTTTGGCAAAAGATTCCTCACC 
C 111 Rev GGGGACAAGTTTGTACAAAAAAGCAGGCTCTAACGGCTCAGTTTCTCGG 
C 112 
TbORC1B Tb927.9.2030 
Fwd GGGGACCACTTTGTACAAGAAAGCTGGGTTTTGCGATTTGACTGTCTCG 
C 113 Rev GGGGACAAGTTTGTACAAAAAAGCAGGCTCTATCGGCTGAGTACGCCTC 
 
Table 2-5. Primers used for cell line confirmation 
 
Number Gene Gene ID Sense Sequence Purpose 
C 40 Blasticidin - Rev AGAGATGGGGATGCTGTTGA 
Endogenous tag integration 
C 41 Bleomycin - Rev AACGGCACTGGTCAACTT 
C 101 TbORC1/CDC6 Tb927.11.7216 Fwd AAGACAGCGTCAGTGAAC 
Endogenous tag 
integration/Wt allele 
C 132 TbORC4 Tb927.10.13380 Fwd AACGGTTACCTAACTCCAC 
C 218 Tb7890 Tb927.10.7980 Fwd GTATACCAACAAGCCCGAAA 
C 220 Tb7890 Tb927.10.7980 Fwd CTTATCGCTCACTGGTACTG 
C 135 Tb3120 Tb927.9.4530 Fwd TACGGTTTCATCTCCAGACAT 
C 137 Tb1120 Tb927.6.1120 Fwd TGTTGATAGTGGTGGTGGTG 
C 136 TbORC1B Tb927.9.2030 Fwd TTGAGTTTTCGGGTGATGTG 
C 215 Neomycin - Rev CAGTCATAGCCGAATAGCC 
KO construct integration 
C 214 Puromycin - Rev GCGTGAGGAAGAGTTCTTG 
C 213 TbORC1/CDC6 Tb927.11.7216 Fwd TAGTGGTTTTAAGGGCGTAGG 
C 212 TbORC4 Tb927.10.13380 Fwd TTTTTGGTGGTGCGTTGTG 
C 209 Tb7890 Tb927.10.7980 Fwd TATCGCTCACTGGTACTGC 
C 210 Tb3120 Tb927.9.4530 Fwd AGGTGGAGGAGAAAGAGGA 
C 221 Tb1120 Tb927.6.1120 Fwd TGTGCAGGTGTGGGAATAAA 
C 211 TbORC1B Tb927.9.2030 Fwd GCCTGTTCTGTTCTCAATCT 
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CTOL_12 TbORC1/CDC6 Tb927.11.7216 Rev CCCCTCGAGCCTTCTTTCGGCTTTGGCTT  
Wt allele 
C 134 TbORC4 Tb927.10.13380 Rev TCGGCGTTGGAACTAGAT 
C 219 Tb7890 Tb927.10.7980 Rev TTAATACCCTCAGCACCCTC 
C 130 Tb3120 Tb927.9.4530 Rev CGTGTGACGCTCCATATGAC 
C 138 Tb1120 Tb927.6.1120 Rev CGCCTCTCCTTCCTCTATG 
C 131 TbORC1B Tb927.9.2030 Rev CTTCACCTTCACACAACGG 
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2.2.3 RNA extraction and purification 
A minimum of 2 x 107 of PCF cells was collected, centrifuged at 1620 g for 10 
min, washed once in 1x phosphate-buffered saline (PBS) buffer solution, and the 
pellets stored at - 80°C. Total RNA was extracted using the RNeasy Mini Kit 
(Qiagen), following the instructions on the provided protocol “Purification of 
Total RNA from Animal Cells Using Spin Technology”. An extra step of on-column 
DNase I (RNase-Free DNase Set, Qiagen) digestion was added after step 5 of the 
protocol. The concentration of the purified RNA samples was then assessed by 
photospectrometry using a NanoDrop 1000™ Spectrophotometer (Thermo 
Scientific), and while a portion of each sample was immediately converted into 
complementary DNA (cDNA) (below), the remainder RNA was stored at - 80°C. 
2.2.4 cDNA preparation  
For each sample, 1 µg of total RNA was converted into complementary DNA 
(cDNA) using the SuperScript™ III Reverse Transcriptase Kit (Invitrogen™, Life 
Technologies), according to the manufacturer’s instructions regarding the “First 
Strand cDNA Synthesis” protocol. Random primers were used, and the final step 
of RNA removal was not performed. The resultant cDNA was stored at - 20°C, 
until analysis. 
2.2.5 Protein Analysis  
2.2.5.1 Whole cell extract sample preparation 
For routine confirmation of the cell lines, approximately 2.5 x 106 cells were 
centrifuged for 10 min at 1620 g (PCFs) or 1000 g (BSFs), and re-suspended in 10 
μl of 1x NuPAGE® LDS Sample Buffer (Life Technologies) diluted in 1x PBS. These 
were either immediately analysed (below) or stored at - 20°C. 
2.2.5.2 Sodium-dodecyl-sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) 
Samples were incubated for 5 min at 100°C, and loaded onto protein gels, either 
10- or 12-well NuPAGE® Novex® 10% Bis-Tris Protein Gels 1.0 mm (Life 
Technologies). The Novex® Sharp Protein Standard was used as protein size 
marker. The gels were ran at 200 v for 50 min in a XCell SureLock™ Mini-Cell 
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Electrophoresis System (Life Technologies), and then were either transferred to 
a nitrocellulose membrane (Western Blot, section 2.2.5.3), or stained with gel 
staining dyes (sections 2.2.5.4), for further protein analysis.  
2.2.5.3 Western Blot: gel transfer and immunodetection by 
chemiluminescence 
After electrophoresis, the protein gel was transferred to a Hybond ECL 
Nitrocellulose blotting membrane (GE Helthcare Life Sciences) for 2 h at 100 v, 
in 1x transfer buffer (25 mM Tris pH 8.3, 192 mM Glycine, and 20% (v/v) 
methanol), using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio Rad). The 
membrane was then washed 5 min in 1x PBS (pH 7.2) with 0.01% of Tween-20 
(Sigma Aldrich), and incubated for 5 min with Ponceau S solution (Sigma 
Aldrich), to confirm the transfer of the proteins from the gel onto the 
membrane. The membrane was then washed 5 min with 1x PBS with 0.01% of 
Tween-20, and left overnight at 4°C, with agitation, in primary antiserum (Table 
2-6) diluted in blocking solution (5% milk (v/v) in 1x PBS with 0.01% of Tween-
20). The membrane was then washed three times, 15 min each, with 1x PBS with 
0.01% of Tween-20, and incubated for 2 h, with agitation, with the secondary 
antiserum conjugated with horse radish peroxidase (HRP) (Table 2-6), diluted in 
blocking solution. Next, the membrane was washed three times, 15 min each, 
with 1x PBS with 0.01% of Tween-20, incubated for 4 min with SuperSignal West 
Pico Chemi-luminescent Substrate (Thermo Scientific) and exposed onto X-ray 
film (Kodak). 
 If more than one protein was to be detected per membrane, after detection of 
the first signal, the membrane was washed for 5 min in 1x PBS with 0.01% of 
Tween-20, followed by 30 min with 5 ml of Restore Western Blot Stripping Buffer 
(Thermo Scientific). The membrane was then washed once for 15 min with 1x 
PBS with 0.01% of Tween-20, before incubating it with the primary antiserum. 
The rest of the process was performed as aforementioned.  
 
 
 
Chapter 2  100 
 
 
Table 2-6. Antisera and concentrations used for Western Blot 
 
Name Host Target Clone Concentration Manufacturer 
α-myc mouse myc 4A6 1:7000 Millipore 
α-HA mouse HA HA-7 1:10000 Sigma Aldrich 
α-Oligopeptidase B 
(OPB) form L. major 
sheep OPB - 1:1000 
(Munday et al., 
2011) 
α-NOG1 from T. brucei rabbit NOG1 - 1:5000 
(Jensen et al., 
2003) 
α-EF-1α (elongation 
factor-1 alpha) 
mouse EF-1α CBP-KK1 1:25000 Millipore 
α-H2A (histone H2A) 
from T. brucei 
rabbit H2A - 1:1000 
Jeremy Mottram 
Lab 
Goat α-mouse IgG (H+L) 
HRP§ conjugate 
goat mouse - 1:5000 Novex® 
Goat α-rabbit IgG (H+L) 
HRP§ conjugate 
goat rabbit - 1:5000 Novex® 
Donkey α-sheep IgG 
HRP§ conjugate 
donkey sheep - 1:5000 Santa Cruz 
§HRP Horse Radish Peroxidase 
 
2.2.5.4 SYPRO® Ruby staining of SDS-PAGE gels 
After electrophoresis, the gel was transferred to a polypropylene box, and fixed 
in 100 ml of 50% (v/v) Methanol and 7% (v/v) Acetic Acid in MilliQ water, with 
agitation, for 30 min, twice. Later, 60 ml of SYPRO® Ruby gel stain (Molecular 
Probes™, Life Technologies) were added to the gel, and left overnight with 
agitation. The gel was then transferred to a new polypropylene container, and 
washed in 100 ml of 10% (v/v) Methanol and 7% (v/v) Acetic Acid in MilliQ water 
for 30 min with agitation, and then washed twice, for 5 min each, with MilliQ 
water. Next, the gel was placed onto a 3 mm glass plate, and scanned using a 
Typhoon 8600 Variable Mode Imager (Amersham Biosciences). The 457 mm Blue I 
and Blue II emission filters were used for imaging.  
2.3 Trypanosoma brucei culture in vitro 
2.3.1 Strains and cell lines used 
For most of the methodologies involving the study of T. brucei PCF cells, the 
strains TREU (Trypanosomiasis Research Edinburgh University) 927 and Lister 427 
(derived from MITat – Molteno Institute T. brucei antigenic type – 1.2 clone 221a) 
were used. For the specific purpose of RNA interference (RNAi) assays, the PCF 
Lister 427 pLew29-pLew13 cell line, here referred to as 29-13 for simplicity 
(Wirtz et al., 1999), was used. For studies involving the bloodstream form cells, 
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the Lister 427 strain (derived from MITat – Molteno Institute T. brucei antigenic 
type – 1.2 clone 221a) was used. For assays involving RNAi, a genetically 
modified BSF Lister 427 cell line (named 2T1) (Alsford et al., 2005) was used.  
2.3.2 In vitro culture of procyclic cell forms 
All used cell lines of T. brucei PCF cells were grown in non-vented flasks at 27°C 
in semi-defined medium, SDM-79 (Brun and Schonenberger, 1979) (Gibco®), 
supplemented with 10% (v/v) heat inactivated foetal bovine serum (FBS) (Sigma 
Aldrich for routine culture, or Gibco®, in the case of the tetracycline free FBS 
for RNAi assays), 5 μg.ml-1 of Haemin (Sigma Aldrich), and 1% (v/v) of 10.000 
U.ml-1 penicillin-streptomycin solution (Gibco®). In the case of genetically 
modified cell lines, the respective selective drugs (InvivoGen) were added at the 
appropriated concentrations (Table 2-7). For cell culture maintenance, cells 
were seeded at a minimum of 5 x 105 cells.ml-1, and used for experiments at 
concentrations ~1 x 107 cells.ml-1 (mid-log phase). Cell concentration was 
assessed using a Neubauer improved hemocytometer (Marienfeld-Superior, 
Germany), as standard.  
Table 2-7. Antibiotics concentrations used for transfection and cell line maintenance, in 
both PCFs and BSFs. 
 
 Concentration 
Name Procyclic Cell Forms Bloodstream Forms 
Hygromycin 50 μg.ml-1 5 μg.ml-1 
Neomycin (G418) 10 μg.ml-1 2.5 μg.ml-1 
Zeocin 10 μg.ml-1 - 
Blasticidin 10 μg.ml-1 10 μg.ml-1 
Phleomycin 2.5 μg.ml-1 2.5 μg.ml-1 
Puromycin 1 μg.ml-1 0.2 μg.ml-1 
 
In one occasion the doubling time of a cell line was calculated using the 
following mathematical formulae: 
Equation 2. Doubling time formula. 
 
𝐶𝑒𝑙𝑙 𝑑𝑜𝑢𝑏𝑙𝑖𝑛𝑔 𝑝𝑒𝑟 ℎ𝑜𝑢𝑟 (𝐾)
=  
(𝐿𝑜𝑔10 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 48 ℎ) − (𝐿𝑜𝑔10 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 0 ℎ)
(0.301 ×  48 ℎ𝑜𝑢𝑟𝑠)
 
𝐷𝑜𝑢𝑏𝑙𝑖𝑛𝑔 𝑡𝑖𝑚𝑒 (𝑔) =  
1
𝐾
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2.3.3 In vitro culture of bloodstream forms 
T. brucei BSF cells Lister 427 and derivative genetically modified cell lines were 
grown in vented flasks at 37°C and 5% CO2, in HMI-9 (Hirumi and Hirumi, 1989) 
(Gibco®), supplemented with 20% (v/v) heat inactivated FBS (Sigma Aldrich) and 
1% of penicillin-streptomycin solution (stock at 10.000 U.ml-1) (Gibco®). 2T1 cell 
lines were grown in HMI-11, which differs from HMI-9 only in that it is 
supplemented with 10% (v/v) of FBS (Gibco®, tetracycline free). For RNAi assays 
which required the incorporation of the thymidine analogue 5-ethynyl-2’-
deoxyuridine (EdU) (section 2.5.6), cells were cultured in HMI-11 thymidine-free 
media (Dr Gloria Rudenko laboratory, personal communication), consisting in 
Iscove’s Modified Dulbecco’s Medium (IMDM) (Gibco®), 10% (v/v) of FBS (Gibco®, 
tetracycline free), 1% of 10.000 U.ml-1 penicillin-streptomycin solution (Gibco®), 
4% (v/v) of HMI-9 mix (0.05 mM of bathocuproine disulphonic acid, 1 mM of 
sodium pyruvate, and 1.5 mM of L-cysteine) (Sigma Aldrich), 1mM of 
hypoxanthine (Sigma Aldrich) and 0.0014% of 2-mercaptoethanol (Sigma Aldrich). 
In the case of genetically modified cell lines, the respective selective drugs 
(InvivoGen) were added at the appropriated concentrations (Table 2-7). For 
culture maintenance, cells were usually seeded at 1 x 104 cells.ml-1, and used 
for experiments at concentrations ~1 x 106 cells.ml-1 (mid-log phase). Cell 
concentration was assessed using a Neubauer improved hemocytometer, as 
standard. 
2.3.4 Stable transfection of procyclic cell forms 
Approximately 2 x 107 PCF cells from a culture at ~1 x 107 cells.ml-1 were 
collected and centrifuged for 10 min at 900 g, room temperature. The 
supernatant (“used SDM-79 media”) was filter-sterilised and saved at 4°C. The 
cell pellet was then re-suspended in 500 μl of ZMnoG buffer (132 mM of NaCl, 8 
mM of KCl, 8 mM of Na2HPO4, 1.5 mM of KH2PO4, and 90 μM of CaAc2), pre-
warmed to 27°C and filter-sterilised, and transferred to an 0.4 cm 
electroporation cuvette (Bio Rad), containing 10 μg of linearised plasmid 
(prepared as described in section 2.2.1.11). The cells were then electroporated 
using a Gene Pulsor II electroporator machine (Bio Rad), and subjected to two 
electric pulses with a voltage of 1.5 Kv and 25 μF of capacitance. The cells were 
then transferred to 10 ml of complete SDM-79 media, and incubated overnight at 
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27°C. Conditioned media, comprising 10% (v/v) FBS (Sigma Aldrich), 15% (v/v) of 
“used SDM-79 media”, 75% (v/v) of fresh SDM-79 media, and the appropriate 
amount of selective drug (Table 2-7), was then prepared, filter-sterilised, and 
warmed-up to 27°C. From the overnight-grown electroporated culture, 100 μl 
were taken and added to 40 ml of conditioned media, from which 20 ml were 
plated onto a 96-well plate, 175 μl per well (high dilution plate). To the 
remaining 20 ml of conditioned media, 1 ml of the culture was added, and the 
mixture plated as before (low dilution plate). The plates were then left at 27°C 
for 10 to 15 days, after which the surviving clones were isolated and grown in 
fresh SDM-79 media supplemented with the selective drug. The clones were 
further confirmed both by PCR and Western Blot, as described in sections 2.2.2 
and 2.2.5.3, respectively. 
2.3.5 Stable transfection of bloodstream forms 
Approximately 3 x 107 cells from a culture at ~1 x 106 cells.ml-1 were collected 
and centrifuged for 10 min at 405 g, room temperature. The resulting pellet was 
transferred to a 1.5 ml tube and centrifuged for 2 min at 665 g. The cells were 
then immediately re-suspended in 100 μl of Amaxa Human T Cell Nucleofactor 
kit solution (Lonza) and transferred to an electroporation cuvette (Lonza), to 
which 10 μg of linearised plasmid (prepared as described in section 2.2.1.11) was 
added. The cells were then electroporated using an Amaxa Nucleofector II 
machine (Lonza), and the X-001 programme. The cells were then immediately 
transferred into a 50 ml tube containing 30 ml of complete HMI-9 (Tube A), and 
inverted several times. From this, 3 ml were transferred to a new 50 ml tube 
containing 27 ml of complete HMI-9 (Tube B) and inverted several times. The 
same process was then repeated in order to have tubes A (1 x 106 cells.ml-1), B 
(1 x 105 cells.ml-1) and C (1 x 104 cells.ml-1). These were then plated onto 24-
well plates, 1 ml per well, and incubated overnight at 37°C with 5% CO2. Next, 
for each batch of three plates, 75 ml of HMI-9 medium containing the double of 
the drugs concentration used selection was prepared, and 1 ml was added to 
each well of the three transfected plates, resulting in the selective drugs 
appropriate concentration, as shown in Table 2-7. The plates were then 
incubated at 37°C with 5% CO2 for 5 to 7 days, during which surviving clones 
were isolated and grown in HMI-9. The clones were then further confirmed both 
by PCR and Western Blot as described in sections 2.2.2 and 2.2.5.3. 
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2.3.6 Stabilate preparation 
For long-term storage of both PCF and BSF cell lines, 800 μl of a mid-log phase 
culture were added to 200 μl of 50% (v/v) of glycerol in complete SDM-79 or HMI-
9 media, respectively, and stored in a 2 ml cryotube (AlphaLaboratories), at -
80°C overnight, wrapped in cotton wool to avoid snap-freezing. Subsequently, 
the tubes were transferred to liquid nitrogen tanks, and the respective 
information data, was submitted to the Wellcome Trust Centre for Molecular 
Parasitology (WTCMP) Freezerworks sample management 
(http://www.freezerworks.com/) database.  
2.4 RNA interference Assays 
2.4.1 RNAi assays in procyclic cell forms 
For this set of experiments, the following cell lines were used: 29-13 wt 
(parental cell line), TbORC1/CDC6 RNAi Cla, TbORC1/CDC6 RNAi Clb, TbORC4 
RNAi Cla, TbORC4 RNAi Clb, Tb3120 RNAi Cla, Tb3120 RNAi Clb, and TbORC1B 
RNAi. 
2.4.1.1 Setting up the RNAi-induced and non-induced cell cultures 
Three days before the experiment, the cultures were passaged into 30 ml of 
SDM-79, supplemented with tetracycline free FBS (Gibco®), at a concentration 
of 5.5 x 105 cells.ml-1, with the appropriate drugs: hygromycin and neomycin for 
the 29-13 parental line, and hygromycin, neomycin and zeocin (Table 2-7) for 
the 29-13 lines containing the integrated RNAi stem loop constructs. In the case 
of the TbORC4 RNAi Clb cell line, which has one allele of TbORC4 endogenously 
tagged with 12myc, blasticidin was also added. On the day of the experiment, 
the different cell cultures’ concentration was assessed, and 9 x 107 cells were 
diluted in 180 ml of SDM-79 with the respective drugs in a 75 cm3 non-vented 
flask, and mixed, in order to have a homogeneous culture with 5 x 105 cells.ml-1. 
From this, 90 ml of culture was transferred into a new 75 cm3 non-vented flask, 
to which tetracycline (Calbiochem®, Merck Millipore) was added to a final 
concentration of 2 μg.ml-1 (Tet+ culture). The two resulting flasks, each with a 
90 ml culture (Tet- and Tet+), were then placed in the upright position, in the 
incubator set at 27°C. 
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2.4.1.2 Growth curves 
Every 24 h, both Tet- and Tet+ cultures were shaken gently, to homogenise the 
culture, and 10 μl of each were taken and used for cell concentration 
assessment using Neubauer improved hemocytometer, as standard. Because of 
the cell density at time points from 48h onwards (24h intervals), 10 μl of each 
culture were taken and diluted 1:20, to allow cell counting. Concentrations at 
the different time points were recorded and plotted on a xy graph using Prism 6 
(GraphPad software Inc.), y-axis as a Log10 scale, x-axis as days post-tetracycline 
induction. 
2.4.1.3 DNA Replication assessment assay 
DNA replication was assessed at 6 h, 12 h and every 24 h time point intervals for 
5 to 7 days by quantifying the number of cells that incorporated the thymidine 
analogue, 5-ethynyl-2´-deoxyuridine (EdU), following the protocol described in 
section 2.5.3. Images were acquired on an Axioskop 2 microscope system, as 
described in section 2.5.7, and were later analysed using the Fiji software 
(http://fiji.sc/Fiji) (Schindelin et al., 2012). EdU-positive and EdU-negative cells 
were counted using the Cell Counter plugin 
http://fiji.sc/wiki/index.php/Cell_Counter), and the percentage of EdU-positive 
cells was calculated for each sample (Tet- and Tet+) per time point. The 
percentage of EdU-positive cells was then calculated relative to the percentage 
of the Tet- sample (considered to be 100%), and the resulting values were 
represented on a column graph, using Prism 6 (GraphPad software Inc.). 
2.4.1.4 Cell cycle analysis by DAPI staining 
Microscopy slides prepared for EdU detection were also stained with 4’,6-
diamidino-2-phenylindole (DAPI), and therefore also allowed the quantification 
of the number of cells in the different cell cycle stages according to their 
nucleus (N) and kinetoplast (K) ratio (1N1K, 1N2K, 2N2K, 0N1K, others). Images 
were acquired on an Axioskop 2 microscope system (section 2.5.7, and were 
analysed using the Fiji (http://fiji.sc/Fiji) (Schindelin et al., 2012). The 
different cell types found in the population were quantified using the Cell 
Counter plugin http://fiji.sc/wiki/index.php/Cell_Counter), and the values 
represented as percentage of cells in each cell cycle stage relative to the total 
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number of cells in the sampled population, on a stacked bars grouped graph, 
using Prism 6 (GraphPad software Inc.). 
2.4.1.5 Cell cycle analysis by flow cytometry 
At 6 h, 12 h, and every 24 h time point intervals for 5 to 7 days, 1 ml of cells was 
collected and centrifuged at 1620 g for 10 min. The cells were then washed in 1x 
PBS supplemented with 5 mM of EDTA (Gibco®), and centrifuged again. The 
resulting pellet was re-suspended in 300 μl of 1x PBS supplemented with 5 mM 
EDTA, to which 700 μl of 100% Methanol (cooled at 4°C) was added, in a drop-
wise fashion, while vortexing gently, in order to have a final fixing solution of 
70% (v/v) Methanol. The cells were then wrapped in aluminium foil paper and 
left at 4°C for at least overnight. Next, the cells were centrifuged at 1620 g for 
10 min, at 4°C, and washed once in 1x PBS supplemented with 5 mM EDTA. The 
pellet was then re-suspended in 1 ml of 1x PBS supplemented with 5 mM EDTA, 
10 μg.ml-1 of Propidium Iodide (PI; Sigma Aldrich), and 10 μg.ml-1 of RNaseA 
(Sigma Aldrich), and incubated for 45 min at 37°C, protected from light. The 
cells were then transferred through a 35 μm nylon mesh cell strainer cap to a 6 
ml tube (BD Falcon™ tube,BD Biosciences), and kept on ice until analysed using a 
BD FACSCalibur™ platform (BD Biosciences). Data was acquired from the FSC, SSC 
and FL2-A channels, using BD CellQuest™ software (BD Biosciences). Data was 
analysed and graphically represented using ©FlowJo software, version X.  
2.4.1.6 Sample preparation for assessment of knock-down efficiency 
For cell lines in which the RNAi targeted gene has been endogenously tagged, 
samples were prepared and analysed by western blot as described in previous 
sections (2.2.5.2 and 2.2.5.3). For the other cell lines, total RNA was extracted 
and converted into cDNA as described earlier (sections 2.2.3 and 2.2.4), which 
was diluted 1:10 in RNase-free water (Qiagen) prior to analysis by quantitative 
real-time PCR (below).  
2.4.1.7 Quantitative Real-Time PCR (qPCR) of RNAi samples 
For quantitative real-time PCR (qPCR), primers (Table 2-8) were designed using 
the Primer Express version 3.0 software (Bio Rad), and according to the 
guidelines (Alvarez-Fernandez, 2013; Dymond, 2013) for primers to be used in 
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qPCR. Primer sequences targeting TbORC1/CDC6 have been published previously 
(Tiengwe et al., 2012b). For normalisation, previously described primers 
targeting the Tb927.10.12970 gene (C1) were used (Kabani et al., 2009), as the 
“endogenous reference” gene. Primer efficiency and specificity were assessed 
for all pairs of primers through, respectively, the analysis of the calibration 
curve and melting profile, which resulted in efficiencies of approximately 100%, 
all within a 15% interval. For each pair of primers, triplicates of each sample 
cDNA were run per plate (MicroAmp® Optical 96-well Reaction Plate, Applied 
Biosystems®, Life Technologies), which were sealed with MicroAmp® clear 
adhesive film (Applied Biosystems®, Life Technologies). Precision™ qPCR 
MasterMix with SYBR Green and low ROX (Primerdesign) was used as follows: 
12.5 μl of 2x MasterMix, 2 μl of primers mix (forward and reverse primers, 10 
pmol stock), 5 μl of cDNA diluted 1:10, and 5.5 μl of RNase-free water (Qiagen), 
to a total of 25 μl per well. All experiments were performed using a 7500 Real 
Time PCR system (Applied Biosystems®), using the following PCR cycling 
conditions: 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 60°C 
for 1 min. Fluorescence intensity data was collected at the end of the extension 
step (60°C for 1 min). The resulting fluorescence intensity data was then 
analysed by relative quantification using the ΔΔCt method (Livak and 
Schmittgen, 2001), using the non-induced sample (Tet-) as the calibrator. 
Analysis of the amplification and dissociation curves was performed using the 
7500 software version 2.3 (Applied Biosystems®), and results were exported to 
Excel (Microsoft Office), with which the ΔΔCt calculations were performed. The 
results were then represented on a column graph, using Prism 6 (GraphPad 
software Inc.).  
Table 2-8. Primers used in qPCR - RNAi assays 
 
Number Gene Gene ID Sense Sequence 
CTOL_7 
TbORC1/CDC6* Tb927.11.7216 
Fwd TTCACCCTGTCATGCAGGTTT 
CTOL_8 Rev GGTTCACTGACGCTGTCTTTCC 
C 95 
C1** Tb927.10.12970 
Fwd TTGTGACGACGAGAGCAAAC 
C 96 Rev GAAGTGGTTGAACGCCAAAT 
C 87 
Tb3120 Tb927.9.4530 
Fwd GCTGCTTTGCAGGAAATACC 
C 88 Rev GCAGTGAAATGCTTCTGCTG 
C 91 
TbORC1B Tb927.9.2030 
Fwd ACGTCAACTGTGCGGATATG 
C 92 Rev TCCAAGCGAACCTGTGAAC 
* (Tiengwe et al., 2012b); ** (Kabani et al., 2009) 
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2.4.2 RNAi assays in bloodstream forms 
For this set of experiments, the following cell lines were used: 2T1 wt (parental 
cell line), TbORC1/CDC6 RNAi Cl9a (with one allele of TbORC1/CDC6 tagged with 
C-terminal 12myc), TbORC1B RNAi Cl2a (with one allele of TbORC1B tagged with 
C-terminal 12myc), TbORC4 RNAi Cl12a, Tb7980 Cl3a (with one allele of Tb7980 
tagged with N-terminal 12myc), and Tb3120 RNAi Cl5a (with one allele of Tb3120 
tagged with C-terminal 12myc). 
2.4.2.1 Setting up the RNAi-induced and non-induced cell cultures 
The day before the experiment, all cell lines were passaged into 10 ml of fresh 
HMI-11 thymidine-free media (described in section 2.3.3) to a concentration of 1 
x 105 cell.ml-1, with the appropriate drug concentrations (Table 2-7): puromycin 
and phleomycin for the 2T1 wt parental line, hygromycin and phleomycin for the 
RNAi lines, and hygromycin, phleomycin and blasticidin for the RNAi and myc-
tagged cell lines. On the day of the experiment, the different cell cultures’ 
concentration was assessed, and 1.4 x 106 cells were diluted in 140 ml of HMI-11 
thymidine free media, with the respective drugs, in a 75 cm3 vented flask, and 
mixed, in order to have an homogeneous culture with 1 x 104 cells.ml-1. From 
this, 70 ml of culture was transferred into a new 75 cm3 vented flask, to which 
tetracycline (Calbiochem®, Merck Millipore) was added to a final concentration 
of 1 μg.ml -1(Tet+ culture). The two resulting flasks, each with a 70 ml culture 
(Tet- and Tet+), were then placed, in the horizontal position, inside the 
incubator set at 37°C, with 5% of CO2. 
2.4.2.2 Growth curves 
Every 24h, both Tet- and Tet+ cultures were shaken gently, to homogenise the 
culture, and 10 μl of each were taken for cell concentration assessment using 
Neubauer improved hemocytometer, as standard. Concentrations at the 
different time points were recorded and plotted on a xy graph using Prism 6 
(GraphPad software Inc.), y-axis as a Log10 scale, x-axis as days post-tetracycline 
induction, Tet- and Tet+ of each cell line on the same graph. 
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2.4.2.3 DNA Replication assessment assay 
For all cell lines, DNA replication was assessed every 24h time point intervals by 
quantifying the number of cells that incorporated EdU, by following the protocol 
described in section 2.5.6. Analysis was performed as in section 2.4.1.3. 
2.4.2.4 Cell cycle analysis by microscopy 
Performed as in section 2.4.1.4. 
2.4.2.5 Sample preparation for assessment of knock-down efficiency 
Performed as in section 2.4.1.6. 
2.4.2.6 Quantitative Real-Time PCR (qPCR) of RNAi samples 
Performed as in section 2.4.1.7. 
2.5 Microscopy Techniques 
2.5.1 Immunofluorescence assay of tagged proteins in PCF cells 
– generic protocol 
Approximately 1 x 107 cells were collected from an exponentially growing PCF 
cell culture (~1 x 107 cells.ml-1), and centrifuged for 10 min at 1620 g. The 
supernatant was then discarded, the pellet washed in 1x PBS (pH 7.2), and 
centrifuged again for 10 min at 1620 g. Next, the pellet was re-suspended in 200 
μl of 1x PBS, and 20 μl of cell suspension was loaded onto each well of a 12 
multi-well glass slide (Thermo Scientific), previously coated with Poly-L-lysine 
(Sigma Aldrich). The cells were allowed to settle for 4 min, after which they 
were fixed with 20 μl (per well) of 3.7% paraformaldehyde in 1x PBS, for 15 min. 
Next, each well was washed three times, for 5 min each, with 20 μl of 3% Bovine 
Serum Albumin (BSA) (Sigma Aldrich) in 1x PBS, and then incubated for 20 min 
with 20 μl of 0.2% Triton X-100 (Promega), diluted in 1x PBS. Subsequently, the 
wells were washed twice, for 5 min each, with 20 μl of 3% BSA in 1x PBS, after 
which each well was incubated for 1 h with 20 μl of the primary antiserum 
diluted in 1% BSA, according to the values on Table 2-9. Next, each well was 
washed three times, for 5 min each, with 20 μl of 3% BSA in 1x PBS, and 
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incubated for 1 h with 20 μl of the secondary antiserum conjugated to a 
fluorophore diluted in 1% BSA, according to the values on Table 2-9, with the 
slide protected from light. The wells were then washed three times, for 5 min 
each, with 20 μl of 3% BSA in 1x PBS, after which 10 μl of Fluoromount G with 
DAPI (Cambridge Bioscience, Southern Biotech) mounting media was added to 
each well, covered with a coverslip, and the slide sealed with regular nail 
varnish. If not imaged immediately, the slide was stored at 4°C, protected from 
light. Note that if the primary antiserum is already conjugated to a fluorophore, 
the secondary antiserum step is omitted. If more than one protein was to be 
detected, another antisera were incubated as described above after the washes 
following the secondary antiserum incubation. All antibodies used for 
immunofluorescence and respective dilutions are summarised in Table 2-9. 
Table 2-9. Antisera used for immunofluorescence assays 
 
Name Host Target Clone Concentration Manufacturer 
α-myc Alexa 
Fluor® 488 
conjugated 
mouse myc 4A6 1:500 Millipore 
α-HA mouse HA HA-7 1:1000 Sigma Aldrich 
α-EP procyclin 
from T. brucei 
mouse EP1/EP2 TBRP1/247 1:500 Cedarlane® 
α-VSG 221 from 
T. brucei 
rabbit VSG 221 - 1:10000 David Horn Lab 
Alexa Fluor® 594 
goat α-mouse IgG 
(H+L) 
goat mouse - 1:1000 
Molecular 
Probes® 
Alexa Fluor® 594 
goat α-rabbit IgG 
(H+L) 
goat rabbit - 1:1000 
Molecular 
Probes® 
Alexa Fluor® 488 
goat α-mouse IgG 
(H+L) 
goat mouse - 1:1000 
Molecular 
Probes® 
 
2.5.2 Immunofluorescence assay of EP-procyclin in PCF cells  
Approximately 1 x 107 cells were collected from an exponentially growing PCF 
cell culture (~1 x 107 cells.ml-1), and centrifuged for 10 min at 1620 g. The 
supernatant was then discarded, the pellet washed in 1x PBS (pH 7.2), and 
centrifuged again for 10 min at 1620 g. Next, the pellet was re-suspended in 200 
μl of 1x PBS, and 20 μl of cell suspension was loaded onto each well of a 12 
multi-well glass slide (Thermo Scientific), previously coated with Poly-L-lysine 
(Sigma Aldrich). The cells were allowed to settle for 4 min, after which they 
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were fixed with 20 μl (per well) of 3.7% paraformaldehyde in 1x PBS, for 5 min. 
The cells were then incubated twice with 35 μl of 100 mM of glycine, for 10 min 
each, and further washed three times with 1x PBS, 5 min each, after which they 
were blocked for 1 h with 35 μl of 1% BSA with 0.2% Tween-20 in 1x PBS. Next, 
the cells were incubated for 1 h with 35 μl of mouse IgG1 α-EP procyclin 
antiserum (Table 2-9) diluted 1:500 in 1% BSA with 0.2% Tween-20 in 1x PBS. The 
wells were then washed three times with 1x PBS, 5 min each, and further 
incubated for 1 h, protected from light, with Alexa Fluor® 488 conjugated goat 
α-mouse antiserum (Table 2-9) diluted 1:1000 in 1% BSA with 0.2% Tween-20 in 
1x PBS. Again, the wells were washed three times with 1x PBS, after which 10 μl 
of Fluoromount G with DAPI (Cambridge Bioscience, Southern Biotech) mounting 
media was added to each well, covered with a coverslip, and the slide sealed 
with regular nail varnish. The protocol was optimised and shared by Fernando 
Fernandez-Cortes, from Jeremy Mottram’s laboratory, University of Glasgow. 
2.5.3 Immunofluorescence assay of incorporated EdU in PCF 
cells 
From an exponentially growing PCF culture (~1 x 107 cells.ml-1), a 1 ml aliquot 
was transferred to a 24-well plate, and the cells were then incubated for 3 h at 
27°C with 50 μM of 5-ethynyl-2´-deoxyuridine (EdU; Life Technologies). The cells 
were then collected and centrifuged for 10 min at 1620 g. The supernatant was 
then discarded, the pellet washed in 1x PBS (pH 7.2), and centrifuged for 10 min 
at 1620 g. Next, the pellet was re-suspended in 200 μl of 1x PBS, and 20 μl of 
cell suspension was loaded onto each well of a 12 multi-well glass slide (Thermo 
Scientific), previously coated with Poly-L-lysine (Sigma Aldrich). The cells were 
allowed to settle for 4 min, after which the cell suspension was removed from 
the wells. The cells were then fixed for 15 min with 20 μl (per well) of 3.7% 
paraformaldehyde in 1x PBS. Following, each well was washed three times, for 5 
min each, with 20 μl of 3% BSA in 1x PBS, and then permeabilised for 20 min with 
20 μl of 0.5% Triton X-100 (Promega), diluted in 1x PBS. Afterwards, the Triton 
solution was removed, and the wells washed twice, for 5 min each, with 20 μl of 
3% BSA in 1x PBS. To each well, 25 μl of Click-iT® EdU detection mix (Click-iT® 
EdU Alexa Fluor® 555 or 594 Imaging Kit – Life Technologies) was added and 
incubated for 1 h. The EdU detection mix (for a volume of 25 μl per well) was 
prepared immediately before use, as follows: 21.5μl of 1x Reaction Buffer, 1 μl 
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of copper sulphate (CuSO4), 0.06 μl of Alexa Fluor® 555 or 0.24 μl of Alexa 
Fluor® 594, and 2.5 μl of 1x Reaction Additive, added by this order. Each well 
was then washed 4-5 times with 3% BSA in 1x PBS (after this step, in the case 
tagged proteins were to be detected, the cells were incubated with the 
appropriate antisera, following the steps described in section 2.5.1), after which 
10 μl of Fluoromount G with DAPI (Cambridge Bioscience, Southern Biotech) 
mounting media was added to each well, covered with a coverslip, and the slide 
sealed with regular nail varnish.  
2.5.4 Immunofluorescence assay of 12myc-tagged proteins in 
BSF cells 
Approximately 2 x 106 cells were collected from an exponentially growing BSF 
cell culture (~1 x 106 cells.ml-1), and centrifuged for 5 min at 1000 g. The 
supernatant was then discarded, the pellet washed in 1 ml of 1x PBS (pH 7.2), 
and centrifuged again for 5 min at 1000 g. The pellet was then re-suspended in 
50 μl of 1x PBS, to which was then added 250 μl of 3.7% paraformaldehyde, 
allowing the cells to fix for 5 min. Next, 10 ml of 1x PBS was added, and the 
cells centrifuged again for 5 min at 1000 g. The supernatant was then discarded, 
leaving ~20 μl to re-suspend the pellet. The cell suspension was then loaded 
onto each well of a 12 multi-well glass slide (Thermo Scientific), previously 
coated with Poly-L-lysine (Sigma Aldrich), and let to settle for 5 min. The cell 
suspension was removed from the wells, and the cells were permeabilised with 
20 μl of 0.2% Triton X-100 (Promega), diluted in 1x PBS. Afterwards, the wells 
were washed three times, for 5 min each, with 20 μl of 3% BSA in 1x PBS. Then, 
each well was incubated for 1 h with 20 μl of mouse α-myc Alexa Fluor 488 
conjugated antiserum (Table 2-9), diluted 1:500 in 1% BSA in 1x PBS, and the 
slide protected from light. Afterwards, each well was washed twice, for 5 min 
each, with 20 μl of 3% BSA in 1x PBS, after which 10 μl of Fluoromount G with 
DAPI (Cambridge Bioscience, Southern Biotech) mounting media was added to 
each well, covered with a coverslip, and the slide sealed with regular nail 
varnish. 
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2.5.5 Immunofluorescence assay of VSG 221 in BSF cells 
Approximately 1 x 106 cells were collected from an exponentially growing BSF 
cell culture (~1 x 106 cells.ml-1), and centrifuged for 5 min at 1000 g. The 
supernatant was then discarded, and the pellet re-suspended in 500 μl of HMI-9 
media, to which 500 μl of 2% formaldehyde was added. The suspension was then 
incubated for 1 h on ice, and then centrifuged at 1000 g for 5 min. The pellet 
was then re-suspended in 1 ml of ice-cold 1x PBS, and centrifuged again. The 
resulting pellet was then re-suspended in 1 ml of 1% BSA in 1x PBS, and 
centrifuged for 5 min at 1000 g. The supernatant was then mostly removed, 
leaving ~30 μl in which the pellet was re-suspended, and then loaded onto each 
well of a 12 multi-well glass slide (Thermo Scientific), previously coated with 
Poly-L-lysine (Sigma Aldrich), and let to settle for 10 min. The wells were then 
washed once in 1x PBS for 5 min, and incubated with 25 μl of 50% FBS (v/v) in 1x 
PBS for 15 min. Following, the cells were incubated with 20 μl of the rabbit α-
VSG 221 antiserum (Prof. David Horn Lab, University of Dundee) diluted 1:10000 
in 3% FBS in 1x PBS, for 1h. Next, the wells were washed twice, 5 min each, with 
1x PBS, and further incubated with 20 μl of Alexa Fluor® 594 conjugated goat α-
rabbit antiserum (Table 2-9) diluted 1:1000 in 3% FBS in 1x PBS, for 1 h, 
protected from light. The wells were then washed twice, 5 min each, with 1x 
PBS, after which 10 μl of Fluoromount G with DAPI (Cambridge Bioscience, 
Southern Biotech) mounting media was added to each well, covered with a 
coverslip, and the slide sealed with regular nail varnish. The protocol was 
adapted from the one routinely used in Professor David Horn’s laboratory, 
University of Dundee. Kindly shared by Dr Lucy Glover. 
2.5.6 Immunofluorescence assay of incorporated EdU in BSF 
cells 
During the course of the RNAi assay, 3 ml of culture were transferred to a vented 
flask, to which 150 mM of EdU was added, and incubated for 4 h at 37°C with 5% 
CO2. The cells were then centrifuged at 1000 g for 5 min, the pellet washed in 
1x PBS, and the cells centrifuged again. The pellet was then re-suspended in 20 
μl of 1x PBS, and loaded onto each well of a 12 multi-well glass slide (Thermo 
Scientific), previously coated with Poly-L-lysine (Sigma Aldrich), and allowed to 
settle for 5 min. The cells were fixed in 3.7% paraformaldehyde for 5 min, and 
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then washed twice, 5 min each, with 3% BSA in 1x PBS. Following, the cells were 
permeabilised with 0.2% Triton X-100 (Promega), diluted in 1x PBS. Afterwards, 
the wells were washed twice, for 5 min each, with 20 μl of 3% BSA in 1x PBS. To 
each well, 25 μl of Click-iT® EdU detection mix (Click-iT® EdU Alexa Fluor® 555 
Imaging Kit – Life Technologies) was added and incubated for 1 h. The EdU 
detection mix (for a volume of 25 μl per well) was prepared just before use, and 
consists of: 21.5μl of 1x Reaction Buffer, 1 μl of copper sulphate (CuSO4), 0.25 μl 
of Alexa Fluor® 555, and 2.5 μl of 1x Reaction Additive, added by this order. 
Each well was then washed 6 times with 3% BSA in 1x PBS, after which 10 μl of 
Fluoromount G with DAPI (Cambridge Bioscience, Southern Biotech) mounting 
media was added to each well, covered with a coverslip, and the slide sealed 
with regular nail varnish. 
2.5.7 Microscopy imaging acquisition and image analysis 
For quantification of localisation and intensity of each protein’s 
(TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc, Tb112012myc and 
TbORC1B12myc) signal throughout the cell cycle, images were acquired using an 
Axioskop 2 fluorescence microscope (Zeiss) attached to a HBO100 lamp and a 
digital ORCA-ER camera and camera controller (Hamamatsu Photonics). In all 
cases, the 63x DIC magnification lens was used. Images were acquired using the 
Volocity® 6.1.1 Cellular Imaging and Analysis software (Perkin Elmer). 
For the acquisition of images with a better resolution, an Olympus IX71 
DeltaVision Core System (Applied Precision, GE) equipped with a CoolSNAP HQ2 
CCD camera (Photometrics®) was used. In all cases, the Olympus 100x/1.40, 
UPLS Apo lens was used, and Z-stacks of 5 μm thick (25 sections of 0.2 μm 
thickness each) were acquired in images with a 512 x 512 resolution using the 
SoftWoRx suite 2.0 software (Applied Precision, GE). Images were deconvolved 
using the ratio conservative method applied by the SoftWoRx software (Applied 
Precision, GE).  
Super resolution structure illumination microscopy was performed using an Elyra 
PS.1 super resolution microscope (Zeiss) equipped with sCMOS PCO camera. In all 
cases, the Plan-Apochromat 63x/1.4 Oil DIC M27 lens was used, and Z-stacks of 4 
μm thick (45 sections of 0.09 μm thickness each) were acquired using the ZEN 
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Black Edition Imaging software (Zeiss). Images were then processed in ZEN Black 
Edition Imaging software (Zeiss), by choosing the structural illumination manual 
processing tool, with a noise filter of -6.0, and an output as SR-SIM (super 
resolution structural illumination microscopy). Microscope handling, image 
acquisition and processing were all done with the essential support of Prof. 
Markus Meissner, Dr Gurman Pall and Carmen Melatti. 
All images were further analysed using Fiji (http://fiji.sc/Fiji) (Schindelin et al., 
2012) in order to generate the images shown in Chapters 3 and 4. In both 
Chapters, all microscopy images shown per figure were obtained from the same 
experiment (same sample and microscopy slide), using the same exposure time, 
and later analysed in Fiji using the same parameters. In cases where brightness 
and contrast were adjusted, the same values were applied to all images being 
processed from the same experiment. In the case of measuring the intensity of 
the detected fluorescent signal (DAPI, myc or EdU), a circular 21 x 21 pixel 
region of interest (ROI) was drawn around each individual cell nucleus. Next, the 
image was treated using the rolling ball background subtraction plugin 
(http://fiji.sc/Rolling_Ball_Background_Subtraction), set up with a radius of 50 
pixels. After the background was removed, the mean pixel intensity within the 
ROI was measured and plotted onto a vertical scatter plot against the 
corresponding cell type (1N1K, 1N1eK, 1N2K, 2N2K), using Prism 6 (GraphPad 
software Inc.). 
2.6 Protein Interactions and Dynamics Assays 
2.6.1 Immunoprecipitation 
2.6.1.1 Preparation of the magnetic beads 
Approximately ~3 x 107 (50 μl) of Dynabeads® M-280 Sheep α-mouse IgG 
(Novex®, Life Technologies) magnetic beads were transferred into a 1.5 ml tube 
(DNase, RNase and protease free). The beads were then washed in 1 ml of cold 
blocking solution (0.5% BSA in 1x PBS, pH 7.2), vortexed gently, and placed on a 
DynaMag™-2 magnet (Life Technologies). The supernatant was discarded, and 
the beads washed again, twice. Finally, the beads were re-suspended in 125 μl 
of blocking solution containing 5 μg of mouse α-myc clone 4A6 antiserum 
(Millipore), and left overnight on mixing rotator, at 4°C.  
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2.6.1.2 Cell lysis 
Around 1.5 x 109 cells were collected from an exponentially growing PCF cell 
culture (~1 x 107 cells.ml-1), and centrifuged for 10 min at 1620 g. The cells were 
then washed once in 1x PBS, and centrifuged again. The pellet was then re-
suspended in 3 ml of whole cell extract buffer (WCE; 50 mM of HEPES pH 7.55, 
100 mM of NaCl, 1 mM of EDTA pH 8, 1 mM of EGTA pH 8, 10% Glycerol, 1% 
Triton X-100, 1 mM of DTT, and 2x complete protease inhibitor cocktail - Roche), 
divided into 3 individual 1.5 ml tubes, 1 ml each, and left on ice for 30 min. The 
lysates were then centrifuged at 15000 g for 30 min, at 4°C, and from the 
supernatant, 900 μl were saved for the immunoprecipitation step, while 30 μl 
were added to 10 μl of 4x NuPAGE® LDS Sample Buffer (Life Technologies), and 
stored at -20°C, as the input sample. Optionally, 2.5 x 106 cells were also 
collected form the cell culture, and the pellet re-suspended in 10 μl of 1x 
NuPAGE® LDS Sample Buffer (Life Technologies) diluted in 1x PBS, and stored at 
-20°C, to be used as a pre-lysis sample. 
2.6.1.3 Immunoprecipitation and Elution 
All steps were performed at 4°C, except otherwise mentioned. The magnetic 
beads were washed three times in blocking solution (as described in section 
2.6.1.1), and re-suspended in 50 μl of blocking solution. To this, 900 μl of cell 
lysate was added, and then incubated for 2 h on a mixing rotator. The 1.5 ml 
tubes were then placed on the magnet, and 30 μl were collected from the 
supernatant, and added to 10 μl of 4x NuPAGE® LDS Sample Buffer (Life 
Technologies), and stored at -20°C, as the flowthrough sample. The remaining 
supernatant was discarded. To the pelleted beads, 1 ml of washing buffer (50 
mM of HEPES pH 7.55, 100 mM of NaCl, 1 mM of EDTA pH 8, 1 mM of EGTA pH 8, 
10% Glycerol, 0.1% Triton X-100, 1 mM of DTT, and 2x complete protease 
inhibitor cocktail) was added, the tube gently shaken, and placed on the mixing 
rotator for 5 min. These washing steps were repeated another three times. After 
the last wash, the supernatant was discarded, and the beads centrifuged for 3 
min at 1000 g. The tubes were placed onto the magnet, and the remainder 
supernatant discarded. The beads were then re-suspended, by gentle vortexing 
and short spin, in 15 μl of 1x NuPAGE® LDS Sample Buffer (Life Technologies) 
diluted in 1x PBS, and incubated for 10 min at 70°C. The samples were then 
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centrifuged for 1 min at 15000 g, room temperature, and placed on the magnet. 
The supernatant was then saved as the elution sample. Because the lysate was 
separated onto three fractions, in the end we will have three eluates that 
correspond to the same original sample. Therefore, these three eluates were 
pooled out into a same final elution sample of 45 μl. All collected samples, pre-
lysis, input, flowthrough and elution, were then incubated for 5 min at 100°C, 
and loaded onto 10 – 12 wells NuPAGE® Novex® 10% Bis-Tris Protein Gels, 1.0 
mm, which were run as described in section 2.2.5.2. For western blot analysis 
(myc-tagged proteins detection), 10 μl of pre-lysis, input, flowthrough samples 
were loaded, while only 1 μl of elution sample was used. The remainder 44 μl of 
elution sample were loaded onto a separate gel, and stained with SYPRO® Ruby, 
as described in section 2.2.5.4. Sections of the gel were then excised using a 
sterile scalpel, stored in a 1.5 ml tube at -20°C, and further sent for mass 
spectrometry analysis at Glasgow Polyomics (University of Glasgow; see below).  
2.6.1.4 Nanoflow HPLC Electrospray Tandem Mass Spectrometry (nLC-ESI-
MS/MS 
The following protocol and analysis were performed at Glasgow Polyomics 
(University of Glasgow) by Dr Christina Naula and Dr Stefan Weidt, under the 
supervision of Dr Richard Burchmore. Protocol provided by Dr Richard 
Burchmore. 
From the received samples, peptides were solubilised in 2% acetonitrile with 
0.1% trifluroacetic acid and fractionated on a nanoflow uHPLC system (Thermo 
RSLCnano). Next, online analysis by electrospray ionisation (ESI) mass 
spectrometry on an Amazon Speed ion trap MS/MS (Bruker Daltonics) was 
performed. Peptide separation was then carried out on a Pepmap C18 reversed 
phase column (LC Packings), and peptides were then desalted and concentrated 
for 4 min on a C18 trap column, followed by an acetonitrile gradient (in 0.1% 
(v/v) formic acid) (3.2 - 32% (v/v) 4 - 27 min, 32% to 80% (v/v) 27 - 36 min, held 
at 80% (v/v) 36- 41 min and re-equilibrium at 3.2%), for a total time of 45 min. A 
solvent flow rate of 0.3 μl.min-1 was used for the analytical column, while the 
trap column solvent flow rate was of 25 μl.min-1, using 2% acetonitrile with 0.1% 
v/v trifluroacetic acid. Mass spectrometric (MS) analysis was performed using a 
continuous duty cycle of survey MS scan, followed by up to ten MS/MS analyses 
Chapter 2  118 
 
 
of the most abundant peptides, choosing the most intense multiply charged ions 
with dynamic exclusion for 120 sec. MS data was then processed using Data 
Analysis software (Bruker) and the automated Matrix Science Mascot Daemon 
server (v2.4.1). Peptides were next identified using the Mascot search engine to 
interrogate protein sequences in the annotated proteins database (TriTrypDB), 
allowing a mass tolerance of 0.4 Da for both MS and MS/MS analyses.  
2.6.2 Co-immunoprecipitation 
Identical to the protocol described in section 2.6.1, but with slight differences. 
Only 5 x 108 cells were collected from an exponentially growing PCF cell culture 
(~1 x 107 cells.ml-1) for lysis, in 1 ml of whole cell extract buffer. All co-
immunoprecipitations presented in this work were performed using the HA-tag as 
“bait”, and therefore the beads were incubated overnight in blocking solution 
with 5 μg of mouse α-HA clone HA-7 antiserum (Sigma Aldrich), as described in 
section 2.6.1.1. All immunoprecipitation, washing, and elution steps were 
performed as described in section 2.6.1.3. All samples were then analysed by 
western blot as described in sections 2.2.5.2 and 2.2.5.3, with the membrane 
being probed for both myc- and HA-tagged proteins detection. 
2.6.3 Cell Fractionation  
Protocol adapted from (Zeiner et al., 2003). Around 5 x 108 PCF cells were 
collected from an exponentially growing PCF cell culture (~1 x 107 cells.ml-1), 
and centrifuged at 1620 g, for 10 min at 4°C. The pellet was then washed twice 
in 5 ml of fractionation buffer (FB; 150 mM of Sucrose, 20 mM of KCl, 3 mM of 
MgCl2, 20 mM of HEPES-KOH, pH 7.9, 1 mM of DTT, and 1x complete protease 
inhibitor cocktail – Roche), and centrifuged at 1620 g, for 10 min at 4°C. The 
pellet was then re-suspended in 1 ml of FB buffer, supplemented with 0.2% (v/v) 
of NP-40. The suspension was then passed through a 26G syringe needle, to 
generate the cell lysate, that was then centrifuged at 20000 g for 10 min at 4°C. 
The supernatant (cytoplasmic fraction) and pellet (nuclear fraction) were then 
separated and treated separately, as follows. The supernatant was then re-
centrifuged twice, at 20,000 g for 10 min at 4°C, each time, transferred to a 
new 1.5 ml tube, and saved at -20°C until analysis by western blot. The pellet 
was then re-suspended in 500 μl of FB buffer, and passed 15x through a 26G 
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syringe needle. The solution was then centrifuged at 20000 g for 10 min at 4°C, 
and the supernatant discarded. The pellet was then rinsed in 500 μl of FB buffer, 
without being re-suspended. Finally, the pellet was re-suspended in 500 μl of FB 
buffer, and stored at -20°C until analysis by western blot. Both cytoplasmic and 
nuclear fractions were then analysed by western blot as described in section 
2.2.5.3, and probed with α-myc antiserum, to detect the myc-tagged protein; α-
NOG1 to detect TbNOG1, or α-H2A to detect histone H2A, and test the presence 
of an exclusively nuclear protein in both fractions; and α-OPB to detect the 
presence of TbOPB, and thus test the presence of a cytoplasmic protein in both 
fractions (antisera information in Table 2-6).  
2.6.4 Gel Filtration 
All steps involving the column and the ÄKTApurifier system were performed by 
Mr Alan Scott (Institute of Infection, Immunity and Inflammation, University of 
Glasgow). 
2.6.4.1 System preparation and column equilibration 
Approximately 24 h before the run, 1 L of running buffer (50 mM of HEPES pH 
7.55, 100 mM of NaCl, 1 mM of EDTA pH 8, 1 mM of EGTA pH 8, 10% Glycerol, 1% 
Triton X-100, 1 mM of DTT, and 0.25x complete protease inhibitor cocktail) was 
prepared, filter sterilised (0.22 μm bottle top filter, Millipore), degasified by 
filtration and kept at 4°C. The column used, HiLoad 16/60 Superdex 200 Prep 
Grade (GE Healthcare Life Sciences), was set up in a ÄKTApurifier system (GE 
Healthcare Life Sciences), and controlled with Unicorn 5.31 software (GE 
Healthcare Life Sciences). By default, the column was kept in 20% Ethanol until 
use. The column was first equilibrated with two column volumes of degasified 
MilliQ water, using a flow rate of 750 µl per min, followed by two column 
volumes of the running buffer, using the same flow rate, before sample 
injection. 
2.6.4.2 Cell lysis 
Around 7.5 x 108 cells were collected from an exponentially growing PCF cell 
culture (~1 x 107 cells.ml-1), and centrifuged at 1620 g for 10 min. The cells were 
washed in 10 ml of 1x PBS, and centrifuged again. The pellet was then re-
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suspended in 2 ml of lysis solution (50 mM of HEPES pH 7.55, 100 mM of NaCl, 1 
mM of EDTA pH 8, 1 mM of EGTA pH 8, 10% Glycerol, 1% Triton X-100, 1 mM of 
DTT, and 2x complete protease inhibitor cocktail), and incubated on ice for 30 
min. The 2 ml of lysate were then transferred into a 2.2 ml thin wall propylene 
centrifuge tubes (11 x 35 mm) (Beckman Coulter), and centrifuged at 100000 g 
for 1 h, at 4°C, using an Optima™ TL Ultracentrifuge (Beckman Coulter) 
equipped with a TLS 55 rotor (Beckman Coulter). The lysate was then filtered 
(0.2 μm Ministart® Syringe Filter, Sartorius), and 30 μl were added to 10 μl of 4x 
NuPAGE® LDS Sample Buffer (Life Technologies), and stored at -20°C, as the 
lysis sample, while the remainder volume was used for the gel filtration. 
2.6.4.3 Gel filtration run and fraction collection  
The 2 ml of lysate were injected into the ÄKTApurifier system, and run in a total 
of 210.8 ml of running buffer at a flow rate of 500 µl.min-1. Fractions of 1 ml 
were collected into ABgene 2.2 ml 96-well storage plates (Thermo Scientific) for 
further analysis. Fractions collected immediately before the void volume peak, 
from 43 ml (corresponding to around 2116 kDa) down to 84 ml (corresponding to 
48 kDa, according to the standards used) of eluted volume, were used (40 µl 
from each fraction) for further western blot analysis, as described in sections 
2.2.5.2 and 2.2.5.3. 
2.7 Fluorescence-Activated Cell Sorting (FACS) 
In all cases, the BD FACSAria I™ Cell Sorter system set up and calibration were 
performed by Ms Diane Vaughan and Mr Craig Lapsley (Flow Cytometry 
Laboratory, Institute of Infection, Immunity and Inflammation, University of 
Glasgow). 
2.7.1 FACS of T. brucei PCFs 
Approximately 1 x 109 cells were collected from an exponentially growing PCF 
culture (~1 x 107 cells.ml-1), and centrifuged for 10 min at 1620 g. The pellet was 
then washed in 10 ml of 1x PBS supplemented with 5 mM of EDTA (Gibco®), and 
centrifuged for 10 min at 1620 g. Next, the cells were re-suspended in 12 ml of 
1x PBS supplemented with 5 mM of EDTA, to which to which 28 ml of 100% ice 
cold-Methanol was added, in a drop-wise fashion while vortexing gently, so that 
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the final fixing solution was of 70% (v/v) Methanol, and the cell concentration of 
2.5 x 107 cells.ml-1. The tube was wrapped in aluminium foil paper and kept at 
4°C from overnight up to three weeks. For every FACS sorting run, four FACS 
tubes (Becton Dickinson) were prepared, each starting with 4 ml of fixed cells 
(~1 x 108 cells). The cells were collected and centrifuged for 10 min at 1000 g, 
at 4°C, washed in 1 ml of 1x PBS supplemented with 5 mM of EDTA, and 
centrifuged again for 10 min at 1000 g, at 4°C. The pellet was then re-suspended 
in 4 ml of 1x PBS supplemented with 5 mM of EDTA, 10 μg.ml-1 of PI (Sigma 
Aldrich) and 10 μg.ml-1 of RNase A (Sigma Aldrich), and incubated for 45 min at 
37°C, in the dark. The cells were then transferred to a FACS tube through a cell 
strainer cap (BD Biosciences), and sorted into G1, early S, late S and G2 phases 
using a BD FACSAria I™ Cell Sorter (BD Biosciences). An average of 1 x 107 cells 
were recovered for the G1 subset, 1 x 106 cells for both early and late S phases, 
and 3 x 106 cells for G2 phase, per FACS sorting session (three sessions were 
done in total for each T. brucei strains). The sorted cells were collected at 4°C 
into new FACS tubes containing 200 μl of lysis buffer (1 M NaCl, 10 mM EDTA, 50 
mM Tris-HCL pH 8.0, 0.5% SDS, 0.4 mg.ml-1 Proteinase K, and 0.8 μg.ml-1 of 
Glycogen) (Azuara, 2006). The collected cells were then incubated for 2 h at 
55°C, and the lysate was stored at -20°C until gDNA extraction (section 2.7.4). 
2.7.2 FACS of T. brucei BSFs 
For each sorting session, approximately 3 x 108 cells were collected from an 
exponentially growing BSF cell culture (~1 x 106 cells.ml-1), and centrifuged for 
10 min at 1000 g. For each pellet containing around 1 x 108 cells (resulting from 
each 100 ml cultures), cells were then re-suspended in 25 ml of 1x PBS and 
centrifuged for 10 min at 1000 g. The pellet was then re-suspended in 500 μl of 
1x PBS, and 9.5 ml of 1% Formaldehyde (methanol-free, Thermo Scientific) 
diluted in 1x PBS was added. The cells were fixed for 10 min at room 
temperature, and then centrifuged for 10 min at 1000 g, washed once in 10 ml 
1x PBS, and centrifuged again for 10 min at 1000 g. The pellet was next re-
suspended in a final volume of 1x PBS so to have a concentration of 2.5 x 107 
cells.ml-1, and was stored protected from light at 4°C overnight. The fixed cells 
were centrifuged for 10 min at 1000 g, and then re-suspended and incubated in 
20 ml of 0.01% Triton X-100 (Promega) in 1x PBS for 30 min at room 
temperature. The cells were then centrifuged for 10 min at 700 g, washed in 20 
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ml of 1x PBS, and centrifuged again. The resulting pellet was then re-suspended 
in a final volume of 1x PBS with 10 μg.ml-1 of PI (Sigma Aldrich) and 100 μg.ml-1 
of RNase A (Sigma Aldrich) so to have a concentration of ~2.5 x 107 cells.ml-1, 
and were incubated for 1 h at 37°C, protected from light. The cells were then 
transferred to a FACS tube through a cell strainer cap (BD Biosciences), and 
sorted into G1, early S, late S and G2 phases using a BD FACSAria I™ Cell Sorter 
(BD Biosciences). An average of 5 x 106 cells were recovered for the G1 subset, 
1.5 x 106 cells for both early and late S phases, and 4 x 106 cells for G2 phase, 
per FACS sorting session (two sessions were done in total). The sorted cells were 
collected at 4°C into new FACS tubes containing 200 μl of lysis buffer (1 M NaCl, 
10 mM EDTA, 50 mM Tris-HCL pH 8.0, 0.5% SDS, 0.4 mg.ml-1 Proteinase K, and 
0.8 μg.ml-1 of Glycogen) (Azuara, 2006). After the sorting has been completed, 
the collected cells were then incubated for 2 h at 55°C, and the lysate was 
stored at -20°C until gDNA extraction (section 2.7.4). 
2.7.3 FACS of L. major and L. mexicana promastigotes 
For these assays, Leishmania major strain Friedlin and Leishmania mexicana 
strain U1103 promastigote cell cultures were kindly set up by Dr Amy Goundry 
(Jeremy Mottram’s laboratory), in 150 ml of modified Eagle’s medium 
(designated HOMEM medium, Gibco®), supplemented with 10% (v/v) FCS and 1% 
(v/v) penicillin-streptomycin solution (Sigma Aldrich), and incubated at 25°C. 
Approximately 1 x 109 cells were collected from an exponentially growing 
promastigote cell culture (~5 x 106 cells.ml-1), and centrifuged for 10 min at 
1000 g. The pellet was then washed in 10 ml of 1x PBS supplemented with 5 mM 
of EDTA (Life Technologies), and centrifuged for 10 min at 1000 g. Next, the 
cells were re-suspended in 12 ml of 1x PBS supplemented with 5 mM of EDTA, to 
which to which 28 ml of 100% ice cold-Methanol was added, in a drop-wise 
fashion while vortexing gently, so that the final fixing solution was of 70% (v/v) 
Methanol, and the cell concentration of 2.5 x 107 cells.ml-1. The tube was 
wrapped in aluminium foil paper and kept at 4°C from overnight up to three 
weeks. For every FACS sorting run, four FACS tubes were prepared, each starting 
with 4 ml of fixed cells (1 x 108 cells). The cells were collected and centrifuged 
for 10 min at 1000 g, at 4°C, washed in 1 ml of 1x PBS supplemented with 5 mM 
of EDTA, and centrifuged again for 10 min at 1000 g, at 4°C. The pellet was then 
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re-suspended in 4 ml of 1x PBS supplemented with 5 mM of EDTA, 10 μg.ml-1 of 
Propidium Iodide (Sigma Aldrich) and 10 μg.ml-1 of RNase A (Sigma Aldrich), and 
incubated for 45 min at 37°C, in the dark. The cells were then transferred to a 6 
ml BD Falcon tube through a cell strainer cap, 35 μm nylon mesh, (BD 
Biosciences), and sorted into G1, early S, late S and G2 phases using a BD 
FACSAria I™ Cell Sorter (BD Biosciences). An average of 1 x 107 cells were 
recovered for the G1 subset, 1 x 106 cells for both early and late S phases, and 3 
x 106 cells for G2 phase, per FACS sorting session (three sessions were done in 
total for each Leishmania species). The sorted cells were collected at 4°C into 
new FACS tubes containing 200 μl of lysis buffer (1 M NaCl, 10 mM EDTA, 50 mM 
Tris-HCL pH 8.0, 0.5% SDS, 0.4 mg.ml-1 Proteinase K, and 0.8 μg.ml-1 of 
Glycogen) (Azuara, 2006). After the sorting has been completed, the collected 
cells were then incubated for 2 h at 55°C, and the lysate was stored at -20°C 
until gDNA extraction (section 2.7.4). 
2.7.4 gDNA extraction of post-FACS samples 
gDNA was extracted using the Blood and Tissue DNA extraction kit, from Qiagen, 
with some adaptations to the manufacturer’s protocol. The lysates from the 
different FACS sorting sessions were thawed at 37°C, and pooled out per cell 
cycle stage. One-third volume of 100% ethanol was then added, the resulting 
solution thoroughly vortexed, and then transferred into a DNeasy Mini spin 
column (Qiagen). The column was then centrifuged for 1 min at 6000 g, and the 
flow through discarded; this step was repeated until all volume had been passed 
through the column. The column was then washed in 500 μl of Buffer AW1, and 
again centrifuged for 1 min at 6000 g, discarding the flowthrough. Next, 500 μl 
of Buffer AW2 were added, and the column was centrifuged for 3 min at 20000 
g, after which the flowthrough was discarded. The gDNA was then eluted in 50 μl 
of Buffer AE, and stored at -20°C until further use. 
2.7.5 Whole cell extract preparation of post-FACS PCF samples 
In the case of analysis by western blot, FACS of PCF cells was performed as 
described in section 2.7.1, but instead of collecting the cells in lysis buffer, the 
cells were collected into 1x PBS supplemented with 5 mM of EDTA. The collected 
cells were then transferred from the collection tubes into 1.5 ml tubes and 
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centrifuged at 2000 g for 10 min. The supernatant was discarded and the pellets 
pooled out per sorting group, repeating the centrifugation step several times. 
Finally, for each sorting group, the pellet was then re-suspended in 10 μl 1x 
NuPAGE® LDS Sample Buffer (Life Technologies), and used for western blot 
analysis as mentioned in sections 2.2.5.2 and 2.2.5.3. 
2.8 Marker Frequency analysis (MFA) 
2.8.1 MFA by deep sequencing (MFA-seq) 
2.8.1.1 DNA Library preparation and sequencing 
Using the gDNA extracted from sorted samples of T. brucei PCFs strain TREU 
927, and L. major and L. mexicana promastigotes, DNA libraries were prepared 
using the Nextera® XT DNA Sample Preparation kit (Illumina), by staff at 
Glasgow Polyomics (University of Glasgow). The libraries were the sequenced 
using the Illumina MiSeq paired-end 250bp sequencing system (Illumina), at 
Glasgow Polyomics (University of Glasgow). In all cases, the samples were 
multiplexed with each of the early S, late S, and G2 phases per species/strain in 
the same run for ease of comparison. In contrast, gDNA from T. brucei PCF and 
BSF Lister 427 cells was sent for sequencing at Eurofins Genomics (Germany). 
The DNA library was prepared using the TruSeq® DNA Sample Preparation kit 
(Illumina), and sequenced using Illumina HiSeq paired- end 100 bp sequencing 
system (Illumina). The samples were multiplexed, with each of the early S, late 
S, and G2 phase samples library DNA, both from BSF and PCF, being processed in 
the same run, for ease of comparison.  
2.8.1.2 Whole genome deep sequencing results analysis 
All program coding and pipeline design was conceived and developed by Dr 
Nicholas J. Dickens (Wellcome Trust Centre for Molecular Parasitology 
Bioinformatics team, University of Glasgow). The generic programming code is 
shown in the appendices section 7.8, with notes. 
Data resultant from the sequencing was firstly analysed for quality control using 
FastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), and 
then trimmed using fastq-mcf (Aronesty, 2011) (http://code.google.com/p/ea-
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utils), to exclude the adapter sequences used during the library preparation and 
sequencing. The reads were then aligned to the respective reference genomes 
(T. brucei TREU 927, L. major Friedlin, and L. mexicana U1103 reference 
genomes were retrieved from TriTrypDB version 6.0; T. brucei Lister 427 was 
retrieved from TriTrypDB version 8.0) using Bowtie2 (version 2.2.0 --very-
sensitive-local -k1) (Langmead and Salzberg, 2012). The aligned reads were then 
compared using a method adapted from the one described previously (Tiengwe 
et al., 2012a), but simplified to facilitate inter-species comparisons. Briefly, the 
reads were binned in 2.5 Kbp sections along each chromosome, and the number 
of reads in each bin was then used to calculate the ratios between early S and 
G2, as well as between late S vs G2 samples, scaled for the total size of the read 
library (reads per 2.5 Kbp per million reads mapped). These data were then 
represented in a graphical form using ggplot2 and the R package (version 3.0.2) 
(R Development Core Team, 2010), or Prism 6 (GraphPad software Inc.) 
2.8.2 MFA by Quantitative Real-Time PCR  (MFA-qPCR) 
A strategy employed previously (Tiengwe et al., 2012a) was used, following the 
MIQE guidelines (Bustin et al., 2009). Primers (Table 2-10) were designed for 
several regions across L. major chromosomes 8, 20, 29, 34 and 36, as well as L. 
mexicana chromosomes 8 and 20, using Primer Express version 3.0 (Bio Rad), and 
according to the guidelines (Alvarez-Fernandez, 2013; Dymond, 2013) for 
primers to be used in qPCR. Primer sizes ranged from 17-24 bp, with melting 
temperatures from 58-60°C, resulting in amplicons of 55-113 bp with melting 
temperatures from 79-85°C. Primer efficiency and specificity was assessed for 
all pairs of primers by the analysis of calibration curves and melting profiles, 
respectively, which resulted in efficiencies of approximately 100%, all within a 
12% interval. For normalization, two different genes were used independently as 
reference: LmjF.34.3440 (I2 pair) was used for chromosome 34 mapping, and 
LmjF.36.1980 (equivalent to LmxM.36.1980 in L. mexicana; R3 pair) was used for 
the fusion chromosomes mapping. For each pair of primers, triplicates of each 
sample (early S and G2 phases) were run per plate (MicroAmp® Optical 96-well 
Reaction Plate, Life Technologies), which were sealed with MicroAmp® clear 
adhesive film (Life Technologies). SYBR Select Master Mix (Life Technologies) 
was used, together with 400 nM of primers (Eurofins MWG Operon, Ebersberg, 
Germany) and 0.01 ng of sample gDNA, to a total of 20 μl per reaction. All 
Chapter 2  126 
 
 
experiments were run in a 7500 Real Time PCR system (Applied Biosystems), 
using the following PCR cycling conditions: 50 °C for 2 min and 95 °C for 2 min, 
followed by 40 cycles of 95 °C for 15 sec, 59 °C for 15 sec, and 72 °C for 1 min. 
Fluorescence intensity data was collected at the end of the extension step (72 
°C for 1 min). The resulting fluorescence intensity data were then exported to 
Excel, and analysed by relative quantification using the ΔΔCt method (Livak and 
Schmittgen, 2001), using the G2 phase sample as the calibrator. Graphs were 
generated using Prism 6 (GraphPad software Inc.). 
Table 2-10. Primers used for MFA-qPCR analysis.  
 
Number Primer Name Gene ID Sense Sequence 
Chr. 
region 
C 222 LmjF_A1_fwd 
LmjF.34.0520 
Fwd CAACCCTCTCAGATGGGCATT 
A 
C 223 LmjF_A1_rev Rev GTGACCCGTCTTCGTCATCTC 
C 228 LmjF_B1_fwd 
LmjF.34.0670 
Fwd TGGCTGGGTGTGTACATTTCC 
B 
C 229 LmjF_B1_rev Rev CTTGGTACTGCGCAAAATGGT 
C 230 LmjF_B2_fwd 
LmjF.34.0710 
Fwd CAGGCGAAGTTAGTGCGAAAG 
B 
C 231 LmjF_B2_rev Rev GTTCTCCGGTGACAAACTGATG 
C 232 LmjF_C1_fwd 
LmjF.34.1000 
Fwd AAGCAGTGCACACCCCACTAC 
C 
C 233 LmjF_C1_rev Rev AAGAAGTTGGCCCGCTTCA 
C 266 LmjF_L2_fwd 
LmjF.34.1500 
Fwd CGCTCCGTAGATCTGAGCATT 
L 
C 267 LmjF_L2_rev Rev CTGTGGGTTGCTCGTAATAGCA 
C 234 LmjF_D1_fwd 
LmjF.34.2020 
Fwd CGCCGTTCCCATTTACGT 
D 
C 235 LmjF_D1_rev Rev TGTTCCAGCTCATGGACATAGC 
C 238 LmjF_E1_fwd 
LmjF.34.2190 
Fwd GGGCATGTTTGGCGACAT 
E 
C 239 LmjF_E1_rev Rev GAAATGCTCTGCTCGCTGATG 
C 240 LmjF_F1_fwd 
LmjF.34.2450 
Fwd TGACCGAGTGATGGAGTCCTT 
F 
C 241 LmjF_F1_rev Rev CCTTGATCACTGTGCCATCCT 
C 268 LmjF_G3_fwd 
LmjF.34.2520 
Fwd CCATCTGCGAGGGTGTGATACT 
G 
C 269 LmjF_G3_rev Rev GATCAAGTCGCTAAAGCAGTCCTT 
C 252 LmjF_H3_fwd 
LmjF.34.2670 
Fwd AGGGTCTGCAGTACGCTGTCTT 
H 
C 253 LmjF_H3_rev Rev GCCATGTGGTTGAACTTGAGGTA 
C 260 LmjF_J2_fwd 
LmjF.34.3750 
Fwd TTTGTGTGCTGGCAGCTACAC 
J 
C 261 LmjF_J2_rev Rev GCAACTGACGCCTTCCACAT 
C 262 LmjF_K1_fwd 
LmjF.34.3930 
Fwd CCGCGAACTGCAAAGTACGT 
K 
C 263 LmjF_K1_rev Rev TTGTCGACCGTCGTGTGAAT 
C 256 LmjF_I2_fwd 
LmjF.34.3440 
Fwd GGCTGGCAACATGAAGTACGT 
I 
C 257 LmjF_I2_rev Rev CCATGTCAGACTGTCCCTTGAC 
C 276 LPhu_N1_Fwd 
LmjF.29.0030 
Fwd CGATGTCGGGACTTACGTAAAGT 
N 
C 277 LPhu_N1_Rev Rev TCCACAGCGTGTATCCTTTCG 
C 280 LPhu_N3_Fwd 
LmjF.08.0090 
Fwd CAGCCTCTACCGCGTCTTTC 
N 
C 281 LPhu_N3_Rev Rev TCTCCTTCAGTCGGACGTATGTC 
C 270 LPhu_M2_Fwd 
LmjF.29.0810 
Fwd CATCATGATCAAGACCCTCGAGTA 
M 
C 271 LPhu_M2_Rev Rev GGCGACTTCGCAGCTTCTC 
C 274 LPhu_M4_Fwd 
LmjF.29.0930 
Fwd ACTCGACTGCGCCTCATTG 
M 
C 275 LPhu_M4_Rev Rev TGACAGGAGAGGGACGAAGAG 
C 302 LPhu_O2_Fwd 
LmjF.29.2060 
Fwd AGCCACCTTTAACGCCATTGT 
O 
C 303 LPhu_O2_Rev Rev GGAACAGGAGGCCATCGAA 
C 306 LPhu_P2_Fwd 
LmjF.08.0260 
Fwd CAACAAGTCGGCCACTTACAAG 
P 
C 307 LPhu_P2_Rev Rev CGCCACATCTGCCATGAG 
C 308 LPhu_P3_Fwd 
LmjF.08.0360 
Fwd CCCTCCGCCACAATGAG 
P 
C 309 LPhu_P3_Rev Rev TTCGCCCACGCTAGTATCG 
C 282 LPhu_Q1_Fwd LmjF.08.1000 Fwd GGAACCTGACCTACCCCTTCTC Q 
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C 283 LPhu_Q1_Rev Rev GTCGAAGTTGAAGACGTTGTTGA 
C 288 LPhu_R2_Fwd 
LmjF.36.1900 
Fwd CCACACACTCGCCTCTTACTACA 
R 
C 289 LPhu_R2_Rev Rev AGCTCAGGGTCACGCAAAAG 
C 310 LPhu_S1_Fwd 
LmjF.36.2830 
Fwd TGCGGAGCGCAAGAATG 
S 
C 311 LPhu_S1_Rev Rev GGCGAGGCGGAACATCT 
C 314 LPhu_S3_Fwd 
LmjF.36.3000 
Fwd TGTGGGAGGAAACAATCAGCTT 
S 
C 315 LPhu_S3_Rev Rev GTGGCGGAGAGGAAAACGTA 
C 292 LPhu_T1_Fwd 
LmjF.36.3790 
Fwd GCACACACGGTACTGCTTCAA 
T 
C 293 LPhu_T1_Rev Rev CACGGGCTAAGCGCACTAG 
C 294 LPhu_U1_Fwd 
LmjF.20.0705 
Fwd TGGGCTAGCTCCTTCTTTCACT 
U 
C 295 LPhu_U1_Rev Rev TTCGTCCTTGAGCTTGTACTTGAC 
C 296 LPhu_V1_Fwd 
LmjF.20.1210 
Fwd GTCGCCGCAACCAGTACAT 
V 
C 297 LPhu_V1_Rev Rev CCGGAGAAGTGCTGGTACA 
C 298 LPhu_W1_Fwd 
LmjF.20.1530 
Fwd TCCGCTGTTTGACGTGTATAGC 
W 
C 299 LPhu_W1_Rev Rev TCAACTCCTCCACCTTGCATATC 
C 290 LPhu_R3_Fwd 
LmjF.36.1980 
Fwd GAGGTTCATGAGCTTGGGTTTAA 
R3 
C 291 LPhu_R3_Rev Rev TGCAAGGGAACAGGTGGTTT 
 
2.9 Analysis of Origins of DNA Replication Features in 
Leishmania and Trypanosoma brucei 
2.9.1 Strand switch region size analysis 
Strand switch regions (SSRs) containing origins were identified, and viewed on 
‘genome browser’ using TriTrypDB version 8.0 (http://tritrypdb.org/tritrypdb/). 
The distance between the two most proximal genes within the SSR (divergent, 
convergent, or head-to-tail) was measured by subtracting the coordinates of the 
stop or start codon of the gene to the left of the SSR from the coordinates of the 
stop or start codon of gene on the right. The same was performed for other 
SSRs, where origins were not detected. The size of the distance between genes 
at the SSRs was then plotted onto a vertical scatter plot using Prism 6 (GraphPad 
software Inc.). 
2.10 Statistical Analysis 
All statistical analyses were performed using Prism 6 (GraphPad software Inc.). 
The statistical tests used (Cann, 2003) are described in the figure legend of the 
corresponding graph, and the reasons for their specific application are explained 
in the main text of Chapters 3, 4 and 5.  
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3 Analysis of putative Origin Recognition 
Complex factors in T. brucei procyclic form cells  
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3.1 Introduction 
Until recently, very little was known about how nuclear DNA replication is 
initiated in T. brucei. Sequencing of the T. brucei genome (El-Sayed et al., 
2005a) has been invaluable in understanding how this process might be carried 
out and, together with various studies in the last few years, has started to 
suggest a surprising scenario: it appears that T. brucei possesses a conserved 
molecular machinery acting in replication fork establishment and synthesis (El-
Sayed et al., 2005a; Tiengwe et al., 2012b; Kaufmann et al., 2012; Liu et al., 
2009; Kim et al., 2013; Tiengwe et al., 2013; Li, 2012), while components of the 
pre-replication complex (pre-RC) appear to be considerably diverged (Tiengwe 
et al., 2012b; Tiengwe et al., 2013; Dang and Li, 2011; Godoy et al., 2009; El-
Sayed et al., 2005a). 
Initial analysis of the kinetoplastid genomes (El-Sayed et al., 2005a) was only 
able to identify a single putative ORC subunit, an orthologue of both the Orc1 
subunit and Cdc6, as these two proteins are believed to be paralogues (Duncker 
et al., 2009; Giraldo, 2003). The inability to identify the remaining subunits of 
ORC (Orc2-6), or Cdc6 and Cdt1, led to the suggestion that the T. brucei and 
related kinetoplastid initiation machineries could resemble that found in the 
majority of archaeal organisms (El-Sayed et al., 2005a; Godoy et al., 2009), 
where a single factor, orthologous to both eukaryotic Orc1 and Cdc6, fulfils the 
role of the 6-subunit eukaryotic ORC (reviewed in Lindas and Bernander, 2013). 
Consequently, the only identified T. brucei Orc-like factor was named 
TbORC1/CDC6 (Godoy et al., 2009). This hypothesis was somewhat undermined 
by later studies that identified four further potential Orc-like factors, all of 
which have been shown to interact with TbORC1/CDC6 in procyclic form (PCF) 
cells (Dang and Li, 2011; Tiengwe et al., 2012b). These factors include another 
putative Orc1-like factor, TbORC1B, which was identified through searching the 
parasite’s genome using Orc1 protein sequences from various organisms as 
queries (Dang and Li, 2011), and a highly divergent putative orthologue of the 
Orc4 subunit, TbORC4, identified via immunoprecipitation (IP) of TbORC1/CDC6 
(Tiengwe et al., 2012b). The two other factors, Tb7980 and Tb3120, were also 
identified as a result of TbORC1/CDC6 IP, although no orthology could be found 
between these and eukaryotic ORC factors, perhaps suggesting kinetoplastid 
specificity (Tiengwe et al., 2012b).  
Chapter 3  130 
 
 
Sequence analysis of the above factors revealed great divergence from ORC 
proteins in other eukaryotes. DNA replication initiator factors, including the 
Orc1-5 subunits of ORC and Cdc6, are members of the DnaA/CDC6/ORC clade of 
the AAA+ superfamily of ATPases (Iyer et al., 2004), although the Orc2 and Orc3 
subunits appear to be more distantly related (Duncker et al., 2009). Sequence 
analyses of TbORC1/CDC6 (Godoy et al., 2009) and TbORC1B (Dang and Li, 2011) 
identified AAA+ domains, while examination of TbORC4 (Tiengwe et al., 2012b) 
and Tb7980 (Tiengwe et al., 2013) suggested potentially degenerate AAA+ 
domains. Scrutiny of the Tb3120 sequence however, did not reveal any AAA+ 
domain homology. Detailed and updated analysis of signature motifs in the 
predicted AAA+ domains of the T. brucei proteins is described below (section 
3.2.3). Another common feature of some ORC subunits and Cdc6 is the presence 
of a C-terminal winged-helix domain (WHD), which is responsible for DNA binding 
(reviewed in Duncker et al., 2009). This domain however, has only been 
predicted in TbORC1/CDC6, though with poor conservation (Godoy et al., 2009). 
An N-terminal bromo-adjacent homology (BAH) domain is a signature domain of 
eukaryotic Orc1 subunits that mediates interaction with transcriptional silencing 
factors and chromatin (reviewed in Duncker et al., 2009; Costa et al., 2013). No 
such domain has been described in TbORC1/CDC6 or any of the other T. brucei 
proteins, including TbORC1B (Dang and Li, 2011). 
Several studies have investigated the functions of TbORC1/CDC6 and it’s 
interacting partners (Godoy et al., 2009; Benmerzouga et al., 2013; Tiengwe et 
al., 2012b) by individual expression downregulation through inducible RNA 
interference (RNAi). In PCF cells, RNAi of each factors resulted in a very similar 
phenotype, in which cellular growth was impaired only after prolonged RNAi, 
and enucleated cells (0N1K, termed zoids) (Robinson et al., 1995) accumulated 
in the cell population (Godoy et al., 2009; Benmerzouga et al., 2013; Tiengwe et 
al., 2012b). To date, no RNAi of TbORC1B has been described. In addition, the 
role of only TbORC1/CDC6 in nuclear DNA replication has been assessed 
(Benmerzouga et al., 2013): incorporation of bromo-5’-deoxyuridine (BrdU), a 
thymidine analogue, was shown to be reduced following RNAi. Like other 
eukaryotic Orc1 factors (Lygerou and Nurse, 1999; Tatsumi et al., 2000; Liang 
and Stillman, 1997; Asano and Wharton, 1999), TbORC1/CDC6 was shown to 
localise, potentially as puncta, to the nucleus of PCF cells throughout the cell 
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cycle, during which it was confirmed to bind to chromatin (Godoy et al., 2009). 
No such localisation has been described for any of the TbORC1/CDC6 interacting 
factors.  
The above summary demonstrates that, although some light has been shed on 
DNA replication in T. brucei, many questions remain. Although TbORC1B, 
TbORC4, Tb7980 and Tb3120 have been shown to interact with TbORC1/CDC6 
(Tiengwe et al., 2012b; Dang and Li, 2011), clear evidence that these have 
replication-associated functions is lacking. In addition, though it has been 
suggested that all these factors may interact in an ORC-like complex (Li, 2012), 
presently, the available data is insufficient to allow such a conclusion to be 
reached (Tiengwe et al., 2013). Moreover, it is also not known if further factors 
interact with TbORC1/CDC6, including in such a complex. For instance, although 
not published (Tiengwe et al., 2012b), other hits were retrieved from the 
TbORC1/CDC6 IP assay that identified TbORC4, Tb7980 and Tb3120 as 
TbORC1/CDC6-interacting partners (Tiengwe, 2010). One of these was 
Tb927.6.1120 (here referred to as Tb1120), which was actually the ‘top’ hit 
obtained (14 peptides, comparing to the 10 peptides that identified TbORC4) in 
the assay but, due to the lack of discernible homology with any replication-
related factor, it was not analysed further (Tiengwe, 2010).  
In this chapter, several techniques are employed to try to answer the above 
questions and, ultimately, better understand how initiation of DNA replication is 
controlled in T. brucei. New analysis of the protein sequences of TbORC1/CDC6, 
TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120 are described (section 3.2), the 
role of some of these factors in DNA replication is investigated and compared 
with TbORC1/CDC6 (section 3.3), as is localisation of these proteins throughout 
the cell cycle (section 3.5). Finally, the question of whether there is an ORC-like 
complex or in T. brucei is examined (section 3.6). 
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3.2 TbORC1/CDC6-binding partners are highly divergent 
from characterised eukaryotic ORC-subunits 
Previous work has described domains and motifs present in the protein 
sequences of TbORC1/CDC6 and its interacting partners (Godoy et al., 2009; 
Dang and Li, 2011; Tiengwe et al., 2012b; Tiengwe et al., 2013). Nevertheless, 
because most of the protein domain, motif and solved structure databases are 
updated frequently (Finn et al., 2014; Roy et al., 2010; Källberg et al., 2012; 
Hunter et al., 2012), we sought to re-examine the proteins’ sequences, and 
combine information obtained through new online tools (described throughout 
this section) to ask if more insight into putative orthology and functions is 
discernible. The protein sequences of TbORC1/CDC6 (Tb927.11.7216), TbORC1B 
(Tb927.9.2030), TbORC4 (Tb927.10.13380), Tb7980 (Tb927.10.7980), Tb3120 
(Tb927.9.4530) and Tb1120 (Tb927.6.1120) were obtained from TriTrypDB 
database (http://tritrypdb.org/tritrypdb/) and used independently as queries in 
the different search engines used. 
3.2.1 Basic Local Alignment Search Tool (BLAST) search  
An initial analysis was conducted using the standard protein-protein Basic Local 
Alignment Search Tool (BLAST) (blastp) (http://blast.ncbi.nlm.nih.gov/Blast.cgi) 
(Altschul et al., 1990), in which each putative T. brucei Orc-like factor protein 
sequence was used as query against the non-redundant protein sequences 
database (nr) (Li et al., 2013). The main purpose of this analysis was to identify 
similar protein sequences available in the database and, if possible, infer 
function or homology.  
As expected, analysis of TbORC1/CDC6 and all its interacting factors retrieved 
orthologues in most other kinetoplastid organisms, including Trypanosoma cruzi 
and most of the Leishmania species (only L. major and L. mexicana represented 
in Table 3-1, together with two strains of T. cruzi). This suggests that these 
factors are conserved throughout the kinetoplastid grouping. Indeed, analysis of 
genomic localisation of the orthologous genes in the different organisms (T. 
brucei, T. cruzi, L. major and L. mexicana) reveals that these are, as expected, 
syntenic in each genome (shown in the appendices, Figure 7.1).  
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Table 3-1.Orthologues of T. brucei TbORC1/CDC6 and its interacting factors in other 
kinetoplastids.  
Orthologues of TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120, in L. major, L. 
mexicana, and T. cruzi (both CL Brener Esmeraldo-like, CLB EL, and Non-Esmeraldo-like, CLB 
NEL, strains). Gene identification numbers as in TriTrypDB, version 8.1. database. E-values and 
percentage sequence identity as retrieved by blastp searches performed in November 2014. 
blastp query L. major L. mexicana T. cruzi CLB EL T. cruzi CLB NEL 
TbORC1/CDC6 
LmjF.28.0030 LmxM.28.0030 TcCLB.508239.10 TcCLB.511159.20 
e-value Identity e-value Identity e-value Identity e-value Identity 
4e-168 55% 2e-168 55% 0.0 79% 0.0 78% 
TbORC1B 
LmjF.26.2210 LmxM.26.2210 TcCLB.507939.14 TcCLB.508119.150 
e-value Identity e-value Identity e-value Identity e-value Identity 
3e-35 42% 1e-33 42% 3e-152 52% 0.0 55% 
TbORC4 
LmjF.18.0720 LmxM.18.0720 TcCLB.506357.20 TcCLB.511277.92 
e-value Identity e-value Identity e-value Identity e-value Identity 
1e-61 42% 8e-65 45% 0.0 54% 0.0 54% 
Tb7980 
LmjF.36.6700 LmxM.36.6700 - TcCLB.506247.280 
e-value Identity e-value Identity e-value Identity e-value Identity 
3e-103 41% 5e-106 43% - - 0.0 66% 
Tb3120 
LmjF.01.0660 LmxM.01.0660 TcCLB.511585.90 TcCLB.510155.90 
e-value Identity e-value Identity e-value Identity e-value Identity 
6e-59 31% 2e-61 32% 0.0 48% 0.0 48% 
Tb1120 
LmjF.12.0180 Lmxm.12.0180 TcCLB.507603.170 TcCLB.509429.240 
e-value Identity e-value Identity e-value Identity e-value Identity 
3e-36 31% 4e-39 33% 2e-175 42% 2e-170 41% 
 
TbORC1/CDC6 was the first initiator factor to be identified and characterised in 
trypanosomatids due to its similarity to other eukaryotes’ Orc1 and Cdc6 protein 
sequences (El-Sayed et al., 2005a; Godoy et al., 2009). Therefore, it was not 
surprising that the TbORC1/CDC6 search retrieved a large number of Orc1 and 
Orc1-like proteins as main hits, with high confidence (the e-values of the first 
1000 hits ranged from 3e-154 to 3e-07). Due to the high number of hits (>2000), 
only a small sample of these is represented in Table 3-2. Amongst these were 
several Orc1 factors that have been experimentally characterised, including the 
protein from Saccharomyces cerevisiae (Liang and Stillman, 1997), 
Schizosaccharomyces pombe (Lygerou and Nurse, 1999), the domestic mouse 
(Zisimopoulou et al., 1998), humans (Tatsumi et al., 2000) and Caenorhabditis 
elegans (Sonneville et al., 2012) (Table 3-2). As expected, since Orc1 and Cdc6 
proteins have long been suggested to be paralogues (Giraldo, 2003), several 
Cdc6 and predicted Cdc6-like proteins were also identified in the search, 
although not as strongly as their Orc1 counterparts, but still with considerable 
confidence (e.g. Cdc6 factor of Arabidopsis thaliana, e-value of 2e-11). 
Together, these observations corroborate previous analysis (El-Sayed et al., 
2005a; Godoy et al., 2009) and strengthen the assumption that TbORC1/CDC6 is 
most likely an Orc1-like factor. Some archaeal Orc1/Cdc6 proteins (Cdc6 from 
Chapter 3  134 
 
 
Sulfolobales archeon; Cdc6 from Sulfolobus acidocaldarius; Cdc6 from 
Sulfolobus solfataricus; and Orc1 from Aeropyrum pernix) were also recovered 
(not shown), though with poorer e-values (for e.g. from 7e-07 to 0.39) when 
compared with most the eukaryote Orc1 and Cdc6 ‘hits’. Whether kinetoplastid 
ORC1/CDC6 provides both Orc1 and Cdc6 functions therefore remains unclear, 
despite experimental evidence showing that it can complement yeast Cdc6 
mutants in culture (Godoy et al., 2009).  
Analysis of TbORC1B resulted in a smaller number of hits, and all with less 
confidence (the lowest e-value being of only 8e-04) than the results obtained for 
TbORC1/CDC6 (Table 3-2). Although TbORC1B was identified as being an Orc1-
related protein (Dang and Li, 2011), and blastp analysis using human and yeast 
Orc1 proteins to interrogate the TriTrypDB database identify TbORC1B as a hit 
(data not shown), the TbORC1B search retrieved mainly Cdc6 or Cdc6-like hits 
(Table 3-2), including the characterised mouse and human proteins, with only a 
single Orc1 candidate recovered. Whether this suggests that TbORC1B is more 
related to Cdc6 than Orc1 remains unclear, however, in particular because the 
high e-values of nearly all hits provide low confidence regarding homology with 
the retrieved sequences. Thus, experimental evidence will be crucial to evaluate 
TbORC1B’s function. This is reinforced by the observation that other replication-
associated proteins were seen as hits (albeit with high e-values of between 0.058 
and 2.1), including a ‘MCM loader’, a replication factor C subunit, and an Orc4 
subunit protein (Table 3-2). All these proteins are predicted to possess an AAA+ 
ATPase domain (identified through InterPro, not shown), which might account 
for their similarity with TbORC1B, which has been suggested to have such 
domain (Dang and Li, 2011; Tiengwe et al., 2013).  
TbORC4 analysis retrieved very few hits, all of which with very low confidence 
(e-values ranging from 0.31 to 4.6) (Table 3-2). However, with one exception, all 
these hits are annotated as Orc4 subunits, thus corroborating previous 
observations (Tiengwe et al., 2012b), and suggesting that it is most likely a 
highly divergent Orc4-like protein. Indeed, sequence alignments of TbORC4 with 
other eukaryotic Orc4 subunits (Tiengwe et al., 2012b) support this likely ORC 
subunit homology (alignments shown in the appendices, Figure 7.4).  
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Table 3-2. List of sequences identified from blastp analysis.  
Results from Trypanosoma and Leishmania species are not listed (shown in Table 3-1 instead), as 
well as unidentified proteins, or those labelled as predicted. Not all hits are represented for 
TbORC1/CDC6 and TbORC1B, as there were too many (>2000 and >350, respectively) and 
therefore only some relevant examples were selected. Accession numbers were retrieved from the 
NCBI database as of November 2014. 
Query blastp hits Accession number Species e-value Identity 
T
b
O
R
C
1
/
C
D
C
6
 
Orc1 subunit EPY20124.1 Strigomonas culicis 3e-154 52% 
Orc1 subunit EPY39172.1 Angomonas deanei 1e-67 47% 
Orc1-like subunit XP_003079059.1 Ostreococcus tauri 4e-18 29% 
Orc1 subunit NP_567440.1 Arabidopsis thaliana 9e-18 27% 
Orc1 subunit EPY51628.1 
Schizosaccharomyces 
cryophilus 
1e-17 27% 
Orc1 subunit NP_477303.1 
Drosophila 
melanogaster 
2e-17 29% 
Orc1 subunit XP_004224191.1 
Plasmodium 
cynomolgi 
4e-17 26% 
Orc1 subunit XP_001616506.1 Plasmodium vivax 1e-16 26% 
Orc1 subunit NP_001014918.1 Bos taurus 6e-15 28% 
Orc1 subunit XP_678269.1 
Plasmodium berghei 
ANKA 
2e-14 27% 
Orc1 subunit XP_001350439.1 
Plasmodium 
falciparum 3D7 
4e-14 28% 
Orc1 subunit NP_499347.1 
Caenorhabditis 
elegans 
5e-13 27% 
Orc1 subunit NP_596060.1 
Schizosaccharomyces 
pombe 
6e-17 27% 
HsORC1 subunit AAC50325.1 Homo sapiens 9e-12 27% 
Cdc6  NP_172207.2 Arabidopsis thaliana 2e-11 24% 
Orc1 subunit NP_035145.2 Mus musculus 1e-10 26% 
Orc1 subunits NP_013646.1 
Saccharomyces 
cerevisiae 
6e-07 24% 
T
b
O
R
C
1
B
 
Cdc protein  EFQ26461.1 
Colletotrichum 
graminicola 
1e-01 29% 
Cdc6 GAA29103.2 Chonorchis sinensis 8e-04 25% 
Cdc protein  XP_003005252.1 Verticillium alfalfae 0.006 27% 
Cdc6 homolog 
isoform a 
NP_035929.1 
Mus musculus 
0.088 
29% 
Cdc6 homolog 
isoform b 
NP_001020950.1 0.089 
DNA Replication 
factor C, large 
subunit 
KEQ79100.1 
Aureobasidium 
pullulans 
0.058 29% 
Cdc6 homolog NP_001179336.1 Bos taurus 0.14 30% 
Cdc6-related 
protein 
NP_001081844 Xenopus laevis 0.69 23% 
Cdc6 homolog NP_001245.1 Homo sapiens 0.75 29% 
Orc1 subunit XP_003868271.1 Candida orthopsilosis 1.1 22% 
MCM loader EEB07000.2 
Schizosaccharomyces 
japonicus 
2.0 29% 
Orc4 subunit EIT78085.1 Aspergillus oryzae 2.1 39% 
T
b
O
R
C
4
 
Orc4 subunit AAD39473.1 
Drosophila 
melanogaster 
0.31 34% 
Predicted: Orc4-
like 
XP_005179312.1 Musca domestica 0.50 30% 
Predicted: Orc4-
like 
XP_004535926.1 Ceratitis capitata 0.68 33% 
ORC subunit XP_001653985.1 Aedes aegypti 4.6 31% 
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Table 3-2. (continued). 
 
Query blastp hits Accession number Species e-value Identity 
T
b
7
9
8
0
 
DNA helicase WP_006043754.1 Prevotella pallens 0.16 35% 
ABC transporter WP_030305899.1 Streptomyces sp. 0.95 43% 
ABC transporter WP_012854200.1 
Thermomonospora 
curvata 
1.9 42% 
DNA polymerase 
III 
WP_020966355.1 Treponema pedis 3.5 22% 
Cell division 
protein 
WP_033044043.1 Pseudomonas putida 5.1 28% 
 
All hits that resulted from the Tb7980 BLAST analysis presented very high e-
values (0.16-5.1), and thus low confidence (Table 3-2). Nevertheless, it is 
intriguing that all these hits were from bacteria, and included a DNA helicase, a 
DNA polymerase III and a ‘cell division protein’, besides two ABC transporter hits 
(Table 3-2). All of these factors possess AAA+ ATPase domains, similar to the 
Orc1-5 proteins (Iyer et al., 2004), supporting the suggestion that Tb7980 might 
possess such a domain (Tiengwe et al., 2013). 
Analysis of both Tb3120 and Tb1120 retrieved only kinetoplastid hits (Table 3-1), 
all of which corresponded to hypothetical and unidentified proteins, possibly 
suggesting that these might be kinetoplastid-specific factors, as it has been 
proposed in the case of Tb3120 (Tiengwe et al., 2012b; Tiengwe et al., 2013). 
3.2.2 Structure Prediction analysis 
In order to complement the information from the blastp analysis, TbORC1/CDC6, 
TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120 protein sequence were further 
analysed through the protein structure and function prediction online platforms 
RaptorX (Källberg et al., 2012) and I-TASSER (Zhang, 2008a; Roy et al., 2010). 
Both platforms rely on a composite approach, in which a combination of various 
prediction techniques is used. For example, analysis using I-TASSER results from 
the combination of various prediction techniques such as comparative modelling 
(e.g. blastp, as discussed above) and threading methods, both template-based 
modelling systems, as well as ab initio modelling, a template-free strategy 
where no structure homologous information is used (Källberg et al., 2012; Roy et 
al., 2010; Zhang, 2008b). For the present analysis, both RaptorX and I-Tasser 
default parameters were used. In both online platforms, experimentally resolved 
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protein structures archived in the Protein Data Bank (PDB) (Berman et al., 2000) 
library were used for template search and modelling. 
Three solved archaeal protein structures were mainly selected by both RaptorX 
and I-TASSER platforms to model the structures of TbORC1/CDC6, TbORC1B, 
TbORC4, and Tb7980: Orc1 from Aeropyrum pernix (PDB identification number 
2V1U) (Gaudier et al., 2007), the Orc1 initiator factor of Sulfolobus solfataricus 
(2QBY) (Dueber et al., 2007), and the Orc1 protein of Pyrobaculum aerophilum 
(1FNN) (Liu et al., 2000) (Table 3-3). Very recently, the crystal structure of the 
D. melanogaster ORC complex has been solved (Bleichert et al., 2015). It will be 
necessary to repeat this analysis in the future once the structures are 
incorporated into the database, as it is possible that these would be more 
appropriate for modelling the T. brucei proteins. Nevertheless, the use of 
archaeal Orc1 and Orc1-like initiator factors strengthens the idea that these 
proteins might indeed be Orc-like proteins. Other protein structures were also 
selected as models for the different T. brucei proteins, although these were not 
common between the four factors (not shown). Nevertheless, these hits were 
generally involved in ATP-binding related functions, and most likely possess 
AAA+ ATPase domains, consistent with the potential presence of these domains 
in TbORC1/CDC6, TbORC1B, TbORC4 and Tb7980.  
In contrast to the abovementioned proteins, and reflecting the results from the 
BLAST analysis, little information was retrieved from modelling both Tb3120 and 
Tb1120. The confidence in the models was poor, and both RaptorX and I-TASSER 
platforms did not use replication-related proteins for the modelling of either 
factor. In the case of Tb3120, nucleoporins, hydrolases and virus capsid proteins 
were mainly used for modelling (Table 3-3), while for Tb1120, transportins were 
predominantly used (Table 3-3). These outputs reinforce the lack of obvious Orc-
like homology in these proteins. Nonetheless, potentially interesting hits in the 
Tb1120 search included a cohesin subunit (4PK7) (Hara et al., 2014), which is 
involved in sister chromatid cohesion after DNA replication is complete, and an 
SYS-1 protein (3C2G) (Liu et al., 2008), which is involved in the positive 
regulation of transcription from RNA polymerase II promoters. Whether these 
hits provide functional clues for Tb1120 is not known, but might imply cell cycle- 
or DNA replication-related roles.  
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Table 3-3. Top hits of solved protein structures used by RaptorX and I-TASSER search 
engines to model TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120.  
Main hits obtained from structure prediction modelling platforms RaptorX and I-TASSER, using 
each of T. brucei Orc-like proteins as queries. Not all hits are shown. Analysis performed in 
November 2014. ID number from both PDB and UniProt (http://www.uniprot.org/) were retrieved in 
November 2014. 
Query PDB  UniProt Protein name Species 
TbORC1/CDC6, 
TbORC1B, 
TbORC4, Tb7980 
2V1U Q9YEV6 Orc1-type protein Aeropyrum pernix 
2QBY Q980N4 Orc1-type protein Sulfolobus solfataricus 
1FNN Q8ZYK1 Orc1-type protein Pyrobaculum aerophilum 
Tb3120 
1IUN P96965 Hydrolase Pseudomonas flurescens 
4KF7 G2QD05 Nup188 nucleoporin Myceliophthora thermophila 
2CSE P11077 Outer capsid protein mu-1 Mammalian orthoreovirus 1 
Tb1120 
4PK7 Q8N3U4 Cohesin subunit SA-2 Homo sapiens 
4C0O Q9YAL0 Transportin-3 Homo sapiens 
3C2G Q9XVI2 Protein SYS-1 Caenorhabditis elegans 
1QBK Q92973 Transportin-1 Homo sapiens 
 
3.2.3 Alignments, and domain and motif searches 
To build further on the analyses performed in the previous sections, the protein 
sequences of TbORC1/CDC6 and its putative interacting partners were further 
analysed through domain and motif online search tools, in order to build up 
schematic representations of the functional domains of the proteins. For initial 
domain searches, all sequences were submitted for analysis through both the 
Pfam (http://pfam.xfam.org/) (Finn et al., 2014) and InterPro 
(http://www.ebi.ac.uk/interpro/) (Hunter et al., 2012) databases. While Pfam 
is mainly a database of curated protein families and clans, defined by 
probabilistic models used to infer homology between protein sequences (Finn et 
al., 2014), InterPro retrieves and combines information from various such 
databases (including Pfam and PHANTER), and therefore may provide a wider set 
of information on protein families and domains within the protein sequences 
(Hunter et al., 2012). To try and identify more specific sequence characteristics, 
and complement the domain search analysis, the sequences were also analysed 
through a series of motif and protein signature databases: the GenomeNet Motif 
search tool (http://www.genome.jp/tools/motif/) (Kyoto University 
Bioinformatics Centre), the MyHits© Motif Scan tool (http://myhits.isb-sib.ch/) 
(Pagni et al., 2007), and the ScanProsite online tool 
(http://prosite.expasy.org/scanprosite/) (Sigrist et al., 2013). Finally, the T. 
brucei protein sequences were aligned with protein sequences from Orc factors 
of other eukaryotes, in order to identify further signatures, domains and motifs 
that might have not been identified through the search engines described above 
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(all alignments are shown in the appendices, section 7.2). The combined output 
of these analyses is summarised in Figure 3.1. 
Analysis of TbORC1/CDC6 protein sequence with Pfam and InterPro retrieved a 
clear AAA+ ATPase domain in the protein’s N-terminus (57-202 aa) (Figure 3.1), 
as well as a Cdc6-related family domain that encompassed most of the protein’s 
length (20-383 aa, not represented in Figure 3.1). However, and as previously 
described, TbORC1/CDC6 lacks a detectable BAH domain (Tiengwe et al., 2013; 
Godoy et al., 2009), which appears to be found in all Orc1 proteins from other 
eukaryotic organisms (reviewed in Duncker et al., 2009; Costa et al., 2013). 
Motif searches combined with sequence alignment of TbORC1/CDC6 with Orc1 
subunits from eukaryotes (detailed in the appendices, Figure 7.2), allowed the 
identification of the Walker A, Walker B and arginine finger motifs characteristic 
of the AAA+ ATPase domain, as well as a putative nuclear localisation signal 
(NLS), as described previously (Godoy et al., 2009; Dang and Li, 2011) (Figure 
3.1). None of the online tools were able to identify the WHD, which is 
characteristic of Orc1-5 proteins and mediates DNA binding (Duncker et al., 
2009). Nonetheless, the region of TbORC1/CDC6 that aligned with the WHD 
regions annotated in the other Orc1 proteins (303-433 aa region, alignment 
shown in detail in Figure 7.2) localised in the C-terminus, which is a region 
previously suggested to harbour the WHD of TbORC1/CDC6 (Godoy et al., 
2009)(Figure 3.1). Alignment of TbORC1/CDC6 with other Orc1 subunits revealed 
further short sequences that are highly conserved between the aligned proteins 
(Figure 3.1), but to which specific activities have not been detailed, and whose 
relevance to protein structure or function is, therefore, unknown. 
TbORC1B domain analysis resembled that of TbORC1/CDC6: a clear AAA+ ATPase 
domain was easily identified in the N-terminal region of the protein (7-270 aa, 
Figure 3.1), as well as a Cdc6-related family domain throughout the protein 
length (2-539 aa, not depicted in Figure 3.1). Motif search tools retrieved a 
potential bipartite NLS (RPTKR), and sequence alignment of TbORC1B with Cdc6 
proteins (from model eukaryotes and Clonorchis sinenis, the first hit from the 
BLAST search, shown in the appendices, Figure 7.3) allowed the identification of 
likely Walker A and Walker B motifs, consistent with those suggested previously 
(Dang and Li, 2011), as well as the identification of a series of potential 
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conserved motifs to which, like for TbORC1/CDC6, it was not possible to allocate 
a specific function or motif name (Figure 3.1). Amongst these motifs, it is worth 
noting that the FE(A/P)Y and the GDVR motifs are common between TbORC1B 
and TbORC1/CDC6 (Figure 3.1). Again, like for TbORC1/CDC6, the search tools 
were not able to identify a WHD, but such a motif could be accommodated in 
the C-terminal region of the protein (419-601 aa, Figure 3.1), based on the 
alignment of TbORC1B with Cdc6 protein sequences in which the WHD has been 
annotated (shown in Figure 7.3). 
 
 
 
Figure 3.1. Schematic representation of TbORC1/CDC6 and other putative ORC factors in T. 
brucei.  
TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120 proteins of T. brucei are 
schematically represented, with the identified domains highlighted in a colour-coded fashion: AAA+ 
ATPase domains in orange, winged-helix domains (WHD) in yellow, nuclear localisation signal 
(NLS) in light blue, arginine finger (Arg Finger) in green, Orc5 domain in black, and Orc2 domain in 
white; further potential motifs, and their sequences, are depicted in pink. Each factor is represented 
in a colour corresponding to the potential orthologue in other model eukaryotes, which are 
represented in the insert box together with their characteristic domains (adapted from (Duncker et 
al., 2009). (*) marks domains that have been rated as non-significant; (?) represents that the 
confidence in the motif is not high. Predicted lengths of the proteins (in amino acids, aa) are shown. 
The overall figure has been adapted from (Tiengwe et al., 2013), © 2013 Elsevier Ltd. All rights 
reserved, to which new information (described in the main text) has been added. 
 
Searches through both Pfam and InterPro, as well as through the motif search 
tools, were unable to identify any domains or motifs in TbORC4. The AAA+ 
ATPase domain was thus mapped through the alignment of TbORC4 with Orc4 
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subunits of other eukaryotes (Figure 3.1, alignments shown in the appendices, 
Figure 7.4), and appears to include both the Walker A and Walker B motifs, as 
well as the sensor 1 and arginine finger motifs (Tiengwe et al., 2012b). 
Nevertheless, in the TbORC4 protein sequence, both the Walker A and Walker B 
motifs fail to possess the characteristic amino acids that usually define these 
motifs (the GX4GK[S/T]
d of the Walker A motif and the hhhh[D/E]e of the Walker 
B); however, it is now recognised, as more protein structures are solved and 
made available in databases, that perhaps these motifs are not as conserved as 
previously thought (Matte and Delbaere, 2010). Still, the TbORC4 Walker B motif 
identified from the alignment appears to be highly divergent and possibly 
degenerate (Tiengwe et al., 2012b), since the sequence LIVCIRR contrasts with 
the apparently highly conserved VIFILDE sequence found in all other analysed 
Orc4 subunits (Figure 7.4). However, re-analysis of the TbORC4 protein sequence 
revealed a VLNSDE sequence, which possesses the DE amino acid combination, 
localises within the putative AAA+ ATPase domain and is positioned downstream 
of the Walker A motif, but whether this is the true Walker B motif is not known. 
In contrast with TbORC1/CDC6 and TbORC1B, it was not possible to infer the 
presence of a WHD in the TbORC4 protein sequence, solely because domain 
searches of the model eukaryotes Orc4 subunits used in the alignment failed to 
identify such a domain (not shown).  
Analysis of Tb7980 through the InterPro database identified an AAA+ ATPase 
domain in the protein’s N-terminus (14-128 aa), which contains a putative 
Walker A motif (GPPGSGKT), identifiable through the ScanProsite online tool. In 
addition, a bipartite NLS profile (77-91 aa) that includes a KRRR motif (like in 
TbORC1/CDC6) was also identified by searches both on ScanProsite and 
MotifScan online tools (Figure 3.1). Analysis of Tb7980 using Pfam version 27.0 
retrieved no results, but searches performed with previous versions of the Pfam 
database retrieved both the AAA+ ATPase domain (similar to the one identified 
by InterPro) and an Orc5 domain, although the latter was categorised as non-
significant (Figure 3.1) (Tiengwe et al., 2013). This difference may result from 
the fact that in previous versions of Pfam it was possible to obtain results 
comprising contextual domain-hits, meaning that it was possible to identify weak 
                                         
d
 X refers to any amino acid.  
e
 h refers to any hydrophobic amino acid. 
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domain hits that fell below the gathering threshold but were supported by 
surrounding domains or sequence features (Finn et al., 2014). Unfortunately, 
this feature was abandoned in the newest version of Pfam (version 27.0). 
Nevertheless, the potential alignment of Tb7980 with eukaryotic Orc5 subunits 
was used to attempt to identify further motifs (shown in the appendices, Figure 
7.5). This provided confirmation of the Walker A motif, and further 
identification of a putative Walker B motif (VVDDADE), as well as a potential 
arginine finger motif (LPRLMLV) (Figure 3.1). Moreover, three other sequence 
patterns, present within the putative Orc5 domain, and to which it was not 
possible to allocate a motif name or function, were also identified (Figure 3.1). 
Similar to TbORC4, it was not possible to infer the presence of a WHD because 
analysis of the eukaryotic Orc5 subunits used for the multi-sequence alignment 
failed to identify this domain, both on Pfam and InterPro databases (not shown). 
Despite this possible homology with Orc5 factors, it is not clear whether or not 
Tb7980 is indeed a T. brucei Orc5 subunit orthologue, and therefore will still be 
referred to in this work as Tb7980. 
Similar to Tb7980, Pfam analysis of Tb3120 retrieved no results when using the 
newest version, although searches using previous versions of the database 
retrieved two regions of the protein as potential Orc2 domains, as well as a 
small region as a WHD, although both were classified as non-significant (Figure 
3.1) (Tiengwe et al., 2013). Further analysis through InterPro and the various 
motif search engines retrieved no results besides a potential bipartite NLS 
profile, SKRRC (Figure 3.1). Strikingly, there were no results suggesting the 
presence of an AAA+ ATPase domain or of the Walker A and Walker B motifs. 
Alignment of Tb3120 with Orc2 subunits from other eukaryotes (shown in the 
appendices, Figure 7.6) also failed to identify both the AAA+ ATPase and WHD 
domains. These observations may be consistent with previous work that showed 
that Orc2 and Orc3 subunits have highly divergent AAA+ ATPase domains and are 
therefore not easily mapped (reviewed in Costa et al., 2013; Duncker et al., 
2009). Alignments of Orc2 subunits from various organisms revealed that though 
the Walker A and Walker B motifs in Orc2 do not follow the canonical sequences 
(mentioned above) present in other Orc proteins such as Orc1 and Orc5, these 
sequences are conserved among the different Orc2 subunits (Speck et al., 2005): 
the Walker A motif sequence is X(L/F)(Y/F)GXGSKXX(L/F), while the Walker B 
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motif is defined by X(L/F)X(I/V)HN(L/I)D(G/S)X(M/S). The alignment of Tb3120 
with the Orc2 subunits of model eukaryotes allowed the identification of such 
motifs in Tb3120 (Figure 3.1) (Figure 7.6), within the predicted (though non-
significant) Orc2 domains. This strengthens the idea that Tb3120 might be an 
Orc-like factor, more precisely an Orc2-like protein, though more evidence, 
especially experimental, will be needed before labelling Tb3120 as being an 
Orc2 subunit. From the alignment it was also possible to identify various 
potential conserved motifs, the majority of which are present within the C-
terminus region of Tb3120 (Figure 3.1), but their functional importance, if any, 
is unknown. It is worth noting that Tb3120 and orthologues in T. cruzi and L. 
major (referred here as Tc3120 and Lm3120, respectively, Figure 7.6) are 
considerably larger than any of the characterised eukaryotic Orc2 subunits 
(ranging from 576-620 aa) used in the alignment, with T. brucei and T. cruzi 
proteins being approximately double the size (1018 aa and 1049 aa, 
respectively), and the L. major almost three times the size (1487 aa). From the 
alignment it appears that, if Tb3120 and its homologues in T. cruzi and L. major 
are indeed Orc2-like factors, the kinetoplastid proteins have undergone an 
expansion in their N-terminus, in which it was not possible to identify any 
characteristic signatures or domains (although it appears to be conserved 
between the three organisms). This interpretation is nevertheless consistent 
with the observation that characterised Orc2 proteins (Figure 7.6) possess their 
Orc2 domains in the C-terminus region of the protein.  
Domain analysis of Tb1120, which is confirmed to interact with TbORC1/CDC6 
later in section 3.6.1, retrieved only a putative zinc knuckle (Pfam family zf-
CCHC4, which was considered non-significant), using the GenomeNet Motif 
search engine and a previous version of Pfam (Figure 3.1). Therefore, Tb1120 
remains the only potential TbORC1/CDC6-interacting protein identified so far 
that has no discernible homology, however weak, with a eukaryotic ORC subunit. 
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3.3 TbORC1/CDC6, TbORC4, Tb3120 and TbORC1B are 
involved in DNA replication 
To facilitate gene function analysis through RNA interference (RNAi), both the 
procyclic and bloodstream form life cycle stages of T. brucei have been 
genetically modified to allow the conditional expression of double-stranded RNA 
(dsRNA), thereby permitting the inducible activation of the RNAi machinery 
against any gene of interest (reviewed in Kolev et al., 2011). The PCF 29-13 cell 
line (Wirtz et al., 1999) is derived from wild type T. brucei PCF cells of strain 
Lister 427 and constitutively expresses the bacteriophage T7 RNA polymerase 
(T7RNAP) as well as the E. coli tetracycline repressor (TetR), the expression of 
the latter being under the control of a T7 promoter (Wirtz et al., 1999). The 
expression of the TetR allows the repression of promoters that are adjacent to a 
tetracycline operator (TetO). Upon addition of tetracycline to the cell, TetR is 
bound by the drug and removed from the TetO, allowing transcription of the 
DNA under the influence of the promoter. The 29-13 cell line has been widely 
used in conjunction with two different strategies to express gene-specific dsRNA. 
One involves the use of opposing (or ‘head-to-head’) promoters’ constructs, in 
which a fragment of the target gene is inserted between two opposing T7 
promoters that, in turn, are flanked by Tet operators (LaCount et al., 2000; 
Wang et al., 2000). The second entails the use of stem-loop vectors, in which 
two identical fragments of a gene of interest are cloned into the vector in 
opposite directions, one on each side of a “stuffer” fragment, thus allowing the 
expression of the dsRNA from a single promoter that is located upstream of a Tet 
operator (Shi et al., 2000; Wang and Englund, 2001; Durand-Dubief et al., 2003). 
In both cases, the constructs are integrated in the ribosomal RNA locus (RRNA) of 
the parasite’s genome. Although both approaches have been shown to be 
efficient in downregulating the expression of targeted genes, the stem-loop 
approach seems to be more efficient (Durand-Dubief et al., 2003), apparently 
because one molecule generates the dsRNA by self-folding (intramolecular 
dsRNA), while in the opposing promoters strategy the two RNA molecules need 
to anneal with each other intermolecularly (intermolecular dsRNA). 
Studies investigating the effects of TbORC1/CDC6 downregulation by RNAi have 
used both the above strategies (Tiengwe et al., 2012b; Godoy et al., 2009; 
Benmerzouga et al., 2013), while the effects of TbORC4, Tb3120 or Tb7980 
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silencing have been analysed using the opposing promoters approach alone 
(Tiengwe et al., 2012b). It was notable that RNAi-induced silencing of the three 
TbORC1/CDC6 interacting factors in PCF cells resulted in just mild effects on cell 
growth and cell cycle progression, which were detected only around four days 
post-RNAi induction; in addition, attempts to evaluate if levels of BrdU 
incorporation changed after RNAi induction were inconclusive (Tiengwe et al., 
2012b). Given the apparently better performance of the stem-loop approach, 
together with the lack of any data on the effects of TbORC1B or Tb1120 silencing 
by inducible RNAi, we sought to generate RNAi cell lines, in the 29-13 cell line, 
for each of the putative T. brucei Orc-like factors using stem-loop constructs 
(below). The RNAi cell lines thus generated were analysed for cell growth, cell 
cycle, and DNA replication defects, as shown in the next sections. A cell line 
targeting TbORC1/CDC6 was also examined, allowing comparison with published 
data (Benmerzouga et al., 2013), while the parental 29-13 cell line was used as a 
negative control. 
3.3.1 RNAi system used and generation of the RNAi PCF cell lines 
The stem-loop vector chosen was a variation of the pLew111 construct (Hoek et 
al., 2000), containing the bleomycin resistance gene marker (BLE, which confers 
resistance to both the zeocin and phleomycin antibiotics). In this version, the 
pLew111 plasmid has been modified to include part of the human polo-like 
kinase 1 (PLK1) gene as a “stuffer” within the HindIII-BamHI linker (Figure 3.2; 
gift from Dr Calvin Tiengwe, Prof. Paul Englund’s laboratory). This created two 
cloning sites, HindIII/XhoI and AflII/BamHI, which allow the sequential insertion, 
in a head-to-head configuration, of two identical PCR products, each flanked 
with one of the two different restriction site combinations. The region of each 
gene to be PCR-amplified (sizes between 400-600 bp), as well as the best pair of 
primers to use, was chosen using RNAit (http://trypanofan.bioc.cam.ac.uk/ 
software/RNAit.html), an automated web-based tool for the selection of gene 
regions more suitable for RNAi targeting in T. brucei (Redmond et al., 2003). 
Each gene sequence (retrieved from TriTrypDB) was used as query. In the case of 
Tb7980, the region suggested by RNAit contained a BamHI site and, therefore, a 
region downstream of this site was used as query. Sequences of restriction sites 
to allow cloning of the PCR products into the vector were added as follows 
(Figure 3.3): PCR product A (to be inserted in the sense orientation) was 
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amplified with a forward primer containing the HindIII restriction site, while the 
reverse primer possessed a XhoI site; PCR product B (to be cloned in the 
antisense orientation) was amplified with a forward primer with a BamHI site, 
while the reverse primer had a AflII restriction site. All gene-specific primers 
used and PCR conditions are described and shown in the materials and methods 
Chapter 2, Table 2-1. After PCR amplification, each PCR product was digested 
with the appropriate restriction enzyme combinations, purified, and ligated into 
the plasmid. For each gene, PCR product A was first cloned into pLew111, and 
PCR product B then cloned after validation, by restriction enzyme digestion, of 
the prior insertion. The final plasmids (Figure 3.4, A-F) were confirmed by 
restriction enzyme digestion using the two enzyme combinations used for cloning 
(Figure 3.4, G), as well as by sequencing. Plasmids targeting TbORC1/CDC6, 
TbORC4, Tb3120 and TbORC1B were produced by Dr Calvin Tiengwe (in Prof. 
Paul Englund’s laboratory in Baltimore, U.S.A.), while the constructs targeting 
Tb7980 and Tb1120 were generated by me in Glasgow. Each plasmid was 
digested with NotI prior to transfection into the 29-13 cells, allowing homology-
directed integration into the genome of the parasite at the RRNA spacer region. 
Transformant clones were selected with 10 μg.ml-1 of zeocin, to which the BLE 
marker confers resistance. Growth of individual clones was examined in the 
presence of 2 μg.ml-1 of tetracycline to look for impairment over a five-day time 
course (data not shown). Clones presenting a mild-severe growth phenotype 
were selected for further analysis. Overall, these included two clones, 
independently obtained, for TbORC1/CDC6, TbORC4, and Tb3120 (clones Cla 
were generated by Dr Calvin Tiengwe in Prof. Paul Englund’s laboratory in 
Baltimore, U.S.A., while clones Clb were generated by me in Glasgow), and one 
clone for TbORC1B. Unfortunately, despite several attempts, no viable clones 
were retrieved for Tb7980 or Tb1120. In the case of Tb7980, a few clones were 
recovered after transfection, but could not be successfully maintained 
thereafter (data not shown). Several attempts were also made to generate RNAi 
cell lines that had one allele of the gene of interest endogenously ‘tagged’ with 
12myc (construct cloning and cell line generation are detailed in sections 3.4.1 
and 3.4.5), so that efficiency of protein loss after RNAi induction could be 
assessed by western blot, but this was only successful for TbORC4 (clone Clb, see 
below).  
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Figure 3.2. pLew111 construct.  
Version of the pLew111 plasmid used as a backbone to generate the stem-loop RNAi constructs 
for TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120. In this version, the original 
pLew111 plasmid (Hoek et al., 2000) has been modified to include a “stuffer” region, made up of a 
fragment of the human PLK1 gene, between the HindIII and BamHI restriction sites (white arrow). 
The red dashed boxes highlight the cloning sites used to introduce the two PCR fragments of each 
gene, in order to generate a stem-loop dsRNA molecule. The Tet operator (yellow) is located 
downstream of the T7 promoter (red) to allow tetracycline-inducible expression of the fragment that 
will result in the dsRNA stem-loop. The bleomycin resistance marker (BLE, shown in orange) is 
flanked by T. brucei aldolase mRNA processing 5’ and the actin mRNA processing 3’ regions 
(represented in dark yellow). The bacterial drug resistance gene, against ampicillin, is shown as 
ampR (in black), and the bacterial origin in depicted as ColE1 origin (in grey). The RRNA spacer 
fragment (green) is shown with the NotI restriction site used to linearize the plasmid for transfection 
into the parasite. 
 
 
Figure 3.3. Stem-loop construct cloning strategy.  
Graphical representation of the cloning process to generate the RNAi stem-loop constructs from 
the pLew111 vector. (1) Both PCR products A and B are amplified using the appropriate pair of 
primers. (2) The pLew111 vector and the PCR product A are digested with HindIII and XhoI, and 
ligated. (3) The resulting plasmid and the PCR product B are then digested with AflII and BamHI, 
and ligated (4), generating the final plasmid containing the two PCR products inserted in opposing 
orientations. Not all features of the plasmid are shown. Diagrams are not to scale.  
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Figure 3.4. Plasmid maps and confirmation restriction digestions of the constructs used for 
RNAi of the different factors.  
Plasmid maps of the constructs used for RNAi of TbORC1/CDC6 (A), TbORC4 (B), Tb7980 (C), 
Tb3120 (D), TbORC1B (E), Tb1120 (F), all derived from pLew111 (Figure 3.2). The gene-specific 
products are shown flanking the “stuffer” region (white), and so are the restriction sites used for 
their cloning into the plasmid. The Tet operator (yellow) is located downstream of the T7 promoter 
(red), and the bleomycin resistance marker (BLE; orange) is shown. The ampicilin resistance gene 
is shown as ampR (in black), and the bacterial origin in depicted as ColE1 origin (grey). The RRNA 
spacer fragment (green) is shown with the NotI restriction site used to linearize the plasmid for 
transfection into the parasite. All constructs were confirmed through restriction enzyme digestions 
(G), detailed description in the main text. The 1 Kb plus DNA ladder (Invitrogen™) is shown as a 
size reference, and the expected fragment sizes are shown below each gel image. (*) digestion 
with HindIII and XhoI results in the excision of PCR product A; (**) digestion with AflII and BamHI 
results in the excision PCR product B. Note that in some cases the gel image has been cropped to 
display the results from the same plasmid side-by-side, and are separated by a white space. 
A) B) 
C) D) 
E) F) 
G) 
 TbORC4 
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3.3.2 Effect of TbORC1/CDC6, TBORC4, Tb3120 or TbORC1B 
expression silencing by RNAi on cell growth, cell cycle 
progression, and DNA replication,  
The effect of depletion of TbORC1/CDC6 by RNAi has been reported in several 
published works (Tiengwe et al., 2012b; Godoy et al., 2009; Benmerzouga et al., 
2013). In each case, depletion of TbORC1/CDC6 in PCF cells caused slowing of 
growth after ~3-4 days (but growth arrest in only one study), accumulation of 
0N1K (zoid) cells and, in one study, reduced BrdU incorporation (Benmerzouga et 
al., 2013). As work from this lab has not previously targeted TbORC1/CDC6 by 
stem-loop RNAi, the new cell line targeting TbORC1/CDC6 in this way was used 
as a positive control and to allow comparison with each of the putative ORC-like 
factors. In order to assess any influence of tetracycline in the assays, the 29-13 
cell line was used as a negative control, as no effect is expected.  
The aim of these assays was to elucidate whether each of the putative ORC-like 
factors are involved in DNA replication. For this purpose, a mid-log phase (~1 x 
107 cells.ml-1) culture of each RNAi cell line was diluted to a concentration of 
5.5 x 105 cells.ml-1, and divided into two different cell culture flasks. To one 
flask, tetracycline (2 μg.ml-1) was added (Tet +) to induce expression of the 
stem-loop dsRNA, while no tetracycline was added to the other, thus serving as a 
non-induced control (Tet -). Cell density was assessed every 24 h in order to 
evaluate growth. Cell cycle progression was also examined at the same time 
points, using two complementary strategies. First, the cells were fixed and 
stained with DAPI, allowing the quantification of the different cell cycle stages 
in the asynchronous cell cultures. This analysis is possible in T. brucei because 
the nuclear and kinetoplastid genomes possess distinct S phase timing, with the 
DNA replication and segregation of the kinetoplast occurring before the nuclear 
S phase (McKean, 2003), as shown in Figure 3.49. Therefore, the analysis of the 
ratio, morphology, and configuration of the nucleus and kinetoplast DNA in a cell 
can be used to identify the cell cycle stage of an individual cell from an 
asynchronous culture (Woodward and Gull, 1990; Siegel et al., 2008). Cells can 
be classified as follows (N – nucleus; K – kinetoplast): most 1N1K cells are 
assumed to be in G1 phase; 1N1eK (eK – elongated kinetoplast; replicating but 
not yet divided kinetoplast) are in S phase; 1N2K cells are in G2 phase; and 2N2K 
cells are post-mitotic cells that are about to, or are already, undergoing 
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cytokinesis (McKean, 2003; Wheeler et al., 2013b). Secondly, the cells were 
fixed and permeabilised with methanol, stained with propidium iodide (PI), and 
analysed by flow cytometry (fluorescence-activated cell sorting, FACS) (Tiengwe 
et al., 2012b; Benmerzouga et al., 2013; Siegel et al., 2008). Propidium iodide is 
a fluorescent DNA intercalating agent, widely used in flow cytometry analysis to 
evaluate cell viabilityf or DNA content in cell cycle studies (Moore et al., 1998). 
Briefly, a minimum of 5 x 105 cells from both the Tet - and Tet + cultures were 
stained with PI and analysed using a FACSCalibur™ (BD Biosciences) flow 
cytometer system, as described in the materials and methods Chapter 2, section 
2.4.1.5. Because PI fluorescence excitation and emission maximums are 535 nm 
and 617 nm, respectively, stained cells were detected in the FL2-A channel of 
the flow cytometer, and plotted onto histograms representing the amount of 
cells according to their DNA content (for example, as shown in Figure 3.11, box). 
A non-perturbed asynchronous cell culture should result in two predominant 
peaks, one at an intensity of around 200 in the FL2-A channel (in this case) 
corresponding to cells in G1 phase (with 2N DNA content), and a smaller peak at 
around 400, representing cells in G2 phase or post-mitotic but pre-cytokinesis 
(G2/M population; 4N content). Cells with fluorescence intensity between these 
two peaks have a variable DNA content between 2N and 4N and correspond to 
cells that are in different stages of S phase. All other populations detected, with 
either more or less DNA content, are considered abnormal. To complement the 
above growth and cell cycle assays, the effect of the RNAi on DNA replication 
was more directly assayed. For this purpose, cells were incubated for three 
hours with 5-ethynyl-2’-deoxyuridine (EdU), a synthetic nucleoside analogue of 
thymidine (Salic and Mitchison, 2008), after which the number of EdU-positive 
cells was assessed. The incubation time of three hours was chosen as it is 
somewhat longer than the predicted nuclear S phase of T. brucei PCF cells 
(estimated to be 1.51 hours), but shorter than S and G2 (G2 phase estimated to 
take around 1.87 hours) phases combined (Woodward and Gull, 1990). 
Therefore, it is short enough so that most cells that are labelled should 
correspond with those undergoing or having just completed DNA synthesis (i.e. 
primarily 1N1eK and 1N2K cells), but not sufficiently long to label 2N2K cells 
that have progressed through the whole of S and G2 phases and have undergone 
                                         
f
 Propidium iodide is a membrane impermeant molecule and is therefore only incorporated by cells 
whose cellular membrane has been compromised (dying or permeabilised cells) and is 
therefore excluded from viable cells. 
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mitosis. In practice, this pattern of labelling was consistently observed in 
unperturbed cells, where ~25% of the cells were labelled with EdU, the vast 
majority of which were 1N1eK or 1N2K cells (data not shown). Like 5-bromo-2’-
deoxyuridine (BrdU), another synthetic thymidine analogue widely used to 
detect DNA synthesis in proliferating cells (Benmerzouga et al., 2013; Gassen et 
al., 2012; Woodward and Gull, 1990; Aparicio et al., 2009; Semple et al., 2006), 
EdU is incorporated into the cell’s DNA and can be detected and quantified after 
cell fixation and staining. The major difference between the two analogues 
resides in the method of detection. BrdU is detected using anti-BrdU antibodies, 
thus requiring denaturation of the DNA helix to access the incorporated 
molecules. In contrast, EdU detection relies on a copper-catalysed (Cu(I)-
catalysed [3+2] cycloaddition, or “click” chemistry) reaction between an alkyne 
group in the EdU molecule and an azide (Salic and Mitchison, 2008; Rostovtsev et 
al., 2002), usually coupled to an AlexaFluor® fluorophore. Because the 
AlexaFluor®-conjugated azide is small enough to access the double-stranded 
DNA (dsDNA), EdU detection does not require treatment of the cells with either 
acid or DNase, thus allowing simultaneous detection of EdU and nuclear proteins 
by immunofluorescence (Salic and Mitchison, 2008). For this study the cells 
stained for EdU incorporation were also counterstained for DAPI, and the same 
samples were used to generate the data on cell cycle, based on DAPI counting, 
as well as the percentage of EdU positive cells. Cells were first categorised into 
the different N/K configurations, and then the same cells were analysed for EdU 
incorporation. EdU positive cells were counted and the percentage of such 
positive cells then calculated for both the Tet – and Tet + samples at every time 
point. To allow comparisons between time points, the number of Tet – EdU 
positive cells was considered to be 100% at each time point, and the percentage 
of Tet + EdU positive cells was then calculated relative to that. To test whether 
the RNAi being induced is targeting the mRNA of the expected gene, it was 
hoped that we could examine protein levels. Because antibodies against the 
factors under study are not available, it was sought to endogenously tag one of 
the alleles of each gene with 12 copies of the myc epitope (12myc; construct 
transfection strategy are detailed in sections 3.4.1, 3.4.4) in the corresponding 
RNAi cell line, as has been previously done (Rudd et al., 2013). This would allow 
protein levels to be assessed throughout the course of the RNAi experiment by 
western blot using anti-myc antiserum (as described in section 3.4.9). 
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Unfortunately, despite several attempts, this was only accomplished for one 
RNAi cell line, the one targeting TbORC4 (here referred to as TbORC4 Clb). For 
the remaining RNAi cell lines, the efficiency of silencing was assessed by reverse 
transcription quantitative real-time PCR (RT-qPCR), similar to other studies 
(Tiengwe et al., 2012b; Jones et al., 2014). For this purpose, primers targeting 
TbORC4, Tb3120 and TbORC1B were designed according to the guidelines for 
primers to be used in quantitative real-time PCR (qPCR) (Alvarez-Fernandez, 
2013; Dymond, 2013), while the primer sequences targeting TbORC1/CDC6 have 
been published previously (Tiengwe et al., 2012b). For normalisation, previously 
described primer sequences targeting the Tb927.10.12970 gene (referred to as 
C1) were used (Kabani et al., 2009). All primer sequences are shown in the 
materials and methods Chapter 2, Table 2-8. Primer efficiency and specificity 
were assessed for all pairs of primers through, respectively, the analysis of 
calibration curves and melting profiles, which resulted in efficiencies of 
approximately 100%, all within a 15% interval (data not shown). For each time 
point, cells from both Tet – and Tet + cultures were collected for RNA extraction 
and subsequent conversion into complementary DNA (cDNA), as described in the 
materials and methods Chapter 2, section 2.4.1.6. The cDNA was then used for 
the qPCR reaction, and the resulting fluorescence intensity data was analysed by 
relative quantification using the ΔΔCt method (Livak and Schmittgen, 2001), 
using C1 as the endogenous control and the respective Tet – sample as calibrator 
(in which the expression of the analysed gene should be 100%), as detailed in the 
materials and methods Chapter 2, section 2.4.1.7. The results below, with the 
exception of the flow cytometry, result from two experiments performed 
independently.  
3.3.2.1 Tetracycline per se has no effect on cell growth, cell cycle 
progression, or on DNA replication 
As expected, no clear differences were observed between the Tet – and Tet + 
cultures of the parental cell line 29-13 (Figure 3.5) in both cell growth (Figure 
3.5, A), cell cycle progression (Figure 3.5, B and C; and Figure 3.11), or EdU 
uptake by the cells (Figure 3.5, D), thus showing that tetracycline causes no 
significant effect in these conditions. The smaller proportions of the 1N2K and 
2N2K cell populations at 72 h, 120 h and 168 h most likely reflect the fact that 
these samples were collected from cultures at high cell densities, where growth 
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rate slows (Figure 3.5, A, days 3, 5 and 7, respectively), rather than an effect of 
tetracycline, as the same percentages were seen for the Tet – sample (data not 
shown individually; in Figure 3.5, B the Tet – values represent the mean 
percentage of each cell type population assessed for the 8 time points). 
Measurement of EdU positive cells showed some variability between experiments 
and time points (Figure 3.5, D), most likely due to either variability in uptake or 
detection.  
 
Figure 3.5. Effect of tetracycline on the parental RNAi 29-13 cell line.  
A) Growth curves depicting the cell growth of the un-induced (Tet -) and tetracycline-induced (Tet 
+) cell cultures over six days. Cell concentration was assessed every 24 h, and plotted on a Log10 
Y-axis graph. The individual points represent the mean from two independent experiments (n = 2), 
while the error bars depict the standard error of the mean (SEM). The red arrow pinpoints a 1:10 
dilution of both Tet - and Tet + cultures. B) Quantification of cells in the different cell cycle stages 
throughout the course of six days under tetracycline induction, based on the nuclear and 
kinetoplast configuration of the cells stained with DAPI. A minimum of 150 cells was counted per 
time point and experimental group (Tet - and Tet +), and percentages of each cell type (1N1K, 
1N2K, 2N2K, 0N1K, and others) were calculated relative to the total amount of cells analysed. The 
graph represents the mean of each cellular population obtained in two independent experiments (n 
= 2), while the error bars refer to SEM. The Tet - bar represents the mean of the percentage of 
each cell type throughout the course of each of the two experiments. C) Histograms representing 
A) 
B) 
C) 
D) 
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the distribution of the cell population according to DNA content, stained with PI (FL2-A channel), 
and assessed by flow cytometry. Approximately 30,000 cells were analysed per sample. 
Histograms from Tet - (full line) and Tet + (dashed line) cell cultures are shown for 24 h and 48 h. 
The histograms of other time points are shown in the appendices, section 7.3.2. Results from only 
one experiment are shown. D) Percentage of EdU positive cells in the Tet + samples relative to the 
percentage of EdU positive cells in the Tet - culture from the same time point. A minimum of 150 
cells were analysed per time point and group (Tet - and Tet +). The mean from two independent 
experiments (n = 2) is shown; error bars represent the SEM.  
 
3.3.2.2 RNAi of TbORC1/CDC6 
Induction of TbORC1/CDC6 RNAi silencing resulted in a pronounced growth 
defect: 48 h post-tetracycline addition, growth slowed and there was evidence 
of cell death thereafter (results from clone b (Clb) are shown in Figure 3.6, A). 
This growth defect was accompanied by a dramatic increase of enucleated cells 
(0N1K, or zoids; an example is shown in Figure 3.6 F): only 1-3% of zoid cells 
were seen prior to RNAi induction, but this increased to 50-60% of the population 
by 48 h post-induction, and reached a maximum of ~70% of the population at ~72 
h (Figure 3.6, C). Concurrently, the numbers of 1N1K cells (an example is shown 
in Figure 3.6 F) decreased almost proportionally, from being approximately 80% 
of the un-induced population to about 30% at 48 h post-induction, and only 15% 
of the cells from 72 h onwards (Figure 3.6, C). As an indication of 
TbORC1/CDC6’s involvement in DNA replication, 2N2K cells (post-mitotic or 
undergoing cytokinesis, an example is shown in Figure 3.6 F) were virtually 
abolished from the population by 72 h post-induction (Figure 3.6, C). Though 
increased levels of 1N2K cells (Figure 3.6, F) might be expected if replication is 
affected, there was little evidence for this (Figure 3.6, C). If anything, levels of 
1N2K cells decreased throughout the experimental time course (Figure 3.6, C). 
In addition, some cells, with no clear classifiable morphology or nucleus to 
kinetoplast ratio, were also observed in late time points after induction, and 
were categorised as “other” (an example is shown in Figure 3.6, F). The amount 
of these ‘other’ cells increased mainly from 72 h after induction, although zoids 
remained the dominant cell type in the population. These results were 
supported by the data obtained by FACS, where the increase in zoids 
corresponded with a decrease in the number of cells in both G1 and G2 phases, 
and a clear increase in the levels of sub-G1 cells (peak below 200 in the FL2-A 
axis in Figure 3.6, D) from 24 h onwards (Figure 3.6,D, shows 24 h, 48 h and 96 h 
time points, and further time points are summarised in Figure 3.11). 
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Figure 3.6. Effect of TbORC1/CDC6 depletion by induction of specific gene targeted RNAi 
over time.  
A) Growth curves of un-induced (Tet -) and tetracycline-RNAi induced (Tet +) cell cultures over five 
days. Cell concentration was assessed every 24 h, and plotted on a Log10 Y-axis graph. The 
individual points represent the mean from two independent experiments, while the error bars depict 
the SEM. The red arrow pinpoints a 1:10 dilution of both Tet - and Tet + cultures. B) Efficiency of 
RNAi knockdown of TbORC1/CDC6 mRNA levels assessed by RT-qPCR. The results represent 
the amount of mRNA at 12 h and 24 h after RNAi induction relative to the non-induced sample (Tet 
-), calculated using the ΔΔCt method. The mean of two independent experiments (n = 2) is shown, 
and the error bars represent SEM. C) Quantification of cells in the different cell cycle stages 
throughout the course of five days of RNAi induction, based on the nuclear and kinetoplast 
configuration of the cells stained with DAPI. A minimum of 150 cells was counted per time point 
and experimental group (Tet - and Tet +), and percentages of each cell type (1N1K, 1N2K, 2N2K, 
0N1K, and others) were calculated relative to the total amount of cells analysed. The graph 
represents the mean of each cellular population obtained in two independent experiments (n = 2), 
while the error bars refer to SEM. D) Histograms representing the distribution of the cell population 
according to DNA content, stained with PI (FL2-A channel), assessed by flow cytometry. 
Approximately 30,000 cells were analysed per sample. Histograms from Tet - (full line) and Tet + 
(dashed line) cell cultures are shown for the 24 h, 48 h and 96 h time points. The histograms of 
other time points are shown in the appendices, section 7.3.2. Results from only one experiment are 
shown. E) Percentage of EdU positive cells in the Tet + samples relative to the percentage of EdU 
positive cells in the Tet - culture from the same time point. A minimum of 150 cells were analysed 
per time point and group (Tet - and Tet +). The mean from two independent experiments is shown 
(n = 2); error bars represent the SEM. An example of an EdU positive cell is shown. F) Examples of 
cells categorised as 1N1K, 1N2K, 2N2K, 0N1K, or other; DAPI (cyan) and DIC (cell outline) are 
shown overlaid. 
A) B) 
C) 
D) 
E) 
F) 
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Overall, the above observations are consistent with the results published for 
TbORC1/CDC6 depletion by RNAi in PCF cells (Tiengwe et al., 2012b; Godoy et 
al., 2009; Benmerzouga et al., 2013), where the predominant phenotype is the 
generation of zoids. The notable difference is that the cell growth impairment 
and accumulation of zoids appear to arise more quickly and are more severe in 
the cell line used here. Whether this is because the stem-loop RNAi system used 
here was more efficient is not clear, though plausible, since (Benmerzouga et 
al., 2013) also used stem-loop RNAi, in which the rapidity of cell growth 
impairment and levels of zoid accumulation were closer to the results here 
shown than those of (Tiengwe et al., 2012b) and (Godoy et al., 2009). Moreover, 
(Tiengwe et al., 2012b) reported ~70% reduction in TbORC1/CDC6 mRNA after 4 
days of RNAi induction, and RT-qPCR here suggests 60-70% loss after 12 h and 24 
h. No later time points were examined by RT-qPCR, as most of the cell 
population was composed of zoids and the lack of a nucleus in such a high 
proportion of cells resulted in aberrant mRNA levels and distorted the RT-qPCR 
analysis (data not shown). 
Recently, loss of TbORC1/CDC6 has been shown to impair DNA replication 
through lowered levels of BrdU incorporation after RNAi (Benmerzouga et al., 
2013), and results herein corroborate these observations. As shown in Figure 3.6, 
E, the number of EdU-positive cells (an example of a positive cell is shown inside 
the box) decreased with time after RNAi induction, until essentially no cells 
displayed EdU labelling after ~72 h. Indeed, reduced EdU staining appeared to 
occur before any growth or cell cycle defect were evident. For instance, at 24 h, 
a 40-50% decrease in EdU positive cells was already observed in the Tet + culture 
compared with Tet – (Figure 3.6, E), although growth was not affected and only 
a small proportion of zoids were detected (Figure 3.6, C). At 120 h after RNAi 
induction, a small increase in EdU-positive cells was seen in one experiment 
(Figure 3.6, E), though not in the other (Figure 3.6, E). It is possible that at this 
stage some ‘revertants’ arose in which RNAi is less effective.  
As mentioned earlier, two clones targeting TbORC1/CDC6 by RNAi have been 
analysed, and all above data refers to one clone (Clb). In the other clone (Cla), 
reversion to growth was seen earlier (from 72 h onwards) in both experimental 
repeats, illustrating that non RNAi-reactive cells arise after that time point 
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(results from one experiment are shown in the appendices, Figure 7.7). 
Nonetheless, until the 48 h time point, the phenotypes observed for clone Cla 
were the same in every aspect to the ones observed for clone Clb.  
Taken together, the growth, cell cycle, and EdU incorporation data strongly 
support TbORC1/CDC6 involvement in DNA replication, and suggest that it is the 
impairment of nuclear DNA replication that results in the formation of zoid cells, 
as has been proposed before (Ploubidou et al., 1999). 
3.3.2.3 RNAi of TbORC4 
In the case of TbORC4, two non-reverting RNAi clones were analysed (clone Cla 
is shown in Figure 3.7, and clone Clb in Figure 3.8). In one of the clones, Clb, 
one allele of TbORC4 was endogenously tagged with 12myc (as described in 
section 3.4.4). Previously, TbORC4 RNAi in PCF cells has been shown to result in 
very similar growth and cell cycle phenotypes to those seen after TbORC1/CDC6 
RNAi, but no measurement of EdU incorporation was attempted (Tiengwe et al., 
2012b). Induction of RNAi resulted in a strikingly similar profile in both TbORC4 
clones. In fact, all phenotypes observed after TbORC4 RNAi closely matched 
those obtained for TbORC1/CDC6 (Figure 3.6): perturbation in cell growth was 
noticeable 48 h post-induction, with growth arresting after 72 h (Figure 3.7 and 
Figure 3.8, A); at the same time points the proportion of the zoid population 
increased, while 1N1K, 1N2K and 2N2K cell types decreased, with both 1N2K and 
2N2K being virtually absent at 120 h (Figure 3.7 and Figure 3.8, C); ~50% 
reduction in EdU incorporation was detected 24 h post-induction, and was 
almost abolished from 72 h onwards (Figure 3.7 and Figure 3.8, E). The RNAi 
perhaps slightly differed from TbORC1/CDC6 in that the amount of cells 
categorised as “other” was higher in both the TbORC4 RNAi cell lines 120 h post-
induction, alongside a more pronounced reduction in 1N1K cells. Most likely, this 
is explained by the suggestion that at this stage in the TbORC1/CDC6 RNAi time 
course there was evidence for reversion (growth recovery and increased EdU 
incorporation relative to 96 h), which was not seen for TbORC4 RNAi. FACS 
analysis (Figure 3.7 and Figure 3.8, D; FACS data is summarised in Figure 3.11) 
confirms the parallels between TbORC4 and TbORC1/CDC6 RNAi, with 
accumulation of sub-G1 phase cells seen from 48 h onwards.  
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Figure 3.7. Effect of TbORC4 depletion by induction of specific gene targeted RNAi over 
time. Clone a.  
A) Growth curves depicting the cell growth of the un-induced (Tet -) and tetracycline-induced (Tet 
+) cell cultures throughout the course of five days. Cell concentration was assessed every 24 h, 
and plotted on a Log10 Y-axis graph. The individual points represent the mean concentration 
calculated from two independent experiments (n = 2), while the error bars depict the SEM. The red 
arrow pinpoints a 1:10 dilution of both Tet – and Tet + cultures. B) Efficiency of the knockdown of 
TbORC4 mRNA levels assessed by RT-qPCR. The results represented refer to the relative amount 
of mRNA levels to the non-induced sample (Tet -), calculated using the ΔΔCt method. The mean of 
two independent experiments (n = 2) is shown, and the error bars represent SEM. C) Quantification 
of cells in the different cell cycle stages throughout the course of five days under tetracycline 
induction, based on the nuclear and kinetoplast configuration of the cells stained with DAPI. A 
minimum of 150 cells was counted per time point and experimental group (Tet - and Tet +), and 
percentages of each cell type (1N1K, 1N2K, 2N2K, 0N1K, and others) were calculated relative to 
the total amount of cells analysed. The graph represents the mean of each cellular population 
obtained in two independent experiments (n = 2), while the error bars refer to SEM. The Tet - bar 
represents the mean of the percentage of each cell type throughout the course of each of the two 
experiments (five days). D) Histograms representing the distribution of the cell population 
according to DNA content, stained with PI (FL2-A channel), assessed by flow cytometry. 
Approximately 30,000 cells were analysed per sample. Histograms from Tet - (full line) and Tet + 
(dashed line) cell cultures are shown overlapped for the 24 h, 48 h and 96 h time points. The 
histograms of other time points are shown in the appendices, section 7.3.2. Results from only one 
experiment are shown. E) Percentage of EdU positive cells in the Tet + sample relative to the 
percentage of EdU positive cells in the Tet - culture from the respective time point. A minimum of 
150 cells were analysed per time point and group (Tet - and Tet +). The mean from two 
independent experiments (n = 2) is shown; error bars represent SEM. 
A) B) 
C) 
D) 
E) 
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Figure 3.8. Effect of TbORC4 depletion by induction of specific gene targeted RNAi over 
time. Clone b.  
A) Growth curves depicting the cell growth of the un-induced (Tet -) and tetracycline-induced (Tet 
+) cell cultures throughout the course of five days. Cell concentration was assessed every 24 h, 
and plotted on a Log10 Y-axis graph. The individual points represent the mean concentration 
calculated from two independent experiments (n = 2), while the error bars depict the SEM. The red 
arrow pinpoints a 1:10 dilution of both Tet – and Tet + cultures. B) The cell line has one allele 
endogenously tagged with 12myc, therefore, efficiency of the RNAi system induction was assessed 
by western blot, through the detection of TbORC4
12myc
 with the anti-myc antiserum (α-myc) in total 
protein extracts from both Tet - and Tet + cultures. The transcription elongation factor Ef1α (α-
Ef1α) was used as a loading control. C) Quantification of cells in the different cell cycle stages 
throughout the course of five days under tetracycline induction, based on the nuclear and 
kinetoplast configuration of the cells stained with DAPI. A minimum of 150 cells was counted per 
time point and experimental group (Tet - and Tet +), and percentages of each cell type (1N1K, 
1N2K, 2N2K, 0N1K, and others) were calculated relative to the total amount of cells analysed. The 
graph represents the mean of each cellular population obtained in two independent experiments (n 
= 2), while the error bars refer to SEM. The Tet - bar represents the mean of the percentage of 
each cell type throughout the course of each of the two experiments (five days). D) Histograms 
representing the distribution of the cell population according to DNA content, stained with PI (FL2-A 
channel), assessed by flow cytometry. Approximately 30,000 cells were analysed per sample. 
Histograms from Tet - (full line) and Tet + (dashed line) cell cultures are shown overlapped for the 
24 h, 48 h and 96 h time points. The histograms of other time points are shown in the appendices, 
section 7.3.2. Results from only one experiment are shown. E) Percentage of EdU positive cells in 
the Tet + sample relative to the percentage of EdU positive cells in the Tet - culture from the 
respective time point. A minimum of 150 cells were analysed per time point and group (Tet - and 
Tet +). The mean from two independent experiments (n = 2) is shown; error bars represent SEM.  
A) B) 
C) 
D) 
E) 
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TbORC4 expression after RNAi levels were assessed in clone Cla by RT-qPCR, as 
previously described for TbORC1/CDC6 RNAi. Surprisingly, in contrast to the 
TbORC1/CDC6 RNAi cell line, which shows an identical phenotype and a ~60% 
decrease in mRNA levels after 24 h, TbORC4 mRNA was only reduced by ~20% 
relative to the non-induced sample (Figure 3.7). How such a small knockdown in 
mRNA levels can lead to such striking and rapid phenotypes, which mimic 
TbORC1/CDC6 (with ~3 times more mRNA loss), is not known. In the 
endogenously tagged cell line, clone Clb, detection of the TbORC412myc protein 
revealed that protein levels decreased progressively with time, with very low 
levels detected 24 h post-induction (when a decrease in 50% of EdU-positive cells 
was already observed), and no detectable signal in cells after 48 h and 72 h 
(Figure 3.8, B). The relative mRNA levels of TbORC4 were not assessed for clone 
Clb, and therefore it is not known whether the mRNA relative levels in this cell 
line are comparable to the ones in clone Cla. Nevertheless, the indistinguishable 
phenotypes observed in the two cell lines would suggest that knockdown of 
TbORC4 may be equivalent. Why, then, the RT-qPCR and western blot analyses 
do not match is unclear. Ultimately, these results show that TbORC4 has an 
important role in DNA replication and, given the strong phenotypic overlap, in 
every aspect studied, with RNAi of TbORC1/CDC6, might support the hypothesis 
that these two factors act on DNA replication in the same complex or, at least, 
play similar roles in the DNA replication process in T. brucei.  
3.3.2.4 RNAi of Tb3120 
Unlike RNAi silencing of TbORC1/CDC6 and TbORC4, RNAi targeting Tb3120 
resulted in a late and mild growth defect, only noticeable four days after 
induction (Figure 3.9, A). Indeed, despite the use of stem-loop RNAi, this 
response was similar to what has been reported by (Tiengwe et al., 2012b). This 
delayed effect on cell growth correlated with a later timing of increase in the 
number of zoid cells, from ~3% in the non-induced culture to ~30% of the cell 
population 96 h after RNAi induction. Unlike in TbORC1/CDC6 or TbORC4 RNAi, 
zoids only reached a maximum of ~43% of the cells at 120 h (Figure 3.9, B), and 
rapidly thereafter (168 h post-induction), the “other” cells became the 
dominant cell type in the population. The “other” did not display consistent cell 
morphology or ratio between nucleus and kinetoplast, as was seen following 
TbORC1/CDC6 and TbORC4 RNAi, although not in such high numbers. Altogether, 
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the cell cycle defects observed by DAPI counting analysis were confirmed by 
FACS (Figure 3.9, C), which showed an increase in zoid cells and a progressive 
reduction of both G1 and G2 phases (results are summarised in Figure 3.11). 
Although some of the cells categorised as “others” appeared to have an enlarged 
nucleus or multiple nuclei, FACS data revealed no detectable cells with a higher 
DNA content than 4N, suggesting that these represented only a minor component 
of the population, not discernible by FACS, or that these cells had not replicated 
their nuclear DNA.  
Despite the slow accumulation of growth and cell cycle phenotypes, analysis of 
EdU incorporation revealed that Tb3120 silencing also had a marked effect on 
DNA replication. Indeed, the timing of the reduction in EdU incorporation 
correlated with the appearance of the growth defects and the increase in 
aberrant cells (Figure 3.9, D). A very small decrease in EdU incorporation (~15 – 
20%) was observed at 24 and 48 h after RNAi induction, suggesting that, like for 
TbORC1/CDC6 and TbORC4, impaired replication precedes the other cell cycle 
phenotypes. Though it is possible that this small decrease might result from 
variability intrinsic to the EdU assay itself, at 72 h a >50% decrease in EdU 
incorporation was seen, immediately preceding the growth and cell cycle 
defects observed at 96 h. Thereafter, the steady increase in the number of 
aberrant cells was accompanied by a progressive decrease in EdU positive cells, 
culminating in a reduction of ~95% of by 168 h (Figure 3.9, D). To check that the 
RNAi correctly targeted Tb3120, RT-qPCR was performed at 24 h, 72 h and at 96 
h, matching when defects were first detected and when the population of 
aberrant cells was less than 50% of the total cell population. An average 
decrease in 50% of mRNA levels relative to the non-induced samples suggests 
that RNAi induction was successful. Indeed, as no difference was seen in relative 
mRNA levels at the three time points examined, it is likely that this corresponds 
with maximum loss of mRNA (Figure 3.9, E). These results raise the question of 
why the phenotypes seen upon Tb3120 RNAi are so late, especially as the levels 
of RNAi knockdown at 24 h are comparable with those seen for TbORC1/CDC6 
RNAi, are stable over time and are higher than the effects measured by RT-qPCR 
for TbORC4 RNAi. One possible scenario is that Tb3120 does not play an as 
central, or crucial role in DNA replication as both TbORC1/CDC6 and TbORC4. 
However, the overall similarity of the phenotypes that ultimately resulted from 
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Tb3120 RNAi relative to both TbORC1/CDC6 and TbORC4 suggests that all these 
three factors act in the same biological context. Therefore another explanation 
is that Tb3120 protein is more stable, perhaps due to a longer half-life or slower 
turnover rate, than TbORC1/CDC6 and TbORC4 and, consequently, requires 
longer RNAi induction to reach lowered protein levels that match the other two 
factors. Unfortunately, it was not possible to tag Tb3120 with 12myc in the RNAi 
cell line and therefore, testing these hypothesis in the PCF cells was not 
possible.  
As for TbORC1/CDC6 and TbORC4, two independently obtained Tb3120 RNAi 
clones, Cla and Clb, were analysed. Clone Cla, which presented an even less 
pronounced phenotype, is shown in the appendices, Figure 7.8. Nonetheless, the 
same broad responses were seen, validating the findings that were here analysed 
more thoroughly for clone Clb (Figure 3.9). 
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Figure 3.9. Effect of Tb3120 depletion by induction of specific gene targeted RNAi over time. 
A) Growth curves depicting the cell growth of the un-induced (Tet -) and tetracycline-induced (Tet 
+) cell cultures throughout the course of eight days. Cell concentration was assessed every 24 h, 
and plotted on a Log10 Y-axis graph. The individual points represent the mean concentration 
calculated from two independent experiments (n = 2), while the error bars depict the SEM. The red 
arrows pinpoint a 1:10 dilution of Tet - and Tet + cultures. B) Quantification of cells in the different 
cell cycle stages throughout the course of five days under tetracycline induction, based on the 
nuclear and kinetoplast configuration of the cells stained with DAPI. A minimum of 150 cells was 
counted per time point and experimental group (Tet - and Tet +), and percentages of each cell type 
(1N1K, 1N2K, 2N2K, 0N1K, and others) were calculated relative to the total amount of cells 
analysed. The graph represents the mean of each cellular population obtained in two independent 
experiments (n = 2), while the error bars refer to SEM. The Tet - bar represents the mean of the 
percentage of each cell type throughout the course of each of the two experiments (six days). C) 
Histograms representing the distribution of the cell population according to DNA content, stained 
with PI (FL2-A channel), assessed by flow cytometry. Approximately 30,000 cells were analysed 
per sample. Histograms from Tet - (full line) and Tet + (dashed line) cell cultures are shown 
overlapped for the 96 h, 120 h and 168 h time points. The histograms of other time points are 
shown in the appendices, section 7.3.2. Results from only one experiment are shown. D) 
Percentage of EdU positive cells in the Tet + sample relative to the percentage of EdU positive 
cells in the Tet - culture from the respective time point. A minimum of 150 cells were analysed per 
time point and group (Tet - and Tet +). The mean from two independent experiments (n = 2) is 
shown; error bars represent SEM. E) Efficiency of the knockdown of Tb3120 mRNA levels 
assessed by RT-qPCR. The results represented refer to the relative amount of mRNA levels to the 
non-induced sample (Tet -), calculated using the ΔΔCt method. The mean of two independent 
experiments (n = 2) is shown, and the error bars represent SEM.
A) 
E) 
B) 
C) 
D) 
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3.3.2.5 RNAi of TbORC1B 
In contrast with the factors described above, the effects of RNAi on TbORC1B 
have never been reported before, and its proposed involvement in DNA 
replication is so far based only on its interaction with TbORC1/CDC6 (Dang and 
Li, 2011). Surprisingly, TbORC1B silencing resulted in a severe growth defect, 
evident as early as 24 h post-induction, one day before any growth effect was 
noticeable following TbORC1/CDC6 or TbORC4 RNAi (Figure 3.10, A). Due to this 
rapid response, putative cell cycle anomalies and defects on DNA replication 
were investigated at earlier time points than the ones analysed for the other 
putative Orc-like factors: 6 h and 12 h post-induction. At 6 h post RNAi 
induction, when there was no detectable emergence of zoids or other aberrant 
cells, a small increase in the proportion of 1N2K and 2N2K cells was seen, 
together with a small decrease in the number of 1N1K cells (Figure 3.10, C). This 
would suggest an increase in cells in G2/M phase and a decrease in G1 phase 
cells, respectively. However, this was not supported by flow cytometry: at the 6 
h time point, an increase in the G1 phase (2N) population was observed together 
with a slight decrease in the G2/M (4N) population (Figure 3.11 and Figure 3.10, 
D). Therefore, it appears that some of the cells morphologically classified as 
1N2K might have not replicated their nuclear DNA after 6 h post-induction. 
Quantification of EdU labelling revealed that EdU positive cells were reduced by 
~60% at 6 h post-induction, suggesting that the number of actively replicating 
cells had already been reduced by more than 50% (Figure 3.10, E). These 
observations are reinforced by data obtained at 12 h post-RNAi. Here, the 
number of EdU positive cells was reduced by ~90% (Figure 3.10, E). This 
decrease in replicating cells was accompanied by a further increase in the 
number of 1N2K cells (~23.5% compared with ~12% in the Tet – sample), a very 
small increase in the amount of detectable zoid cells, further reduction of 1N1K 
cells, and near loss of 2N2K cells (Figure 3.10, C). FACS data at this time point 
suggest a decrease in G2/M (4N) cells, consistent with the observed reduction in 
2N2K cells. Together with an increase in G1 (2N) cells, despite the observed 
reduction in numbers of 1N1K cells and the striking reduction in EdU 
incorporation, the decrease in G2/M (4N) cells strongly suggests that the 1N2K 
cells have not replicated their nuclear DNA, although the kinetoplast has 
replicated and segregated as normal. At 24 h post-induction, when EdU 
incorporation was essentially undetectable, >60% of the population was 
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composed of zoid cells, while both 1N1K and 1N2K populations were reduced, 
and virtually no 2N2K cells were observed (Figure 3.10, C), mirroring the cell 
cycle phenotypes seen at ~48 h post RNAi for TbORC1/CDC6 or TbORC4. This was 
reflected by the FACS data at 24 h post RNAi, which showed hugely reduced G1 
(2N) and G2/M (4N) cell populations, and increased levels of cells with a 
fluorescent signal smaller than G1, supporting the increase in the percentage of 
zoid cells in the population (Figure 3.10, D, and Figure 3.11). Between 48 h and 
72 h post-induction, cell growth stalled (Figure 3.10, A), and thereafter cell 
numbers decreased, which was accompanied by the number of zoids continuing 
to rise to ~70-80% of the cell population, in parallel with a further decrease in 
1N1K and 1N2K cells, complete abolishment of 2N2K cells, and a small increase 
in ‘others’ cells (reaching ~15% at the latest time point, 120 h; Figure 3.10, C).  
 
Figure 3.10. Effect of TbORC1B depletion by induction of specific gene targeted RNAi over 
time.  
A) B) 
C) 
D) 
E) 
Chapter 3  166 
 
 
A) Growth curves depicting the cell growth of the un-induced (Tet -) and tetracycline-induced (Tet 
+) cell cultures throughout the course of five days. Cell concentration was assessed every 24 h, 
and plotted on a Log10 Y-axis graph. The individual points represent the mean concentration 
calculated from two independent experiments (n = 2), while the error bars depict the SEM. The red 
arrow pinpoints a 1:10 dilution of the Tet - culture. B) Efficiency of the knockdown of TbORC1B 
mRNA levels assessed by RT-qPCR. The results represented refer to the relative amount of mRNA 
levels to the non-induced sample (Tet -), calculated using the ΔΔCt method. The mean of two 
independent experiments (n = 2) is shown, and the error bars represent SEM. C) Quantification of 
cells in the different cell cycle stages throughout the course of five days under tetracycline 
induction, based on the nuclear and kinetoplast configuration of the cells stained with DAPI. A 
minimum of 150 cells was counted per time point and experimental group (Tet - and Tet +), and 
percentages of each cell type (1N1K, 1N2K, 2N2K, 0N1K, and others) were calculated relative to 
the total amount of cells analysed. The graph represents the mean of each cellular population 
obtained in two independent experiments (n = 2), while the error bars refer to SEM. The Tet - bar 
represents the mean of the percentage of each cell type throughout the course of each of the two 
experiments (five days). D) Histograms representing the distribution of the cell population 
according to DNA content, stained with PI (FL2-A channel), assessed by flow cytometry. 
Approximately 30,000 cells were analysed per sample. Histograms from Tet - (full line) and Tet + 
(dashed line) cell cultures are shown overlapped for the 6 h, 12 h, 24 h and 48 h time points. The 
histograms of other time points are shown in the appendices, section 7.3.2. Results from only one 
experiment are shown. E) Percentage of EdU positive cells in the Tet + sample relative to the 
percentage of EdU positive cells in the Tet - culture from the respective time point. A minimum of 
150 cells were analysed per time point and group (Tet - and Tet +). The mean from two 
independent experiments (n = 2) is shown; error bars represent SEM.  
 
Silencing of TbORC1B was assessed by RT-qPCR at 6 h and 12 h post-RNAi (Figure 
3.10, B); as before, later time points were not considered due to the potentially 
confounding influence of >50% of the population being zoids (Figure 3.10, C). A 
decrease of ~40-45% in the mRNA levels of TbORC1B relative to the non-induced 
samples (Figure 3.10, B) were seen, which is broadly comparable with 
TbORC1/CDC6 knockdown at 12 h and confirms the RNAi is on-target.  
Together, the above results strongly suggest TbORC1B’s involvement in DNA 
replication, with its silencing resulting in similar phenotypes to those obtained 
upon the RNAi of TbORC1/CDC6 or TbORC4. The major difference, however, lies 
in the time frame for the emergence of such DNA replication-related defects: 
while growth and cell cycle defects were only detected 48 h after RNAi induction 
targeting either TbORC1/CDC6 or TbORC4, the same anomalies were clearly 
noticeable in the TbORC1B RNAi cell line 24 h earlier, with DNA replication being 
severely affected as early as at 6 h post-tetracycline addition to the media. This 
faster appearance of the same phenotypes may suggest that TbORC1B plays a 
crucial role in DNA replication, even more necessary than the one played by 
TbORC1/CDC6 or TbORC4. T. brucei PCF cells are estimated to divide every 8.5 
hours (the time to go through the cell cycle) (Woodward and Gull, 1990). 
Calculations (mathematical formula is shown in the materials and methods 
Chapter 2, Equation 2) suggest a doubling time of the non-induced TbORC1B 
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RNAi cell line to be 12-13 h (compared to 11-12 h for the 2913 parental cell 
line). The detection of such a severe impact on DNA replication 6 h after RNAi 
induction, which is ~half the time needed for the cell to complete a cell cycle, 
reinforces the rapidity of the effect, which data below suggests can be 
explained by differences in expression of TbORC1B relative to other T. brucei 
Orc-like factors during the cell cycle.  
 
Figure 3.11. Summary of the flow cytometry results obtained for each cell line.  
Each individual graph represents the summary of the data obtained by flow cytometry on DNA 
content, through the staining of cells with PI. The histogram within the box represents an example 
of a normal cell cycle profile (in this case, the 29-13 cell line, Tet - culture, time point of 48 h). 
Gates were drawn to allow the quantification of the percentage of the population in G1 or G2/M 
phases (blue and pink gates, respectively), and cells that contained sub-G1 DNA content signal 
suggesting the lack of a nucleus. These were thus labelled as zoids (yellow gate). The percentages 
given in each gate were plotted on a XY graph, as frequency in population (%) per hours post 
tetracycline (Tet) induction. Blue points represent cells in G1 phase, pink points G2 phase and 
yellow represents the population of zoids. In all cases, full line represents Tet -, and dashed line 
Tet +. The 29-13 graph represents the parental cell line Tet - and Tet + cultures throughout the 
experimental period, as a control. The remaining graphs, TbORC1/CDC6 Clb, TbORC4 Cla, 
TbORC4 Clb, Tb3120 Clb, and TbORC1B, represent the results obtained for those specific cell 
lines over time. The histograms and data used to generate these graphs are shown in the 
appendices, section 7.3.2. 
Chapter 3  168 
 
 
3.4 Generating TbORC1B, TbORC4, Tb7980, Tb3120 and 
Tb1120 in situ – tagged cell lines 
In order to try and better understand the different timing of the phenotypes 
resultant from the RNAi induction of the different factors described above, and 
to gain further insight into the roles of the putative Orc-like factors in PCF cells, 
the remaining sections of this chapter describe various sets of experiments 
exploring the different proteins’ localisation, expression and interaction with 
TbORC1/CDC6, besides trying to understand whether there is an ORC-like 
complex in T. brucei.  
In the absence of antibodies recognising any of the putative Orc-like proteins, 
epitope tagging of each protein was necessary, as it allows the detection of the 
epitope-tagged proteins using highly sensitive and specific antibodies that are 
commercially available against most used tags (Brizzard, 2008). In T. brucei, a 
wide range of molecular tools have been developed to allow the expression of 
proteins as translational fusions with tags such as the c-myc and the human 
influenza virus hemagglutinin (HA) (Oberholzer et al., 2006; Kelly et al., 2007; 
Alsford and Horn, 2008). One strategy encompasses the inducible over-
expression of the tag-fused protein (either tagged at the N- or C-terminus) 
(Alsford and Horn, 2008; Kelly et al., 2007), for instance using the 29-13 cell line 
described in section 3.3.1 (Wirtz et al., 1999; Alsford et al., 2005). 
Nevertheless, this strategy carries the risk that, in some cases, over-expression 
of the tagged protein may result in its mis-localisation and possible assembly 
into non-physiological complexes (Alsford and Horn, 2008; Shen et al., 2001). 
Another strategy relies upon adding the epitope tag, either to the N- or C-
terminus of the protein, in situ (Oberholzer et al., 2006; Kelly et al., 2007). In 
this approach one of the chromosomal copies of the gene is modified, leading to 
the expression of the tagged protein from the gene’s endogenous locus, and, in 
principal, at normal physiological levels (Shen et al., 2001; Oberholzer et al., 
2006; Kelly et al., 2007; Alsford and Horn, 2008). In this strategy, endogenous 
tagging is achieved through homologous recombination between specifically 
generated cassettes or plasmids (with part of the gene of interest fused to the 
tag) and the endogenous locus after transformation. Because the tag is inserted 
fused to the gene at its endogenous locus, this strategy can be applied in 
different cell line backgrounds, including the ones used for inducible RNAi 
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(Oberholzer et al., 2006). In this way, it is possible to assess the knockdown 
efficiency of the inducible RNAi experiment through the detection of the 
corresponding tagged protein throughout the assay (strategy employed in section 
3.3.2.3). Nonetheless, it is important to keep in mind that there is always the 
risk that the fusion of the protein with a tag might interfere with the protein’s 
structure and thus potentially alter its function and/or localisation (Brizzard, 
2008). It is therefore important to ensure that the tagged version of the protein 
is indeed functional by, for example, deleting the remaining endogenous allele 
of the gene (Kelly et al., 2007).  
3.4.1 Cloning constructs for endogenous tagging with c-myc 
In order to better understand the TbORC1/CDC6 interacting factors, each was 
tagged at its endogenous locus, either with c-myc or HA, essentially as described 
previously in (Tiengwe et al., 2012b). In order to insert a c-myc epitope tag in 
the C-terminus of TbORC1B, TbORC4, Tb7980, Tb3120, and Tb1120, the 
construct pNATx12M (Alsford and Horn, 2008), containing 12 copies of the c-myc 
tag (12myc), and the blasticidin (BSD) resistance gene (the latter flanked by T. 
brucei tubulin and actin processing sequences), was used. This construct has 
been reported to generate fusion proteins that show very little cross-reactivity 
with native proteins when detected with commercially available anti-c-myc 
antibodies, and the 12myc tag has never been reported to display toxicity or to 
have cryptic localisation signals that might influence the tagged protein 
localisation (Alsford and Horn, 2008). Besides, it had been previously 
successfully used for the generation of the TbORC1/CDC6 C-terminal 12myc-
tagged cell line (Tiengwe et al., 2012b). A schematic representation depicting 
the strategy employed to generate the tagging constructs is shown in Figure 
3.12, A. Briefly, the 3’ end of the open reading frame (ORF) of the gene of 
interest (GOI) was PCR-amplified using primers containing specific restriction 
sites that allow the insertion of this fragment into the pNATx12M plasmid 
backbone. In all cases, when designing the reverse primer, the gene’s stop 
codon was excluded, allowing the translation of the fusion of the upstream ORF 
fragment and the epitope. In addition, the amplified PCR product possessed a 
unique restriction site that is not present in the plasmid backbone, allowing 
linearization by enzymatic digestion prior to transformation into the parasite, 
and driving homologous integration into the gene.  
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Figure 3.12. Cloning strategy used to generate the plasmids for endogenous tag with N- or 
C-terminal 12myc, and C-terminal 6HA.  
Schematic representation of the cloning strategy used to generate the C- terminal 12myc or 6HA 
tag (A), or N-terminal 12myc tag (B). 5’ UTR (untranslated region) refers to the 5’ intergenic region 
of the gene of interest, as the 5’ UTR regions of the genes had not been annotated in TriTrypDB at 
the time these constructs were designed and conceived. ORF refers to open reading frame. 
Diagrams are not to scale. 
 
At the start of this project, Dr Calvin Tiengwe had already generated constructs 
for the 12myc C-terminal tagging of TbORC1/CDC6, TbORC4, Tb7980 and Tb3120 
during the course of his PhD (plasmid repository numbers pBM3, pBM35, pBM37, 
and pBM36, respectively). However, with the exception of pBM3, none of the 
plasmids had been confirmed by either enzymatic digestion or sequencing. 
A) 
B) 
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Because these constructs had to be re-made for transfection of Lister 427 strain 
cell lines (explained in Chapter 4, section 4.3.1), the cloning strategies 
employed for the tagging of TbORC4, Tb7980 and Tb3120 are also described 
below, as well as the strategies for tagging TbORC1B and Tb1120. Full details are 
in the materials and methods, Chapter 2, section 2.2.1. 
A fragment of 455 base pairs (bp) from the 3’ region of the TbORC1B ORF was 
PCR-amplified from TREU 927 genomic DNA (gDNA) using the forward primer C5, 
containing the HindIII restriction site, and the reverse primer C6, containing the 
XbaI restriction sequence. Similarly, a fragment of 638 bp was amplified from 
TbORC4, using primers CTOL_65g (HindIII site) and CTOL_66 (XbaI site); a region 
of 639 bp of Tb7980 was amplified using primers CTOL_69 (HindIII site) and 
CTOL_70 (XbaI site); a region of 659 bp of Tb3120 was amplified using the C120 
(HindIII site) and C121 (XbaI site); and a section of 1037 bp from Tb1120, was 
amplified using the primers C3 (HindIII site) and C4 (XbaI site). After 
purification, the PCR products and the pNATx12M plasmid were digested with both 
HindIII and XbaI, further purified, ligated and transformed into competent DH5α 
E. coli bacteria (details in materials and methods, Chapter 2, section 2.2.1). The 
resulting plasmids, TbORC1B-12mycBSD, TbORC4-12mycBSD, Tb3120-12mycBSD 
and Tb1120-12mycBSD (maps shown in Figure 3.13, B, D, E and F), were then 
purified from the bacteria, and confirmed by restriction enzyme digestion, using 
two combinations of enzymes: HindIII and XbaI, for confirmation of the gene 
fragment, and XbaI with BamHI, to confirm the presence of the 12myc tag, 
which is 445 bp in size (Figure 3.13, G). The TbORC1/CDC6-12mycBSD plasmid 
(Tiengwe et al., 2012b) map and confirmation digestion are also shown in Figure 
3.13 (A and G). All plasmids were further sequenced using the HA/myc primers 
pair (MP 15h and MP 16, sequence shown in materials and methods, Chapter 2, 
Table 2-2) and, with the exception of the Tb7980 C-terminal tag construct (not 
shown, but discussed further below), all were confirmed to have the correct 
sequence of the gene insert. 
                                         
g
 Primers labelled as CTOL were designed by Dr Calvin Tiengwe during the course of his PhD, and 
can be found in Tiengwe et al., 2012, as well as in his thesis, Tiengwe, 2010. 
h
 Dr Marko Prorocic designed primers labelled as MP during the course of his Post-Doc in Dr 
Richard McCulloch’s lab. 
Chapter 3  172 
 
 
 
Figure 3.13. Plasmid maps and confirmation enzymatic digestions of the constructs used 
for endogenous tagging with N- or C-terminal 12myc.  
Detailed plasmid maps of the constructs used for endogenous tagging with 12myc at the C-
terminus (A, B, D, E, and F), or at the N-terminus (C). The 12myc tag is represented in green, the 
bacterial ampicillin resistance gene is shown as ampR and in black, and the bacterial origin 
depicted as ColE1 origin and in grey. Each gene region cloned into the construct is shown and 
labelled with the gene name used throughout this work, and the drug resistance gene, used for 
parasite clone selection, blasticidin, is represented as BSD and in orange. Relevant restriction sites 
are also shown. All constructs were confirmed through restriction enzyme digestions, shown in G, 
with more detailed description in the main text. In each case, the 1 Kb plus DNA ladder 
A) B) 
C) D) 
E) F) 
G) 
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(Invitrogen™) is shown as a size reference and the expected sizes, resulting from the different 
enzymatic digestions, are shown below each gel image: for C-terminal 12myc tag plasmids, (*) 
digestion with HindIII and XbaI results in the excision of the gene fragment cloned into the plasmid; 
(**) digestion with XbaI and BamHI results in the excision of the 12myc tag from the plasmid; for 
the N-terminal 12myc tag plasmids, (§) digestion with SpeI and KpnI excises the ORF region 
cloned into the plasmid, while (§§) digestion with KpnI and BamHI results in the excision of the 
5’UTR fragment cloned into the plasmid. Note that in some cases the same gel image has been 
cropped to display the results from the same plasmid side-by-side, and are separated by a white 
space. 
 
Generation of a construct to be used for Tb7980 C-terminal 12myc tagging was 
attempted several times, but was never successfully recovered (data not 
shown). A different forward primer (C103), containing a SacI restriction site 
already present in the gene sequence, was therefore designed and used for 
cloning, adapting the strategy above with the SacI restriction site instead. 
Although it was possible to obtain the correct plasmid (confirmed both through 
enzymatic digestion and sequencing; data not shown), it was never possible to 
recover any parasites after transfection with this construct (data not shown). To 
circumvent these problems, it was decided to tag Tb7980 endogenously with 
12myc at the N-terminus instead. For this, a modified version of the pEnT6B 
construct (Kelly et al., 2007), generated by Dr Anna Trenaman during the course 
of her PhD (Trenaman, 2012), and containing the BSD selection marker, was 
used. A schematic representation of the strategy used is shown in Figure 3.12, B. 
In this case, to allow homologous recombination into the parasite’s genome, two 
fragments are PCR-amplified: a region from the 5’ end of the gene’s ORF, 
beginning at the second codon (and thus excluding the start codon), and a 
section from upstream of the ORF start codon and in the 5’ intergenic region 
(Kelly et al., 2007). As before, all pairs of primers contain restriction enzyme 
sites, but the key aspect in this cloning strategy is that the unique restriction 
site that will be used for the linearization of the plasmid prior to transfection 
(KpnI in this case), is included in the reverse primer used for the amplification of 
the gene’s ORF fragment, as well as in the forward primer used for the 
amplification of the 5’ intergenic region (Figure 3.12) (Kelly et al., 2007; 
Trenaman, 2012). The two PCR fragments, as well as the plasmid, are then 
digested with the appropriate restriction enzymes, and simultaneously cloned in 
a “three-piece ligation” reaction. In this case, a 367 bp 5’ region of the Tb7980 
ORF was PCR-amplified using the primer pair C186 (containing the SpeI 
restriction site) and C187 (KpnI site), while the 5’ intergenic region upstream of 
the Tb7980 ORF was amplified using the C185 (containing the KpnI site) and C184 
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(with the BamHI site) primer pair (sequences shown in the materials and 
methods, Chapter 2, Table 2-1). After cloning and purification from bacteria, 
the resulting plasmid, 12myc-Tb7980-BSD (map depicted in Figure 3.13, C), was 
confirmed by restriction enzyme digestion using the SpeI and KpnI combination, 
to extract the ORF fragment, as well as KpnI and BamHI, to extract the 5’ 
intergenic region (shown in Figure 3.13, G). In addition, the cloned regions were 
further confirmed through sequencing using the AT120i and AT121 primers 
(shown in materials and methods, Chapter 2, Table 2-2). 
3.4.2 Cloning constructs for endogenous tagging with HA 
To analyse protein interactions, T. brucei cell lines expressing two proteins 
endogenously tagged with different tags have been generated in the past (Dang 
and Li, 2011; Tiengwe et al., 2012b). One successful combination encompasses 
the use of the c-myc and HA tags, and it has been used to confirm the 
interaction of TbORC1/CDC6 (tagged with 12myc) with TbORC4, Tb7980 and 
Tb3120 (each tagged individually with HA) (Tiengwe et al., 2012b). Although it 
was identified has a strong hit following the mass-spectrometry analysis of 
TbORC1/CDC6 immunoprecipitation (IP), the predicted interaction between 
Tb1120 and TbORC1/CDC6 was never confirmed (Tiengwe, 2010). Therefore, it 
was decided to endogenously tag Tb1120 at the C-terminus with 6 copies of HA 
(6HA), using a variant of pNATx12M where the 12myc tag and the blasticidin 
resistance gene have been replaced, respectively, with a 6HA tag and the 
bleomycin resistance gene (BLE) (Tiengwe et al., 2012b). TbORC1B was 
previously shown to interact with TbORC1/CDC6 using a different combination of 
tags (Dang and Li, 2011): 3HA and PTP. To provide comparable data with all 
other putative Orc-like factors, it was also decided to tag TbORC1B with 6HA. 
The cloning strategy used was identical to the one described for C-terminal 
tagging of proteins with 12myc in the previous section (shown in Figure 3.12). 
Because the 6HA plasmid is a derivation of pNATx12M, the restriction sites used 
for cloning remained the same and, therefore, the cloning process was the same 
as described in section 3.4.1. Plasmid maps of the TbORC1B-6HABLE and Tb1120-
6HABLE constructs are shown in Figure 3.14, together with the confirmation 
                                         
i
 Primers labelled as AT were designed by Dr Anna Trenaman during the course of her PhD, and 
can be found in her thesis, Trenaman, 2012. 
Chapter 3  175 
 
 
digestions: HindIII and XbaI to extract the gene insert, and XbaI in combination 
with BamHI to isolate the 6HA tag, of 211 bp in size.  
 
Figure 3.14. Plasmid maps and confirmation enzymatic digestion of the constructs used for 
endogenous tagging of proteins with C-terminal 6HA tag.  
Detailed plasmid maps of the constructs used for endogenous tag TbORC1B (A) and Tb1120 (B) 
with 6HA at the C-terminus. The 6HA tag is represented in red, the bacterial drug resistance gene, 
against ampicillin, is shown as ampR and in black, and the bacterial origin in depicted as ColE1 
origin and in grey. Each gene region cloned into the construct is shown and labelled with the gene 
name used throughout this work, and the drug resistance gene, used for parasite clone selection, 
bleomycin, is represented as BLE and in orange. Relevant restriction sites are also shown. The 
constructs were confirmed through restriction enzyme digestions, shown in C, with more detailed 
description in the main text. In each case, the 1 Kb plus DNA ladder (Invitrogen™) is shown as a 
size reference, and the expected sizes, resultant from the different enzymatic digestions, are 
shown below each gel image: (*) digestion with HindIII and XbaI results in the excision of the gene 
fragment cloned into the plasmid; (**) digestion with XbaI and BamHI results in the excision of the 
6HA tag from the plasmid. Note that in the final images shown, the same gel image has been 
cropped so to display the results from the same plasmid side-by-side, and are separated by a white 
space. 
 
3.4.3 Cloning constructs for in situ gene disruption 
As briefly mentioned in section 3.4, it is important to confirm whether the 
protein fused with the tag is functional. The most commonly used strategy is to 
delete one allele and then tag the remaining allele, which will result in the only 
protein expressed in the cell being the tagged one (Kelly et al., 2007). This has 
been successfully achieved for TbORC1/CDC6 (Tiengwe et al., 2012b), and it 
relies on the transfection of a construct that, by homologous recombination with 
the gene’s 5’ and 3’ intergenic flanking regions, will lead to deletion of the 
A) B) 
C) 
Chapter 3  176 
 
 
endogenous gene by replacing it with a selective drug marker gene. In this study, 
a plasmid modified by Dr Marko Prorocic from the pmtl23 plasmid (gift from 
Professor Marshall Stark, University of Glasgow), so to harbour a drug resistance 
gene between two multiple cloning sites, was used (a detailed plasmid map is 
shown in the appendices, Figure 7.34). Several variations of pmtl23 have been 
generated, so to have puromycin (PURO), blasticidin (BSD), bleomycin (BLE), or 
the neomycin (NEO) resistance genes, and thus allow a wide choice of selective 
drugs that can be used. Like other constructs used for gene deletion (e.g. the 
modified pBluescript KS plasmid used for deletion of one of TbORC1/CDC6 alleles 
(Tiengwe et al., 2012b), which is shown in Figure 3.16, A), a region of 
approximately 450-600 bp is PCR-amplified from the gene ORF’s immediate 5’ 
and 3’ intergenic regions (here referred to as untranslated regions, UTRs), with 
primers containing specific restriction enzymes sites (Figure 7.34), to allow 
cloning into the plasmid flanking the drug resistance gene (Figure 3.15). Due to 
the presence of multiple cloning sites on either end of the selective drug 
marker, forward and reverse primers can be designed such that four different 
enzymes are used for the digestion of the 5’ and 3’ UTR fragments prior to 
ligation into the plasmid backbone (two combinations, two enzymes each PCR 
fragment). The parent plasmid is digested, separately, twice: once with the 
enzyme present in the forward primer of the 5’UTR fragment and with the 
enzyme in the reverse primer of the 3’UTR PCR product, generating the plasmid 
backbone; and once with the enzyme present in the reverse primer of the 5’UTR 
fragment, together with the enzyme in the forward primer used to amplify the 
3’UTR region, which will result in excision of a fragment containing the drug 
selective marker gene. The two isolated plasmid fragments are therefore 
incompatible, as they were excised using different enzyme combinations and are 
not able to re-ligate with one another. The 5’ and 3’ UTR PCR products, purified 
after enzymatic digestion, are then added to the two plasmid fragments, and 
simultaneously cloned in a “four-piece ligation” reaction, which will only result 
in full length plasmids (and therefore bacterial colonies) if the four fragments 
are ligated to each other in the correct order and orientation. This strategy 
allows cloning of two PCR products into the plasmid in one cloning step, rather 
than consecutive ligation reactions. Another advantage of using this construct 
lies in the fact that both the forward primer used for the 5’ UTR PCR 
amplification and the reverse primer used for the 3’ UTR PCR contain, in the 
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cases here, a NotI restriction site, allowing excision of a fragment encompassing 
the two UTRs and the drug resistance cassette (to be used for transfection into 
the parasite cells) using a single restriction enzyme. Because this site is included 
in the primers, other enzyme sites can be used, giving this construct a great 
flexibility regarding the choice of restriction sites that can be used prior to 
transfection into the parasite cells.  
 
Figure 3.15. Cloning strategy to generate constructs for gene deletion.  
Schematic representation of the cloning strategy used to generate the gene deletion (KO) 
constructs from the modified pmtl23 plasmid (a detailed map of the modified pmtl23 plasmid is 
shown in the appendices, Figure 7.34). The 5’ UTR (untranslated region) refers to the 5’ intergenic 
region of the gene of interest, while the 3’ UTR refers to the 3’ intergenic region of the gene, as 
both the 5’ and 3’ UTR regions of the genes had not been annotated in TriTrypDB at the time these 
constructs were designed and generated. The selective drug can be blasticidin, puromycin, 
bleomycin or neomycin, depending on the variation of the plasmid used. In the presented example, 
two combinations of restriction enzymes that can be used are depicted (HindIII and XbaI; SacI/KpnI 
and ClaI sites). The NotI restriction sites are inserted with the primers to allow excision of the 
fragment containing the drug selective marker flanked by the 5’ and 3’ UTR regions to be used for 
parasite cells transfection. Representations herein shown are not to scale. 
 
In the present work, only the variation of the pmtl23 plasmid containing the 
neomycin resistance gene (pmtl23-NEO) was used. For cloning of the constructs 
targeting TbORC1B, TbORC4, Tb7980 and Tb3120 (Figure 3.16, B-E), the 5’ UTR 
region was amplified using primer pairs containing the HindIII and NotI 
restriction sites in the forward primer and the XbaI site in the reverse one 
(TbORC1B primers C201 and C202; TbORC4 primers C189 and C190; Tb7980 
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primers C193 and C194; and Tb3120 primers C197 and C198), while the 3’ UTR 
fragment was amplified using a forward primer with the SacI site in conjugation 
with a reverse primer containing both the NotI and ClaI restriction sites 
(TbORC1B primers C203 and C204; TbORC4 primers C191 and C192; Tb7980 
primers C195 and C196; and Tb3120 primers C199 and C200). All primer 
sequences are shown in the material and methods Table 2-1. For the construct 
targeting Tb1120 (Figure 3.16, F), the 5’ UTR region was amplified as described 
above (primers number C205 and C206), while the 3’UTR fragment, which has a 
SacI site, was amplified using a forward primer containing a KpnI restriction site 
instead (primer C207), and a reverse primer containing both the NotI and ClaI 
restriction sites (primer C208). All plasmids were confirmed by enzymatic 
digestion using the NotI restriction enzyme (Figure 3.16, G), as well as 
sequencing, using the standard vector primers M13 uni (-43) and M13 rev (-49) 
(sequences shown in material and methods, Chapter 2, Table 2-2). For 
simplicity, the resulting plasmids are here referred to as TbORC1B-KO-NEO, 
TbORC4-KO-NEO, Tb7980-KO-NEO, Tb3120-KO-NEO, and Tb1120-KO-NEO (NEO, 
neomycin resistance gene). The construct generated by Dr Calvin Tiengwe 
targeting TbORC1/CDC6 chromosome locus (Tiengwe et al., 2012b) is here 
referred to as TbORC1/CDC6-KO-PURO (PURO, puromycin resistance gene). 
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Figure 3.16. Plasmid maps of the constructs used for TbORC1B, TbORC4, Tb7980, Tb3120 
and Tb1120 gene deletion.  
Detailed plasmid maps of the constructs used for gene deletion of one allele of TbORC1/CDC6 (A), 
TbORC4 (B), Tb7980 (C), Tb3120 (D), TbORC1B (E) and Tb1120 (F). Each gene’s 5’ and 3’ UTR 
(intergenic) regions cloned into the construct are shown and labelled with the gene name used 
throughout this work, and the drug resistance genes, used for parasite clone selection, puromycin 
(PURO) in A, and neomycin (NEO) in B-F, are represented as in orange. The bacterial drug 
A) B) 
C) D) 
E) F) 
G) 
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resistance gene, against ampicillin, is shown as ampR and in black, and the bacterial origin in 
depicted as ColE1 origin and in grey. Relevant restriction sites are also shown. All constructs were 
confirmed through restriction enzyme digestions and are shown in G, with more detailed 
description in the main text. In each case, the 1 Kb plus DNA ladder (Invitrogen™) is shown as a 
size reference, and the expected sizes, resultant from the different enzymatic digestions, are 
shown below each gel image. Note that in some cases the same gel image has been cropped so to 
display the results from the same plasmid side-by-side, and are separated by a white space. 
 
3.4.4 Generation of TbORC1B 12myc, TbORC4 12myc, Tb3120 
12myc and Tb1120 12myc PCF cell lines 
To allow tagging, the constructs are linearised and transfected into T. brucei 
cells. Once transfected, the constructs can integrate into the target gene 
through homologous recombination, guided by the 3’ region of the ORF in the 
construct (Figure 3.17). As a result, the 12myc tag is incorporated in-frame into 
the 3’ end of the gene’s ORF, together with the remainder of the construct. This 
means that while the 5’ UTR remains unchanged, the 3’ UTR of the gene is no 
longer the native one (Figure 3.17, iv), having been replaced by the T. brucei βα 
tubulin mRNA processing signal (5’), the drug resistance marker gene, and the T. 
brucei actin mRNA processing signal (3’), allowing the correct splicing of the 
drug resistance gene (Oberholzer et al., 2006; Kelly et al., 2007). In addition, it 
also results in the duplication of the gene fragment used in the construct 
downstream of the tagged locus (Kelly et al., 2007). However, because this does 
not comprise the whole gene, and is lacking the start codon, it is presumed that 
this is inactive (represented in Figure 3.17, iv), as “Incomplete ORF”). In this 
tagging strategy, expression of the targeted gene can be altered if the control 
for expression is dependent on the endogenous 3’ UTR, for instance through 
mRNA stability changes during the cell or life cycle. Estimates of mRNA 
abundance during the cell cycle have been made genome-wide following 
elutriation-based cell cycle synchronisation (Archer et al., 2011), and these data 
are available on TriTrypDB. For each of the Orc-like genes, these data were 
recovered (shown in the appendices, Figure 7.35), and only TbORC1B mRNA 
levels displayed any evidence for mRNA variation, with ~2-fold increased 
abundance in ‘late G1’ (3 hours after synchronisation). However, whether this 
effect is dictated by the gene’s 3’UTR or is related to replication is unknown. 
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Figure 3.17. Integration of the C-terminal 12myc tag constructs into the genome by 
homologous recombination.  
Simplified schematic representation of the process followed to tag a gene endogenously with 
12myc tag. i) General representation of the C-terminal tagging plasmid, with the unique restriction 
site highlighted in red, approximately in the middle of the gene fragment cloned into the plasmid 
(“PCR product”, and shown in blue). In this illustration, the 12myc tag is represented in green, and 
the selective drug resistance gene is shown in orange, while the other features of the plasmid are 
not shown. ii) After digestion of the plasmid with the unique restriction site enzyme, the linearised 
plasmid is transfected into the parasite cells. iii) The linearised plasmid then recombines with the 3’ 
region of the endogenous gene by homologous recombination, resulting in the endogenously 
tagged gene locus, as depicted in iv). Diagrams are not to scale. The same strategy applies to the 
integration of the constructs designed for C-terminal endogenous tagging with 6HA. 
 
For linearization, TbORC1B-12mycBSD was digested with ClaI, TbORC4-12mycBSD 
with SmaI, and both Tb3120-12mycBSD and Tb1120-12mycBSD were individually 
digested with NsiI. Each linearised plasmid was individually transfected into PCF 
cells, strain TREU 927 (see materials and methods, Chapter 2, section 2.3.4) and 
transformants were selected with 10 μg.ml-1 of blasticidin. The resulting cell 
lines are referred to throughout this work as TbORC1B 12myc, TbORC4 12myc, 
Tb3120 12myc, and Tb1120 12myc. Confirmation of correct integration of the 
constructs by PCR and of the expression of the 12myc fused proteins by western 
blot is shown, respectively, in sections 3.4.8 and 3.4.9.  
3.4.5 Generation of cell lines co-expressing both 
TbORC1/CDC612myc and TbORC1B6HA, or Tb11206HA 
For co-localisation and co-immunoprecipitation studies, the 6HA C-terminal 
tagging constructs for TbORC1B and Tb1120 were transfected into PCF TREU 927 
cell lines that already had one allele of TbORC1/CDC6 tagged with 12myc and 
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the other replaced with a puromycin resistance gene cassette (Tiengwe et al., 
2012b). This was performed as described for the C-terminal 12myc tag 
constructs and transformants were confirmed by PCR and western blot as 
described in sections 3.4.8 and 3.4.9. These lines are referred to henceforth as 
TbORC1/CDC6 -/12myc TbORC1B 6HA and TbORC1/CDC6 -/12myc Tb1120 6HA 
cell lines. The TbORC1/CDC6 -/12myc Tb1120 6HA cell line was generated with 
the help of Emily Ross, during her undergraduate project. 
3.4.6 Generation of 12myc Tb7980 cell line 
For N-terminal 12myc tagging of Tb7980, the 12mycTb7980-BSD construct was 
linearised with KpnI (Figure 3.13), and transfected into PCF TREU 927 cells. 
Transformants were selected with 10 μg.ml-1 of blasticidin. In this strategy, the 
5’ UTR and the 12myc fused ORF regions in the construct allow its integration 
into the gene allele (Figure 3.18). As a result, the 12myc tag is incorporated in 
the 5’ of the ORF, meaning that the gene’s 3’ UTR is not modified. The gene’s 5’ 
UTR is also still present, but is separated from the gene’s ORF by the drug 
resistance gene (itself flanked at the 5’ and 3’ by the T. brucei βα tubulin and 
actin mRNA processing signals), as well as the rest of the construct. 
Transformants recovered were confirmed by PCR and western blotting, as 
discussed in sections 3.4.8 and 3.4.9.
 
Figure 3.18. Integration of N-terminal 12myc tag constructs into the genome by homologous 
recombination.  
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Simplified representation of the process followed to tag a gene endogenously with a N-terminal 
12myc tag. i) General representation of the N-terminal tagging plasmid, with the 12myc tag (green) 
fused with the cloned region of the gene ORF (shown in blue and as “ORF PCR”), which is 
separated from the 5’UTR (in grey, “5’UTR PCR”), by a KpnI restriction site (highlighted in yellow). 
In addition, the selective drug resistance gene is shown in orange, while the other features of the 
plasmid are not shown. ii) After digestion with KpnI, the plasmid is linearised and transfected into 
the parasite cells. iii) The linearised plasmid recombines with the endogenous gene locus, both at 
its 5’UTR and the 5’ end of the ORF, through homologous recombination, resulting in the 
endogenously tagged gene locus, as depicted in iv). Representations are not to scale. 
 
3.4.7 Generation of cell lines with one allele tagged and the other 
allele deleted 
To attempt to confirm functionality of the tagged proteins, the gene deletion 
constructs (section 3.4.3, Figure 3.15 and Figure 3.16) were transformed into 
cognate cell lines in which the gene had previously been tagged in one allele. In 
this strategy, the gene’s 5’ and 3’ UTRs were cloned flanking the drug resistance 
gene (already flanked by the T. brucei βα tubulin and actin mRNA processing 
signals, which allows the trans-splicing and polyadenylation of the drug 
resistance gene once integrated into the parasite’s genome), allowing the 
integration of the construct, by homologous recombination with the native 
allele’s 5’ and 3’ UTRs, into the parasite’s genome, leading to the complete 
replacement of the endogenous gene ORF with the drug resistance marker. 
For transfection, TbORC1B-KO-NEO, TbORC4-KO-NEO, Tb7980-KO-NEO, Tb3120-
KO-NEO, and Tb1120-KO-NEO were digested with NotI (shown in Figure 3.16), 
and transfected into PCF strain TREU 927 cells confirmed to have one allele 
endogenously tagged with 12myc (see sections 3.4.8 and 3.4.9); transformants 
were selected with 10 μg.ml-1 of geneticin (G418®). However, despite 
transfecting all constructs, correct integrants were only recovered with Tb7980-
KO-NEO, generating the cell line referred to here as Tb7980 -/12myc 
(confirmation is shown in sections 3.4.8 and 3.4.9). In case this reflected 
impaired function of the tagged proteins, all constructs were also transfected 
into non-tagged TREU 927 cells, but this was again unsuccessful. The reasons for 
this remain unclear, but incorrect constructs for Tb3120-KO-NEO and Tb1120-KO-
NEO, and lethal effects of tagging these proteins, can be ruled out, since 
integrants were successfully obtained in bloodstream form T. brucei cells 
(discussed in Chapter 4). Nonetheless, attempts to mutate TbORC4 and 
TbORC1B, both in PCF and BSF cells, failed despite various transformation 
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attempts. This might suggest that both copies of these genes are needed, a 
hypothesis that is potentially supported by the results obtained through RNAi, as 
reduction in less than 50% of the mRNA levels of either TbORC4 or TbORC1B led 
to a severe growth phenotype (sections 3.3.2.3 and 3.3.2.5, respectively).  
 
Figure 3.19. Schematic representation of the replacement of a gene copy by a drug 
resistance gene through the integration of the KO plasmids by homologous recombination.  
Schematic representation of the process followed to delete a copy of the gene, by replacing the 
endogenous gene ORF with a drug resistance gene. i) General representation of the gene deletion 
(KO) plasmid, with the NotI restriction sites (yellow), flanking the gene’s 5’ and 3’ UTRs (in grey), 
enclosing the selective drug resistance gene (orange). For simplicity, other features of the plasmid 
are not depicted. ii) After digestion of the plasmid with the NotI, the plasmid fragment containing the 
UTR regions and the drug resistance gene is excised and transfected by electroporation into the 
parasite cells. iii) This fragment then recombines with both the 5’ and 3’ UTR regions of the 
endogenous locus, replacing the gene’s ORF with the selective drug resistance gene, as 
represented in iv). Representations are not to scale.  
 
3.4.8 Confirmation of the endogenously tagged cell lines by PCR  
Various clones were obtained for each tagged gene. However, the results 
presented here refer only to the cell lines used in all experiments discussed later 
on in this chapter. All cell lines were routinely confirmed by both PCR and 
western blot (discussed in the next section) prior to performing any other 
experiments. These include the cell line with a TbORC1/CDC6 allele 
endogenously tagged with C-terminal 12myc and the other allele replaced with 
the puromycin resistance gene (generated by Dr Calvin Tiengwe and referred to 
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as TbORC1/CDC6 -/12myc) (Tiengwe et al., 2012b). Therefore, primers used for 
its confirmation are also described.  
A schematic representation of the PCR confirmation strategy is shown in Figure 
3.20, A-C). Integration of the C-terminal tagging constructs, either 12myc or 
6HA, was confirmed using a forward primer recognising an area upstream of the 
region of the gene that had been cloned into the plasmid, and a reverse primer 
recognising a region of the drug resistance marker gene sequence (Figure 3.20). 
Each forward primer is specific to each targeted gene and recognises a region 
absent from the construct, meaning that they can only generate a PCR product 
with the resistance gene primer when the construct has been integrated 
correctly, and will not amplify the non-tagged locus (wild type – Wt – allele) or 
transformed, but not integrated, plasmid. The reverse primer C40 (recognising a 
region of the BSD gene) was used in conjugation with the forward primers C102 
(TbORC1/CDC6), C136 (TbORC1B), C132 (TbORC4), C135 (Tb3120), or C137 
(Tb1120). PCR products of the expected size were generated in each case, as 
shown in Figure 3.20, D, panel 3 (myc PCR). For the confirmation of the C-
terminal 6HA endogenous tag, in the cell lines described in section 3.4.5, the 
reverse primer C41 (recognising a region of the BLE gene) was used instead, in 
combination with C136 (TbORC1B) or C137 (Tb1120), and results are shown in 
Figure 3.20, E. For confirmation of integration of N-terminal 12myc endogenous 
tagging, primers were designed such that the forward primer recognises a region 
of the plasmid immediately upstream of the 12myc tag, and the reverse primer 
recognises a sequence of the tagged gene downstream of the section present in 
the construct (Figure 3.20, B). Again, this allows amplification only from the 
correctly endogenously tagged gene locus, with no amplification from the non-
tagged allele or the non-integrated plasmid. For confirmation of the 12myc N-
terminal tag Tb7980 cell line (named Tb7980 -/12myc), primers numbers C218 
and C219 were used, and the correct size PCR product was generated, as shown 
in Figure 3.20, D, panel 3 (myc PCR). The successful deletion of the non-tagged 
allele, which was only possible for TbORC1/CDC6 and Tb7980, was confirmed 
using primers designed to recognise sequences upstream of the 5’UTR region 
cloned into the plasmid (forward primer) and within the drug resistance gene 
(reverse primer). For confirmation of the deletion of Tb7980, forward primer 
C209 was used with reverse primer C215, which recognises a sequence within the 
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neomycin resistance gene. The correct size PCR product generated is shown in 
Figure 3.20, D, panel 4 (KO PCR). Deletion of the TbORC1/CDC6 allele was 
confirmed with primers C213 and C214, the latter recognising a sequence within 
the puromycin resistance gene (Figure 3.20, D, panel 4 (KO PCR). Importantly, 
all cell lines were also tested for the presence of the wild type endogenous 
allele (Wt allele), which has not been either tagged or deleted. For this, primer 
pairs were designed so that only the non-modified allele (Wt allele) can be PCR-
amplified. Although in all cases these primers recognise sequences also present 
in the endogenously tagged allele, the distance between them is always longer 
than 4.5 Kbp (minimum size of the constructs used for transfection). By using a 
PCR programme suitable only for the amplification of PCR products no longer 
than 2.5 Kbp, amplification of the >4.5 Kbp PCR product from the endogenously 
tagged allele is minimised, and only the product corresponding to the Wt allele 
is successfully amplified. In a cell line where one allele has been tagged and the 
other has been deleted, no amplification is observed using these sets of primers. 
For amplification of the Wt alleles the following pairs of primers were used: 
C101 and CTOL_12 (TbORC1/CDC6); C136 and C131 (TbORC1B); C132 and C134 
(TbORC4); C220 and C219 (Tb7980); C135 and C130 (Tb3120); and C137 and C138 
(Tb1120). Correct size PCR products in the different cell lines are shown in 
Figure 3.20, D, panel 2 (Wt allele PCR). Note that the forward primer used in the 
amplification of the Wt allele of TbORC1/CDC6, TbORC1B, TbORC4, Tb3120 and 
Tb1120 is the same one used for the confirmation of the C-terminal 
endogenously tagged allele, while for Tb7980 the reverse primer is the same as 
the one used for the confirmation of the N-terminal endogenously tagged allele. 
For all PCRs, the wild type, non-tagged cell line (represented as Wt in Figure 
3.20, D and E), was used both as a negative (tag integration and allele deletion 
PCRs) or positive control (Wt allele PCRs). Furthermore, in all cases, a PCR 
reaction using the primer pair C1 and C2, targeting the TbMCM10 gene, was used 
as a control of the PCR reaction itself, and the same PCR conditions (PCR master 
mix and PCR program) were applied (Figure 3.20, D and E, panel 1 – Control 
PCR). All primer sequences and PCR protocols are described in materials and 
methods Chapter 2, section 2.2.2, Table 2-1 and Table 2-5.  
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Figure 3.20. Confirmation of integration of the constructs by PCR.  
A) 
B) 
C) 
D) 
E) 
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Schematic representation of the resultant loci when endogenously tagged with C-terminal 12myc 
(or 6HA) (A), tagged with N-terminal 12myc (B), or replaced with a gene deletion construct (C). 
Different arrows illustrate the forward and reverse primers designed to confirm the integration of the 
different constructs at the target locus. Primer binding sites are also depicted for confirmation of the 
presence of the Wt allele (A-C). The 12myc-tagged cell lines were confirmed by PCR, which is 
shown in D. Panels 2-4 show the resulting products from the PCR reactions using different pairs of 
primers designed specifically to assess the presence of the Wt allele (panel 2), confirm integration 
of the C- and N-terminal endogenous tagging constructs (panel 3), and successful allele deletion 
(panel 4). Panel 1 shows an amplification product from TbMCM10, un-related to any of the 
modified gene loci, as a control of the PCR reaction itself. In all PCR reactions the parental, wild 
type, cell line was used both as a negative (myc PCR and KO PCR) or positive control (Wt allele 
PCR), and is here represented as Wt (far left lane). E) Confirmation by PCR of the generated 6HA-
tagged TbORC1B and Tb1120 cell lines, also expressing TbORC1/CDC6 tagged with 12myc and 
with one TbORC1/CDC6 allele deleted. Like in D, panel 1 shows the control PCR (primers 
targeting TbMCM10); panel 2 shows amplification of the TbORC1/CDC6 wild type allele; panel 3 
shows the PCR confirming the deletion of one TbORC1/CDC6 allele; panel 4 shows the PCR 
confirming the integration of the 12myc-tag plasmid into the TbORC1/CDC6 allele; and panel 5 
shows the integration of the 6HA-tag construct into one of the alleles of TbORC1B (left) or Tb1120 
(right). In each case, the 1 Kb plus DNA ladder (Invitrogen™) is shown as a size reference, and the 
expected PCR product sizes, resultant from the different PCR reactions, are shown below each gel 
image. Note that in some cases the same gel image has been cropped so to display the results 
from the same PCR reaction, and are separated by a white space. Note that all PCR reactions, 
although using different primer pairs, were performed simultaneously using the same PCR program 
and machine. 
 
3.4.9 Confirmation of the expression of 12myc or 6HA tagged 
proteins by Western Blot 
In order to confirm that the tagged proteins were being expressed, around 2.5 x 
106 cells were collected from cell cultures at approximately 1.0 x107 cells.ml-1, 
lysed in protein loading buffer, and the total protein extract analysed by 
western blot. As detailed in materials and methods, Chapter 2, section 2.2.5.3, 
for detection of proteins fused with 12myc, the protein extract was separated by 
SDS PAGE on a 10% Bis-Tris gel, transferred onto a nitrocellulose membrane, and 
probed with mouse α-myc antiserum (diluted 1:7000) and detected with goat α-
mouse horse radish peroxidase (HRP) conjugated antiserum (diluted 1:5000). In 
the case of double-tagged cell lines expressing TbORC1/CDC612myc, and TbORC1B 
or Tb1120 C-terminally tagged with 6HA, the membrane was stripped after myc 
detection and further incubated with mouse α-HA antiserum (diluted 1:10000), 
followed by incubation with the goat α-mouse horse radish peroxidase (HRP) 
conjugated antiserum (diluted 1:5000). Several clones were tested for each cell 
line, although only one clone of each was used for further analysis, and these 
are the ones shown in Figure 3.21. In all cell lines, signal reacting with the 
appropriate antiserum of the expected sizes for the tagged proteins was seen: 
TbOrc1/CDC612myc, 66.34 kDa; TbORC1B12myc, 83.19 kDa; TbORC412myc, 94.99 kDa; 
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12mycTb7980, 66.50 kDa; Tb312012myc, 130.64 kDa; Tb112012myc, 98.4 kDa; 
TbORC1B6HA, 72.09 kDa; and Tb11206HA, 87.30 kDa.  
 
Figure 3.21. Confirmation of the expression of epitope tagged proteins by western blot.  
Total protein extracts from single or double-tagged cell lines were separated by SDS PAGE and 
analysed by western blot. The two panels on the left depict cell lines with TbORC1/CDC6, 
TbORC1B, TbORC4, Tb7980, Tb3120 or Tb1120 tagged with 12myc, while the remaining panels 
show the cell lines expressing TbORC1/CDC6 tagged with 12myc and either TbORC1B or Tb1120 
tagged with 6HA. (*) represents the signal obtained with the incubation of the membranes with the 
α-myc antiserum (α-myc); (**) represents the signal obtained with α-HA antiserum (α-HA). Note 
that for representation, the two right hand side panels represent two different images, one from α-
myc detection and the other for α-HA exposure; these are separated by a white space. In each 
case, the Novex® Sharp Protein Standard was used as protein size marker.  
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3.5 Cellular localisation and cell cycle dynamics of 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, 
Tb312012myc, Tb112012myc and TbORC1B12myc in 
procyclic form cells 
Analysis of the subcellular localisation and dynamics throughout the cell cycle of 
T. brucei proteins by comparing them with their model eukaryotes counterparts 
may shed some light on their putative role in the parasite’s cell cycle, as it has 
been shown recently for the identification of the kinetochore proteins (Akiyoshi 
and Gull, 2014). Following the same rationale, we aimed to investigate the 
subcellular localisation of TbORC1/CDC6 and interacting factors in order to 
better understand their biological role, infer whether they might be acting in a 
complex, and potentially correlate their localisation and dynamics throughout 
the cell cycle with already identified and described proteins from model 
eukaryotes.  
3.5.1 Cell lines  
Although TbORC1B, TbORC4, Tb7980, and Tb3120 have been shown to interact 
with TbORC1/CDC6 (Dang and Li, 2011; Tiengwe et al., 2012b), their subcellular 
localisation has not been investigated. To examine this, we sought to detect 
these proteins using the cell lines described above, in which each protein was 
endogenously tagged with 12myc (section 3.4). Because our aim was to analyse 
factors that are hypothesised to be involved in the initiation of DNA replication, 
it was important to ensure that the endogenously tagged cell lines showed 
normal cell growth, as well as similar DNA replication levels and cell cycle 
profile, when compared to the unmodified, parental cell line (927 wt). As 
depicted in Figure 3.22, A, all cell lines showed a similar growth rate, when 
inoculated at a starting concentration of 1 x 106 cells.ml-1. For the 
TbORC1/CDC6 -/12myc and Tb7980 -/12myc cell lines, where only the 12myc-
tagged version of the protein (TbORC1/CDC612myc and 12mycTb7980, respectively) 
is present in the cell, unchanged growth rate (Figure 3.22, A) suggests that the 
tagged versions of these proteins are functional. To ask if DNA replication is 
altered, EdU incorporation was assessed for all cell lines, as described in detail 
in section 3.3.2. In all cases, approximately 20% of EdU positive cells (Figure 
3.22, B) were seen after incubation for 3 hours in EdU-supplemented media at a 
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cell density of 1 x 107 cells.ml-1. The same samples were also counterstained 
with DAPI, and cell cycle stages were assessed as described in section 3.3.2. 
Again, and reflecting the results obtained from both the growth curves and EdU 
incorporation, no cell cycle differences were evident between the 927 wt cells 
and any of the tagged cell lines, including TbORC1/CDC6 -/12myc and Tb7980 -
/12myc (Figure 3.22, C). Because the cell lines expressing 12myc-tagged 
TbORC1B, TbORC4, Tb3120 or Tb1120 still have one wild type allele (as 
discussed in section 3.4.7), and therefore express an unmodified version of the 
protein, it is not possible to determine if the tagged versions of these proteins 
are functional. Nevertheless, if the tagged proteins impede the action of the 
unmodified protein or impair other proteins (for instance if they cannot interact 
with them), this is not reflected in any detectable changes in growth, DNA 
replication or cell cycle progression.  
 
Figure 3.22. Analysis of the endogenously 12myc tagged cell lines regarding growth in cell 
culture, DNA replication efficiency and cell cycle progression.  
Growth Curves: the different cell lines were transferred to a new culture flask with fresh SDM-79 
culture media without drugs, starting at a concentration of 1 x 10
6
 cells.ml
-1
. Cell density was 
A) 
B) C) 
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assessed every 24 h, and plotted on a Log10 Y-axis graph, as shown in A). The individual dots on 
the graph represent the mean of two independent experiments (n = 2), and the error bars depict 
the standard error of the mean (SEM). DNA Replication: cells at a density of 1 x 10
7
 cells.ml
-1
 were 
collected and incubated with EdU for 3 hours, and then stained for EdU detection and quantification 
by microscopy. A minimum of 125 cells was counted per experiment, and the percentage of EdU 
positive cells was calculated to from the number of cells counted per cell line. B) represents the 
mean % of EdU positive cells resultant from two independent experiments (n = 2), and the error 
bars the SEM. Cell Cycle: the cells used for EdU detection were also counterstained with DAPI, 
and the different cell types quantified. A minimum of 125 cells was analysed per experiment, and 
the percentage of cells of each cell type was calculated from the total number of cells counted per 
cell line. C) represents the mean of two independent experiments (n = 2) in the case of Tb7980 -
/12myc, Tb3120 12myc and Tb1120 12myc, while for 927 wt, TbORC1/CDC6 -/12myc, TbORC1B 
12myc and TbORC4 12myc, the mean of three independent experiments (n = 3) is shown. The 
error bars represent the SEM. 
 
3.5.2 Subcellular localisation of TbORC1/CDC612myc, TbORC412myc, 
12mycTb7980, Tb312012myc, and Tb112012myc 
The different proteins fused with 12myc were next detected by direct 
immunofluorescence using a commercially available anti-myc monoclonal 
antibody conjugated with AlexaFluor® 488 (Millipore, and used as detailed in the 
materials and methods, Chapter 2, section 2.5.1). This antiserum was generated 
from the same clone (4A6) and manufacturer (Millipore) as that used for 
detecting expression of the tagged proteins by western blot in section 3.4.9. As 
shown in Figure 3.21 (927 wt lane), this antiserum recognised specifically the 
myc-tagged proteins, and no cross-reactivity with any native parasite proteins 
was observed. Nevertheless, for each immunofluorescence assay (IFA) 
experiment, the parental, untagged cell line, 927 wt, was used as a negative 
control, also allowing the assessment of the background level of auto 
fluorescence or non-specific signal detected by the appropriate filter set (Alexa 
filter on the DeltaVision imaging system, and FITC on the Axioskop microscope). 
As a positive control, the cell line TbORC1/CDC6 -/12myc (Tiengwe et al., 
2012b) was used, as TbORC1/CDC6 has been shown to localise to the nucleus 
throughout the cell cycle of PCF cells by indirect immunofluorescence using a 
polyclonal anti-T. cruzi TcORC1/CDC6 antiserum (Godoy et al., 2009) and it is, 
therefore, expected that the 12myc-tagged version of the protein 
(TbORC1/CDC612myc) will behave identically.  
As expected, no myc signal was detected in 927 wt cells (Figure 3.23, A), and 
TbORC1/CDC612myc localised to the nucleus of the cell throughout the cell cycle 
(Figure 3.23, B), as described previously (Godoy et al., 2009). These images, 
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acquired using a DeltaVision imaging system (and deconvolved using the ratio 
conservative method on the SoftWoRx software), revealed that 
TbORC1/CDC612myc localised to the nucleus in a punctate pattern (Figure 3.23, 
B), which is consistent throughout the cell cycle (i.e. indistinguishable in 1N1K, 
1N2K and 2N2K cells). In addition, no TbORC1/CDC612myc signal appeared to 
localise to the nucleolus (Figure 3.23, B). In contrast to the observations made 
for TcORC1/CDC6 in T. cruzi promastigotes (Calderano et al., 2011b), 
TbORC1/CDC612myc did not appear to re-localise to the nuclear periphery during 
the G1 to S phase transition or to remain there during S phase (Figure 3.23, B). 
Co-imaging of TbORC1/CDC612myc (with anti-myc antiserum) and incorporated 
EdU (detected with an AlexaFluor® 594-conjugate azide) (Figure 3.24) suggested 
that TbORC1/CDC612myc co-localised, to some extent, with newly replicated 
regions of the nucleus (yellow regions, myc + EdU panel). Imaging of 
TbORC1/CDC612myc by super resolution structure illumination microscopy (SR-
SIM), using a Zeiss Elyra microscope system, allowed a better analysis of 
TbORC1/CDC6 localisation (Figure 3.25). These images confirmed that 
TbORC1/CDC612myc did not localise homogenously within the nucleus, and many 
discrete puncta were visible. Moreover, the number of such puncta appeared to 
be more abundant in S phase cells (1N1eK, and 1N2K – late S or G2 phase), 
although they did not appear to localise to any specific region within the nucleus 
(Figure 3.25). The images support exclusion of TbORC1/CDC612myc from the 
nucleolus, although confirmation will only be possible by counterstaining that 
structure with, for instance, an antibody targeting a nucleolar protein, such as 
TbNOG1 (Park et al., 2001), or the L1C6 monoclonal antibody, which recognises 
an unknown antigen and has been widely used in T. brucei as a nucleolar maker 
(Durand-Dubief and Bastin, 2003; Názer and Sánchez, 2011). Discrete localisation 
of TbORC1/CDC6 may correlate with the genomic sites mapped previously by 
chromatin immunoprecipitation (ChIP) (Tiengwe et al., 2012a). Co-localisation of 
TbORC1/CDC612myc with replicated DNA by visualising incorporated EdU by SR-SIM 
was attempted, but the weak signal obtained for EdU using the AlexaFluor® 594-
conjugate azide was not sufficient to perform any analysis (data not shown).  
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Figure 3.23. Immunofluorescence of TbORC1/CDC6
12myc
.  
A) panels inside the box show the staining of 927 wt cells with DAPI (top panel), AlexaFluor® 488-
conjugated anti-myc antibody (middle panel), and the cell outline by DIC. B) panels show the 
staining of TbORC1/CDC6 -/12myc cells with DAPI (top row panels), allowing their classification in 
1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K cells (post-
mitosis). Panels in the middle row show TbORC1/CDC6
12myc
, recognised by the anti-myc 
antiserum, localising to the nucleus of the cells throughout the cell cycle, as punctate. Lower panel 
row shows the cells outline by DIC. Arrows direct the reader’s attention to the cell in question for 
each cell cycle stage. Images in both A) and B) were acquired using a DeltaVision imaging system, 
and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar represents 
5 μm. 
 
 
Figure 3.24. Immunofluorescence of TbORC1/CDC6
12myc
 and newly synthesised DNA.  
A 1N1eK cell is shown stained with DAPI (far left panel), anti-myc antiserum (middle left panel), 
and AlexaFluor® 594 azide, detecting EdU (middle panel). The middle right panel depicts a merge 
of the myc and EdU staining, where yellow regions suggest co-localisation between 
TbORC1/CDC6
12myc
 and newly synthesised DNA. Cell outline is shown in the DIC image, in the far 
right panel. Scale bar represents 5 μm. 
 
A) B) 
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Figure 3.25. Super resolution imaging of TbORC1/CDC6
12myc
.  
Images acquired with a Zeiss Elyra super resolution microscope system. Detailed localisation of 
TbORC1/CDC6 within the nucleus of the cell in the different cell cycle stages. Top panel, nucleus 
and kinetoplast stained with DAPI; middle panel, TbORC1/CDC6
12myc
 stained with the anti-myc 
antiserum; bottom panel, merge of the DAPI and myc signals. Scale bar represents 5 μm. 
 
Immunolocalisation of TbORC412myc, 12mycTb7980, Tb312012myc, and Tb112012myc, 
showed that these behave very similarly to TbORC1/CDC612myc: they all localised, 
as puncta, to the nucleus of the cell throughout the cell cycle (Figure 3.26, 
Figure 3.27, Figure 3.28, and Figure 3.29, respectively). The various subunits of 
ORC in model eukaryotes have been shown to localise to the nucleus of the cell 
throughout the cell cycle (Tatsumi et al., 2000; Lygerou and Nurse, 1999; Pak et 
al., 1997), which may support the idea that TbORC1/CDC6, TbORC4, Tb7980, 
Tb3120, and Tb1120 act together in a highly divergent ORC complex. It is 
perhaps worth noting that the signal for 12mycTb7980 appeared to be stronger 
than all the other factors (Figure 3.27; images were acquired using the same 
exposure time and further processed the same way using Fiji, as detailed in the 
materials and methods Chapter 2, section 2.5.7). This may reflect the 
apparently greater protein levels seen in western blot analysis (Figure 3.21), but 
what, if any, biological significance this might have is unclear, in particular 
because the role of Tb7980 in DNA replication has not been firmly validated to 
date. Indeed, RNAi of Tb1120 has also not been conducted, so a role in 
replication or even cell cycle control is speculation at this stage. 
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Figure 3.26. Immunofluorescence of TbORC4
12myc
.  
Panels show the staining of TbORC4
12myc
 cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K 
cells (post-mitosis). Panels in the middle row show TbORC4
12myc
, recognised by the anti-myc 
antiserum, localising to the nucleus of the cells throughout the cell cycle, as punctate. Lower panel 
row shows the cells outline by DIC. Images were acquired using a DeltaVision imaging system, and 
deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar represents 5 
μm. 
 
 
Figure 3.27. Immunofluorescence of 
12myc
Tb7980.  
Panels show the staining of 
12myc
Tb7980 cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K 
cells (post-mitosis). Panels in the middle row show 
12myc
Tb7980, recognised by the anti-myc 
antiserum, localising to the nucleus of the cells throughout the cell cycle, as punctate. Lower panel 
row shows the cells outline by DIC. Arrows direct the reader’s attention to the cell in question for 
each cell cycle stage. Images were acquired using a DeltaVision imaging system, and deconvolved 
using the ratio conservative method, on SoftWoRx software. Scale bar represents 5 μm.
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Figure 3.28. Immunofluorescence of Tb3120
12myc
.  
Panels show the staining of Tb3120
12myc
 cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K 
cells (post-mitosis). Panels in the middle row show Tb3120
12myc
, recognised by the anti-myc 
antiserum, localising to the nucleus of the cells throughout the cell cycle, as punctate. Lower panel 
row shows the cells outline by DIC. Arrows direct the reader’s attention to the cell in question for 
each cell cycle stage. Images were acquired using a DeltaVision imaging system, and deconvolved 
using the ratio conservative method, on SoftWoRx software. Scale bar represents 5 μm. 
 
 
Figure 3.29. Immunofluorescence of Tb1120
12myc
.  
Panels show the staining of Tb1120
12myc
 cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K 
cells (post-mitosis). Panels in the middle row show Tb1120
12myc
, recognised by the anti-myc 
antibody, localising to the nucleus of the cells throughout the cell cycle, as punctate. Lower panel 
row shows the cells outline by DIC. Images were acquired using a DeltaVision imaging system, and 
deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar represents 5 
μm. 
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Quantification of the number of cells containing the individual proteins’ signal in 
the nucleus, clearly showed that TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, 
Tb312012myc, and Tb112012myc constitutively localise to the nucleus, as in all cases 
~100% of the cells showed a signal (Figure 3.30). In striking contrast, 
TbORC1B12myc signal was detected in the nucleus of only ~33% of cells in the 
population (Figure 3.30). A detailed analysis of TbORC1B12myc signal revealed 
that this factor localised to the nucleus of specific cell cycle stages, and is 
therefore discussed in a dedicated section (3.5.6).  
 
 
Figure 3.30. Percentage of cells containing nuclear myc signal.  
Representation of the percentage of cells, per cell line, containing the respective tagged protein in 
the nucleus. The mean of three independent experiments (n = 3) is shown, with the error bars 
representing the standard error of the mean. In each experiment, at least 125 cells were counted 
per cell line. Percentage is calculated to the total number of cells counted per cell line in the three 
experiments. 
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3.5.3 Subcellular co-localisation of TbORC1/CDC612myc with 
TbORC46HA, Tb79806HA, Tb31206HA, and Tb11206HA 
Although TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc, and 
Tb112012myc were shown to localise to the nucleus throughout the cell cycle, in 
very similar punctate patterns (previous section), attempts were made to 
analyse co-localisation of these factors in order to test the hypothesis that they 
act together in a highly divergent ORC-like complex. Using the cell lines 
expressing both TbORC1/CDC612myc and either TbORC4, Tb7980, or Tb3120 
endogenously tagged with 6HA (generated and described in Tiengwe et al., 
2012b), and the cell line expressing both TbORC1/CDC612myc and Tb1120 tagged 
with 6HA (described in section 3.4.5), co-localisation between the myc and HA 
signals was tested. In contrast with the 12myc tagged cells lines (as shown 
above), which were analysed for growth, replication and cell cycle defects, 
these detailed analyses were not performed for these double-tagged cell lines. 
Nevertheless, routine maintenance did not suggest any marked cell growth 
anomalies. In order to conduct co-immunofluorescence detection of both 12myc 
and 6HA signals, TbORC1/CDC612myc was detected as described previously with 
the AlexaFluor® 488 conjugated anti-myc antiserum, while the HA tagged 
proteins were detected by indirect immunofluorescence using a primary 
monoclonal anti-HA antiserum (the same used for western blot detection shown 
in Figure 3.21) and a secondary polyclonal anti-mouse antiserum conjugated 
with AlexaFluor® 594 (all detailed in the materials and methods Chapter 2, 
section 2.5.1). Detection of 6HA in the cells was not straightforward and failed 
with several batches of anti-HA antiserum, including when conjugated to the 
FITC fluorophore, an antibody previously described for HA detection in T. brucei 
PCF cells (Dang and Li, 2011). The level of 6HA signal that was eventually 
detected was lower than the one for 12myc and it was not possible to acquire 
high-resolution images using the DeltaVision imaging system, nor super 
resolution data with the Zeiss Elyra system. Nevertheless, results from wide field 
fluorescence imaging using the Zeiss Axioskop 2 light microscope system, 
allowed us to make preliminary inferences regarding co-localisation of each of 
the different factors relative to TbORC1/CDC612myc (Figure 3.31).  
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Figure 3.31. Immunofluorescence of TbORC1/CDC6
12myc
 and TbORC4
6HA
, Tb7980
6HA
, 
Tb3120
6HA
, and Tb1120
6HA
.  
A-D) top panel shows the staining of the cells with DAPI. The second panel shows 
TbORC1/CDC6
12myc
, recognised by the anti-myc antiserum. The third panel shows the signal 
correspondent to the proteins tagged with 6HA. The fourth panel shows a merge of the signals 
detected with both the anti-myc and the anti-HA antibodies. The bottom panel row shows the cells 
outline by DIC. A) cells expressing TbORC4
6HA
; B) cells expressing Tb7980
6HA
; C) cells expressing 
Tb3120
6HA
; and D) cells expressing Tb1120
6HA
. Arrows direct the reader’s attention to the cell in 
question for each cell cycle stage. All images were acquired using an Axioskop 2 imaging system. 
Scale bar represents 5 μm.  
A) B) 
C) D) 
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In order to confirm specificity of the immunofluorescence signals for each tag, 
and to exclude cross-reaction between the mouse anti-myc antiserum and the 
mouse anti-HA primary and secondary antisera (anti-mouse), various 
combinations of controls were used. Because the anti-HA and anti-myc 
AlexaFluor® 488-conjugate antisera were both raised in mouse, the cells were 
first incubated with mouse anti-HA antiserum, followed by the anti-mouse 
antiserum conjugated with the AlexaFluor® 594 fluorophore. Next, and only 
after thorough washing with blocking solution, were the cells incubated with the 
AlexaFluor® 488 conjugated mouse anti-myc antiserum. The 927 wt cell line was 
used as negative control for both tags, while the TbORC1/CDC6 -/12myc cell line 
was used as a control for interference of the signal emitted by the anti-myc 
antiserum and the one emitted by the anti-HA/anti-mouse secondary antisera 
combination, as well as for the potential cross-reaction between the various 
antibodies. In addition, and to further test whether the use of this combination 
of antibodies would not lead to the labelling of the anti-myc antiserum by the 
anti-mouse AlexaFluor® 594-conjugate, or if the secondary antiserum would 
recognise the HA tag directly, the TbORC1/CDC6 -/12myc TbORC1B 6HA cell line 
was incubated with anti-myc and the anti-mouse secondary antisera alone, as an 
extra control. As shown in the appendices Figure 7.36, no myc or HA signal was 
detected in the 927 wt cell line, while only the myc signal was detected in both 
TbORC1/CDC6 -/12myc and TbORC1/CDC6 -/12myc TbORC1B 6HA cell lines, 
showing that following the designed protocol, using this combination of 
antibodies, lead to no cross-reactions and interference of the two signals. 
Nonetheless, all controls were run in parallel with the IFA of each of the double-
tagged cell lines.  
Similar to the observations made for their respective 12myc-tagged versions, 
TbORC46HA, Tb79806HA, Tb31206HA, and Tb11206HA appeared to localise to the 
nucleus throughout the cell cycle as puncta (Figure 3.31), although the signal 
was weaker than the one from the myc-tagged proteins. Nevertheless, 
reproduction of the localisation patterns obtained for the 12myc-tagged versions 
of the proteins may suggest that neither tag interferes with the proteins’ 
functions, although it would be necessary to delete the remaining wild type 
allele to ultimately confirm this. The overlap of the signal obtained for 
TbORC1/CDC612myc and TbORC46HA, Tb79806HA, Tb31206HA, or Tb11206HA appeared 
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to suggest co-localisation between the proteins, although this would be more 
evident in images acquired with better resolution. Unfortunately, the 
microscope used has the inherent problem of shifting slightly when the different 
excitation/emission filters are changed, resulting in the images acquired with 
the different filters not overlapping completely (quite evident in the third panel 
of Figure 3.31, A). Nevertheless, these preliminary observations appear 
consistent with the observed interaction of TbORC1/CDC612myc with TbORC46HA, 
Tb79806HA, Tb31206HA (Tiengwe et al., 2012b) and Tb11206HA, as shown in section 
3.6.1. Again, TbORC1B6HA detection and localisation in relation to 
TbORC1/CDC612myc will be discussed in a separate section (3.5.6.5). 
It will be of value, in the future, to generate cell lines that have different 
combinations of these factors tagged with 12myc and 6HA, and examine whether 
all the factors co-localise with each other or if different interacting patterns are 
observed.  
3.5.4 Subcellular distribution of TbORC1/CDC612myc, 
TbORC1B12myc, TbORC412myc, 12mycTb7980, Tb312012myc, and 
Tb112012myc by cell fractionation 
In order to complement the information obtained by microscopy-related 
techniques, many studies have used cell fractionation methods to understand a 
protein’s localisation at the subcellular level. For instance, studies from various 
model organisms have revealed that while the ORC subunits clearly localise to 
the nucleus and are mainly detected in the nuclear fraction of the cells, they 
can also be detected in the cytoplasmic fraction, even if such localisation is not 
so clearly detected by fluorescence microscopy (Tatsumi et al., 2000; Lygerou 
and Nurse, 1999; Semple et al., 2006). 
In T. brucei PCF cells, isolation of nuclear and cytoplasmic fractions of the cell 
has been successfully achieved by aqueous fractionation (Zeiner et al., 2003), a 
protocol that coupled with western blot has been used in the field for the 
analysis of proteins involved in various cellular processes (Trenaman et al., 
2013). Various characterised nuclear and cytoplasmic proteins have been used as 
markers for the efficiency of fractionation, including the nucleolar protein 
TbNOG1 (Park et al., 2001) as the nuclear marker (Trenaman et al., 2013; Jones 
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et al., 2014), and oligopeptidase B (TbOPB) (Morty et al., 1999) as a cytoplasmic 
marker. Therefore, to assess the presence of TbORC1/CDC612myc and interacting 
factors in the cytoplasmic and nuclear fractions of PCF cells, sheep serum raised 
against L. major LmOPB (Munday et al., 2011) (gift, Jeremy C. Mottram’s 
Laboratory), which has been shown to recognise TbOPB (Trenaman et al., 2013; 
Jones et al., 2014), was used as the cytoplasmic marker, while the anti-TbNOG1 
antibody, raised in rabbit (Park et al., 2001) (gift, Marilyn Parsons’ Laboratory), 
was used as the nuclear marker. Unfortunately, the amount of anti-TbNOG1 
antibody was very limited, and only the results for Tb112012myc are shown using 
this marker (Figure 3.32). As an alternative, recently obtained rabbit antibody 
raised against T. brucei histone H2A (Dr Tiago D. Serafim, unpublishedj; gift) was 
used (Figure 3.32). For simplicity, these antibodies are henceforth referred to as 
anti-OPB, anti-NOG1, and anti-H2A. 
As for the microscopy assays, all the 12myc-endogenously tagged cell lines 
(section 3.4.9), were grown in culture at a starting concentration of 1 x 106 
cells.ml-1, and used for aqueous fractionation at a concentration of ~1 x 107 
cells.ml-1. Around 5 x 108 cells were collected, lysed, and fractionated as 
described by (Zeiner et al., 2003). Immediately after extraction, both the 
nuclear and cytoplasmic fractions were separated by SDS-PAGE electrophoresis, 
alongside with a sample of the lysate used for the fractionation, as a control of 
the presence of the tagged protein, and were further analysed by western blot, 
as described in the materials and methods Chapter 2, section 2.6.3. Both the 
anti-OPB anti-NOG1 antisera gave very strong signals. Consequently, stripping of 
the nitrocellulose membrane after immunodetection was never successful, and 
subsequent detection of another protein was impossible (not shown). Therefore, 
for the aqueous fractionation experiments in Figure 3.32, each sample was 
equally loaded onto different SDS-PAGE gels and each probed with different 
antiserum (anti-myc, diluted 1:7000; anti-OPB, diluted 1:1000; anti-NOG1, 
diluted 1:5000; and anti-H2A, diluted 1:1000). These different antibodies were 
detected using goat anti-mouse (for anti-myc), donkey anti-sheep (for anti-OPB), 
or goat anti-rabbit (for both anti-NOG1 and anti-H2A), all IgG horseradish (HRP)-
conjugated antisera, and diluted 1:5000. As shown in Figure 3.32, 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and Tb112012myc were 
                                         
j
 The anti-H2A antibody was generated against the peptide described in Glover et al., 2012. 
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each detected both in the cytoplasmic (C) and nuclear (N) fractions of the cells, 
which, according to the signals detected with the anti-OPB and anti-H2A/NOG1 
antisera, were successfully separated (i.e. no OPB signal in the nuclear fraction, 
and absence of NOG1 or H2A signal in the cytoplasmic fraction). These results 
somewhat coincide with observations made for other eukaryotes’ ORC subunits, 
which have been detected in both nuclear and cytoplasmic fractions of the cells 
under study (Tatsumi et al., 2000; Lygerou and Nurse, 1999; Semple et al., 
2006). In those studies, however, the ORC subunits were mainly detected in the 
nuclear fraction, with only a small proportion of the proteins being observed in 
the cytoplasmic fraction. This is similar to what was observed for Tb112012myc 
(Figure 3.32), while TbORC1/CDC612myc, TbORC412myc, 12mycTb7980 and 
Tb312012myc appeared to be equally distributed between the fractions. Why 
Tb1120 may differ, and whether it forms part of a putative ORC-like complex, is 
unclear, though it is worth noting that this analysis was only performed once 
with the Tb1120 12myc cell line, while the assay was repeated three times 
(same results, not shown) for all the others. It is nonetheless possible the less 
intense cytoplasmic signal merely reflects poor western blot detection.  
 
Figure 3.32. Detection of TbORC1/CDC6
12myc
, TbORC1B
12myc
, TbORC4
12myc
, 
12myc
Tb7980, 
Tb3120
12myc
 and Tb1120
12myc
 in the nuclear and cytoplasmic fractions of the cell.  
Untagged T. brucei PCF cells (927wt) or PCF cells expressing 12myc tagged variants of 
TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 or Tb1120 were lysed (L), and further 
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fractioned into cytoplasmic (C) and nuclear (N) fractions (Zeiner et al., 2003). The lysate and the 
two fractions were then separated by SDS-PAGE and analysed by western blot. The 12myc tagged 
proteins were detected with the α-myc antiserum (top panel). Histone H2A (~14.2 kDa, detected 
with α-H2A antiserum, gift from Dr Tiago D. Serafim) or NOG1 (~74.75 kDa, detected with α-Nog1 
antiserum, (Park et al., 2001) were used as nuclear markers (middle panel), while oligopeptidase B 
(~80.5 kDa, detected with α-OPB serum, (Munday et al., 2011), was used as the cytoplasmic 
marker (bottom panel).  
 
Interestingly, TbORC1B12myc showed a different pattern to all the other factors: 
full length TbORC1B12myc (predicted size 83.19 kDa, but ran just below 110 kDa) 
was exclusively detected in the nuclear fraction (Figure 3.32, top row, third 
group of panels). A smaller band, of around 65 - 70 kDa was consistently 
detected in this analysis, and a small amount of this species was also seen in the 
cytoplasmic fraction, but not the lysate. The same band has also been observed 
in immunoprecipitation assays (shown in section 3.6.2), but it is not clear what 
this band might be. Since it is not seen in the other cell lines, it is most likely 
derived from full length TbORC1B12myc and must then comprise the C-terminal 
end of the protein, where the 12myc tag is fused. It may simply be that 
TbORC1B is prone to proteolysis, which is limited in the lysate due to the fact 
that this sample was frozen at – 20°C immediately after lysis. Nevertheless, the 
different behaviour of TbORC1B, as discussed below (section 3.5.6), and perhaps 
reflected in the RNAi data, may mean that these observations suggest some 
unknown aspect of protein expression or function, though further analysis would 
be needed to examine this.  
3.5.5 Analysis of the cell cycle dynamics of TbORC1/CDC612myc, 
TbORC412myc, 12mycTb7980, Tb312012myc, and Tb112012myc  
In previous sections it was shown that TbORC1/CDC612myc, TbORC412myc, 
12mycTb7980, Tb312012myc and Tb112012myc appear to localise to the nucleus of the 
cell throughout the cell cycle. However, it remains possible that analysis of 
merely counting the proportion of cells that show 12myc nuclear signal might 
miss dynamic expression changes of these proteins as the cell cycle progresses. 
In an attempt to address this, the fluorescent intensity of the nuclear 12myc 
signal was measured and analysed per cell cycle stage. The 12myc-tagged cell 
lines were used again as described in section 3.5.2, with images acquired using 
the Axioskop imaging system. Although the image quality and resolution is 
poorer when compared to the images captured using the DeltaVision microscope 
system, it allows the capture of images containing a larger number of cells, thus 
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allowing the quantification of different parameters from a large number of cells. 
For this analysis, cells were incubated with EdU for 3 h, and prepared for DAPI 
staining and anti-myc immunofluorescence, as detailed in section 3.5.2 and in 
the materials and methods Chapter 2, section 2.5.3. The presence of EdU, allied 
to N-K configuration allowed the identification of cells that were undergoing 
replication. Intensity of the DAPI and myc fluorescence signals was measured per 
individual cell by drawing a circular 21 x 21 pixel region of interest (ROI) around 
the cell’s nucleus in Fiji (Schindelin et al., 2012) (described in Chapter 2, 
section 2.5.7). Because light dispersion throughout an image is not always 
homogeneous when using the Axioskop microscope system, every analysed image 
was treated using the rolling ball background subtraction plugink, set up with a 
radius of 50 pixels. After background was removed, the mean pixel intensity of 
the DAPI and myc individual signals inside each circular ROI was measured and 
plotted on a graph against the corresponding cell type (1N1K, 1N1eK, 1N2K or 
2N2K). A minimum of 150 cells was analysed per cell line and, in the event of a 
single image having more than 150 cells, a minimum of two images was still 
examined per cell line. Data from one experiment is shown below but, because 
the maximum and minimum intensities of the DAPI, myc and EdU signals can 
differ between experiments, an experimental repeat is shown in the appendices, 
section 7.6, which revealed the same dynamics profile for each of the factors.  
DAPI and myc signals were first measured in the parental cell line, 927 wt 
(Figure 3.33), as a control. This allowed both the assessment of a normal DAPI 
intensity progression throughout the cell cycle and the basal level of auto 
fluorescence of the cell that is detected by the FITC filter set used to detect the 
myc signal when using the AlexaFluor® 488-conjugate antibody. Figure 3.33, A, 
shows representative images of normal cell types during the cell cycle, as 
identified by N-K ratio detected by DAPI (1N1K, 1N1eK, 1N2K and 2N2K). No 
detectable signal was seen in the myc images (second panel row), and EdU was 
detected in cells either in mid to late S phase (1N1K, 1N1eK) as well as in G2 
(1N2K) phase (third panel row). DAPI fluorescence intensity (Figure 3.33, B) 
increased as cells progressed from G1 phase cells (1N1K; ~6 units) through S 
phase (1N1eK), where cells showed a wider variety of intensity values 
representing cells in the different stages of S phase – from early S to late S phase 
                                         
k
 Available at http://fiji.sc/Rolling_Ball_Background_Subtraction  
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stages. The DAPI signal peaked in G2 cells (1N2K), which showed approximately 
double (~12 units) the signal of G1 phase cells, consistent with the DNA being 
completely replicated (Figure 3.33, B). After mitosis (2N2K cells), the signal of 
each individual nucleus of the cell decreased back to the intensity values 
observed for G1 cells (Figure 3.33, B), as expected upon completing nuclear 
division. The signal resulting from auto fluorescence of the cells in the FITC 
filter set showed no change during the cell cycle (Figure 3.33, C), suggesting 
that there is no influence of the DAPI signal (e.g. bleed through) on the signal 
detected with this filter setting, nor unspecific signal from incubation with the 
anti-myc antiserum. The average background anti-myc signal of the whole cell 
population, thus derived from these measurements, is represented as a dashed 
red line in the myc intensity plots (C) in Figure 3.34, Figure 3.35, Figure 3.36, 
Figure 3.37, and Figure 3.38. 
In all analysed cell lines, TbORC1/CDC6 -/12myc, TbORC4 12myc, Tb7980 -
/12myc, Tb3120 12myc and Tb1120 12myc, the intensity of the DAPI signal 
followed the dynamics described for the 927 wt parental cell line (in B of Figure 
3.34, Figure 3.35, Figure 3.36, Figure 3.37, and Figure 3.38), supporting the 
suggestion that all these 12myc-tagged cell lines have no clear cell cycle defects 
(section 3.5.1). Furthermore, each of the tagged proteins was localised to the 
nucleus of the cells throughout the cell cycle (in A of Figure 3.34, Figure 3.35, 
Figure 3.36, Figure 3.37, and Figure 3.38), as expected from earlier analysis 
(section 3.5.1). Measurement of the intensity of the anti-myc signal revealed 
that virtually all cells, from each cell line, presented a higher than the measured 
background signal (in C of Figure 3.34, Figure 3.35, Figure 3.36, Figure 3.37, and 
Figure 3.38). Moreover, all the cell lines showed a similar intensity profile, 
which followed the dynamics of the DAPI signal: the signal increased gradually 
from G1 phase cells (1N1K) through S phase cells (1N1eK), peaking in G2 cells 
(1N2K), and reducing back to the intensity levels found in G1 phase cells in post-
mitotic (2N2K) cells (in C of Figure 3.34, Figure 3.35, Figure 3.36, Figure 3.37, 
and Figure 3.38). Indeed, in all cases, the average signal level detected in the 
G2 phase cells was approximately double that seen in G1 phase and post-mitotic 
cells, a significant difference (p-value <0.05) also seen in the DAPI signal 
intensity profiles (sections B and C of Figure 3.34, Figure 3.35, Figure 3.36, 
Figure 3.37, and Figure 3.38). The similarity in dynamics of the DAPI and myc 
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intensity profiles suggests that the amount of these factors in the nucleus 
increased as the amount of DNA in the nucleus of the cell increased, peaking in 
1N2K cells, when the genomic DNA is almost or completely replicated, rather 
than remaining constant throughout the cell cycle. As TbORC1/CDC6 has been 
shown to bind to chromatin throughout the cell cycle (Godoy et al., 2009), it is 
possible that these data indicate that all these putative Orc-like factors might 
bind to newly synthesised origins of replication as S phase progresses, as has 
been observed in other eukaryotes (Lygerou and Nurse, 1999).  
 
Figure 3.33. Analysis of the DAPI signal and background signal of myc detection in the 
parental cell line, 927 wt.  
A) staining of 927 wt cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc antibody 
(second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and the cell 
outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging system. 
Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented (dots) as 
the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), drawn 
A) 
B) C) 
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around each individual cell nucleus. In C), the red dotted line represents the average background 
signal measured in the 927 wt cell line. A total of 275 cells were analysed (n = 275). In both B) and 
C) the median of the values is represented, with the error bars depicting the interquartile range. 
Statistical significance between the different cell cycle stages was assessed through analysis using 
the Kruskal-Wallis non-parametric test. (***) p-value < 0.001; (****) p-value <0.0001. Intensity of the 
EdU signal is shown in the appendices, Figure 7.40.  
 
 
Figure 3.34. TbORC1/CDC6
12myc
 subcellular localisation and dynamics throughout the cell 
cycle.  
A) staining of TbORC1/CDC6 -/12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated 
anti-myc antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third 
panel), and the cell outline by DIC (bottom panel). Arrows denote the cell in the specific cell cycle 
stage of interest, where other cells are present. All images were acquired using an Axioskop 2 
imaging system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is 
represented (dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 
21 pixels), drawn around each individual cell nucleus. In C), the red dotted line represents the 
average background signal measured in the 927 wt cell line. A total of 591 cells were analysed (n = 
591). In both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistic significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (**) p-value < 0.01; (***) p-value < 
0.001; (****) p-value <0.0001. Intensity of the EdU signal is shown in the appendices, Figure 7.40. 
A) 
B) C) 
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Figure 3.35. TbORC4
12myc
 subcellular localisation and dynamics throughout the cell cycle.  
A) staining of TbORC4 12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc 
antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and 
the cell outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging 
system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented 
(dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), 
drawn around each individual cell nucleus. In C), the red dotted line represents the average 
background signal measured in the 927 wt cell line. A total of 242 cells were analysed (n = 242). In 
both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistic significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (*) p-value < 0.05; (****) p-value 
<0.0001. A), B) and C) show results obtained from the same experiment. Intensity of the EdU 
signal is shown in the appendices, Figure 7.40. 
 
A) 
B) C) 
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Figure 3.36. 
12myc
Tb7980 subcellular localisation and dynamics throughout the cell cycle.  
A) staining of Tb7980 -/12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc 
antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and 
the cell outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging 
system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented 
(dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), 
drawn around each individual cell nucleus. In C), the red dotted line represents the average 
background signal measured in the 927 wt cell line. A total of 315 cells were analysed (n = 315). In 
both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistic significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (*) p-value < 0.05; (**) p-value < 
0.01; (****) p-value <0.0001. A), B) and C) show results obtained from the same experiment. 
Intensity of the EdU signal is shown in the appendices, Figure 7.40. 
 
A) 
B) C) 
Chapter 3  212 
 
 
 
Figure 3.37. Tb3120
12myc
 subcellular localisation and dynamics throughout the cell cycle.  
A) staining of Tb3120 12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc 
antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and 
the cell outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging 
system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented 
(dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), 
drawn around each individual cell nucleus. In C), the red dotted line represents the average 
background signal measured in the 927 wt cell line. A total of 288 cells were analysed (n = 288). In 
both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistic significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (**) p-value < 0.01; (****) p-value 
<0.0001. A), B) and C) show results obtained from the same experiment. Intensity of the EdU 
signal is shown in the appendices, Figure 7.40. 
 
A) 
B) C) 
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Figure 3.38. Tb1120
12myc
 subcellular localisation and dynamics throughout the cell cycle.  
A) staining of Tb1120 12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc 
antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and 
the cell outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging 
system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented 
(dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), 
drawn around each individual cell nucleus. In C), the red dotted line represents the average 
background signal measured in the 927 wt cell line. A total of 296 cells were analysed (n = 296). In 
both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistic significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (**) p-value < 0.01; (****) p-value 
<0.0001. A), B) and C) show results obtained from the same experiment. Intensity of the EdU 
signal is shown in the appendices, Figure 7.40. 
 
As in the previous sections, the results obtained for TbORC1B are shown and 
discussed in a dedicated section (3.5.6).  
A) 
B) C) 
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3.5.6 The exceptional case of TbORC1B: cell cycle-dependent, 
dynamic subcellular localisation 
In contrast to TbORC1/CDC6, TbORC4, Tb7980, Tb3120 and Tb1120, which 
appeared to localise to the nucleus and to show a similar dynamics throughout 
the cell cycle, possibly suggesting that these factors may be interacting in a 
complex, TbORC1B seemed to behave quite differently in every performed 
assay. In this section, all results obtained from the assays discussed in the 
previous sections are shown for TbORC1B alone.  
3.5.6.1 Subcellular localisation of TbORC1B12myc 
Subcellular localisation of TbORC1B12myc was assessed using anti-myc antiserum 
as described in section 3.5.2. Like TbORC1/CDC612myc and all its interacting 
partners described above, TbORC1B12myc localised exclusively to the nucleus in 
an apparent punctate pattern, and appeared to be absent from the nucleolus 
(Figure 3.39). Super resolution images (Figure 3.40) suggest that TbORC1B12myc 
puncta resemble those observed for TbORC1/CDC612myc (Figure 3.25), possibly in 
approximate number and size. The striking difference between TbORC1B12myc 
and all the other factors, however, is that it was not detected in every cell. 
Quantification revealed that TbORC1B12myc nuclear signal was only present in 
approximately 33% of the cellular population (Figure 3.30, green bar; Figure 
3.41, B). Categorisation of the N-K ratios of the cells showed that TbORC1B12myc 
signal was not evenly distributed amongst the detectable cell cycle phases. In 
only 10% of 1N1K cells was TbORC1B12myc signal detected, and no 2N2K cells 
displayed any signal (Figure 3.41, B). In contrast, ~70% of 1N1eK cells had 
detectable signal, as well as ~50% of 1N2K cells (Figure 3.41, B). Taken together, 
these data indicate that TbORC1B12myc was only detected in the nucleus of cells 
that appeared to be at the onset of S phase (1N1K and 1N1eK), in S phase 
(1N1eK), and either in late S or G2 phases (1N2K) (Figure 3.39). It is important to 
note that the categorisation of 1N1eK cells is not a straightforward process: such 
cells are clear when the kinetoplast is evidently elongated (and perhaps 
approaching segregation), and it is possible that some cells categorised as 1N1K 
may actually be already undergoing kinetoplast replication, and thus be in late 
G1 or early S phases. In principle, it may have been considered that such cells 
would have been detected by EdU incorporation in the kDNA, but in all assays 
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performed, incorporation of EdU into the kDNA was never observed. In addition, 
nuclear EdU signal was barely detected in these cells, most likely because the 
amount of incorporated EdU at such early stages of nuclear DNA replication is 
below detection. As an alternative, staining of the newly synthesised flagellum 
has been shown to allow the differentiation between 1N1K cells that are in G1 
phase (have one flagellum) and 1N1K cells that are in S phase (two flagella) 
(Godoy et al., 2009), and could potentially have been of value here. As already 
mentioned, TbORC1B12myc was detected in the nucleus of approximately half of 
the 1N2K cells analysed (Figure 3.41, C). Whether these cells are in late S phase, 
or whether TbORC1B12myc is retained in the nucleus through at least part of G2 
phase is difficult to evaluate. However, detailed examination suggested that 
TbORC1B12myc signal was never detected in 1N2K cells that had an elongated 
nucleus and in which the two kinetoplasts were localised very distant from each 
other (an example is shown in Figure 3.39), suggesting that the protein becomes 
undetectable either late in G2 phase or when nuclear mitosis begins. It could be 
interesting to label the cells with a mitosis marker, such as the antibody against 
di-methylated histone H3 lysine 76 (anti-H3K76me2) (Janzen et al., 2006) or the 
commercially available anti-KMX-1 (an antibody against β-tubulin) that has been 
used to stain the mitotic spindle (Hu et al., 2014), in order to examine these 
observations further. 
 
Figure 3.39. Immunofluorescence of TbORC1B
12myc
.  
Panels show the staining of TbORC1B 12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K cells (G2 phase), and 2N2K 
cells (post-mitosis). Panels in the middle row show TbORC1B
12myc
, recognised by the AlexaFluor® 
488-conjugated anti-myc antiserum. Lower panel row shows the cells outline by DIC. Arrows direct 
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the reader’s attention to the cell of interest. Images were acquired using a DeltaVision imaging 
system, and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar 
represents 5 μm. 
 
 
Figure 3.40. Super resolution imaging of TbORC1B
12myc
.  
Top panel, nucleus and kinetoplast stained with DAPI; middle panel, TbORC1B
12myc
 stained with 
the anti-myc antiserum; bottom panel, merge of the DAPI and myc signals. Scale bar represents 5 
μm. Images acquired with a Zeiss Elyra super resolution microscope system. 
 
 
Figure 3.41. Quantification of cells containing nuclear TbORC1B
12myc
 signal.  
A) schematic representation of the cells based on the ratio between nucleus (N) and kinetoplast (K) 
per cell: 1N1K, 1N1eK, 1N2K, and 2N2K. Bar below the cells schematics represents the different 
cell cycle phases to which each cell type (above) corresponds. Cells that contain TbORC1B signal 
in the nucleus have the nucleus coloured in green. The diagram was generated based on 
A) 
B) C) 
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information and schematics from (Field and Carrington, 2009; McKean, 2003). B) Quantification of 
the proportion of cells containing TbORC1B
12myc
 signal. Approximately 33% of the cells (inset box) 
showed TbORC1B
12myc
 signal in the nucleus, and the percentage of this total is shown by cell cycle 
type as determined by N-K ratio (dark blue, 1N1K cells; light blue, 1N1eK cells; yellow, 1N2K cells, 
red, 2N2K). Results were obtained from two independent experiments; the mean is represented (n 
= 2), and the error bars depict the standard deviation. C) Percentage of individual cell cycle stage 
cells that display TbORC1B
12myc
 signal (2N2K cells are not represented, as none showed 
TbORC1B
12myc
 signal in any of the experiments). The mean of four independent experiments is 
represented; error bars correspond to the standard deviation. Statistical significance between the 
different groups was assessed through analysis using the one-way ANOVA parametric test. (***) p-
value < 0.001; (****) p-value <0.0001. 
 
3.5.6.2 Cell cycle dynamics of TbORC1B12myc 
Overall, the above results indicate that TbORC1B localises to the nucleus of the 
cells at the onset and throughout S phase, but is no longer present in the nucleus 
of cells in late G2 or that have started mitosis (diagram in Figure 3.41, A). 
Results from aqueous fractionation suggested that TbORC1B12myc localises 
exclusively to the nucleus of the cell (Figure 3.32), excluding regulation of its 
function by re-localisation to the cytoplasm outside S phase, as has been 
described for the Orc1 subunits of other organisms (Romanowski et al., 1996). It 
is possible, however, that TbORC1B expression and availability is cell cycle 
regulated, as is the case for the human and D. melanogaster Orc1 subunits 
(Tatsumi et al., 2000; Asano and Wharton, 1999). In order to better understand 
TbORC1B12myc localisation dynamics, intensity of the DAPI and anti-myc signals 
were analysed as described in section 3.5.5. Similarly to 927 wt, and all other 
cell lines (Figure 3.33 to Figure 3.38), the TbORC1B 12myc cell line showed a 
normal DAPI intensity profile (Figure 3.42, B), supporting the idea that this cell 
line progresses normally through the cell cycle (Figure 3.22, C). Measurement of 
the intensity of anti-myc signal, however, revealed a different profile from any 
of the other putative Orc-like factors (Figure 3.42, C). In contrast to 
TbORC1/CDC612myc and the other factors, where the intensity peaked in 1N2K 
cells, the TbORC1B12myc signal peaked in 1N1eK cells and decreased in 1N2K cells 
(the difference between these two cell types is not statistically significant, 
Figure 3.42, C). Consistent with the lack of visual detectable TbORC1B12myc signal 
in 2N2K cells, the signal was indistinguishable from background in 2N2K cells 
(Figure 3.42, C). Indeed, the average signal in 1N1K cells was also at background 
levels, with some cells showing higher levels, consistent with TbORC1B12myc being 
expressed in only a fraction of this cell type. The signal intensity in 1N1K and 
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2N2K cells (at or near background signal) was statistically different from the 
signal obtained in 1N1eK and 1N2K cells (which is visually detectable, Figure 
3.42, C). In Figure 3.42, C, many (n >400) cells were counted and, within these, 
cells that were categorised visually as being TbORC1B12myc positive (values used 
to generate Figure 3.30 and Figure 3.41, B and C) are represented as light green, 
whereas cells with TbORC1B12myc signal below visual detection are shown as dark 
green, most of which had an intensity below background signal. These findings 
are consistent with the fact that, unlike for TbORC1/CDC612myc and its other 
interacting factors, TbORC1B12myc signal is undetectable in many cells. Indeed, it 
remains possible that the 1N1eK cells that showed signal below visual detection 
(dark green) might represent a group of miss-categorised cells, as discussed 
above. These data are derived from one experiment, but a second experiment is 
shown in the appendices, section 7.6, for comparison. 
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Figure 3.42. TbORC1B
12myc
 subcellular localisation and dynamics throughout the cell cycle.  
A) staining of TbORC1B 12myc cells with DAPI (top panel), AlexaFluor® 488-conjugated anti-myc 
antibody (second panel), AlexaFluor® 555-conjugated azide (for EdU detection; third panel), and 
the cell outline by DIC (bottom panel). All images were acquired using an Axioskop 2 imaging 
system. Scale bar represents 5 μm. Intensity of the DAPI (B) and myc (C) signals is represented 
(dots) as the mean of pixel intensity within the circular region of interest (ROI, of 21 x 21 pixels), 
drawn around each individual cell nucleus. In C), the red dotted line represents the average 
background signal measured in the 927 wt cell line, dark green dots represent the cells in which 
TbORC1B
12myc
 signal is not visually detected, while light green dots represent the cells with 
TbORC1B
12myc
 signal strong enough to be detected by eye. A total of 412 cells were analysed (n = 
412). In both B) and C) the median of the values is represented, with the error bars depicting the 
interquartile range. Statistical significance between the different cell cycle stages was assessed 
through analysis using the Kruskal-Wallis non-parametric test. (*) p-value < 0.05; (**) p-value < 
0.01; (***) p-value < 0.001; (****) p-value <0.0001. A), B) and C) show results obtained from the 
same experiment. Intensity of the EdU signal is shown in the appendices, Figure 7.40. 
 
A) 
B) C) 
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3.5.6.3 TbORC1B12myc expression appears to be cell cycle-regulated 
The data from localisation and signal intensity measurements of TbORC1B12myc 
suggest that the expression of this factor might be cell cycle regulated, or that 
the protein becomes detectable only when it localises in the nucleus. In order to 
examine this further, different cell cycle stages were isolated and analysed by 
western blot for the presence of TbORC1B12myc. Briefly, TbORC1B 12myc cells 
were set up in culture at a starting concentration of 1 x 106 cells.ml-1, and used 
for the experiment when at a concentration of approximately 1 x 107 cells.ml-1. 
Around 109 cells were collected from the asynchronous culture, fixed in 70% 
methanol, and stained with propidium iodide (PI), as detailed in the materials 
and methods Chapter 2, sections 2.7.1 and 2.7.5. The cells were then analysed 
and separated in G1, early S, late S and G2/M phase fractions (Figure 3.43, A), 
by using a BD FACS Aria I™ flow cytometer sorting system (BD Biosciences). In 
order to avoid contamination of the G1 phase population with cells in S phase, 
the G1 phase “gate” was designed to capture cells that were on the left hand 
side of the G1 peak of the histogram profile (Figure 3.43, A). It is important to 
note that the cells sorted into the G2/M phase population include both 1N2K 
cells that have completed DNA replication and 2N2K cells that have not 
completed cytokinesis, as these are detected by doubled DNA content relative to 
G1. The different cell cycle fractions were then analysed by western blot as 
described in the materials and methods, Chapter 2, section 2.2.5.3 (Figure 3.43, 
B). As a loading control, the translation elongation factor 1 alpha (Ef1α, gene 
Tb927.10.2100) was detected using a commercially available antibody. These 
data showed that TbORC1B12myc was undetectable in the G1 (2N content) 
fraction, while it was strongly present in both early and late S phase fractions 
(Figure 3.43, B). TbORC1B12myc was also detected in the G2/M (4N content) 
fraction (though perhaps in slightly reduced levels); since no 
immunofluorescence signal could be seen in 2N2K cells (previous section), these 
data perhaps suggest that TbORC1B12myc expression continues through G2 phase 
(Figure 3.43, B). These data strongly support the hypothesis that TbORC1B 
expression might be cell cycle regulated, though at present the nature of this 
regulation is unknown. Transcriptome information (Archer et al., 2011) suggests 
that TbORC1B mRNA levels are highest in late G1, reduce somewhat in S phase 
and are lowest in early G1 and G2 phases (appendices, Figure 7.35). Such 
fluctuations would need confirmation in the TbORC1B 12myc cell line, for 
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instance by RT-qPCR using primers for the 12myc tag, such as described in 
section 3.3.2. However, whether or not mRNA level control can explain the 
changing proteins levels documented here is unclear. 
 
 
Figure 3.43. TbORC1B expression appears to be regulated throughout the cell cycle.  
A) Histogram depicting the cell cycle profile of a mid-log phase PCF cell culture, reflecting the 
fluorescent signal emitted by the staining of DNA with propidium iodide (PI). Dashed vertical lines 
represent the gates defined to isolate the different cell cycle populations using a FACS Aria I 
sorting flow cytometer machine. The asynchronous cell population was separated into G1, early S, 
late S and G2/M phases. B) The sorted fractions of the cell cycle were analysed by western blot for 
the detection of TbORC1B
12myc
. The transcription elongation factor Ef1α was used as a loading 
control for each fraction.  
 
3.5.6.4 TbORC1B12myc appears to not co-localise to newly replicated DNA 
Together, the data here presented strongly suggests that TbORC1B expression 
and cellular localisation are cell cycle regulated, in contrast with TbORC1/CDC6 
and all the other analysed factors, which localise to the nucleus throughout the 
cell cycle. It appears that TbORC1B expression is limited to a period of the cell 
cycle stretching from the beginning of (or immediately before) S phase until late 
S or G2. This suggests that TbORC1B might have a regulatory function rather 
than being a static member of a potential ORC-like complex. In section 3.5.2, it 
was shown that TbORC1/CDC612myc appeared to co-localise in the nucleus with at 
least some regions of newly replicated (EdU positive) DNA in 1N1eK cells (Figure 
3.24). A similar overlay of anti-myc and newly synthesised EdU-labelled DNA in 
1N1eK and 1N2K TbORC1B12myc cells did not suggest the same extent of co-
localisation (Figure 3.44): by eye, the extent of overlap of TbORC1B12myc and EdU 
signals appeared less than for that seen for TbORC1/CDC612myc and EdU, although 
further less subjective tests would be needed to validate this.  
 
A) B) 
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Figure 3.44. Immunofluorescence of TbORC1B
12myc
 and newly synthesised DNA.  
Two representative 1N1eK cells are shown in the top panel stained with DAPI (far left panel), anti-
myc antiserum (middle left panel), and AlexaFluor® 594 azide, detecting EdU (middle panel). The 
middle right panel depicts a merge of the myc and EdU staining, where the lack of yellow regions 
does not suggest co-localisation between the TbORC1B
12myc
 and newly synthesised DNA. Cell 
outline is shown in the DIC image, in the far right panel. Images were acquired using a DeltaVision 
imaging system, and deconvolved using the ratio conservative method, on SoftWoRx software. 
Scale bar represents 5 μm. 
 
3.5.6.5 TbORC1B6HA co-localisation with TbORC1/CDC612myc 
By now, it was clear that TbORC1B appears to be different from all the other 
factors that have also been analysed, including TbORC1/CDC6. Using a cell line 
with TbORC1/CDC6 endogenously tagged with 12myc and TbORC1B tagged with 
6HA (described in section 3.4.5), it was asked whether these two factors co-
localise, as has been described for the other factors in section 3.5.3. Again, it 
was not possible to acquire better resolution images with, for instance, the 
DeltaVision imaging system. Nevertheless, images acquired with the Axioskop 
system showed that TbORC1B6HA presents the same subcellular pattern as the 
12myc tagged version of the protein: it is detected, as puncta, in the nucleus of 
1N1K, 1N1eK and 1N2K cells (Figure 3.45). Overlay of the TbORC1/CDC612myc and 
TbORC1B6HA signals suggested that the two proteins localise to the same regions 
of the nucleus, but it was not clear whether the factors show as extensive 
overlap as TbORC1/CDC612myc displayed with the other putative Orc-like factors. 
Higher resolution imaging would be crucial to examine this is more detail.  
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Figure 3.45. Immunofluorescence of TbORC1/CDC6
12myc
 and TbORC1B
6HA
.  
Top panel shows the staining of the cells with DAPI. The second panel shows TbORC1/CDC6
12myc
, 
recognised by the anti-myc antiserum. The third panel shows the signal correspondent to the 
TbORC1B
6HA
. The fourth panel shows a merge of the signals detected with both the anti-myc and 
the anti-HA antisera. The bottom panel row shows the cells outline by DIC. Images were acquired 
using an Axioskop 2 imaging system. Scale bar represents 5 μm. 
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3.6 Do TbORC1/CDC6, TbORC4, Tb7890, Tb3120, Tb1120, 
and TbORC1B interact in a complex? 
To date, TbORC1/CDC6 has been shown to interact with TbORC1B, TbORC4, 
Tb7980 and Tb3120 (Dang and Li, 2011; Tiengwe et al., 2012b). TbORC1B 
interaction with TbORC1/CDC6 was examined by co-immunoprecipitation (co-IP) 
using a cell line with TbORC1/CDC6 endogenously tagged with PTP and TbORC1B 
tagged with three copies of the HA tag (3HA) (Dang and Li, 2011). In contrast, 
TbORC4, Tb7980 and Tb3120 interaction with TbORC1/CDC6 was examined 
through co-IP using TbORC1/CDC612myc and each of the factors tagged with 6HA 
(Tiengwe et al., 2012b). None of these experiments however, addressed whether 
all these proteins interact with each other in a complex.  
From the TbORC1/CDC612myc immunoprecipitation (IP) assay (Tiengwe, 2010), 
more hits were retrieved than just TbORC4, Tb7980 and Tb3120. Amongst the 
other hits was Tb1120, which was the protein recovered that displayed the 
highest number of identified peptides (14 peptides) (Tiengwe, 2010). Tb1120, 
however, was not further investigated and its interaction with TbORC1/CDC6 
was not confirmed. Interestingly, no peptides corresponding to TbORC1B were 
recovered from TbORC1/CDC612myc IP hits (Tiengwe, 2010).  
3.6.1 Co-immunoprecipitation of TbORC1/CDC612myc with 
TbORC46HA, Tb79806HA, Tb31206HA, Tb11206HA, or 
TbORC1B6HA 
In order to confirm the interaction between TbORC1/CDC6 and Tb1120, co-IP 
using the TbORC1/CDC6 -/12myc Tb1120 6HA cell line was performed. Likewise, 
the interaction between TbORC1/CDC612myc and TbORC1B6HA was also 
investigated, to check that the proteins interact with this combination of 
epitopes. As controls, the following cell lines were also used: the 927 wt cell 
line, which does not possess any tag, as a negative control for both HA and myc 
detection; TbORC1/CDC6 -/12myc, as a negative control for HA; Tb7980 6HAl, as 
a negative control for myc; and TbORC1/CDC6 -/12myc TbORC4 6HA, 
TbORC1/CDC6 -/12myc Tb7980 6HA, and TbORC1/CDC6 -/12myc Tb3120 6HA, as 
positive controls (Tiengwe et al., 2012b). The IP, using the HA-tagged proteins 
                                         
l
 Cell line generated by Dr Calvin Tiengwe during the course of his PhD. 
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as “bait”, was performed as described in (Tiengwe et al., 2012b; Tiengwe, 
2010), with few modifications. Around 5 x 108 cells of each cell line were 
collected from cultures with a density of around 1 x 107 cells.ml-1, and lysed in 1 
ml whole cell extract buffer (WCE buffer), for 30 minutes at 4°C, as described in 
the materials and methods Chapter 2, section 2.6.2. In this case, 1 mM of DTT 
(as described in (Dang and Li, 2011)) and 2x protease inhibitors were added to 
the WCE solution described in (Tiengwe et al., 2012b). The new variation of the 
lysis solution was tested and confirmed to not interfere with the binding of the 
proteins to the magnetic beads coated with anti-HA antibodies used in the assay 
(not shown). For each cell line, a sample was taken from the cells prior to (PL – 
pre-lysis) and after lysis (I – input or lysate), to be used as a positive control of 
the presence of the proteins of interest before and after the cells were lysed. 
Each lysate (input for the IP) was then incubated with magnetic Dynabeads® M-
280 sheep anti-mouse IgG (which had been previously coated with mouse anti-HA 
antiserum) for 2 h at 4°C, as detailed in the materials and methods, Chapter 2, 
section 2.6.2. A sample was collected at the end of the incubation to be used as 
flowthrough sample (F- flowthrough), representing the protein’s fraction that 
had not attached to the coated beads. The beads were further washed with a 
washing solution identical to the WCE solution, with the exception of the 
amount of detergent present (0.1% Triton X-100) and the absence of DTT. As 
already mentioned, IP of TbORC1/CDC612myc failed to identify TbORC1B as a 
potential interacting partner (Tiengwe, 2010; Tiengwe et al., 2012b). In the 
study by (Tiengwe et al., 2012b), washes were performed using a high salt 
containing solution, with 500 mM LiCl and 0.7% sodium deoxycholate, an anionic 
detergent (Tiengwe et al., 2012b). This contrasted with the less stringent 
solution used in (Dang and Li, 2011), which contained only 100 mM of NaCl and 
1% NP-40. As it is possible that the high levels of salt and strong detergent in 
(Tiengwe et al., 2012b) might have disturbed the interaction between 
TbORC1/CDC612myc and TbORC1B, the solution used here for washing contained 
only 100 mM NaCl, like the WCE solution. After washing, the proteins bound to 
the beads were eluted directly in protein loading buffer (E – elution sample), 
separated on an SDS-PAGE gel, and analysed by western blot, as detailed in the 
materials and methods, Chapter 2, sections 2.2.5.3. Membranes were first 
probed with anti-myc antiserum, and then stripped before being incubated with 
the anti-HA antiserum.  
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Figure 3.46. Immunoprecipitation of HA-tagged proteins, and co-detection of 
TbORC1/CDC6
12myc
.  
Cell lines were lysed and the HA-tagged proteins were immunoprecipitated as described in the 
main text and in the materials and methods chapter. PL – pre-lysis sample; I – input or lysate 
sample; F – flowthrough sample; E – eluate sample. Each cell line is represented separately, with 
the top panel depicting the membrane probed for myc detection, and the lower panel showing the 
membrane probed for HA detection. Anti-myc and anti-HA are represented as α-myc and α-HA, 
respectively. (*) highlights the detection of TbORC1/CDC6
12myc
 in the membrane probed for HA 
detection, still present after stripping of the membrane post-myc detection. While arrows call the 
attention of the reader to the anti-HA antibody heavy chain, which was eluted with the remaining 
proteins since the antibody was not cross-linked to the magnetic beads used for the IP. Red arrows 
signalise the HA-tagged proteins. A second, independently performed IP experiment is shown for 
the TbORC1/CDC6 -/12myc TbORC1B 6HA cell line, within the dashed box.  
 
Figure 3.46 shows that no signal was detected for myc or HA in the lysate of the 
927 wt cell line, showing again that both antibodies are specific for each of 
these tags. The band (~50 kDa) present in both anti-myc and anti-HA panels 
corresponds to the heavy chain of the anti-HA antibody used in the IP, as this 
was not cross-linked to the magnetic beads, and was therefore eluted together 
with the bound proteins (highlighted in Figure 3.46, white arrows). In the case of 
the cell line expressing only Tb79806HA, the protein was efficiently recognised by 
the anti-HA antibody bound to the magnetic beads (E fraction), and was not 
detected in the membrane probed with anti-myc, showing that the anti-myc 
antiserum did not recognise the HA tagged protein. The absence of signal in the 
flowthrough (F) fraction may suggest that most of the HA-tagged protein was 
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successfully attached to the antibody bound to the beads during the IP. On the 
other hand, IP using the TbORC1/CDC6 -/12myc cell line showed that 
TbORC1/CDC612myc was not detected in the eluate fraction in both membranes 
probed either with anti-myc or anti-HA, confirming that it did not bind non-
specifically to the anti-HA-coated beads. Because the same nitrocellulose 
membrane was used for sequential myc and HA detection, it was stripped 
between incubation with the two antisera. Because both anti-myc and anti-HA 
antibodies used in this study were raised in mice, the same anti-mouse HRP-
conjugated antiserum was used to detect both primary antibodies. Despite the 
fact that the membrane was incubated with the stripping buffer, it is clear that 
this was not entirely successful, and some anti-myc antibody was still attached 
to TbORC1/CDC612myc when the membrane was probed for the detection of the 
HA tag. The outcome was the detection of TbORC1/CDC612myc in the PL, L and F 
fractions after probing for HA. This was also observed for all other cell lines 
containing TbORC1/CDC612myc, and is highlighted in Figure 3.46 with an asterisk. 
Results from the IP of TbORC46HA, Tb79806HA and Tb31206HA, confirm that these 
three factors interact with TbORC1/CDC612myc, as the latter is detected in the 
elution (E) fractions in the anti-myc probed membrane (Figure 3.46), and each 
individual HA-tagged factors is detected in the E fraction of the anti-HA probed 
membrane (highlighted with a red arrow, Figure 3.46). Likewise, Tb11206HA was 
shown to interact with TbORC1/CDC612myc (Figure 3.46), validating the IP and 
mass spectrometry detection of this interaction (Tiengwe, 2010). Surprisingly, no 
TbORC1/CDC612myc could be detected in the E fraction from the IP of 
TbORC1B6HA, although the latter was detected in this fraction, confirming that 
TbORC1B6HA was successfully attached to the anti-HA-coated beads (Figure 3.46). 
Because the TbORC1B6HA protein is only slightly larger than TbORC1/CDC612myc, it 
is not clear whether the bands seen in the PL, L and F fractions in the membrane 
probed with anti-HA represent detection of TbORC1B6HA or remnants of 
TbORC1/CDC612myc still bound by anti-myc antibodies and not removed by the 
stripping treatment of the membrane. Nevertheless, a repeat of the same 
experiment failed to co-IP TbORC1B6HA and TbORC1/CDC12myc, as shown in Figure 
3.46 (panels within the dashed box). These results support the non-detection of 
TbORC1B by (Tiengwe et al., 2012b), and question the proposed interaction 
between TbORC1B and TbORC1/CDC6, which was reported using similar lysis and 
washing conditions (Dang and Li, 2011) as the ones used here.  
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3.6.2 Immunoprecipitation of TbORC1/CDC612myc, TbORC412myc 
and TbORC1B12myc 
One potential way to ask if the putative Orc-like factors interact together in a 
complex would be to tag them in pairs, e.g. with 12myc and 6HA, and perform 
co-IPs with all different combinations. However, this would require generating 
cell lines expressing all the possible combinations between the known factors, 
which would be very time consuming. As an alternative, it was decided to IP 
selected factors, separate the eluted samples on SDS-PAGE gels, and identify 
interacting proteins by mass spectrometry, as was done previously for 
TbORC1/CDC612myc (Tiengwe et al., 2012b). It was decided to perform the IPs 
using the 12myc tagged cell lines because detection of myc-tagged protein has 
always been easier than HA-tagged ones (perhaps due to the efficiency of the 
antisera), and to focus on TbORC4 and TbORC1B. 
As a starting point, IP of TbORC1/CDC612myc was performed as described before 
(Tiengwe et al., 2012b), using the TbORC1/CDC6 -/12myc cell line, in parallel 
with the 927 wt cell line, used as a negative control in order to identify non-
specific binding of proteins to the magnetic beads coated with anti-myc 
antibody. Unfortunately, no differences were seen between the two IP samples 
when compared on coomassie-stained gels, despite the fact that the IP worked, 
as confirmed by western blot (data not shown). Other attempts were performed 
using different amounts of cells and concentrations of salt (both NaCl and LiCl), 
without improving specificity. In an attempt to decrease the non-specific binding 
of proteins to the beads, the cell lysates were incubated with magnetic beads 
that had not been coated with the anti-myc antiserum, prior to incubation with 
the anti-myc coated magnetic beads. Again, this did not allow the identification 
of specific bands once the eluate samples had been separated in SDS-PAGE gels 
and stained with coomassie blue (not shown). Finally, the IP conditions 
described in the previous section were used but this time the resulting SDS-PAGE 
gel was stained with SYPRO® Ruby, instead of coomassie blue; though there was 
still considerable overlap between the banding patterns from the 927 wt and 
myc-tagged cells, some apparently specific protein bands were seen in the latter 
IPs (Figure 3.47, B). The IP conditions used were those described for the co-IP 
experiment discussed in the previous section, though 1.5 x 109 cells were used 
and lysed in 3 ml of WCE solution (each 1 ml of lysate incubated with a set of 
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coated-beads), and the magnetic beads were coated with anti-myc antibody, as 
described in the materials and methods, Chapter 2, section 2.6.1. The success of 
the IP was confirmed by western blot, with proteins of the sizes expected for 
the myc-tagged variants recovered from the cognate cell line and absent from 
the 927 wt cells (Figure 3.47, A). As discussed in section 3.5.4, two bands were 
detected in the TbORC1B 12myc cell line IP: one most likely corresponding to 
the full size TbORC1B12myc protein (running between 80 and 110 kDa), and a 
smaller band, just larger than 60 kDa (Figure 3.47, A, highlighted by a white 
asterisk). The smaller band was not detected in the pre-lysis sample (PL), 
suggesting that it may have arisen due to degradation during the experiment 
course. Due to the large numbers of bands in each gel, a section of each lane 
(Figure 3.47, B, highlighted by the parentheses), instead of individual bands, was 
excised and sent for nanoflow liquid chromatography-electrospray tandem mass 
spectrometry (nLS- ES MS/MS) analysis (Glasgow Polyomics, University of 
Glasgow; Performed and initial analysis by Dr Richard Burchmore, Dr Christina 
Naula and Dr Stefan Weidt). A preliminary analysis was performed, but a 
thorough analysis will be needed in the future. 
Figure 3.47, B, shows a summary of the “hits” obtained for each IP that were not 
present in the non-tagged cell line sample (927 wt), and thus were precipitated 
most likely due to unspecific binding to the coated beads, but were precipitated 
by each of the 12myc tagged proteins. Because the section of the gel excised 
and sent for analysis enclosed only proteins larger than 60-65 kDa, the number 
of hits resultant from the IP of TbORC1/CDC612myc here shown was smaller than 
in (Tiengwe, 2010). Nevertheless, it was possible to identify Tb3120, and a set of 
other proteins that did not appear in the previous analysis (Tiengwe, 2010) 
(Figure 3.47, B). It was not possible, however, to identify peptides from TbORC4 
and Tb1120, though these proteins are larger than 60 kDa. Moreover, 
TbORC1/CDC6 was not detected in the sample, though TbORC1/CDC612myc is ~66 
kDa in size. IP of TbORC412myc was able to pull down TbORC4 itself as well as 
Tb1120 and Tb3120, besides other hits (Figure 3.47, B). These data support the 
idea that TbORC4, Tb1120, Tb3120 and TbORC1/CDC6 interact in a complex. 
However, neither TbORC1/CDC6 nor TbORC1B were retrieved from this analysis, 
most likely because as TbORC1/CDC6 is ~48 kDa and TbORC1B is ~65.5 kDa, and 
were therefore excluded from the sampled region of the gel. TbORC1B12myc IP 
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did not retrieve any of the Orc-like factors, perhaps indicating that it is not a 
part of a stable complex with these factors. Nevertheless, IP of each of the 
three proteins, TbORC1/CDC612myc, TbORC412myc and TbORC1B12myc, retrieved a 
common hit, which was absent from the non-tagged control sample (927 wt): 
Tb927.10.2240, an hypothetical protein according to data on TriTrypDB v9.0 (as 
of February 2015). InterPro analysis (as described in section 3.2.3) suggests that 
it has a nuclear transporter factor 2 (NTF2) domain at its N-terminus, as well as 
a RAS GTPase-activating protein-binding protein domain, covering the protein’s 
full length. Proteins from these groups have been involved in various roles 
including nuclear transport of other proteins. It will be necessary to validate the 
interaction of this factor with TbORC1/CDC6, TbORC4 and TbORC1B, and assess 
whether it may be an extra member of the putative ORC-like complex, and 
which role might it have in DNA replication. It is nevertheless surprising that it 
was not detected in the previous TbORC1/CDC612myc IP, in which the whole gel 
lane was analysed.  
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Figure 3.47. Immunoprecipitation of TbORC1/CDC6
12myc
, TbORC4
12myc
 and TbORC1B
12 myc
.  
A) Confirmation of the success of the IP using magnetic beads coated with anti-myc antibody by 
western blot. PL – pre-lysis sample; I – input or lysate sample; F – flowthrough sample; E – eluate 
sample. Each cell line is represented separately. White arrows call the attention of the reader to the 
anti-myc antibody heavy chain (band just above the 50 kDa size marker), which was eluted with the 
remaining proteins since the antibody was not cross-linked to the magnetic beads used for the IP. 
White asterisks call the attention of the reader to the second, smaller band, observed in the 
TbORC1B 12myc sample. B) SDS-PAGE gel stained with SYPRO® Ruby showing the eluate 
fractions obtained from the IP. The dark bands around 50 kDa and close to the end of the gel 
correspond to the antibody, which was eluted with the proteins attached to the beads. Black arrows 
pinpoint potential specific bands not present in the untagged cell line, 927 wt. Parentheses demark 
the region of each lane that was extracted for further mass spectrometry (MS) analysis. Results 
from MS analysis, showing hits not present in the non-tagged cell line (927 wt), but identified in 
each of the other proteins’ IP samples. TbORC4 is highlighted in yellow, Tb3120 in blue and 
Tb1120 in pink. A common hit to the three cell lines IP was found, and is highlighted in green.  
 
A) 
B) 
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3.6.3 Size exclusion chromatography, or Gel Filtration 
Despite the common hits from the different IPs described above, the approach 
used does not address if the proteins interact in a complex or individually. To 
address this, a gel filtration analysis was conducted. Approximately 7.5 x 108 
cells were collected from a TbORC1/CDC6 -/12myc cell line culture at a 
concentration of 1 x 107 cells.ml-1 and lysed in 2 ml of WCE solution, as 
described in the materials and methods, Chapter 2, section 2.6.4.3. The lysate 
was then centrifuged and filtered, in order to remove any particulate material, 
and the resultant supernatant was then subjected to size exclusion 
chromatography through a HiLoad 16/60 Superdex 200 Prep Grade column (GE 
Healthcare Life Sciences) using a flow rate of 500 μl per minute, as described in 
materials and methods, Chapter 2, section 2.6.4.3. Fractions of 1 ml were 
collected and analysed for the presence of TbORC1/CDC612myc by western blot 
using anti-myc antiserum; as a positive control, a sample taken from the lysate 
was run per gel. All steps related to the gel filtration technique, including 
column preparation, system calibration, and system set up, were performed by 
Mr Alan Scott who, together with Dr Jaspreet Grewal and Dr Jeziel Damasceno, 
helped with the analysis of the elution profile. Based on the profile recovered 
(shown in the appendices, Figure 7.41), appropriate samples to be analysed by 
western blot were chosen. These samples corresponded to volumes from 
immediately before the void volume (corresponding to ~2116 kDa; peak at 43 
ml), until samples corresponding to 48 kDa (84 ml peak), according to the size 
standards used (Figure 3.48, A). TbORC1/CDC612myc was detected in fractions 
corresponding to proteins ranging from ~1334 kDa to 530 kDa, having a peak of 
intensity in the fractions corresponding to ~1011 kDa to 841 kDa (Figure 3.48, A). 
Similar to what was reported for S. pombe SpOrc1 (Lygerou and Nurse, 1999), 
the monomeric form of TbORC1/CDC612myc (around 66 kDa) was not detected 
(Figure 3.48, A), suggesting that the protein is mainly (or exclusively) present in 
a complex with other factors. The broad range of TbORC1/CDC612myc signal may 
suggest complexes (or sub-complexes) of various sizes. However, the 
predominance of signal at around 900-1000 kDa suggests a predominant 
multiprotein species. The composition of this putative complex requires further 
analysis, but if TbORC1/CDC612myc formed an ORC-like complex with only 
TbORC4, Tb7980, Tb3120 and Tb1120, the resulting size would be only of 386 
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kDa, smaller than what was seen. If TbORC1B were also part of this putative 
complex, a species of 451 kDa would be predicted, again smaller than the ones 
observed (Figure 3.48, A). The individual sizes of several further replication-
related factors, including the TbMCM2-7 helicase complex, TbCDC45, the TbGINS 
complex, and TbMCM10 are shown in Figure 3.48, B, and then combined with the 
putative ORC-like complex to predict the resulting molecular size of potential 
complexes (Figure 3.48,C). Amongst these, the putative pre-RC, composed of 
“ORC” and the MCM-2-7 helicase would be ~1003 kDa to 938 kDa in size, 
depending on whether TbORC1B is included or not. In turn, putative pre-IC 
complexes, containing “ORC”, the TbMCM2-7 helicase, TbCDC45, TbGINS and 
either containing or lacking TbMCM10, would range from 1123 kDa to 1267 kDa. 
 
Figure 3.48. Gel filtration of TbORC1/CDC6 -/12myc.  
A) Detection of TbORC1/CDC6
12myc
 with the anti-myc (α-myc) antiserum in the different fractions 
resulting from gel filtration of TbORC1/CDC6 -/12myc cell line lysates. The estimate molecular 
weight corresponding to relevant fractions is shown next to the corresponding black arrow. Dashes 
underneath the western blot panels depict the lanes with negative (grey), positive (black) and most 
intense (red) signals. (*) pinpoints the lanes loaded with the lysate sample, as a positive control in 
each western blot membrane. The white arrow draws attention to a panel showing the positive 
lanes, where the signal was acquired with a shorter exposure time. A-F highlight the bands that 
might correspond to the potential complexes proposed in (B). B) Table showing the molecular 
weight (in kDa) of the presently known interacting partners of TbORC1/CDC6, the TbMCM2-7 
helicase complex, TbCDC45, the TbGINS complex, and TbMCM10, as available in TriTrypDB v9.0 
as of January 2015 (§). Columns A to F suggest potential correspondence between these putative 
C) 
B) 
A) 
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complexes and the signals detected by western blot shown in (A). The different combinations of 
factors present in the potential complexes are represented as (+, presence) and (-, absence). The 
colour scheme corresponds to the one used in the diagrams shown in (C). C) Schematic 
representations of the potential complexes highlighted in (B); not to scale. 
 
3.7 Discussion 
This chapter describes experiments that address three central questions in the 
field of initiation of nuclear DNA replication in Trypanosoma brucei, each 
leading to an overarching question: does an origin recognition complex (ORC) 
exist in this parasite, or not? The first question was whether TbORC1/CDC6, 
TbORC1B, TbORC4, Tb7980, Tb3120 and Tb1120, are recognisably related to the 
six subunits of conventional eukaryotic ORCs. All these factors have been shown 
to interact with TbORC1/CDC6 in PCF cells of T. brucei, but at the outset of this 
work it was unknown if they interact together in a complex involved in nuclear 
DNA replication. The second question was: are TbORC1B, TbORC4, Tb7980, 
Tb3120 and Tb1120 involved in DNA replication? Only TbORC1/CDC6 had been 
directly implicated in DNA replication, both through genome-wide localisation 
studies and examining the effects of RNAi on BrdU incorporation (Tiengwe et al., 
2012a; Benmerzouga et al., 2013). Therefore, similar phenotypes for each of 
these proteins could be suggestive of the factors acting in the same biological 
process. The third question addressed asked about the localisation of each 
factor: was this consistent with a nuclear function, and did the localisation 
display evidence for cell cycle dependency that might be related to replication? 
The work described here is limited to PCF T. brucei, building on the available 
data on replication in T. brucei and related kinetoplastids, which has been 
obtained from studies investigating the insect stages of the parasites’ life cycles. 
For most of the questions addressed, only partial answers were revealed. These 
questions and their answers are discussed in in the next few sections, where 
potential models are suggested, and new questions are raised.  
3.7.1 A fresh analysis into TbORC1/CDC6 and its interacting 
partners: are these Orc-like proteins? 
A new analysis of the protein sequences of TbORC1/CDC6, TbORC1B, TbORC4, 
Tb7980, and Tb3120, has allowed refinement on the information available for 
these factors (Godoy et al., 2009; Tiengwe et al., 2012b; Dang and Li, 2011; 
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Tiengwe et al., 2013). In addition, new analysis was performed on Tb1120, a 
TbORC1/CDC6 interacting partner that has never been analysed in depth 
(Tiengwe, 2010). BLAST analysis has confirmed that all these factors are well 
conserved in other kinetoplastid organisms, such as T. cruzi and various species 
of Leishmania (Table 3-1), and that the genes for each are syntenic between, at 
least, T. brucei, T. cruzi, and Leishmania major (appendices, Figure 7.1).  
Altogether, re-analysis of TbORC1/CDC6 and TbORC4 protein sequences further 
support the categorisation of these factors as Orc-like proteins. TbORC1/CDC6 
was recognisably related to Orc1 factors from other eukaryotes and has 
demonstrated ATPase activity, as well as being able to complement the lack of 
Cdc6 activity in yeast (Godoy et al., 2009). TbORC4 remained classified as a 
divergent Orc4 protein, with an apparent degenerate AAA+ ATPase domain 
containing a putatively conserved arginine finger (Tiengwe et al., 2013). It is 
most likely that TbORC4 does not possess ATPase activity (Tiengwe et al., 2013), 
similar to other eukaryotic Orc4 subunits. It has been suggested that Orc4 does 
not bind ATP itself, most likely because it has a modified P-loop (Walker A 
motif), which has been shown to be required for Orc1 and Orc5 binding to ATP 
(Davey et al., 2002b). It has, however, been hypothesised that the conserved 
arginine finger of Orc4 is necessary for Orc1 ATP hydrolysis, by supplying the 
arginine finger to Orc1’s ATP-binding site (Davey et al., 2002b; Duncker et al., 
2009), a scenario consistent with AAA+ ATPases requiring an arginine finger from 
a binding partner (Iyer et al., 2004). This has been recently supported by the S. 
cerevisiae and D. melanogaster ORC structure, derived from cryo-electron 
microscopy (cryo-EM) and negative-stain electron microscopy, respectively (Sun 
et al., 2012; Bleichert et al., 2013). In S. cerevisiae, the upper lobe of ScORC is 
suggested to be composed of Orc1, Orc4 and Orc5, the ScORC subunits 
containing conserved AAA+ ATPase domains, in which the putative arginine 
finger of Orc4 ATPase domain is facing the putative ATP-binding site of Orc1, 
although at a distance too remote to allow cooperative ATP hydrolysis. It has 
been proposed that this is resolved upon ATP hydrolysis by Cdc6, which leads to 
conformational changes in the ORC complex, bringing the Orc4 arginine finger 
closer to Orc1’s ATP-binding site (Sun et al., 2012). It is possible that a similar 
core interaction between TbORC4 and TbORC1/CDC6 is conserved in T. brucei, 
and it may be possible to investigate this by using purified proteins. One piece of 
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evidence supporting a close functional relationship between TbORC1/CDC6 and 
TbORC4 is that individual silencing of either factor results in strikingly similar 
phenotypes (see below). Even if this picture is correct, it is complicated by 
uncertain homology in factors beyond TbORC1/CDC6 and TbORC4. 
One area of uncertainty is whether T. brucei possesses a Cdc6 orthologue. As 
mentioned earlier, TbORC1/CDC6 has been shown to have ATPase activity and to 
complement Cdc6 activity in yeast (Godoy et al., 2009). It is therefore plausible 
that TbORC1/CDC6 may have double functionality, performing the roles of both 
Orc1 and Cdc6. Why this separation of function is needed in other eukaryotes 
but could be absent in T. brucei is unclear, though archaeal organisms 
accommodate all ORC and Cdc6 functions in a single protein, Orc1/Cdc6 (Barry 
and Bell, 2006). BLAST analysis of TbORC1B mainly retrieved Cdc6 hits, which 
could suggest it to be the T. brucei Cdc6-like factor. However, the failure to 
detect ATPase activity (Dang and Li, 2011) in purified TbORC1B argues against 
this. Moreover, though in other eukaryotes Cdc6 is clearly a focus for regulation 
of ORC and pre-RC function, the pattern of expression of TbORC1B is highly 
atypical of that described for Cdc6 (see below). Nevertheless, alignment of 
TbORC1B with other eukaryotic Cdc6 protein sequences allowed the mapping of 
a putative winged-helix domain (WHD) towards its C-terminus, similar to 
TbORC1/CDC6. Whether one or both factors can bind to DNA through these 
putative motifs is unknown, though TbORC1/CDC6 has been shown to bind to the 
chromatin throughout the cell cycle (Godoy et al., 2009). It is not known 
however, whether TbORC1B binds to chromatin.  
An even greater area of uncertainty is how, if at all, the other putative T. brucei 
Orc-like factors might map onto the ORC architecture as proposed in S. 
cerevisiae (Sun et al., 2012) and D. melanogaster (Bleichert et al., 2013; 
Bleichert et al., 2015). Previously, Tb7980 was suggested to have an AAA+ 
ATPase domain, though no characteristic signatures of the domain were 
identified besides a potentially conserved Walker A motif (Tiengwe et al., 
2012b). The new analysis suggested that this conservation may be more 
extensive: weak (indeed non-significant) homology with Orc5 proteins at the C-
terminus of Tb7980 allowed alignments with other eukaryotic Orc5 sequences 
and revealed a putative Walker B motif, as well as a potential arginine finger 
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(albeit not within the predicted AAA+ ATPase domain). It will be valuable to test 
if Tb7980 possesses ATPase activity, but at this stage it remains premature to 
label it as an Orc5 subunit, in particular because it was not possible to 
investigate whether it is involved in DNA replication (see below). When first 
identified, the only suggestion of Tb3120 being an ORC-like protein relied on 
very weak evidence suggesting structural similarity with other archaeal 
Orc1/Cdc6 proteins. No evidence for an AAA+ ATPase domain was found 
(Tiengwe et al., 2012b). Fresh analysis based on Pfam domain analysis revealed 
very weak evidence for two regions of similarity to an Orc2 domain at the C-
terminus of the protein, together with a putative WHD domain. From this, 
alignment of Tb3120 with Orc2 subunits from different eukaryotes revealed the 
presence of relatively conserved Walker A and Walker B motifs within the 
putative Orc2 domain, though these did not follow the canonical sequences 
associated with these motifs, but instead the diverged motif sequences 
characteristic of various eukaryotes Orc2 subunits (Speck et al., 2005). One 
aspect of the alignment of Tb3120 with other eukaryotic Orc2 subunits was 
notable: the protein sequences of Tb3120 and its orthologues in T. cruzi 
(Tc3120) and L. major (Lm3120) are considerably larger (1018 aa, 1049 aa, and 
1487 aa, respectively) than all the Orc2 subunits analysed (ranging from 576-620 
aa). If these kinetoplastid proteins are indeed Orc2-like factors, they appear to 
have undergone an expansion of their N-termini. Analysis of this region may 
provide a route to understand if these factors provide kinetoplastid-specific 
adaptation of Orc2 factors, perhaps affecting the configuration of an ORC-like 
complex, or influencing other aspects of DNA replication. Finally, sequence 
analysis of the previously uncharacterised Tb1120, which has now been shown to 
interact with TbORC1/CDC6, and also possibly with TbORC4 and Tb3120, was 
fruitless: no replication-related homology was retrieved from any of the 
sequence analysis performed. Tb1120 remains the most diverged putative Orc-
like factor to date, with no evidence linking it to any Orc subunit. RNAi targeting 
Tb1120 will be important to test if it acts in DNA replication.  
One final aspect of sequence divergence is that TbORC1/CDC6 (and indeed 
TbORC1B, if it is also an Orc1-related factor) (Dang and Li, 2011), lacks the 
bromo-adjacent homology domain (BAH) in its N-terminus (Godoy et al., 2009), a 
domain that is assumed to be universally conserved amongst eukaryotic Orc1 
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subunits (Costa et al., 2013). In the structure of ScORC, it is proposed that 
ScOrc1’s BAH domain is displayed to the ‘back’ of the complex, where it may 
allow ScOrc1 interaction with transcription silencing factors and histones, 
without interfering with the ORC complex bound to the origin (Sun et al., 2012). 
It remains unclear what the absence of a BAH domain in TbORC1/CDC6 means 
for T. brucei (and indeed kinetoplastid) biology, and for the overall structure of 
a potential ORC-like complex.  
Together, this re-analysis of the sequences of TbORC1/CDC6 and its interacting-
partners was able to confirm and enhance the available data, suggesting that 
TbORC1/CDC6, TbORC1B and TbORC4 are most likely Orc-like proteins. 
Additionally, very tentative data suggest the possibility of Tb7980 being an Orc5-
like subunit, and Tb3120 an Orc2-like factor. Allied to the new RNAi and gel 
filtration analyses (see below), greater weight can be placed on the hypothesis 
that a putative ORC-like complex in T. brucei is likely to exist, though whether 
all canonical six subunits are present remains unclear. The analysis of 36 
genomes from organisms across the various eukaryotic supergroups revealed that 
the typical six-subunit ORC complex is not found in all eukaryotic groups (Aves et 
al., 2012). Indeed, none of the genomes from organisms of the Excavata 
supergroup (to which T. brucei belongs) appeared to possess the Orc3 and Orc6 
subunits of ORC, as well as Cdc6 and Cdt1 (Aves et al., 2012), perhaps explaining 
why various studies have failed to identify these factors over the years (El-Sayed 
et al., 2005a; Tiengwe et al., 2012b; Tiengwe et al., 2013; Dang and Li, 2011). It 
is, nevertheless, possible that other proteins, highly diverged in terms of protein 
sequence, but functionally conserved, are performing the role of these missing 
factors. For instance, in archaea, organisms from the Methanococcales group do 
not possess Orc1/Cdc6 homologs, but a sequence-unrelated factor performs the 
same role in DNA replication in these organisms (Raymann et al., 2014). Whether 
this is the case of Tb1120, and potentially Tb2240 (identified in section 3.6.2), 
as well as of other presently unidentified factors, it is not known.  
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3.7.2 TbORC1/CDC6, TbORC4 and Tb3120 are involved in nuclear 
DNA replication  
Only TbORC1/CDC6 has been directly shown to be involved in DNA replication 
(Benmerzouga et al., 2013), as downregulation of its expression by RNAi led to a 
decrease in the number of replicating cells. Although silencing of TbORC4, 
Tb7980 or Tb3120 expression resulted in similar growth and cell cycle defects, 
these were slow to arise and had not been confirmed to result from impairment 
in nuclear DNA replication (Tiengwe et al., 2012b). The effects of TbORC1B or 
Tb1120 downregulation have never been investigated. The results presented 
here confirm the role of TbORC1/CDC6, TbORC4, Tb3120 and TbORC1B in T. 
brucei PCF DNA replication, while the involvement of Tb7980 and Tb1120 in this 
biological process remains unclear. Due to its peculiarity, TbORC1B is discussed 
separately in section 3.7.4.  
Induction of RNAi silencing of either TbORC1/CDC6 or TbORC4 resulted in a 
strikingly similar phenotype: growth defects arising after ~2-3 cell doublings, 
accompanied by severe cell cycle anomalies comprising mainly the substantial 
increase in the number of enucleated cells that retain a kinetoplast (0N1K, 
zoids) (Robinson et al., 1995). Though similar to results reported in previous 
studies (Tiengwe et al., 2012b; Godoy et al., 2009; Benmerzouga et al., 2013), 
the time frame for the effects to become noticeable, as well as the severity of 
the phenotypes, were more pronounced in this study. In both TbORC1/CDC6 and 
TbORC4 RNAi, zoid cells accumulated to around 60-70% of the population at 48-
96 h post-induction, when compared to only 20-25% of zoids observed previously 
at the 96 h time point, and a maximum of 30% at 144 h (Tiengwe et al., 2012b; 
Godoy et al., 2009; Benmerzouga et al., 2013). The amount of 1N1K cells 
decreased almost proportionally with the increase in zoids, and virtually no 2N2K 
cells (post-mitotic and undergoing, or about to start, cytokinesis) were 
detected, while 1N2K cell numbers were also reduced. It is not clear why the 
RNAi cells used in this study responded so dramatically (Tiengwe et al., 2012b; 
Godoy et al., 2009; Benmerzouga et al., 2013), especially as mRNA levels 
assessed by RT-qPCR suggest that knockdown efficiency was not markedly 
greater than those described by (Tiengwe et al., 2012b) (here ~60% for 
TbORC1/CDC6 RNAi and only 20% in TbORC4, compared with 90% and 75%, 
respectively, albeit assessed ~72 h later). The appearance of zoids has been a 
Chapter 3  240 
 
 
hallmark phenotype in studies of DNA replication and mitosis in PCF T. brucei 
cells, as in this life cycle stage of the parasite cytokinesis appears not to be 
dependent on completion of mitosis or DNA synthesis taking place, since the 
mitosis to cytokinesis checkpoint is lacking (Ploubidou et al., 1999; Hammarton, 
2007). For instance, treatment of PCF cells with Aphidicolin, which inhibits 
nuclear DNA synthesis (Ploubidou et al., 1999), results in a rise in the number of 
zoids, which are thought to generate as 1N2K cells, that should be theoretically 
in G2 phase, but have not replicated their nuclear DNA, divide into a zoid and a 
1N1K cell (Figure 3.49, bottom panel). Because the failure in replicating their 
nuclear DNA results in an inhibition of mitosis, but not cytokinesis, the 2N2K cell 
population disappears (Ploubidou et al., 1999). The increase in the number of 
zoids is almost equivalent to the reduction in the numbers of 1N1K cells, as from 
one 1N2K cell only one 1N1K cell is returned to the cell population rather than 
the usual two that would result from a normal cell division (Ploubidou et al., 
1999). In the case of inhibiting mitosis but not DNA replication, for e.g. by 
incubating the cells with an anti-microtubule agent such as rhizoxin (Ploubidou 
et al., 1999) or by targeting by RNAi TbCYC6, a mitotic cyclin (Hammarton et 
al., 2003), G2 phase 1N2K cells do not undergo mitosis, generating a zoid and a 
1N1K cells with a fully replicated nucleus, which would be detected as G2 phase 
cells by flow cytometry. In the present study, the cell cycle phenotypes arose 
following impaired nuclear DNA replication, since for both TbORC1/CDC6 and 
TbORC4 assessment of EdU (thymidine analogue) incorporation showed that 
reduced DNA replication was already detected 24 h post RNAi induction (when 
EdU incorporation decreased by ~50%), which preceded the emergence of the 
growth and cell cycle defects. It should also be noted that the very large number 
of zoids that emerged after RNAi of either factor argue that replication of the 
kDNA is largely unaffected, suggesting that the roles of these factors are strictly 
nuclear (consistent with their localisation) and that there may be little 
communication between the nuclear and kinetoplast replication processes, at 
least in PCF cells.  
Silencing of Tb3120 resulted in similar phenotypes, though not as fast or 
pronounced as observed for TbORC1/CDC6 and TbORC4: a growth defect was 
only noticeable at day four post-induction, in parallel with an increase in the 
number of zoids to 30% of the cell population. Thereafter, the phenotype 
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became more severe than described in (Tiengwe et al., 2012b), with near 
growth arrest by 7 days post-induction, when the number of zoids reached >40% 
of the cell population (compared with to 20% in (Tiengwe et al., 2012b)). Like 
for TbORC1/CDC6 and TbORC4, replication impairment preceded the cell cycle 
and growth defects, with ~50% reduced EdU uptake taking place 24 h earlier. 
Together, these results confirm that Tb3120 is also involved in DNA replication. 
Why the phenotypes of this loss are delayed relative to TbORC1/CDC6 and 
TbORC4 is unclear, but two possible explanations might be considered. The first 
is that Tb3120 might not play such a central role in the process of nuclear DNA 
replication and, therefore, the delayed phenotype, although similar in outcome, 
reflects the fact that loss of Tb3120’s role is not detected for several cell 
divisions after RNAi is firstly induced. What such a secondary role might be is 
unclear, however, and that would be unlikely if Tb3120 formed part of the T. 
brucei ORC-like complex. The second, perhaps more likely explanation, is that 
Tb3120 protein is more stable than TbORC1/CDC6 and TbORC4, and 
consequently, requires longer RNAi induction to lower the protein levels in the 
cell. This may be consistent with the fact that all three proteins are 
constitutively expressed (see below), and therefore coordinated turnover rates 
are not needed.  
 
Figure 3.49. Schematic representation of cell cycle progression in PCF cells.  
(Top panel) normal cell cycle progression in PCF cells. (N) Nucleus, and nuclear phases; (K) 
Kinetoplast, and kinetoplast phases. (G1) G1 phase; (S) S phase; (G2) G2 phase; (M) Mitosis; (C) 
Cytokinesis; (D) Division; (A) Anaphase. Diagram based on the descriptions and diagrams from 
(McKean, 2003; Field and Carrington, 2009). (Lower panel) Progression of a 1N1K cell in which 
nuclear DNA replication has been impaired. Red crosses mark the nuclear stages that were 
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blocked. White asterisks demark nucleuses that were supposed to be replicating or replicated, but 
are not. The result is a 1N1K cell and a 0N1K zoid. It is possible that the resultant 1N1K cell goes 
through the process again, as indicated by the dashed arrow. Diagram based on the description 
from (Ploubidou et al., 1999) 
 
3.7.3 A closer look at TbORC1/CDC6, TbORC4, Tb7980, Tb3120 
and Tb1120: nuclear, no matter which stage of the cell cycle 
Analysis of protein localisation at the subcellular level is critical to 
understanding the biological process a protein acts in, its relationship with 
interacting partners and to ask questions about its regulation (Brand et al., 
2007). Moreover, it is an important piece of evidence in support of information 
obtained by biochemical and molecular biology methodologies on protein-protein 
interactions, such as immunoprecipitations and yeast-two-hybrid assays (Brand 
et al., 2007). For instance, recently, a group of T. brucei proteins have been 
identified as putative kinetochore factors through the comparison of their 
subcellular localisation dynamics during the cell cycle, despite the fact that 
none appear to be related to previously characterised eukaryotic kinetochore 
complex members (Akiyoshi and Gull, 2014). Although TbORC1B, TbORC4, 
Tb7980 and Tb3120 have been shown to interact with TbORC1/CDC6, their 
localisation in the cell has never been investigated, or indeed their potential co-
localisation with TbORC1/CDC6, which has been examined previously (Godoy et 
al., 2009). Below, the subcellular localisation of all putative T. brucei Orc-like 
factors is described and compared with other eukaryotic proteins involved in 
DNA replication. Again, results obtained for TbORC1B will be discussed in a 
dedicated section (3.7.4). 
TbORC1/CDC6 localises to the nucleus of PCF cells throughout the cell cycle, 
during which is remains bound to chromatin (Godoy et al., 2009), similar to what 
has been reported for ORC in both budding (Liang and Stillman, 1997) and fission 
yeasts (Lygerou and Nurse, 1999), where the ORC complex remains intact and 
chromatin-bound at all times. This contrasts with observations in other 
multicellular eukaryotes, in which at least one ORC subunit, usually Orc1, has 
been shown to be cell cycle-regulated by various different mechanisms, like 
selective degradation (Li and DePamphilis, 2002) and nuclear exclusion 
(Romanowski et al., 1996), during S phase (reviewed in DePamphilis, 2005). In T. 
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cruzi, TcORC1/CDC6 shows exactly the same cell cycle characteristics as 
TbORC1/CDC6 in replicating epimastigotes (insect stage of the parasite) (Godoy 
et al., 2009), although a more recent study has suggested that TcORC1/CDC6 
sub-nuclear localisation is not constant and homogeneous, but cell cycle 
dependent (Calderano et al., 2011b). During most of the cell cycle, 
TcORC1/CDC6 is dispersed throughout the nucleus, while in the G1 to S phase 
transition it is re-located to the nuclear periphery (Calderano et al., 2011b), 
matching previous observations suggesting that in T. cruzi the chromosomes 
become restricted to regions of the nuclear periphery during DNA replication 
(Elias et al., 2002). Such re-localisation has not been reported in T. brucei, and 
the data here shown did not suggest such a pattern for TbORC1/CDC612myc, 
although a clear punctate pattern is seen in all parts of the nucleus (with an 
apparent exclusion of the nucleolus) throughout the cell cycle. Likewise, the 
ORC1/CDC6 orthologue in Leishmania major, LmORC1/CDC6, was shown to 
localise to the nucleus throughout the cell cycle, with no intra-nuclear specific 
re-localisation being reported (Kumar et al., 2008). Nevertheless, the data in L. 
major was obtained using cells expressing LmORC1/CDC6 fused to GFP from an 
episomal plasmid, meaning that the number of copies of the protein in the 
analysed parasites might have been variable (Kumar et al., 2008). Further 
evidence for the difference in replication between T. brucei and T. cruzi comes 
from the localisation of the replication-sliding clamp PCNA. Like TcORC1/CDC6, 
TcPCNA has been shown to localise to the nucleus throughout the cell cycle of 
epimastigote cells, but to also re-localise to the nuclear periphery in S phase 
(Calderano et al., 2011b). In T. brucei PCF cells, TbPCNA localisation was shown 
to be cell cycle-dependent, being only detected in the nucleus of S phase cells, 
where it was seen as many puncta throughout the nucleus (Kaufmann et al., 
2012). In L. donovani promastigotes (insect stage), LdPCNA is seen in the nucleus 
throughout the cell cycle, with the levels of the protein peaking in G1 and S 
phases, although it is not clear whether the protein is re-located to any 
particular region of the nucleus during DNA replication (Kumar et al., 2009). 
PCNA orthologues in all three parasites have been shown to co-localise with 
replicating DNA, potentially at replication ‘factories’, but no work has asked 
whether there is any overlap with the punctuate localisation described for 
TbORC1/CDC6. Why the localisation pattern and dynamics of these replication-
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related proteins differ between the kinetoplastids is unclear, including whether 
this reflects differing mechanisms involved in nuclear DNA replication. 
Localisation of TbORC1/CDC612myc by super resolution imaging resolved the 
puncta visible at lower resolution, and showed that the protein localises in a 
large number of discrete points, apparently throughout the nucleus and not in 
any specific intra-nuclear regions. The number of discrete TbORC1/CDC612myc 
points appeared to increase in S and G2 phase cells. What these abundant points 
correspond with is unknown. It is possible that they might correspond to 
TbORC1/CDC6 bound to the origins of replication in the genome, which have 
been estimated at ~42, though it is unclear what number of points were present. 
Alternatively, the points might correspond with the much larger number of 
TbORC1/CDC6 binding sites, some of which might co-localise in discrete sub-
nuclear domains. Addressing these questions requires further work. For instance, 
it will be interesting to co-localise TbORC1/CDC6 with specific regions by 
fluorescence in situ hybridisation (FISH), using a probe recognising one of the 
origins, for instance. An alternative would be to co-localise TbORC1/CDC6 with 
histone H4 acetylated in lysine 10 (H4K10ac) (Siegel et al., 2009), which is 
enriched at transcription start sites, and which have been shown to lie close to 
TbORC1/CDC6-binding sites in the genome (Tiengwe et al., 2012a). As far as we 
know, this is the first time that an ORC protein has been analysed by super 
resolution imaging. 
Analysis of TbORC4, Tb7980, Tb3120 and Tb1120, each individually endogenously 
tagged with 12myc revealed the same subcellular localisation pattern as 
observed for TbORC1/CDC612myc: all localise to the nucleus as discrete puncta 
throughout the cell cycle, without any noticeable changes in intra-nuclear 
localisation related to a specific cell cycle stage. Again, none of these factors 
seemed to localise to the nucleolus. In general, although some exceptions exist, 
it appears that the Orc2-6 subunits remain bound to chromatin throughout the 
cell cycle (DePamphilis, 2005; McNairn et al., 2005), which coincides with the 
observations made for TbORC4, and support, to some extent, the suggestions 
that Tb7980, Tb3120 and Tb1120 might also be Orc-like factors. An attempt to 
co-localise these factors, this time endogenously tagged with 6HA, suggest co-
localisation of each factor with TbORC1/CDC612myc, although better resolution 
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images, including super resolution, as well as optimisation of the detection of 
the HA signal, will be needed to confirm these observations and quantify the 
extent of overlap. Nevertheless, these results may suggest that these factors act 
in a complex, though it would be valuable to ask whether TbORC4, Tb7980, 
Tb3120 and Tb1120 are, like TbORC1/CDC6, bound to the chromatin throughout 
the cell cycle (Godoy et al., 2009). Subcellular fractionation revealed that 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and Tb112012myc all 
display similar levels of protein in the nucleus and in the cytoplasm, as has been 
reported for various ORC subunits in other eukaryotes (Lygerou and Nurse, 1999; 
Tatsumi et al., 2000; Semple et al., 2006). Why the cytoplasmic pool for any of 
the T. brucei factors cannot be detected by microscopy is unclear. However, it 
has been shown in human cells that ORC assembly is a dynamic process where, 
for example, Orc1 and Orc6 are transported into the nucleus independently of 
the other ORC members, which assemble in the cytoplasm as a sub-complex 
comprising Orc2-5 (Ghosh et al., 2011). The human Orc2-5 sub-complex is then 
imported to the nucleus where it accumulates, but only binds to chromatin when 
later associated with Orc1 (Ghosh et al., 2011). One potential way to ask about 
the relationship between the putative T. brucei ORC and that of mammals would 
then be to ask whether TbORC1/CDC6, TbORC4, Tb7980, Tb3120 and Tb1120 
interact in the cytoplasm and in the nucleus and if they form any sub-complexes. 
This could be done by performing immunoprecipitations using the different 
cellular fractions, besides potentially also reveal regulation processes involved in 
nuclear DNA replication in T. brucei.  
Although TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and 
Tb112012myc localise to the nucleus throughout the cell cycle without a clear 
evidence of cell cycle-dependent regulation, measurement of the signal 
intensity of each of these factors obtained by microscopy revealed that their 
levels are not static. The levels of TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, 
Tb312012myc and Tb112012myc, followed the same trend: starting at a basal level in 
G1 phase cells, the signal increased progressively as the cells entered and 
progressed through S phase, finally peaking in G2 phase cells, when the DNA has 
been completely duplicated, and later decreasing by half, back to G1 phase 
levels, in each individual nucleus of post-mitotic cells. In budding and fission 
yeast, where ORC has been shown to bind to the chromatin throughout the cell 
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cycle (Liang and Stillman, 1997; Lygerou and Nurse, 1999), it has been presumed 
that new ORCs bind to newly synthesised origins of replication as S phase 
progresses (DePamphilis, 2005; Arias and Walter, 2007). Nevertheless, re-
replication does not take place because regulatory mechanisms, such as 
phosphorylation of the Orc2 and Orc6 subunits in budding yeast (Nguyen et al., 
2001), ensure that the remaining members of the pre-RC complex do not bind to 
ORC until the late mitosis to G1 phase transition. The common pattern of 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and Tb112012myc levels 
throughout the cell cycle is further evidence that these factors might act 
together. Indeed, the potential co-localisation of TbORC1/CDC612myc and EdU 
seems to suggest that TbORC1/CDC6 associates with newly synthesised DNA, but 
more detailed analysis is needed, besides performing the same analysis for 
TbORC4, Tb7980, Tb3120 and Tb1120. 
Altogether, the data here presented support the idea of TbORC1/CDC6, TbORC4, 
Tb7980, Tb3120 and Tb1120 might be acting in the same biological process, but 
it will be essential to investigate with more detail the co-localisation of these 
factor with each other, as well as their cell cycle dynamics, and eventually, 
their regulation. 
 
3.7.4 The odd case of TbORC1B: is TbORC1B a regulatory factor? 
Initially identified as a second Orc1-like protein in T. brucei (Dang and Li, 2011), 
TbORC1B has revealed itself to be the most intriguing TbORC1/CDC6-interacting 
factor here analysed. Besides its interaction with TbORC1/CDC6 and lack of 
ATPase activity, although the fact that it appears to have a quite conserved 
AAA+ ATPase domain (Dang and Li, 2011), nothing was known about TbORC1B 
prior to this study. Despite this lack of knowledge, it was suggested that 
TbORC1B most likely acts simply as one component of the T. brucei ORC-
complex, along with TbORC1/CDC6 (Li, 2012). 
The first piece of evidence suggesting a distinct role for TbORC1B relative to 
TbORC1/CDC6 came from the RNAi assay. The effects of TbORC1B expression 
silencing by inducible RNAi arose at least twice as quickly as those seen for 
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TbORC1/CDC6 (and TbORC4), and were more severe. A clear growth defect was 
seen at 24 h post-RNAi induction, which was accompanied by a severe cell cycle 
defect, with around 60% of the cell population being zoids. Despite this, the 
level of knockdown of TbORC1B mRNA was equivalent to that of TbORC1/CDC6 
in the corresponding cell line, albeit as measured by RT-qPCR. Because of the 
rapidity with which cell cycle defects arose, the effects of TbORC1B RNAi on 
replication were measured at early time points after tetracycline addition to the 
media, revealing that as early as 6 h post RNAi induction (estimated as half of 
the cell cycle in this cell line) there was already a 60% loss of EdU incorporation. 
Importantly, this impairment in replication again preceded the cell cycle 
defects, since a small increase in 1N2K and 2N2K cells was observed at 6 h, 
which was followed at 12 h by a clear increase in the number of 1N2K cells, a 
decrease in 1N1K and 2N2K cells, and the subsequent appearance of zoids. 
Although an increase in 1N2K cells could suggest that these cells stall in the G2 
phase, flow cytometry showed that there is actually a decrease in G2 phase cells 
at these time points, suggesting that nuclear DNA replication is severely and 
rapidly affected by loss of TbORC1B, although the kinetoplast is still replicated 
and segregated. A hypothesis for the rapidity of the emergence of these defects 
is suggested below, after the results on TbORC1B localisation and dynamics are 
discussed.  
TbORC1B subcellular localisation was analysed by endogenously tagging it with 
12myc, similar to TbORC1/CDC6 and the other factors. Unlike 12myc tagged 
TbORC1/CDC6, TbORC4, Tb7980, Tb3120 and Tb1120, TbORC1B12myc was 
detectable in the nucleus of only ~33% of the cells in the cell population. Cell 
cycle characterisation showed that TbORC1B12myc was seen in the nucleus of only 
cells that are in late G1 to late S or early G2 phase, since no TbORC1B12myc signal 
was detected in the majority of 1N1K cells, in any 2N2K cells, nor in 1N2K cells 
that had enlarged nuclei and separated kinetoplasts, suggesting they were 
approaching or had begun mitosis. The majority of the cells containing 
TbORC1B12myc nuclear signal were 1N1eK cells, which are assumed to be in S 
phase. These predictions were supported by measurements of the intensity of 
the TbORC1B12myc nuclear signal, which showed that TbORC1B12myc did not follow 
the pattern of TbORC1/CDC612myc or any of the other interacting factors, since 
the signal peaked in 1N1eK cells, was markedly reduced in 1N2K cells and 
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completely absent from 2N2K cells. Finally, TbORC1B12myc cells were FACS sorted 
into early-mid G1, early S, late S and G2 phases and the protein levels of 
TbORC1B12myc were assess by western blot. TbORC1B12myc was found in both S 
phase samples, as well as in G2, although at lower levels, but was not detected 
in G1, showing that the microscopic detection does not simply reflect cell cycle 
regulated transport into the nucleus, but cell cycle regulation of protein 
expression instead. This clearly shows that TbORC1B12myc expression is cell cycle 
regulated, being expressed mainly during S phase cells. Evidence from a cell 
cycle transcriptome study (Archer et al., 2011) suggests that TbORC1B mRNA 
levels peak in late G1, and then reduce somewhat in S phase and further still in 
early G1 and G2 phasesm. In the work described here, insertion of the 12myc-
tagging construct into the endogenous locus of TbORC1B alters the gene’s 3’ UTR 
region, potentially interfering with such controls. If so, the fact that protein 
levels and localisation of TbORC1B12myc clearly change during the cell cycle argue 
for further expression controls based on the protein, though the basis for this is 
unknown. Taken together, all these data strongly suggest that TbORC1B 
expression is cell cycle regulated, implicating this factor as being central to 
control of T. brucei DNA replication. 
Once detected in the nucleus, TbORC1B12myc displayed the same punctate 
staining that was seen for TbORC1/CDC612myc and the other non-cell cycle 
regulated proteins examined. Indeed, super-resolution microscopy revealed the 
same: abundant puncta throughout the nucleus (except the nucleolus) as seen 
for TbORC1/CDC612myc. This may argue that TbORC1B is recruited to the putative 
ORC once in the nucleus, but the co-localisation studies attempted to date were 
somewhat unclear. Indeed the inability to detect interaction between TbORC1B 
and TbORC1/CDC6 by co-IP, despite this being reported previously, is perhaps 
surprising in this regard. However, the limited expression of TbORC1B in the cell 
cycle may make detection of such interaction problematic. One other problem in 
this study is that it has not proved possible to validate that the 12myc-tagged 
version of TbORC1B is essential in PCF cells. Attempts to delete the remaining 
untagged allele in the TbORC1B 12myc cell line were made, but unfortunately, 
all of these failed to recover any transformants. However, it also proved 
                                         
m
 Data available on TriTrypDB, gene page for Tb927.9.2030, the gene ID for TbORC1B, and in the 
supplementary information of Archer et al., 2011. 
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impossible to remove one allele of TbORC1B in the wild type cell line 927 wt 
(including in wild type BSF cells, Chapter 4), where both alleles are unmodified, 
perhaps suggesting that a single functional allele is insufficient for cell survival.  
If TbORC1B interacts with ORC, the data presented here show that it is not a 
static component of a putative ORC-like complex, and instead any interaction 
with such a complex is most likely transitory and occurs at most through late G1 
to early G2 phase of the cell cycle. This would suggest that TbORC1B acts as a 
regulatory factor. If so, does this explain the speed and nature of the RNAi 
effects? A hypothesis for the course of the events following TbORC1B RNAi is as 
follows. In a normal asynchronous culture, cells progress through the cell cycle 
normally, and TbORC1B localises to the nucleus of some 1N1K cells, most or all 
1N1eK, and some 1N2K cells (Figure 3.50, A, TbORC1B presence depicted in 
green). At 6 h post-RNAi induction, when RT-qPCR suggests TbORC1B mRNA is 
already reduced by ~40%, no clear cell cycle differences are observed by DAPI 
staining, although flow cytometry suggests a decrease in the number of G2 phase 
cells. The ~60% reduction in EdU incorporation 6 h post RNAi induction shows 
that loss of TbORC1B begins to prevent replication of the DNA. Since TbORC1B is 
expressed only from late G1 to late S or early G2, and is potentially degraded at 
other times, one can hypothesise the following: if a cell had TbORC1B at the 
time tetracycline was added, or had finished DNA replication (Figure 3.50, B, 0 h 
row) but not completed cytokinesis, then RNAi induction may not have an effect, 
and the cells would progress into G1 (Figure 3.50, B, 6 h row). On the other 
hand, if TbORC1B were not present in the cell – in most 1N1K cells that are in G1 
phase – RNAi induction would prevent synthesis of TbORC1B as they reach S-
phase, and these cells would not be able to start DNA replication. From 
(Ploubidou et al., 1999), it is known that in PCF cells, blocking DNA replication 
can inhibit mitosis, but not cytokinesis. Moreover, because the kinetoplast S 
phase is independent from the nuclear one (reviewed in McKean, 2003; 
Hammarton, 2007), the cells would still replicate and segregate their 
kinetoplast, generating a cell that would be morphologically 1N2K (suggestive of 
being in G2 phase), but with the nuclear content of a cell in G1 phase (Figure 
3.50, B, 6 h row, nucleus with white asterisk). Because the majority of cells in 
an asynchronous population are in G1 phase, in which TbORC1B is not largely 
expressed, unlike TbORC1/CDC6 and TbORC4, this might explain the more rapid 
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onset of replication-associated defects in the TbORC1B RNAi cell line, as well as 
the appearance of the unusual 1N2K cells with a nucleus in G1 phase (Figure 
3.50, B, 12 h row). As the time course of RNAi induction progresses, the 1N2K 
cells with a non-replicated nucleus would undergo cytokinesis and generate a 
1N1K cell and a zoid, while the 1N1K cells would generate a 1N2K cell with a 
non-replicated nucleus (Figure 3.50, B, 12 h row). This scenario can explain the 
transient increase in the number of 1N2K cells (but lowered numbers of G2 
phase cells in the flow cytometry analysis), as well as the rapid loss of 2N2K cells 
at early time points, and the slight increase in zoid cells at the same time (as 
suggested by both DAPI counting and flow cytometry analysis). Thereafter, the 
number of zoids would continue to increase and 1N2K cells would be lost, as 
eventually no cells would be able to replicate their nuclear DNA (Figure 3.50, B, 
24 h row). Indeed, broadly the same effects are seen following RNAi of the other 
putative Orc-like factors, but take longer to emerge and are less easy to 
capture, as samples were not taken as frequently. It is not known how long a 
zoid cell survives in culture, or whether it can further divide to generate two 
zoids. Nevertheless, some of the cells categorised as “others” had no nucleus 
but two or more kinetoplasts, suggesting this may be possible. Of course, to 
validate these suggestions it will be essential to tag TbORC1B or raise antisera 
against it in order to assess protein levels at the different time points after 
RNAi. 
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Figure 3.50. Hypothetical model of TbORC1B RNAi.  
A) Schematic representation of the different cell cycle stages, according to their nucleus to 
kinetoplast ratio. Same diagram shown in Figure 3.41. B) Schematic representation of what might 
occur upon TbORC1B expression silencing by RNAi induction. Detailed description in the main 
text. Green nucleus – cells with nuclear TbORC1B signal; white asterisks – cells with a non-
replicated nucleus.  
 
If TbORC1B acts as a regulatory factor in nuclear DNA replication in T. brucei, 
does its expression and localisation compare with any known replication 
regulators in other eukaryotes? One possibility is that TbORC1B acts as Cdc6, in 
particular because TbORC1B BLAST hits were mainly Cdc6 proteins, but also 
A) 
B) 
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because Cdc6 expression and subcellular localisation is cell cycle regulated in 
other organisms (reviewed in Costa et al., 2013; Siddiqui et al., 2013). The 
context for this regulation is that, in characterised eukaryotes, the pre-RC 
complex (ORC-MCM2-7 with Cdc6 and Cdt1) is loaded onto origins from late 
mitosis through G1 phase. Upon entering S phase, the origins are activated, but 
must only fire once per cycle, and re-replication is prevented by some pre-RC 
disassembly. For instance, in mammalian cells, Cdc6 localises to the nucleus in 
G1 phase but at least some is transferred to the cytoplasm as the cell enters S 
phase (Delmolino et al., 2001; Petersen et al., 1999). Cdc6 in budding yeast and 
in fission yeast doesn’t display re-localisation, but instability (Kearsey and 
Cotterill, 2003; Piatti et al., 1995): transcription of both genes is limited to 
mitosis to G1 phase and the proteins are degraded as the cells enter S phase 
(Luo et al., 2003). Cdc6 (named Cdc18 in S. pombe) removal appears to be 
regulated via ubiquitylation and consequent degradation by the proteasome 
(Arias and Walter, 2007; Borlado and Mendez, 2008; Diffley, 2010; Li and Jin, 
2010). Thus, despite the potential sequence homology, TbORC1B’s behaviour is 
quite unlike Cdc6, primarily because TbORC1B is absent in G1 phase cells and 
localises to the nucleus from only late G1, if not at the onset of S phase. In 
addition, TbORC1B may not have ATPase activity, present in Cdc6, perhaps due 
to the lack of the signature arginine finger (Dang and Li, 2011). Nevertheless, it 
is possible that TbORC1B is also regulated by ubiquitylation upon entering G2 
phase; attempts were made in the present work to address this (data not 
shown), but were hampered by problems regarding the anti-ubiquitin antiserum 
used. Nonetheless, it will be of value to test this again to get insight into 
TbORC1B potential regulation. 
Regulation of the activity of ORC subunits has also been reported in eukaryotes, 
and in particular the Orc1 subunit, to which TbORC1B also resembles. In general, 
it appears that the Orc2-6 subunits remain bound to chromatin throughout the 
cell cycle (DePamphilis, 2005; Bell et al., 2013; McNairn et al., 2005). One 
exception has been described in Xenopus laevis, where the ORC complex 
interaction with chromatin weakens during S phase. In mammals Orc1 function 
has been shown to be cell cycle-regulated by different mechanisms, including 
selective degradation (Li and DePamphilis, 2002) and nuclear exclusion 
(Romanowski et al., 1996). However, these alterations, which occur during S 
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phase (reviewed in DePamphilis, 2005; Bell et al., 2013), differ dramatically 
from the nuclear accumulation we see for TbORC1B at this cell cycle stage. The 
closest analogy seen between TbORC1B expression dynamics and ORC in any 
other eukaryote is with DmOrc1 of D. melanogaster. In the fly, DmOrc1 is 
detectably expressed only from late G1 phase through S until G2, and is 
degraded at mitosis and during G1 phase by the Anaphase Promoting Complex 
(APC) (Araki et al., 2003) - expression patterns that are strikingly similar to 
TbORC1B. D. melanogaster DmOrc1 levels are to a large extent controlled by 
ubiquitin-mediated degradation through signals in the protein’s N-terminus. 
Perhaps surprisingly, however, mutation of D. melanogaster DmOrc1 to prevent 
mitosis to G1 degradation has no effect on cell cycle progression (Park and 
Asano, 2011), and it has been suggested that the expression control may be 
needed for lineage-specific replication-mediated gene amplification (Park and 
Asano, 2012). It is unclear if T. brucei possesses any such discrete replication 
reactions. Furthermore, D. melanogaster DmOrc1 is highly conserved relative to 
‘model’ eukaryotic Orc1 subunits, including retention of an N-terminal BAH 
domain, and interacts with a conventional six subunit ORC that bears substantial 
structural homology with that of yeast (Bleichert et al., 2013; Clarey et al., 
2008; Bleichert et al., 2015). TbORC1B is more diverged in sequence from Orc1 
than TbORC1/CDC6 and lacks any equivalent N-terminal sequence to that used in 
D. melanogaster DmOrc1 degradation. Thus, the analogy with D. melanogaster, 
while intriguing, is limited, and it remains likely that TbORC1B S phase 
restriction is central to the control of replication in T. brucei. 
Another candidate for functional analogy with TbORC1B is Cdt1, despite the fact 
that the proteins share no sequence homology. Nevertheless, this association is 
possible because TbORC1B has been shown to interact with the MCM2-7 helicase, 
at least via MCM3, which has also been reported to interact with TbORC1/CDC6 
(Dang and Li, 2011). In other eukaryotes, Cdt1 interacts with MCM2-7 (reviewed 
in Bell and Kaguni, 2013) and mediates the interaction of the helicase with ORC, 
apparently through Orc6 (Takara and Bell, 2011; Bell and Kaguni, 2013). If Cdt1 
is absent in T. brucei, then it is possible that TbORC1B acts to mediate loading 
of MCM2-7, possibly through MCM3, onto TbORC1/CDC6, and potentially the ORC-
like complex, bound to the chromatin. Again, however, expression dynamics of 
TbORC1B appear incompatible with what has been described in other eukaryotes 
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(reviewed in Costa et al., 2013; Siddiqui et al., 2013), where Cdt1 acts in 
loading the MCM2-7 helicase to origins bound by ORC from late mitosis through 
G1 phase, and up to the onset of S phase. Indeed, like Cdc6, Cdt1 function is 
repressed by various mechanisms during S phase in many eukaryotes: e.g. by 
nuclear exclusion in S. cerevisiae (Tanaka and Diffley, 2002), by degradation in 
S. pombe (Nishitani et al., 2000), and activity suppression (through binding 
Geminin) in mammalian cells (Wohlschlegel et al., 2000; Nishitani et al., 2001) 
(reviewed in Siddiqui et al., 2013).  
TbORC1B nuclear localisation dynamics are, somehow similar to one protein in T. 
brucei: TbPCNA (Kaufmann et al., 2012), the sliding clamp involved in DNA 
polymerase association with the DNA, which is only detectable in the nucleus of 
PCF cells from late G1 phase to late S phase. Indeed, TbPCNA localisation in the 
nucleus was analysed by super-resolution microscopy and showed similar large 
numbers of puncta (Kaufmann et al., 2012) as seen for TbORC1B. This striking 
overlap between expression profiles fits with the hypothesis that TbORC1B acts 
as a positive regulator of DNA replication, and it will be interesting to test the 
co-localisation between these two factors. TbPCNA localisation has also been 
partly overlapped with newly replicated DNA, assessed by EdU labelling 
(Kaufmann et al., 2012). Whether the TbORC1B puncta overlap with replicated 
DNA was rather less clear, and requires more investigation.  
It will be of interest to explore TbORC1B further, and to elucidate its role in 
replication in detail, including in T. cruzi and L. major, where replication 
organisation appears to differ in the nucleus. The complete absence of TbORC1B 
in G1 phase cells may suggest that it is important for the start of DNA replication 
and therefore, only acts at the onset of S phase. If TbORC1B acts to activate the 
initiation of DNA replication, it will be important to ask whether it binds to the 
chromatin and, if so, whether this is cell cycle dependent, and if it only binds to 
the origins of replication that are activated, or whether it interacts with 
TbORC1/CDC6 at origin-active and inactive sites in the genome (Tiengwe et al., 
2012b).  
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3.7.5 Does T. brucei have an ORC complex? 
In the course of this study, it was confirmed that TbORC1/CDC6 interacts with 
TbORC4, Tb7980 and Tb3120, as well as with Tb1120, and clear functions for 
TbORC1B, TbORC4 and Tb3120 in replication were shown. Of course it remains 
possible that more interacting partners exist in the putative ORC-like complex, 
and one new candidate is Tb2240 (Tb927.10.2240), though no validation of this 
has been attempted. It remains unknown, however, if TbORC1/CDC6, TbORC4, 
Tb7980, Tb3120 and Tb1120 interact together in a complex or not. However, gel 
filtration of extracts from PCF cells expressing TbORC1/CDC612myc provides the 
first evidence that at least this Orc-like protein interacts relatively stably with a 
number of other factors, perhaps in a complex. From this experiment, which 
should be repeated, the size of the putative complex (most likely ~900-1100 
kDa) appears to be too large to be composed of only TbORC1/CDC6 (66.34 kDa 
with the 12myc tag), TbORC4 (77.29 kDa), Tb7980 (48.8 kDa), Tb3120 (112.9 
kDa) and Tb1120 (80.7 kDa) that, with or without TbORC1B (65.49 kDa), sums up 
to a complex of 386 kDa or 415 kDa, respectively, at least if each interacts in a 
1:1 ratio. This might suggest that TbORC1/CDC6 interacts more stably with 
further, unidentified factors than those recovered above by IP or, more likely, 
these Orc-like factors form a highly diverged ORC that interacts with further 
proteins, which are still to be identified. Though highly speculative, the large 
size of the putative TbORC1/CDC612myc-containing complex is big enough to 
represent the putative ORC-like complex bound to the T. brucei TbMCM2-7 
helicase, which would represent the pre-RC, as well as potentially the TbGINS 
complex, TbCDC45 and TbMCM10, and thus the pre-IC complex. Indeed, the most 
abundant sizes of the putative complex (~900-1100 kDa) are big enough to 
harbour the five Orc-like factors here described as well as the TbMCM2-7 
helicase, thus the pre-RC; it makes sense that this is possibly the most abundant 
complex, since the cells used in this experiment were collected from an 
asynchronous culture, where ~80% of the cells are 1N1K, assumed to be in G1 
phase, when the pre-RC is assembled in all other studied eukaryotes (reviewed 
in Costa et al., 2013). Further experiments will be needed to test these 
predictions, but the ability to detect such a complex also provides an 
experimental route to begin dissecting the regulation of T. brucei DNA 
replication initiation.  
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4 Analysis of initiation of DNA replication in T. 
brucei bloodstream form cells 
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4.1 Introduction 
Trypanosoma brucei has a complex life cycle, where the parasite has to undergo 
drastic developmental changes in order to infect two distinct hosts, the mammal 
and the tsetse fly. Two replicative life cycle stages are routinely cultured: the 
long slender bloodstream form (BSF), which causes pathology in the mammal, 
and the procyclic form (PCF) that replicates in the fly midgut. These two 
developmental stages were adapted to culture and have been shown to differ in 
many aspects of their cellular biology, such as morphology (reviewed in Field 
and Carrington, 2009; Fenn and Matthews, 2007; Ooi and Bastin, 2013), proteins 
expressed at the cell surface (reviewed in Dyer et al., 2013; McCulloch et al., 
2014), metabolic pathways (reviewed in Creek et al., 2012), cell division 
checkpoints (reviewed in Hammarton, 2007; McKean, 2003; Li, 2012), nuclear 
architecture and chromatin structure (reviewed in Daniels et al., 2010; 
Schlimme et al., 1993; Rout and Field, 2001; Figueiredo et al., 2009; Maree and 
Patterton, 2014; Siegel et al., 2009), and gene expression (Siegel et al., 2010; 
Jensen et al., 2009; Jensen et al., 2014; Brems et al., 2005; Urbaniak et al., 
2012; Urbaniak et al., 2013).  
To date, most of the work investigating nuclear DNA replication in T. brucei has 
been performed using PCF cells (Tiengwe et al., 2012b; Tiengwe et al., 2012a; 
Benmerzouga et al., 2013; Godoy et al., 2009). Studies in BSF cells have been 
restricted to analysis of the effects that result from RNAi depletion of 
TbORC1/CDC6, TbORC4 or Tb7980 (Tiengwe et al., 2012b; Benmerzouga et al., 
2013). Perhaps reflecting differences in cell cycle checkpoint between PCF and 
BSF cells (Hammarton, 2007; McKean, 2003; Li, 2012), the RNAi phenotypes 
described in the two stages were quite different (see below, section 4.2). 
Presently, and reflecting the results obtained in PCF cells, only TbORC1/CDC6 
was shown to be involved in DNA replication in BSF cells (Benmerzouga et al., 
2013). In addition, TbORC1/CDC6 depletion by RNAi resulted in a reduced 
expression silencing of the variant surface glycoproteins (VSGs) in BSF cells 
(Benmerzouga et al., 2013), an effect also reported in PCF cells (Tiengwe et al., 
2012a). Intriguingly, the results of TbORC1/CDC6 downregulation in BSF cells 
appeared to be different between the two studies in which it was analysed 
(Benmerzouga et al., 2013; Tiengwe et al., 2012a) (discussed more fully below, 
section 4.2). To elucidate the discrepancies between these two studies, as well 
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as to investigate the differences between RNAi phenotypes in BSF and PCF cells, 
and to assess whether TbORC4, Tb7980, Tb3120 and TbORC1B are also involved 
in DNA replication in BSF cells, RNAi cell lines targeting individually each of 
these factors were created and analysed in detail for growth, cell cycle, and 
DNA replication defects.  
To date, none of the putative ORC factors have been localised in BSF cells. 
Considering that the two life cycle stages differ in so many aspects, it is relevant 
to investigate these factors’ subcellular localisation and cell cycle dynamics in 
BSF cells. By applying the strategies described in Chapter 3 for PCF cells, these 
parameters were also investigated in BSF cells.  
Origins of replication have also only been mapped in PCF cells (Tiengwe et al., 
2012a). Because PCF and BSF cells are distinct, developmentally differentiated 
cell types, and in other eukaryotes it has been shown that different cell types of 
the same organism activate different origins of replication, or use a different 
replication (origin activation) timing programme (Ryba et al., 2010), replication 
origins were mapped in BSF cells (Tiengwe et al., 2012a). Because of the 
complexity of origin function, this area is introduced more fully in the relevant 
results section (section 4.5).  
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4.2 TbORC1/CDC6, TbORC4 and TbORC1B are involved 
in DNA replication  
Since T. brucei was confirmed to possess a functional RNA interference (RNAi) 
machinery, RNAi has become the method of choice to examine essential gene 
function in this parasite, as has been already explored in Chapter 3. In order to 
understand the role of TbORC1/CDC6 and interacting partners in T. brucei 
biology, and to complement the data from studies in PCF cells, inducible RNAi 
cell lines targeting individually TbORC1/CDC6, TbORC4 and Tb7980, have been 
generated in BSF cells (Benmerzouga et al., 2013; Tiengwe et al., 2012b). 
Interestingly, the phenotypes reported in BSF cells after RNAi of these factors 
differed from the consistently observed effect seen in PCF cells (Tiengwe et al., 
2012b; Godoy et al., 2009; Benmerzouga et al., 2013), in which the formation 
and accumulation of enucleated cells (0N1K or zoids) predominates (Chapter 3). 
Moreover, the phenotype described following TbORC1/CDC6 downregulation in 
BSF cells was different in the two studies published (Tiengwe et al., 2012b; 
Benmerzouga et al., 2013). In one study, induction of RNAi individually targeting 
TbORC1/CDC6, TbORC4 or Tb7980, resulted in strikingly similar, rapid 
phenotypes: growth defects were detectable as early as 18 h post-induction, 
with a parallel increase in the number of multi-nuclei and multi-kinetoplast cells 
(Tiengwe et al., 2012b). Surprisingly, flow cytometry analysis of these cells 
suggested that they had replicated their DNA, with a population containing 
double the DNA content (8N) present in G2/M cells (4N) appearing, perhaps 
suggesting re-replication of the nuclear DNA (Tiengwe et al., 2012b). Although it 
was suggested that this might result from the inhibition of non-replication roles 
of TbORC1/CDC6, TbORC4 or Tb7980, what such roles might be is unclear. In 
another study, RNAi against TbORC1/CDC6 in BSF cells also resulted in a growth 
defect, although at a later time point (48 h) post-induction (Benmerzouga et al., 
2013). Here, growth perturbation was accompanied by the appearance of zoid 
cells (although not to the same levels as seen following RNAi in PCF cells), and 
the accumulation of multi-nuclei and multi-kinetoplast cells (Benmerzouga et 
al., 2013). In contrast with (Tiengwe et al., 2012b), an accumulation of cells in 
G2/M phase (4N) was observed by flow cytometry analysis, while cells with 
higher DNA content were not detected (Benmerzouga et al., 2013). Still, this 
would suggest that the cells progressed though S phase, but arrested in G2/M 
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phase. Nevertheless, BrdU incorporation (thymidine analogue, mentioned and 
discussed in Chapter 3), suggested that DNA replication was impaired, 
confirming that TbORC1/CDC6 is involved in DNA replication in BSF cells. The 
somewhat contradictory phenotypes in the two studies may be accounted for by 
suggesting that in BSF cells TbORC1/CDC6 performs other roles not directly 
related to DNA replication, or that such roles assume greater prominence than in 
PCF cells. Indeed, like Orc1 in other eukaryotes (reviewed in Costa et al., 2013), 
TbORC1/CDC6 has been shown to be involved in gene silencing: RNAi induction 
resulted in increased levels of metacyclic VSG mRNAs in PCF cells (Tiengwe et 
al., 2012a) and, in one study, led to the expression of elevated levels of VSG 
mRNAs derived from the silent VSG expression sites in BSF cells (Benmerzouga et 
al., 2013). However, whether this function accounts for the differences in RNAi 
phenotypes between BSF and PCF cells is not known, in particular because 
TbORC1/CDC6 RNAi induction in PCF cells was shown to result in genome-wide 
changes of the mRNA levels (Tiengwe et al., 2012a), meaning that the VSG 
mRNA changes may not represent a specific effect. 
4.2.1 RNAi system used and generation of the RNAi BSF cell lines 
To allow individual inducible RNAi silencing of TbORC1/CDC6, TbORC4, Tb7980, 
Tb3120 and TbORC1B in T. brucei BSF cells, the 2T1 cell line (Alsford et al., 
2005) was used. This cell line expresses constitutively the tetracycline repressor 
(TetR), and has been modified to have an incomplete fragment of the 
hygromycin (HYG) resistance gene (the 3’ region of the gene’s ORF), followed by 
a complete puromycin (PUR) resistance marker gene (the cells are resistant to 
puromycin but not to hygromycin), integrated into one of the ribosomal RNA 
(RRNA) locus (Alsford et al., 2005) (Figure 4.4). Several plasmids have been 
designed to allow integration of an RNAi construct, by homologous 
recombination, into the 2T1 cells genome (e.g. pRPAiSL (Alsford and Horn, 2008) 
and pGL2084 (Jones et al., 2014; Alsford and Horn, 2008). These plasmids 
contain the remaining part of HYG (5’ region of the ORF), plus an overlapping 
region of the HYG fragment present in the parasite’s genome, downstream of 
the EP procyclin promoter. In addition, the plasmids contain regions to allow 
cloning to generate gene-specific stem-loop dsRNA downstream of a RRNA 
promoter and a tetracycline operator (TetO). Finally, they also possess a 
fragment of the RRNA spacer (Alsford and Horn, 2008; Jones et al., 2014). 
Chapter 4  261 
 
 
Integration of the construct after transformation is thus locus-specific, based on 
the overlapping HYG sequence and RRNA spacer, leading to the excision of PUR 
and generation of a complete HYG ORF; this means that transformants should be 
hygromycin-resistant, but puromycin sensitive, cells (Alsford and Horn, 2008; 
Alsford et al., 2005). The use of these plasmids and 2T1 cells allows locus-
specific integration of a tetracycline inducible stem-loop RNAi construct (Alsford 
and Horn, 2008), with demonstrated higher transfection efficiency and, it is 
thought, greater clone-to-clone reproducibility (Alsford et al., 2005). 
Furthermore, dsRNA expression is driven by a RRNA promoter, circumventing the 
need to have a cell line expressing the bacteriophage T7 RNA polymerase, as 
other systems (Wirtz et al., 1999), including the ones described in Chapter 3.  
Here, the construct pGL2084 (Jones et al., 2014) was used (Figure 4.1). This 
construct was originally modified from pRPaiSL (Alsford and Horn, 2008) to 
include two inverted regions containing Gateway® cloning recombination 
attachment (att) sites, attP1 and attP2, flanking a ccdB gene (a bacterial 
negative selective marker) separated by a 150 bp lacZ gene fragment (“stuffer”) 
(Figure 4.1), in order to allow high throughput recombinational cloning of PCR 
products using the Gateway® system (Hartley et al., 2000). For this, a gene-
specific PCR product flanked by attB sites is generated using a forward primer 
containing the attB1 site (5’ end) and a reverse primer harbouring an attB2 site 
(in the 5’ end) (Figure 4.2). The attB1-PCR-attB2 product is then incubated with 
the pGL2084 vector in the presence of BP clonase™ enzyme mix (containing the 
bacteriophage lambda integrase (Int) and the E. coli integration host factor (IHF) 
enzymes), allowing the BP recombination between the attB sites-containing 
substrate (PCR product) and the attP-containing substrate (pGL2084 vector). 
This results in an attL-containing construct and excision of the ccdB gene flanked 
by attR sites (thus allowing the growth of the bacteria transformed with the 
recombined plasmid, as expression of CcdB inhibits the growth of most of the E. 
coli strains used in laboratory) (Hartley et al., 2000) (Figure 4.2). The pGL2084 
construct was designed so that the attB1 site only recombines with the attP1 
site, and the attB2 site only recombines with the attP2 site, providing 
orientation-specific insertion of the PCR product (Hartley et al., 2000). 
Furthermore, because the pGL2084 vector possesses two inverted regions 
containing the attP1 and attP2 sites, it allows the integration, in a single cloning 
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step, of a single PCR product, into two places in the plasmid, generating a final 
construct with the gene-specific PCR fragment inserted in a tail-to-tail 
orientation separated by the “stuffer”, and thus allowing the expression of a 
dsRNA stem-loop once integrated into the parasite’s genome (Jones et al., 2014) 
(Figure 4.2). In order to confirm the correct integration of the PCR product, 
pGL2084 was designed to allow diagnostic enzymatic digestion, using several 
restriction enzymes (Jones et al., 2014) (Figure 4.3, F). Moreover, the presence 
of two AscI restriction sites adjacent to the incomplete HYG gene and the RRNA 
fragment, allows excision of the construct prior to transfection into 2T1 cells 
(Jones et al., 2014).  
 
Figure 4.1. Plasmid map of pGL2084.  
Detailed map of the pGL2084 vector (Jones et al., 2014) generated via modification of the pRPa
iSL
 
construct (Alsford and Horn, 2008), as detailed in the main text. The attP1 (white arrows) and attP2 
(pink arrows) sites have been inserted in two regions of the plasmid, inverted, separated by a 150 
bp “stuffer” fragment of the bacterial lacZ gene (black arrow). Each of these attP sites pairs flank 
one copy of the ccdB gene (blue arrows), which will be excised upon recombination with the PCR 
product flanked by attB sites. Features from the pRPa
iSL
 construct such as the RRNA promoter 
(green arrow) and tetracycline operator (yellow) are placed upstream of the first attP1 site, to allow 
inducible expression of the fragments cloned downstream. Also, the incomplete hygromycin 
resistance (HYG) gene, comprising the 5’ region of the ORF (orange arrow), is localised 
downstream of the EP procyclin promoter (red arrow), and allows construction of the complete 
gene once the construct is integrated into the parasite genome. The RRNA spacer is shown 
downstream of the second attP1 site, which also allows homologous recombination with the 
parasite genome upon transfection. The bacterial ampicillin resistance gene (ampR, large black 
arrow) and the bacterial origin (ColE1, grey arrow) are also shown. The relevant restriction sites 
are shown. Some features, such as the mRNA processing regions upstream of the incomplete 
HYG, are not shown for simplicity. 
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Figure 4.2. Recombinational cloning of PCR products into pGL2084.  
Graphic representation of the cloning process used to generate the RNAi stem-loop constructs in 
the pGL2084 vector (Jones et al., 2014). A) A single PCR product is amplified from parasite gDNA 
using a pair of primers containing an attB1 site in the forward primer (green primer), and an attB2 
site in the reverse primer (yellow primer). B) The PCR product is then incubated with the pGL2084 
vector in the presence of the BP clonase™ mix, allowing recombination between the attB1 and 
attP1 (white) sites, as well as the attB2 and attP2 (pink) sites. Because pGL2084 has two pairs of 
attP sites, in opposite directions, two PCR products are inserted into the vector, one in the sense 
orientation (), and the other in the antisense orientation (), both flanked by newly generated 
attL1 and attL2 sites, and separated by the “stuffer” (black) (C). The insertion of the PCR fragments 
results in the excision of the ccdB genes, flanked by attR sites (not represented). Not all features of 
the pGL2084 plasmid are shown. The diagram was designed based on descriptions in (Jones et 
al., 2014) and (Hartley et al., 2000), and is not represented to scale. 
 
The 2T1 cells/pGL2084 construct strategy for RNAi targeting of TbORC1/CDC6, 
TbORC4, Tb7980, Tb3120 and TbORC1B was chosen because we considered that 
using a stem-loop RNAi approach in BSF cells, as was used in PCF cells (Chapter 
3), could provide the best chance of comparing results between the life cycle 
stages. The region of each gene to be PCR-amplified (between 400-600 bp), as 
well as the best pair of primers to be used, was chosen using RNAit 
(http://trypanofan.bioc.cam.ac.uk/ software/RNAit.html) (Redmond et al., 
2003), as described in Chapter 3, section 3.3.1. To the primer sequences, attB 
sites were added, as described in (Jones et al., 2014). The PCR reactions, using 
primers C 108 and C 109 (TbORC1/CDC6), C 114 and C 115 (TbORC4), C 116 and 
C 117 (Tb7980), C 110 and C 111 (Tb3120), and C 112 and C 113 (TbORC1B), as 
A) 
B) 
C) 
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well as the cloning and transfection into E. coli DH5α bacteria, were performed 
as detailed in (Jones et al., 2014), and are explained in the materials and 
methods Chapter 2, section 2.2.1.10. The plasmids were then purified and 
confirmed by restriction enzyme digestion as described in (Jones et al., 2014), 
and are shown in Figure 4.3, F: double digestion with BamHI and XbaI results in 
the excision of the two opposing PCR fragments and attL sites; digestion with 
ClaI excises one of the PCR fragments and respective attL sites; digestion with 
StuI excises the other PCR fragment and attL sites; and digestion with AscI 
excises the entire insert fragment for transfection into the 2T1 cells. All 
constructs produced the expected restriction digestion patterns, except the 
Tb7980 construct, where digestion with BamHI and XbaI resulted in an extra 
band, since the PCR product included a BamHI restriction site (Figure 4.3, F). All 
constructs were then digested with AscI and transfected into 2T1 cells, as 
described in the materials and methods Chapter 2, section 2.3.5. Transformants 
were selected in the presence of 5 μg.ml-1 of hygromycin, and isolated antibiotic 
resistant clones were further tested for puromycin sensitivity (in the presence of 
0.2 μg.ml-1 of puromycin, as integration should remove PUR) (Jones et al., 2014; 
Alsford et al., 2005). Clones (Cl) sensitive to puromycin were selected for each 
gene, and used for further experiments: TbORC1/CDC6 RNAi Cl9a, TbORC4 
Cl12a, Tb7980 Cl3a, Tb3120 Cl5a, and TbORC1B Cl2a. In the case of 
TbORC1/CDC6, TbORC1B, Tb7980 and Tb3120, the RNAi constructs were 
transfected into 2T1 cells that had been previously endogenously tagged in one 
allele with 12myc, and confirmed to express the fused version of the respective 
protein, as described in section 4.3, and using the tagging-constructs described 
previously in Chapter 3. This allowed the assessment of the RNAi induction 
efficiency by the detection of the 12myc-tagged protein levels. For reasons that 
are unclear, it was not possible to generate a 2T1 cell line with TbORC4 
endogenously tagged with 12myc. 
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Figure 4.3. Plasmid maps and confirmatory enzymatic digestions of the constructs used for 
RNAi of the different factors in BSF cells.  
Detailed plasmid maps of the constructs used for RNAi. (A) plasmid for targeting of 
TbORC1/CDC6; (B) TbORC4; (C) Tb7980; (D) Tb3120; and (E) TbORC1B. The gene-specific 
products, flanked by an attL1 and an attL2 sites, are shown integrated in opposing directions, 
C) D) 
E) 
F) 
A) B) 
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flanking a 150 bp lacZ gene fragment (“stuffer”, black arrow). The gene-specific products are 
expressed by the RRNA promoter (green arrow), regulated by tetracycline (Tet operator, TetO, 
localised downstream of the promoter shown in yellow), while the incomplete hygromycin (HYG) 
ORF (orange arrow) is shown downstream of the EP procyclin promoter (red arrow), localised 
upstream of the RRNA promoter. The bacterial ampicillin resistance gene is shown (ampR, large 
black arrow), as well as the bacterial origin (ColE1 origin, grey arrow). All relevant restriction sites 
are shown. (G) All constructs were confirmed through restriction enzyme digestions, as described 
in (Jones et al., 2014). In each case, the 1 Kb plus DNA ladder (Invitrogen™) is shown as a size 
reference. The expected sizes of the products resulting from the different enzymatic digestions are 
shown below each gel image. Note that in some cases the same gel image has been cropped so to 
display the results from the same plasmid side-by-side, and are separated by white space.  
 
 
Figure 4.4. Graphic representation of the integration of the RNAi constructs into the genome 
of 2T1 cells by homologous recombination.  
Simplified schematic representation of the process followed to integrate the RNAi construct into the 
parasite’s genome. A) The construct is digested with AscI, excising a fragment containing the 
incomplete hygromycin (HYG) ORF, the two gene-specific PCR products, and the RRNA spacer. 
This is then transfected into the 2T1 cells. B) The excised fragment of the plasmid is then 
integrated into the parasite genome at the RRNA locus that has been tagged with the remaining 
part of HYG (3’ region of the gene’s ORF). Homologous recombination between the two HYG 
fragments, as well as between the RRNA spacer regions takes place, resulting in the integration of 
the construct fragment into the cell’s genome, thus generating a complete HYG ORF expressed 
from the EP procyclin promoter (therefore, hygromycin-resistant cells), as well as deletion of the 
puromycin resistance gene (rendering the cells susceptible to puromycin) (C). Once integrated, the 
PCR products and “stuffer” are expressed from the inducible RRNA promoter, controlled by 
tetracycline as described in the main text. The diagram was designed based on the descriptions in 
(Alsford and Horn, 2008; Alsford et al., 2005), and is not represented to scale.  
 
A) 
B) 
C) 
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4.2.2 Effect on growth, cell cycle progression, and DNA 
replication of TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, 
and Tb3120 expression downregulation by RNAi 
In order to investigate the effect of TbORC1/CDC6, TbORC4, Tb7980, Tb3120 
and TbORC1B expression silencing in BSF cells, assays were performed as 
described previously for PCF cell in Chapter 3, with some adaptations to BSF 
cells. To assess effects on cell growth, mid-log phase cell cultures (of ~1 x 106 
cells.ml-1) were diluted to a concentration of 1 x 104 cells.ml-1, and divided into 
two cell culture flasks. To one, 1 μg.ml-1 of tetracycline was added (Tet +) in 
order to induce expression of the stem-loop dsRNA targeting the gene of 
interest, while the other was left as the non-induced control without 
tetracycline (Tet -). Cell concentration was then assessed every 24 hours, at 
which times samples were taken for cell cycle analysis by DAPI staining (as 
described in Chapter 3), as well as for assessment of EdU incorporation (see 
below). Due to the low concentration of the cultures and severity of some 
phenotypes, it was not possible to analyse the samples for DNA content by flow 
cytometry, as described for PCF cells in Chapter 3 and as performed in both 
(Tiengwe et al., 2012b; Benmerzouga et al., 2013). In contrast to the cell 
culture media in which PCF cells are grown (SDM-79), the media routinely used 
to grow BSF cells, either HMI-9 (Hirumi and Hirumi, 1989) or its variations such 
as HMI-11 used to grow 2T1 cells (Alsford et al., 2005), contains a considerable 
amount of thymidine. This rendered EdU-incorporation assays very unreliable (Dr 
Daniel Paape, personal communication), as the thymidine in the HMI-9 and -11 
media appears to compete with EdU for incorporation into the DNA. For this 
reason, cells were cultured in thymidine-free HMI-11 media (Dr Gloria Rudenko 
lab, personal communication; recipe in materials and methods Chapter 2, 
section 2.3.3) for 24 h prior to the assay, as well as for the full course of the 
experiment. For cloning and routine maintenance, however, the cells were 
cultured in regular HMI-11 medium. Furthermore, although the use of a 
thymidine-free media improved EdU uptake by the 2T1 cells, it was necessary to 
increase both the concentration of EdU used and the incubation period relative 
to PCF cells to generate a reproducible and reliable experimental protocol: 
whereas PCF cells were incubated for 3 h with 50 μM of EdU, here BSF 2T1 cells 
were incubated for 4 h with 150 μM of EdU (optimal conditions established by Dr 
Daniel Paape). BSF cells have a faster generation time in culture than PCF, 
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though measurements of replication rate suggest this does not differ 
dramatically between the two life cycle stages (Calderano et al., 2015). It seems 
likely, then, that the need for increased levels of EdU and incubation time might 
be a consequence of non-cell cycle factors, such as EdU uptake. It should be 
noted, however, that EdU (like BrdU) is somehow, though not to the same extent 
as in Leishmania, toxic to T. brucei (Reynolds et al., 2014; Borst and Sabatini, 
2008), as well as to other cells (Zhao et al., 2013; Fujii et al., 2002; Duque and 
Rakic, 2011), leading to pronounced S phase arrest at the concentrations used if 
incubated for long periods of time (Dr Daniel Paape, unpublished). Therefore, 
limiting the incubation time was felt necessary to exclude (as much as possible) 
confounding effects on DNA replication and cell cycle. Efficiency of the 
induction of the gene-specific targeting RNAi was assessed either by RT-qPCR, 
for the TbORC4 RNAi cell line, or western blot, for the remaining cell lines, both 
as described in Chapter 3 and in the materials and methods Chapter 2, sections 
2.4.2.6 and 2.2.5.3. Overall, effects of individual downregulation of 
TbORC1/CDC6 and TbORC1B were assessed in two independently performed 
experiments, while the effects of Tb7980, Tb3120 and TbORC4 silencing were 
only investigated once. In each experiment, the parental cell line, referred to 
here simply as 2T1 wt, was used as a negative control.  
4.2.2.1 Cellular growth, cell cycle progression and DNA replication, are not 
affected in 2T1 cells by the presence of tetracycline 
As expected, no clear growth or DNA replication defects were observed between 
the Tet – and Tet + cultures of the parental 2T1 wt cells (Figure 4.5, A-C), thus 
showing that the presence of tetracycline alone did not cause detectable effects 
on any of the analysed parameters. Nevertheless, there was some variability in 
the cell cycle profile obtained by analysis of the nuclear (N) and kinetoplast (K) 
ratios of DAPI-stained cells. The profile appeared to change between 24 h and 48 
h, even in the absence of tetracycline, perhaps reflecting the change in cell 
density from mid-log phase at the 24 h time point, to a high density by 48 h 
(Figure 4.5, A). Therefore, the cell cycle profile of the non-induced cultures (Tet 
-) is shown for all cell lines (below) at both 24 h and 48 h post RNAi induction 
(Figure 4.5, B). Addition of tetracycline also did not cause any impairment in 
EdU uptake by the cells, suggesting no effects on DNA replication: with or 
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without tetracycline, ~95% of cells displayed a detectable nuclear signal at both 
time points analysed (Figure 4.5, C). 
 
Figure 4.5. Effect of tetracycline on the parental 2T1 cell line, and effect of TbORC1/CDC6 
expression silencing by RNAi.  
A) to C) 2T1 cell line, and D) to F) TbORC1/CDC6 RNAi cell line. A) and D) show growth curves 
comparing cultures containing tetracycline (Tet +) or not (Tet -). Cell concentration was assessed 
every 24 h, and plotted as Log10 values (y-axis). The individual points represent the mean 
concentration calculated from two independent experiments (n = 2), while the error bars depict the 
standard error of the mean (SEM). In D) (insert box), TbORC1/CDC6
12myc
 protein levels in the Tet - 
and Tet + samples at 24 h post-induction are shown by a western blot of cell extracts probed with 
anti-myc antiserum. The transcription elongation factor Ef1α (α-Ef1α) was used as a loading 
control. B) and E) show the quantification of cells in the different cell cycle stages at 24 h and 48 h 
after RNAi induction, based on the nuclear (N) and kinetoplast (K) configuration of individual cells 
stained with DAPI. A minimum of 125 cells was counted per time point and experimental group (Tet 
- and Tet +), and percentages of each stage (1N1K, 1N2K, 2N2K, and “others”) were calculated 
relative to the total amount of analysed cells. The graph represents the mean of each cellular 
population obtained in two independent experiments (n = 2), while the error bars refer to the SEM. 
A) D) 
B) E) 
C) F) 
G) 
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C) and F) show the percentage of EdU positive cells in the Tet + sample relative to the percentage 
of EdU positive cells in the Tet - culture from the respective time point. A minimum of 125 cells 
were analysed per time point and group (Tet - and Tet +). The mean from two independent 
experiments is shown (n = 2), with error bars representing the SEM. G) representative DAPI-
stained and DIC images of cells categorised as ‘others’, seen at 24 h and 48 h after 
TbORC1/CDC6 RNAi induction.  
 
4.2.2.2 RNAi of TbORC1/CDC6 
Induction of RNAi against TbORC1/CDC6 resulted in a growth defect that was 
noticeable at 24 h post-induction and, subsequently, apparent cell death (Figure 
4.5, D). This growth impairment was accompanied by a severe change in the cell 
cycle profile, with an increase, to ~40% of the population at 24 h, in the number 
of cells displaying an abnormal nucleus and kinetoplast ratio (distinct from the 
expected 1N1K, 1N2K and 2N2K configurations) (Figure 4.5, E). This was further 
aggravated at 48 h, with abnormal cells constituting more than 60% of the 
population, with a parallel decrease in the number of 1N1K and 1N2K cells, and 
the virtual abolishment of 2N2K cells (Figure 4.5, E). The abnormal cells 
displayed a variety of morphologies (Figure 4.5, G): large cells with multiple 
nuclei and kinetoplasts, cells with only multiple kinetoplasts, cells with multiple 
flagella, and zoids (0N1K, although these were rare). Thus, there was not a clear 
common morphology amongst the aberrant cells, which were therefore simply 
categorised as “others” (Figure 4.5, E). Analysis of EdU incorporation showed 
that loss of EdU signal was concomitant with the emergence of the growth and 
cell cycle defects: the number of EdU positive cells was reduced by ~50% in the 
induced cells when compared to un-induced (Tet –) at 24 h, and further reduced 
to only ~5% by 48 h post-induction (Figure 4.5, F). Analysis, by western blot, of 
the levels of TbORC1/CDC612myc showed that virtually no protein could be 
detected 24 h after RNAi induction (Figure 4.5, D, insert box). Together, these 
results, in particular the abrogation of EdU incorporation, corroborate previous 
evidence claiming the involvement of TbORC1/CDC6 in DNA replication in BSF 
cells (Benmerzouga et al., 2013). However, these phenotypes observed as a 
whole do not entirely overlap with the previous reports, as discussed below 
(section 4.6.1).  
4.2.2.3 RNAi of TbORC1B 
Prior to this work, the effects of TbORC1B expression silencing have not been 
reported. Like in PCF cells, efficient downregulation of TbORC1B (no 
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TbORC1B12myc protein was detectable 24 h post-induction; Figure 4.6, A, insert 
box) resulted in the most severe phenotype amongst the analysed Orc-like 
factors. A clear growth impairment was observed 24 h after RNAi induction, with 
pronounced cell death by 48 h (Figure 4.6, A). Thereafter, growth appeared to 
recover, as cell numbers increased by 72 h (Figure 4.6, A), and were apparently 
growing normally 96 h after tetracycline addition (data not shown). Other clones 
analysed showed the same results (data not shown), and it is possible that this 
represents selection for revertants in which RNAi knockdown is no longer 
effective. This however, was not confirmed by western blot detection of protein 
levels at such time points. Nevertheless, during the period of growth impairment 
(24 h and 48 h time points) a reduction in more than 90% in the number of EdU 
positive cells (Figure 4.6, C) was observed, suggesting a strong impairment of 
DNA replication. In addition, abnormal cells (“others”) accumulated during this 
period, constituting more than 60% of the population at 24 h post-induction, and 
~90% of the population at 48 h, with a severe reduction in 1N1K and 2N2K cells, 
and a mild reduction in 1N2K cells (Figure 4.6, B). These aberrant cells shared 
the same, mixed nucleus and kinetoplast ratios as seen following TbORC1/CDC6 
RNAi (data not shown). Taken together, these data show that, like in PCF cells, 
the effects of TbORC1B silencing were more severe than the ones observed with 
TbORC1/CDC6 downregulation, appearing to show the same phenotypes earlier 
after RNAi induction (24 h versus 48 h). Overall, these results confirm that 
TbORC1B, like in PCF cells, has a role in DNA replication in BSF cells, and its loss 
affects this process more rapidly than the loss of TbORC1/CDC6, perhaps 
supporting the hypothesis of TbORC1B as a regulatory factor, suggested in 
Chapter 3. 
4.2.2.4 RNAi of TbORC4 
In PCF cells, TbORC4 silencing resulted in an identical phenotype to that seen 
after TbORC1/CDC6 downregulation, suggesting that the two factors act in the 
same biological context, potentially in a complex (Chapter 3). Previous results in 
BSF cells suggested the same overlapping response (Tiengwe et al., 2012b). 
Surprisingly, this phenocopying was not observed here (Figure 4.6, D). No clear 
effects on growth, cell cycle or EdU incorporation were observed 24 h post-
induction of TbORC4 RNAi (Figure 4.6, D-F). Nevertheless, a small growth defect 
was noticeable at 48 h post-induction, in parallel with a reduction in ~35% of 
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EdU positive cells and an increase in the number of abnormal cells (“others”) in 
the population (to ~40% of the population), with concomitant reduction in the 
number of 1N1K cells (Figure 4.6, D-F). Unfortunately, it was not possible to 
endogenously tag TbORC4 in order to monitor protein levels. Instead, RT-qPCR 
was performed, suggesting only a small reduction in ~20% relative TbORC4 mRNA 
levels at 24 h after RNAi-induction. It is possible that such a small reduction 
indicates inefficient degradation of TbORC4 mRNA after RNAi-induction, and 
might explain the differences in phenotype relative to TbORC1/CDC6. However, 
it is worth noting that this is a similar level of TbORC4 mRNA loss observed in the 
PCF TbORC4 RNAi cells, which resulted in a severe phenotype (Chapter 3). This 
experiment was only conducted once, and therefore requires repeating (and 
perhaps analysis of other clones), but the results suggest a role for TbORC4 in 
DNA replication in BSF cells, though at present, it is not clear how comparable 
this function is to that of TbORC1/CDC6. 
 
Figure 4.6. Effect of TbORC1B and TbORC4 expression silencing by RNAi.  
A) to C) TbORC1B RNAi cell line, and D) to F) TbORC4 RNAi cell line. A) and D) shows growth 
curves comparing cultures containing tetracycline (Tet +) or not (Tet -). Cell concentration was 
assessed every 24 h, and plotted as Log10 values (y-axis). In A), the individual points represent the 
A) D) 
B) E) 
C) F) 
Chapter 4  273 
 
 
mean concentration calculated from two independent experiments (n = 2), while the error bars 
depict the SEM. In D) the results refer to a single experiment, thus no error bars are represented. 
In A) (insert box), TbORC1B
12myc
 samples at 24 h post-induction are shown by a western blot of 
cell extracts probed with anti-myc antiserum. The transcription elongation factor Ef1α (α-Ef1α) was 
used as a loading control. In D), TbORC4 relative mRNA levels assessed by RT-qPCR are shown 
within the insert box. The results refer to the relative amount of mRNA levels in the Tet + sample to 
the non-induced sample (Tet -), calculated using the ΔΔCt method. Results refer to a single 
experiment (n = 1) using three technical replicates (the mean is represented), and therefore no 
error bars are shown. B) and E) show the quantification of cells in the different cell cycle stages at 
24 h and 48 h after RNAi induction, based on the nuclear (N) and kinetoplast (K) configuration of 
individual cells stained with DAPI. A minimum of 125 cells was counted per time point and 
experimental group (Tet - and Tet +), and percentages of each stage (1N1K, 1N2K, 2N2K, and 
“others”) were calculated relative to the total amount of analysed cells. In B), the graph represents 
the mean of each cellular population obtained in two independent experiments (n = 2), while the 
error bars refer to the SEM. In E) results refer to a single experiment so error bars are not shown. 
C) and F) show the percentage of EdU positive cells in the Tet + sample relative to the percentage 
of EdU positive cells in the Tet - culture from the respective time point. A minimum of 125 cells 
were analysed per time point and group (Tet - and Tet +). In C) the mean from two independent 
experiments (n = 2) is shown, with error bars representing the SEM. F) Shows the results of a 
single experiment and therefore no error bars are shown.  
 
4.2.2.5 RNAi of Tb7980  
In a previous study (Tiengwe et al., 2012b), downregulation of Tb7980 in BSF 
cells resulted in a strikingly similar phenotype to the one detected for 
TbORC1/CDC6 silencing, but it was not confirmed to be a result of impaired DNA 
replication. Unfortunately, none of the RNAi clones obtained here for this gene 
(one representative is shown) showed any growth phenotype (Figure 4.7, A), or 
evidence for reduction in protein levels after RNAi induction (Figure 4.7, A, 
insert box). No differences in cell cycle or EdU incorporation were observed at 
the 24 h and 48 h time points (Figure 4.7, B-C), although the cell line had, 
intrinsically, a considerable number of abnormal cells (Figure 4.7, B, “others”). 
It appears unlikely that effective RNAi against Tb7980 occurred, precluding 
discussion of its function in the BSF. It will be therefore, necessary to generate 
new cell lines and test more clones for an efficient reduction in Tb7980 protein 
levels in order to take elations on Tb7980’s role in DNA replication.  
4.2.2.6 RNAi of Tb3120 
The effects of Tb3120 silencing have never been investigated in BSF cells, while 
in PCF cells, the effects were only noticeable at later time points than those 
observed for TbORC1/CDC6, TbORC4 or TbORC1B downregulation (Chapter 3). 
Although protein levels appeared to decrease 48 h after RNAi induction (Figure 
4.7, D, box insert), no growth, cell cycle or EdU incorporation effects were 
detected at that time point (Figure 4.7, D-F). Like in PCF cells, it is possible that 
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any effects of Tb3120 RNAi induction will only emerge after a certain number of 
generations, and it may then be important to repeat the experiment for a longer 
period of time. Presently, however, nothing can be inferred about Tb3120’s role 
in DNA replication in BSF cells.  
 
Figure 4.7. Effect of Tb7980 and Tb3120 expression silencing by RNAi.  
A) to C) Tb7980 RNAi cell line, and D) to F) Tb3120 RNAi cell line. A) and C) show the growth 
curves comparing cultures containing tetracycline (Tet +) or not (Tet -). Cell concentration was 
assessed every 24 h, and plotted as Log10 values (y-axis). The results refer to a single experiment, 
thus no error bars are shown. In A) and D) (insert boxes), Tb7980
12myc
 and Tb3120
12myc
 
(respectively) protein levels in the Tet - and Tet + samples at 24 h and 48 h post-induction are 
shown by a western blot of cell extracts probed with anti-myc antiserum. The transcription 
elongation factor Ef1α (α-Ef1α) was used as a loading control. B) and E) show the quantification of 
cells in the different cell cycle stages at 24 h and 48 h after RNAi induction, based on the nuclear 
(N) and kinetoplast (K) configuration of individual cells stained with DAPI. A minimum of 125 cells 
was counted per time point and experimental group (Tet - and Tet +), and percentages of each 
stage (1N1K, 1N2K, 2N2K, and “others”) were calculated relative to the total amount of analysed 
cells. The results refer to a single experiment, so error bars are not shown. C) and F) show the 
percentage of EdU positive cells in the Tet + sample relative to the percentage of EdU positive 
cells in the Tet - culture from the respective time point. A minimum of 125 cells were analysed per 
time point and group (Tet - and Tet +). Both represent the results of a single experiment and 
therefore no error bars are shown.  
 
A) D) 
B) E) 
C) F) 
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Together, the results of these RNAi studies confirm roles for TbORC1/CDC6 and 
TbORC1B, and to some extent, TbORC4 as well, in DNA replication in BSF cells, 
while no conclusions could be drawn about Tb7980 or Tb3120 function in this life 
cycle stage of the parasite. Complementing these experiments with DNA content 
analysis by flow cytometry would be valuable, as well as generating a cell line 
targeting Tb1120 in order to test the function of this factor in BSF cells. 
 
4.3 Generation of TbORC1/CDC6, TbORC1B, TbORC4, 
Tb7980, Tb3120 and Tb1120 in situ – tagged cell lines 
In Chapter 3, the subcellular localisation of TbORC1/CDC6, TbORC1B, TbORC4, 
Tb7980, Tb3120 and Tb1120 was investigated in PCF cells after tagging each 
factor endogenously with 12myc. With the exception of TbORC1B, this revealed 
that all these factors localise to the nucleus of the cell throughout the cell 
cycle, while TbORC1B expression and localisation appeared to be cell cycle 
dependent. To date, no information is available on these factors’ localisation 
and dynamics in BSF cells. As shown in Chapter 3 and in the previous section, 
some of the phenotypes resulting from TbORC1/CDC6 expression silencing are 
different in PCF and BSF cells. Thus, although it might be predicted that these 
factors would display the same subcellular behaviour in both PCF and BSF cells, 
in the case that each of these acts as a core component of the replication 
initiation process, it was considered that analysis of the proteins subcellular 
localisation and dynamics in BSF cells could be informative. 
4.3.1 Cloning the constructs for endogenous tagging with 12myc  
The constructs described in Chapter 3, section 3.4.1, formed the basis for the 
experiments below. These plasmids were designed and constructed using the 
DNA sequences and gDNA from T. brucei cells of strain TREU 927, the strain in 
which the PCF localisation studies described in Chapter 3 were conducted. The 
cells used for protein localisation in the BSF stage of the parasite were, 
however, strain Lister 427. Alignments of the gene sequences available on 
TriTrypDB for TREU 927 and Lister 427 revealed that, while TbORC1/CDC6 and 
TbORC1B were identical in the two strains, all other gene sequences possessed 
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minor nucleotide differences that resulted in amino acid changes. Some of these 
were in the 3’ region of the gene ORFs cloned into the pNATx12M plasmid vector 
(alignments of the 3’ regions cloned into the vector are shown in appendices 
section 7.4.1). For this reason, the constructs for the endogenous tagging of 
TbORC4, Tb3120 and Tb1120, with 12myc at the C-terminus, and Tb7980, with 
12myc at the N-terminus, were re-made using Lister 427 gDNA, as detailed in 
Chapter 3, section 3.4.1. The resulting plasmids maps are in all identical to the 
ones shown in Chapter 3, section 3.4.1, and therefore are not shown here. The 
new constructs were confirmed by enzymatic digestion (shown in the 
appendices, Figure 7.33), as well as sequencing, as detailed in Chapter 3, 
section 3.4.1, and described in the materials and methods Chapter 2, sections 
2.2.1.9. 
4.3.2 Generation of the 12myc endogenously tagged 
TbORC1/CDC6, TbORC1B, TbORC4, Tb7980, Tb3120 and 
Tb1120 cell lines, and confirmation by PCR and western blot 
As explained in Chapter 3, it is important, whenever possible, to ask if the 
tagged version of a protein is functional. One way to address this relies on 
deleting the non-tagged allele, thus ensuring that only the tagged protein is 
expressed in the cell and allowing checking for relevant phenotypes. As 
described in Chapter 3, constructs were generated to delete one of the alleles of 
each factor’s gene by replacing it with an antibiotic resistance marker gene 
(Chapter 3, section 3.4.3). To attempt this in the BSF cells, one of the two 
alleles was first deleted, prior to the endogenous tagging of the remaining 
allele. For this, BSF Lister 427 cells (here referred to as 427 wt), were 
transfected with the KO constructs TbORC1/CDC6-KO-PURO, TbORC1B-KO-NEO, 
TbORC4-KO-NEO, Tb7980-KO-NEO, Tb3120-KO-NEO and Tb1120-KO-NEO (maps 
shown in Chapter 3, Figure 3.16), as described in the materials and methods 
Chapter 2, section 2.3.5. One of the gene alleles was successfully deleted for 
TbORC1/CDC6, Tb7980, Tb3120 and Tb1120, as confirmed by PCR (detailed in 
the materials and methods Chapter 2, section 2.2.2): in each of these cell lines, 
here referred to as TbORC1/CDC6 -/+, Tb7980 -/+, Tb3120 -/+, and Tb1120 -/+, 
the KO construct integrated into the right locus (Figure 4.8, row 4, KO PCR), and 
the remaining wild type allele was still detectable (Figure 4.8, row 2, Wt allele 
PCR). To date, although attempted multiple times, it was not possible to disrupt 
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one of the alleles of either TbORC1B and TbORC4, and it is not clear whether the 
parasite requires the presence of the two copies of each gene for survival. The 
TbORC1/CDC6 -/+, Tb7980 -/+, Tb3120 -/+, and Tb1120 -/+ cell lines were 
further transfected with the respective 12myc-tag constructs, whose integration 
was confirmed by PCR (Figure 4.8), as described previously in Chapter 3 (Figure 
4.8, row 3, myc PCR). These cell lines, named TbORC1/CDC6 -/12myc, Tb7980 -
/12myc, Tb3120 -/12myc and Tb1120 -/12myc, were also confirmed to not 
possess a copy of the wild type allele (Figure 4.8, row 2, Wt allele PCR), and to 
have retained the deleted allele (Figure 4.8, row 4, KO PCR). Parental 427 wt 
cells were transfected with the 12myc-tag constructs for the endogenous tagging 
of TbORC1B and TbORC4. The resulting cell lines, TbORC1B 12myc and TbORC4 
12myc, were then confirmed by PCR (Figure 4.8, row 3, myc PCR), and shown to 
still possess the wild type allele (Figure 4.8, row 2, Wt allele PCR). Like for the 
PCF cell lines (Chapter 3), the expression of each 12myc-tagged protein was 
confirmed by western blot, as described in the materials and methods Chapter 
2, section 2.2.5.3. All cell lines were confirmed to express a 12myc-tagged 
protein of the expected size, as shown in Figure 4.9, and were therefore used 
for further analysis. 
 
Figure 4.8. Confirmation of construct integration by PCR.  
Panels 2-4 show the products resulting from PCR reactions using different pairs of primers 
designed specifically to assess the presence of the wild type allele (row 2), to confirm integration of 
the C- or N-terminal endogenous tagging constructs (12myc, row 3), and successful allele deletion 
(KO, row 4). Panels in row 1 show a PCR-amplification from TbMCM10, an unrelated gene, as a 
control for the presence of gDNA. In all PCR reactions, the parental wild type cell line, 427 wt 
(represented as Wt), was used both as a negative (12myc PCR and KO PCR) or positive control 
(Wt allele PCR). The heterozygote TbORC1/CDC6 -/+, Tb7980 -/+, Tb3120 -/+, and Tb1120 -/+ cell 
lines, generated prior to 12myc tagging, provide an extra negative control of the 12myc PCR, and a 
positive control of the KO PCR. In each case, the 1 Kb plus DNA ladder (Invitrogen™) is shown as 
a size reference, and the expected PCR product sizes, resulting from the different PCR reactions, 
are shown below each gel image. Note that in some cases the same gel image has been cropped 
so to display the results from the same PCR reaction, and are separated by a white space.  
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Figure 4.9. Confirmation of the expression of 12myc tagged proteins in BSF cells.  
Total protein extracts from 427 wt, TbORC1/CDC6 -/12myc, Tb7980 -/12myc, Tb320 -/12myc, 
TbORC1B 12myc, Tb1120 -/12myc and TbORC4 12myc cell lines were separated by SDS PAGE 
and analysed by western blot. The 12myc-tagged proteins were detected with an anti-myc 
(represented as α-myc) antiserum. Only the cell lines used for further experiments are represented. 
The Novex® Sharp Protein Standard is shown as a size reference.  
 
4.4 Cellular localisation and cell cycle dynamics of 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7890, 
Tb312012myc, Tb112012myc and TbORC1B12myc in 
bloodstream form cells 
4.4.1 Cell lines 
In order to investigate whether the endogenously 12myc-tagged cells, generated 
as described in the previous sections, behaved comparably to the parental cell 
line, 427 wt, all cells were set up in culture at a concentration of 1 x 104 
cells.ml-1, and their cell density monitored every 24 h for a total period of 72 h. 
Like what was observed for the endogenously tagged PCF cells (Chapter 3, 
section 3.5.1), no growth defects were observed for any of the BSF cells, each of 
which grew in culture at a rate indistinguishable from the untagged 427 wt 
(Figure 4.10). Growth curve analysis was not performed for the TbORC4 12myc 
cell line, but routine maintenance in cell culture did not suggest any defects 
(not shown). In contrast to the PCF cells (shown in Chapter 3, section 3.5.1), no 
cell cycle or DNA replication analyses were performed, but from their normal 
growth rate, it has been assumed that these 12myc-tagged cell lines behave 
similarly to the wild type parental cell line, 427 wt, and therefore, that at least 
TbORC1/CDC612myc, 12mycTb7980, Tb312012myc and Tb112012myc versions of the 
proteins are functional. As shown in section 4.2.2.3, depletion of TbORC1B by 
RNAi results in a severe phenotype, possibly suggesting that if the 12myc-tagged 
version of the protein were not functional, a defect in growth would be 
observed, which is not the case. 
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Figure 4.10. Analysis of the growth of endogenously 12myc tagged cells in culture.  
The different cell lines were transferred to a new culture flask with fresh HMI-9 culture medium, 
without drugs, at a starting concentration of 1 x 10
4
 cells.ml
-1
. Cell density was assessed every 24 
h, and plotted as Log10 values (y-axis). The individual points on the graph represent the mean of 
three independent experiments (n = 3), with the error bars representing the standard error of the 
mean. 
 
4.4.2 Subcellular localisation and cell cycle dynamics of 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc, 
Tb112012 myc, and TbORC1B12myc 
TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and Tb112012myc were 
detected by immunofluorescence assay (IFA) as described in detail in Chapter 3, 
section 3.5.2, with slight changes to the overall protocol as a consequence of 
the morphological differences between the PCF and BSF cells (detailed in the 
materials and methods Chapter 2, section 2.5.4). All images shown below were 
acquired with a DeltaVision imaging system. 
As for PCF cells, the anti-myc monoclonal antibody conjugated with AlexaFluor® 
488 used in these assays appears to be specific to the 12myc tagged proteins, as 
IFA of non-tagged 427 wt cells resulted in no discernible signal (Figure 4.11, A). 
Nevertheless, it appears that in BSF cells there is a greater background signal 
than the one that was detected in PCF cells. Immunofluorescence of 
TbORC1/CDC6 -/12myc cells showed that TbORC1/CDC612myc localised to the 
nucleus of the cells, as a punctate signal, throughout the cell cycle (Figure 4.11, 
B). The same pattern of localisation was also observed for TbORC412myc (Figure 
4.12), 12mycTb7980 (Figure 4.13), Tb312012myc (Figure 4.14) and Tb112012myc 
(Figure 4.15) when analysing TbORC4 12myc, Tb7980 -/12myc, Tb3120 -/12myc 
and Tb1120 -/12myc cell lines, respectively. Moreover, quantification of the 
cells displaying nuclear staining showed that TbORC1/CDC612myc, TbORC412myc, 
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12mycTb7980, Tb312012myc and Tb112012myc were found in the nucleus of ~100% of 
cells (Figure 4.17, A). Thus, each of the above factors displayed constitutive 
nuclear localisation throughout the cell cycle – the same pattern of localisation 
that was seen in PCF cells (Chapter 3, section 3.5).  
 
 
Figure 4.11. Immunofluorescence of TbORC1/CDC6
12myc
.  
A) Panels within the box show the staining of 427 wt cells with DAPI (top panel), AlexaFluor® 488-
conjugated anti-myc antibody (middle panel), and the cell outline by DIC. B) Panels show the 
staining of TbORC1/CDC6 -/12myc cells with DAPI (top row panels), allowing their classification in 
1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells (post-mitosis). 
Panels in the middle row show TbORC1/CDC6
12myc
, recognised by the anti-myc antiserum. Lower 
panel row shows the cell outline by DIC. Images were acquired using a DeltaVision imaging 
system, and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar 
represents 5 μm. 
 
A) B) 
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Figure 4.12. Immunofluorescence of TbORC4
12myc
.  
Panels show the staining of TbORC4 12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells 
(post-mitosis). Panels in the middle row show TbORC4
12myc
, recognised by the anti-myc antiserum. 
Lower panel row shows the cell outline by DIC. Images were acquired using a DeltaVision imaging 
system, and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar 
represents 5 μm. 
 
 
Figure 4.13. Immunofluorescence of Tb7980
12myc
.  
Panels show the staining of Tb7980 -/12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells 
(post-mitosis). Panels in the middle row show Tb7980
12myc
, recognised by the anti-myc antiserum. 
Lower panel row shows the cells outline by DIC. Images were acquired using a DeltaVision 
imaging system, and deconvolved using the ratio conservative method, on SoftWoRx software. 
Scale bar represents 5 μm. 
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Figure 4.14. Immunofluorescence of Tb3120
12myc
.  
Panels show the staining of Tb3120 -/12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells 
(post-mitosis). Panels in the middle row show Tb3120
12myc
, recognised by the anti-myc antiserum. 
Lower panel row shows the cell outline by DIC. Images were acquired using a DeltaVision imaging 
system, and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar 
represents 5 μm. 
 
 
Figure 4.15. Immunofluorescence of Tb1120
12myc
.  
Panels show the staining of Tb1120 -/12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells 
(post-mitosis). Panels in the middle row show Tb1120
12myc
, recognised by the anti-myc antiserum. 
Lower panel row shows the cell outline by DIC. Images were acquired using a DeltaVision imaging 
system, and deconvolved using the ratio conservative method, on SoftWoRx software. Scale bar 
represents 5 μm. 
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In contrast, and again similar to the observations made in PCF cells (Chapter 3, 
section 3.5.6), TbORC1B12myc localised to the nucleus of only ~45% of cells 
(Figure 4.17, A). Within the population that showed TbORC1B12myc signal, 18% 
were 1N1K cells, 68% 1N1eK, and ~13% were 1N2K cells (Figure 4.17, B), which 
corresponded with ~21% of the total 1N1K cells, 88% of 1N1eK cells and ~45% of 
1N2K cells (Figure 4.17, C). TbORC1B12myc signal was detected in only one 
putative 2N2K cell out of 38 2N2K cells examined from two independent 
experiments (total of 481 analysed cells). These results show a pronounced 
similarity with those obtained for PCF TbORC1B 12 myc cells, suggesting that 
TbORC1B expression or localisation is cell cycle regulated in both life cycle 
stages. Again, TbORC1B 12myc localised to the nucleus as puncta (Figure 4.16). 
 
 
Figure 4.16. Immunofluorescence of TbORC1B
12myc
.  
Panels show the staining of TbORC1B 12myc cells with DAPI (top row panels), allowing their 
classification in 1N1K cells (G1 phase), 1N1eK cells (S phase), 1N2K (G2 phase), and 2N2K cells 
(post-mitosis). Panels in the middle row show TbORC1B
12myc
, recognised by the anti-myc 
antiserum. Lower panel row shows the cell outline by DIC. Images were acquired using a 
DeltaVision imaging system, and deconvolved using the ratio conservative method, on SoftWoRx 
software. Scale bar represents 5 μm.  
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Figure 4.17. Analysis of the percentage of cells containing nuclear myc signal.  
A) Representation of the percentage of cells, per cell line, containing signal for the respective 
12myc-tagged protein in the nucleus. The mean of two independent experiments is shown (n = 2), 
with the error bars representing the standard error of the mean (SEM). In each experiment, at least 
125 cells were counted per cell line. Percentage is calculated to the total number of cells counted 
per cell line in the two experiments. B) Quantification of the proportion of cells containing 
TbORC1B
12myc
 nuclear signal. Only approximately 45% of the cells showed TbORC1B
12myc
 signal in 
the nucleus as shown in A), and here separated (inside the insert box) into the different cell types 
(dark blue, 1N1K cells; light blue, 1N1eK cells; yellow, 1N2K cells; pink, 2N2K cells). The main 
graph represents the total of cells (45% of the total cell population) with TbORC1B
12myc
 nuclear 
signal, with the percentage of each different cell type individually represented; the mean of two 
independent experiments (n = 2) is represented, and the error bars correspond to the SEM. C) 
percentage of TbORC1B
12myc
-positive cells, per cell type; the mean of two independent 
experiments is represented (n = 2), and the error bars depict the SEM. 
 
 
B) C) 
A) 
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4.5 Origins of DNA replication in T. brucei bloodstream 
form cells 
In characterised eukaryotes, by the end of G1 phase, in order to ensure 
complete genome replication within a cell cycle, cells must have licensed all 
potential origins of replication in the genome by binding the pre-replication 
complex (pre-RC). However, only a subset of these sites will eventually be 
activated during S phase, in an apparent stochastic manner (reviewed in Masai et 
al., 2010; Mechali, 2010; Leonard and Mechali, 2013; McIntosh and Blow, 2012; 
Costa et al., 2013). Depending on whether the pre-RC sites are activated or not, 
and in which circumstances, replication origins have been categorised into three 
types: constitutive – origins that are always used in every cell cycle or cell type; 
flexible – potential origins that can be used stochastically in different cells and 
in different conditions; and dormant – potential origins that in normal growth 
conditions are not used during the cell cycle, but can be activated in specific 
cellular programmes (e.g. during development or differentiation) or in 
conditions of stress (reviewed in Mechali, 2010). Once cells enter S phase, no 
more origins can be licensed in order to prevent re-replication of the genome 
(reviewed in Costa et al., 2013; Masai et al., 2010). Therefore, the excess of 
licenced origins in G1 phase provides the cell with a flexible choice of origins 
that can be used in the event of replicative stress, obstacles encountered by the 
replication machinery, poor growth conditions, environmental cues, as well as 
changes in the chromatin context or transcription program of the cell that might 
occur upon cellular differentiation (reviewed in Mechali, 2010; Leonard and 
Mechali, 2013; McIntosh and Blow, 2012). Indeed, it appears that there is a 
relationship between transcription and DNA replication, with early replicating 
regions being associated with actively transcribed genes, frequently at the 
promoter regions, and late replicating origins being associated with non- or 
poorly transcribed regions of the genome (reviewed in Mechali, 2010; Leonard 
and Mechali, 2013; McIntosh and Blow, 2012). This association may be because 
transcription influences chromatin structure at these sites, for instance, by 
increasing the accessibility of the chromatin, and indeed some histone 
modifications are associated with gene expression and origins of replication. 
However, transcription may also interfere with DNA replication, and thus cross 
talk between the two molecular machineries is most likely essential for the 
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maintenance of genome stability and cell identity during development and 
cellular differentiation (reviewed in Mechali, 2010; Helmrich et al., 2013). 
Nevertheless, though there is flexibility in the choice of activated origins among 
pre-RC sites in a specific cell type or tissue, origin location and firing timing are 
reproducibly found at the same sites in a cellular population. For instance, if a 
different subset of origins is activated in a cell cycle, e.g. due to replication 
stress or cellular differentiation, this subset will be used in the next cell cycle, 
and thus forming the innate origin profile of the different cell types (reviewed in 
Mechali, 2010; Masai et al., 2010; Leonard and Mechali, 2013; Jackson et al., 
2012). Therefore, at least in multicellular organisms, the origins of replication 
activated per cell cycle may differ between cell types, perhaps reflecting 
differences in the transcription programs, nuclear organisation or chromatin 
structure, and epigenetic characteristics of the differently differentiated cells 
(reviewed in Rhind and Gilbert, 2013; Jackson et al., 2012; Mechali, 2010). 
Indeed, it was shown that the timing programme of origin activation is highly 
stable and conserved between several cell lines of a single cell type, but differ 
between cell types, to the point that the replication timing profiles can be used 
for the identification of the different cell types (Ryba et al., 2010). 
Recently, both TbORC1/CDC6-binding sites and active origins of replication have 
been mapped in T. brucei PCF cells (Tiengwe et al., 2012a). This genome-wide 
analysis revealed that, like in other eukaryotes, the amount of initiator 
(TbORC1/CDC6) binding sites, assumed to be potential origins, outnumbered the 
detectable active origins. TbORC1/CDC6-binding sites localised with high density 
to the subtelomeric, VSG-rich regions of each chromosome, where no origins 
were mapped. In the chromosome cores, TbORC1/CDC6 was more dispersed and 
localised virtually exclusively to the boundaries of the polycistronic transcription 
units, at the strand-switch regions (SSRs) (Tiengwe et al., 2012a). Of the sites 
detected in the chromosome core, around 92% of TbORC1/CDC6-binding sites 
localised to transcription start sites, which had been previously inferred by 
localisation of histone H4 acetylated at lysine 10 (H4K10ac) (Siegel et al., 2009), 
while the remaining localised to transcription termination sites. This, perhaps 
even more than in other eukaryotes, suggested that there is a pronounced 
association between DNA replication and transcription (Tiengwe et al., 2012a), 
possibly functional, since RNAi of TbORC1/CDC6 altered mRNA abundance at 
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many of the mapped binding sites. Active origins were mapped by marker 
frequency analysis (MFA, detailed in the next section) coupled with next 
generation sequencing (MFA-seq) using cells in early-mid S phase and G2 phase 
(Tiengwe et al., 2012a). This analysis identified 42 well-spaced, broad peaks of 
varying height, representing one origin per approximately 600 Kbp, all within the 
chromosomes cores and localising to TbORC1/CDC6-binding sites at the SSRs 
(Tiengwe et al., 2012a). The different heights of the active origins suggested an 
activation timing programme of replication origins in T. brucei, with higher and 
lower peaks denoting early and late firing origins, respectively. Indeed, the MFA-
seq peaks with highest amplitude, and thus earliest replicating, co-localised with 
mapped centromeres (chromosomes 1 to 8) (Obado et al., 2007), suggesting 
these features are amongst the earliest replicating, as reported in other 
eukaryotes, like fission yeast (Kim et al., 2003). Overall, T. brucei seems to 
possess a very low density of active origins when compared to other eukaryotes, 
with origin number correlating to chromosome size (Tiengwe et al., 2012a). 
In light of the differing pattern of origin usage in different cell types and during 
development in other eukaryotes, it is reasonable to ask if the putative timing 
programme of origin activation seen in PCF T. brucei cells is conserved in BSF 
cells. These distinct life cycle stages of T. brucei display major changes in gene 
expression associated with, for instance, their distinct cell morphology, cell 
surface protein expression, and metabolic activity (as mentioned in the 
introduction to this chapter). Many of these changes may be directed by 
alterations in nuclear architecture and chromatin structure (reviewed in Daniels 
et al., 2010; Schlimme et al., 1993; Rout and Field, 2001), by changes in histone 
modifications (reviewed in Figueiredo et al., 2009; Siegel et al., 2009; Maree 
and Patterton, 2014), and by the presence (BSF cells) or absence (PCF cells) of 
base J (Borst and Sabatini, 2008; van Leeuwen et al., 1997; Reynolds et al., 
2014). Nonetheless, differences in gene expression between BSF and PCF cells 
(Siegel et al., 2010; Jensen et al., 2009; Jensen et al., 2014; Brems et al., 2005; 
Urbaniak et al., 2012; Urbaniak et al., 2013), unlike most of other eukaryotes, 
appear to not be a result of changes in the transcription regulation per se 
(reviewed in Clayton, 2002), but instead, a consequence of differential 
regulation at the post-transcriptional level (Clayton, 2013; Kramer, 2012; Siegel 
et al., 2011), as a consequence of their unusual genome organisation in large 
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polycistronic transcription units (El-Sayed et al., 2005a; El-Sayed et al., 2005b; 
Berriman et al., 2005; Jackson, 2014; Daniels et al., 2010). Moreover, it has 
been recently shown that the DNA replication rate in BSF cells is 15% faster than 
PCF cells (4.4 Kbp/min versus 3.7 Kbp/min, respectively) (Calderano et al., 
2015), and whether this has an effect on, or results from, the origins that are 
activated or their activation timing during the S phase, it is not known.  
In consideration of these differences between the two life cycle stages, and in 
order to investigate origin flexibility in T. brucei, the origins of replication in 
BSF cells were mapped and compared against the ones in PCF cells, as detailed 
in the next few sections.  
4.5.1 Mapping origins of DNA replication: the concept 
Origins of replication and TbORC1/CDC6 localisation have to date only been 
mapped in T. brucei PCF cells of strain TREU 927 (Tiengwe et al., 2012a), the 
reference genome strain (Berriman et al., 2005). Here, BSF cells from strain 
Lister 427 were used. In order to avoid potential differences in origin usage 
between the TREU 927 and Lister 427 strains, and allow direct comparison of 
origin usage between the two life cycle stages, replication origins were mapped 
in both PCF and BSF Lister 427 cells. Briefly, both cell types were cultured as 
described in the materials and methods Chapter 2, section 2.3, and collected for 
analysis when at a concentration corresponding to mid-late log phase (~1 x 107 
cells.ml-1 for PCF cells, and ~1 x 106 cells.ml-1 for BSF cells). A total of 1 x 109 
PCF cells and 3 x 108 BSF cells were collected and fixed, respectively, in 70% 
methanol and 1% formaldehyde (Tiengwe et al., 2012a), as described in the 
materials and methods Chapter 2, section 2.7.1 and 2.7.2. The fixed cells were 
then stained with propidium iodide (PI), and sorted into early S, late S and G2/M 
phases by FACS, using a BD FACSAria I™ cell sorter (BD Biosystems), according to 
their DNA content. A schematic representation of the gates used is shown in 
Figure 4.18 A (BSF cells), and B (PCF cells). Each fraction was collected directly 
into lysis solution, and gDNA was purified and sent to Eurofins Genomics 
(Germany), where a DNA library of each sample was prepared with the TruSeq® 
DNA Sample Preparation kit (Illumina), and sequenced using the Illumina HiSeq 
paired-end 100 bp sequencing system (Illumina). For sequencing, the samples 
were multiplexed, with each of the early S, late S, and G2 phase libraries, both 
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from BSF and PCF, processed in the same run. The resulting data was then 
analysed by MFA using a script similar to the one described in (Tiengwe et al., 
2012a), and adapted by Dr Nicholas J. Dickens (WTCMPn Bioinformatics team 
leader, University of Glasgow). The general process is detailed in the materials 
and methods Chapter 2, section 2.8.1.2, represented in a simplified fashion in 
Figure 4.19, and the script used is shown in the appendices, section 7.8. Briefly, 
the sequence reads from each sample were aligned to the Lister 427 reference 
genome, retrieved from TriTrypDB v8.0. The Lister 427 genome also contains the 
sequences for the telomeric BSF VSG expression sites (BES) (Hertz-Fowler et al., 
2008), absent from the TREU 927 reference genome. For each sample, the 
frequency of reads (coverage) was assessed per base pair (each base pair acts as 
a marker). The genome was then “broken down” in 2.5 Kbp sections (bins) and 
the median of the frequency of reads per bin was assessed, and then used to 
calculate the ratios between the early S phase, or late S phase, versus G2 phase 
data that, ultimately, were used to generate the graphical representations 
shown in Figure 4.20. In this type of analysis, MFA coupled with deep sequencing 
(MFA-seq), a non-replicating sample, either G1 or G2 phases (though G2 phase is 
most commonly used (Muller et al., 2014; Muller and Nieduszynski, 2012), and 
appears to confer more robust results – Dr Nick J. Dickens, personal 
communication), is used for normalisation, since both should have an even read 
coverage across the whole genome, thus excluding ‘noise’ in, for instance, 
regions of the genome where there is poor coverage (e.g. with high CG content). 
The same approach has been used in yeast (Muller et al., 2014; Muller and 
Nieduszynski, 2012), where it is termed Sort-seq, and in archaea (Hawkins et al., 
2013), though the strategies for isolating replicating and non-replicating DNA 
vary. In the MFA-seq approach, the median of read depth (within a bin) of the S 
phase sample is compared to the general coverage (genome-wide average 
number of reads) of that sample, and is then compared with the median of reads 
(within the same bin) of the G2 phase sample (also compared to the genome-
wide average number of reads). The S/G2 ratios in each bin, thus derived, are 
then plotted relative to the genome. Across a chromosome, peaks occur in 
regions where S phase reads occur more frequently than in the rest of the 
genome (relative to G2 phase). Because replication occurs bidirectionally, the 
S/G2 ratios increase as they approach an origin – hence why the plots form 
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peaks, where the highest point localises the origin. In contrast, “valleys” 
represent broad zones of termination, where two opposite replication forks 
converge (de Moura et al., 2010; Muller et al., 2014). 
 
Figure 4.18. Sorting of asynchronous cultures into early S, late S and G2 phases by FACS.  
Histograms depicting the cell cycle profile of a mid-log phase BSF (A) and PCF (B) cell cultures, 
reflecting the fluorescent signal emitted by the staining of DNA with PI. Different rectangles 
represent the gates defined to purify the different cell cycle populations. 
 
 
Figure 4.19. MFA-seq workflow.  
Simplified schematic representation of the workflow followed to obtain the MFA-seq graphs. Details 
are in the main text and materials and methods, while the coding script is shown in the appendices.  
A) B) 
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4.5.2 Mapping the origins of DNA replication in T. brucei BSF cells 
MFA-seq results for the eleven megabase chromosomes of T. brucei from both 
BSF and PCF cells, comparing early S with G2 phase (BSF cells light red, PCF cells 
light green), as well as late S with G2 phase (BSF cells dark red, PCF cells, dark 
green), are shown in Figure 4.20. It is important to bare in mind that MFA-seq 
analysis allows the identification of origins of replication that are activated at 
the population level – most likely it is able to detect mainly constitutive origins 
and therefore, origins that are activated less frequently at the population level 
(for instance, flexible origins, which may be activated differently from cell to 
cell in the population), might not be detected. Consequently, the analysis and 
conclusions here drawn relate to the detected active origins, and thus does not 
take in consideration potential differences between the two life cycle stages in 
respect to origins that might be activated differently between individual cells. 
The overall MFA-seq pattern of peak location was strikingly similar when 
comparing early S phase BSF and PCF cells, and when comparing late S phase BSF 
and PCF cells (Figure 4.20; chromosome 8 is shown in more detail in Figure 
4.21). These data suggest that origin location within the chromosomes core 
regions is unaltered between the two life cycle stages, thus suggesting that 
following a distinct cellular differentiation programme does not lead to, at least, 
drastic changes in the overall subset of origins that are activated in S phase. 
Late S MFA-seq has not been reported for T. brucei, though it was inferred that 
the number of mapped origins (counted as 42) might be underestimated by the 
early-mid S phase sampling, and that the actual origin number may be at least 
the double of that (Tiengwe et al., 2012a). However, this prediction appears to 
be inaccurate, as the peaks detected in the late S samples were merely wider 
than the early S peaks, and no clear, further peaks were seen; indeed, in several 
locations early S peaks appeared to have merged as replication forks converged 
(Figure 4.20).
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Figure 4.20. Mapping origins of replication in T. brucei BSF and PCF cells.  
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Each set of four graphs (data represented in light red, dark red, light green, and dark green dots) 
shows the distribution of the active origins of replication in each of the megabase chromosomes 
(depicted as Chr1 to Chr11), assessed by MFA-seq, as in (Tiengwe et al., 2012a). At the top of 
each set of graphs a track represents the genes in the chromosome: in blue the open reading 
frames (ORFs) are transcribed from the left to the right, and in red the genes are transcribed from 
right to left. Below, a track is shown depicting histone H4K10ac-enriched sites, as described in 
(Siegel et al., 2009). Dr Nicholas J. Dickens generated both tracks using the R package software 
and data available for the TREU 927 reference genome. Each of the four graphs shows the ratio 
between the coverage (read-depth) between early S phase and G2 phase samples, or late S phase 
and G2 phase samples, where each point (light red, light green, dark red and dark green) 
represents the median S/G2 ratio (y-axis) per 2.5 Kbp section across the chromosome (x-axis). 
Each x-axis gap represents 500 Kbp intervals. The y-axis scale is the same for all graphs, but 
legend is only shown in those on the far left. All graphs are scaled according to chromosome size. 
Light red graph shows the results for the BSF early S sample, while dark red represents the data 
from late S phase. PCF data is shown in light green, early S, and dark green, late S. Full grey lines 
across the four graphs represent the origins identified previously (Tiengwe et al., 2012a), while 
grey dashed lines highlight extra replication origins observed in this study. Individual graphs were 
generated using GraphPad v6.0. 
 
 
Figure 4.21. Chromosome 8 in detail.  
Representation of chromosome 8 in more detail, as shown in Figure 4.20, enlarged. Description as 
in Figure 4.20. 
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The identified origins here coincided with most of the previously mapped origins 
(Tiengwe et al., 2012a) (Figure 4.20, grey lines), with minor exceptions. In 
chromosome 2 (Figure 4.20, Chr2), in both the early S BSF and PCF samples, a 
single peak was observed around 0.325 Mbp, co-localising with the centromere, 
while in (Tiengwe et al., 2012a) two peaks were reported in the same region. 
Only in the late S phase PCF samples shown here is there evidence for two 
peaks, corresponding with the origins predicted by (Tiengwe et al., 2012a). It is 
possible that greater read coverage in the TREU 927 PCF analysis, or differences 
in S phase sampling, as well as data representation, result in slightly decreased 
resolution in the present work. Alternatively, this might represent a difference 
in centromere annotation or structure between the TREU 927 and Lister 427 
genomes. Likewise, two closely located origins were previously predicted in 
chromosomes 1 and 3 (around 0.75 and 1.0 Mbp, respectively) (Tiengwe et al., 
2012a). In the present study, the same two peaks were observed in the PCF early 
S sample, while only a single clearly defined peak was observed in the BSF early 
S sample (Figure 4.20). Analysis of the late S samples appears to suggest that the 
PCF peaks have broadened more than the respective BSF ones, perhaps 
supporting the idea of PCF cells having an extra origin in chromosomes 1 and 3. 
Nevertheless, this may merely suggest that delineation of closely separated 
peaks is dependent on sample collection during the FACS sorting, and further 
analysis will be needed to infer whether there is a real difference between BSF 
and PCF cells in these chromosomes.  
Five origins were observed in the present data, both in the BSF and PCF samples 
(Figure 4.20, grey dashed lines), which were not predicted previously (Tiengwe 
et al., 2012a). All these were “weak” origins, with low peak heights and it is 
therefore possible that they were observed here due to the more compressed 
graphical representation of the data compared to the representation in (Tiengwe 
et al., 2012a), rather than activation of origins in Lister 427 that are not used in 
strain TREU 927. Nonetheless, all these origins were present in the larger 
chromosomes: one in chromosomes 7 and 10, and three in chromosome 11 
(Figure 4.20, grey dashed lines). Though TbORC1/CDC6 and histone H4K10Ac 
binding sites have not been mapped to the Lister 427 reference genome, using 
the mapping made to the TREU 927 genome (Tiengwe et al., 2012a; Siegel et 
al., 2009), it is clear that these five origins localise to both TbORC1/CDC6 and 
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histone H4K10ac enriched sites at the boundaries of the polycistronic 
transcription units (Figure 4.20). This adds weight to the suggestion that these 
are active origins, and conforms with the proposal that origins localise only at 
the boundaries of the transcription units: in chromosomes 7 and 10, the two 
origins localised to divergent strand switch regions (dSSRs), while the same was 
observed for one of the origins in chromosome 11; the remaining two origins 
localised to head-to-tail SSRs (Figure 4.20, grey dashed lines). 
MFA-seq data from (Tiengwe et al., 2012a) clearly showed that peak height 
varied across chromosomes, suggesting an activation timing programme of 
replication origins: peaks with the highest amplitude being origins replicating 
earliest in S phase, and those with smaller amplitude corresponding with origins 
replicating later in S phase. The overall pattern of MFA-seq peak height shown 
here was strikingly similar to the one shown in (Tiengwe et al., 2012a) for each 
chromosome, as exemplified by the highest peaks in each of chromosomes 1-8 
co-localising with the centromere. Moreover, comparison between the BSF and 
PCF MFA-seq data suggests that the replication timing programme is conserved 
between the BSF and PCF life cycle stages, and minor differences in peak height 
between BSF and PCF samples are most likely due to sampling differences during 
the FACS cell sorting of the two cell types. 
Taken as a whole, the above MFA-seq analysis suggests striking rigidity in the 
coordination of nuclear DNA replication in T. brucei. First, the same origin 
locations were detected in Lister 427 PCF T. brucei cells that had been seen 
previously in TREU 927 PCF cells, with the exception of five very weak origins. 
Second, the same origins locations were seen in BSF and PCF cells. Third, the 
timing of origin firing, as assessed by MFA-seq peak height, was roughly the same 
in the two life cycle stages and in the two strains. Finally, all peaks were 
mapped to the core of the chromosomes, with the exception of the strongest 
origin in chromosome 6, which may be subtelomeric. 
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4.5.3 DNA replication at the bloodstream VSG expression sites 
T. brucei BSF cells evade the mammalian host immune response by antigenic 
variation, a process through which the parasite alters (“switches”) the variant 
surface glycoprotein (VSG) that covers the parasite’s surface as a coat (reviewed 
in McCulloch et al., 2014; Glover et al., 2013b), protecting it from the immune 
responses targeting the parasite’s previously expressed VSG. Although the 
parasite possesses a huge repertoire of VSG genes and pseudogenes (Marcello 
and Barry, 2007), only one VSG is expressed at a given time in the cell. In the 
BSF cell, the expressed VSG is found in one of ~15-25 telomeric BSF transcription 
sites known as the bloodstream VSG expression sites (BES) (Hertz-Fowler et al., 
2008). Although their sizes vary, the BES share a similar generic architecture 
(Figure 4.22), with a telomere-distal RNA polymerase I promoter, an array of 
expression site associated genes (ESAGs) and pseudogenes (including VSG 
pseudogenes), a block of 70 bp repeats and, finally, the functional VSG, 
localised close to the telomere repeats (Hertz-Fowler et al., 2008) (reviewed in 
Glover et al., 2013b; McCulloch et al., 2014). Thus all BES, including the singular 
one from which the VSG coat is expressed, are located adjacent to the 
telomeres of the megabase and intermediate chromosomes. Unlike most of the 
genome, which is transcribed by RNA polymerase (RNA Pol) II, the active BES is 
transcribed by RNA Pol I (Gunzl et al., 2003; Gunzl et al., 2014), which is 
recruited to the BES promoter, and localises in a discrete region of the nucleus 
known as the expression site body (Chaves et al., 1998; Navarro and Gull, 2001). 
In contrast, inactive BES localise to the nuclear peripheral heterochromatin 
(reviewed in Glover et al., 2013b). Although it is present throughout the cell 
cycle in BSF cells, the expression site body has never been observed in PCF cells 
(reviewed in Glover et al., 2013b), being apparently lost during differentiation, 
with the active BES relocating to the nuclear periphery of the cells (Landeira and 
Navarro, 2007). Like the VSG in BSF cells, procyclins, the surface antigens of PCF 
cells, are transcribed by RNA Pol I from a promoter at two procyclin loci, which 
also localise to a specific region of the nucleus: the nucleolar periphery 
(Landeira and Navarro, 2007). The tightly regulated expression of these life 
cycle specific genes by RNA Pol I most likely allows the high expression of the 
resultant cell surface proteins (reviewed in Maree and Patterton, 2014; 
McCulloch et al., 2014; Gunzl et al., 2014). Generally, present data suggests 
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that chromatin status (for instance, histone modifications and variants) 
(Narayanan and Rudenko, 2013; Kramer, 2012; Rudenko, 2010) and physical 
localisation of the BES play an important role in maintaining all BES as silent in 
PCF cells (Pandya et al., 2013), as well as allowing the expression of only one 
BES at a time (active BES) in BSF cells, in addition to regulating the molecular 
mechanisms (not discussed here) that drive antigenic variation (reviewed in 
Glover et al., 2013b).  
The BES repertoire of T. brucei Lister 427 has been sequenced after directed 
cloning, and appears to be composed of 14 distinct BES (Figure 4.22) (Hertz-
Fowler et al., 2008; Becker et al., 2004). The sequences of the clones used to 
identify the individual BES have been annotated as contigs in the available Lister 
427 reference genome, and although these have not been allocated to specific 
chromosomes, it is known that a subset is present in intermediate chromosomes 
(BES 2, 4, 10, 11, 13, and 17), while the rest are located in the telomeres of the 
megabase chromosomes, with BES 1 localising to the right-hand side telomere of 
chromosome 6a (Hertz-Fowler et al., 2008; Glover and Horn, 2014). BES 
sequences are not available for the TREU 927 reference genome, thus analysis of 
their replication was not possible from previous MFA-seq data (Tiengwe et al., 
2012a). Given that a single active BES is highly transcribed at a time in BSF cells, 
but all BES are silenced in PCF cells (reviewed in Glover et al., 2013b; McCulloch 
et al., 2014), we took advantage of the Lister 427 BES sequences and used the 
MFA-seq data to ask about replication dynamics at these loci in the two life 
cycle stages.  
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Figure 4.22. Schematic representation of the BES described in T. brucei strain Lister 427.  
Diagrams representing the different described bloodstream expression sites (BES) identified and 
annotated to the Lister 427 genome. The top diagram represents a model of the generic structure 
of a BES. TAR refers to transformation-associated recombination clones, with the numbers 
referring to the clones sequenced in (Hertz-Fowler et al., 2008). The VSGs present in each BES 
are also highlighted. The figure is shown to facilitate the interpretation of the data shown below in 
Figure 4.23 only. Figure reproduced in full from (Hertz-Fowler et al., 2008), © 2008 Hertz-Fowler et 
al., all rights reserved. 
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The MFA-seq data was processed as described for the compiled genome (previous 
section), and mapped to the 16 available contigs representing the 14 different 
BES (Figure 4.23). Note that there are two sequences for BES 7 (ϕ – TARo 65; ϕϕ – 
TAR 153) and BES 17 (ϕ – TAR 51; ϕϕ – TAR 59), each of which is shown in 
separate (Figure 4.23). In these data, peaks cannot be discerned, as the sizes of 
the BESs are smaller than the distance covered by the replication forks at most 
origins in both early and late S phase. Thus, at the higher resolution used here, 
the MFA-seq mapping is seen as multiple discrete points, corresponding to the 
S/G2 phases ratio in each bin across the BES. For all but one of the BES, there 
are no clear differences between the MFA-seq mapping in the BSF and PCF cells, 
either for early or late S phase (Figure 4.23). Indeed, there was no evidence that 
the BES had been replicated, even in the BSF and PCF late S samples (Figure 
4.23, dark red and dark green, respectively), since there was no consistent 
enrichment in S phase reads relative to G2 (S/G2 ratios were all ~1.0). These 
data suggest that these BES sites, which localise to the telomeres of the 
chromosomes, are replicated very late in S phase, similar to the telomeres in 
other eukaryotes (reviewed in Masai et al., 2010; Rhind and Gilbert, 2013). 
BES 1 appears to be a striking exception to the above trend. In this contig 
(Figure 4.23, within red dashed box), BSF S phase reads (both early and late) 
were markedly enriched relative to G2 (S/G2 ratio >1). In contrast, the MFA-seq 
for BES 1 did not show such enrichment in the PCF cells samples (again in either 
early or late S), with the S/G2 ratios being comparable with the ones in all other 
BES, at ~1.0. This suggests that BES 1, unlike all others, was replicated early in S 
phase in BSF cells. In contrast, there was no evidence for BES1 replication in PCF 
cells, suggesting it may only be replicated in this life cycle stage very late in S 
phase, like the other BES (Figure 4.23). Interestingly, BES 1 differs from all other 
BES because it is the actively transcribed one, encoding VSG 221 in the BSF 
parasites used in this study: strain Lister 427, derived from MITat 1.2 clone 221a 
(the same used in Hertz-Fowler et al., 2008). To verify this, expression of VSG 
221 on the surface of the BSF cells, but not in PCF cells, was confirmed by 
immunofluorescence using anti-VSG 221 antiserum (Figure 4.24, A), as described 
previously (Glover et al., 2013a). In parallel, expression of EP procyclin in the 
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 Transformation-associated recombination (TAR) clones, numbered as in Hertz-Fowler et al., 
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PCF cells, and its absence from the BSF cells surface, was confirmed with anti-
EP procyclin antiserum (Figure 4.24, B), as described before (Richardson et al., 
1988). Both protocols are detailed in the materials and methods Chapter 2, 
sections 2.5.2 and 2.5.5. The observation that the only clear difference in 
replication timing between BSF and PCF cells may lay in the only locus that is 
transcriptionally active in BSF cells and is silenced in PCF cells, reinforces the 
idea that DNA replication and transcription are functionally related in T. brucei 
(Tiengwe et al., 2012a).  
 
Figure 4.23. DNA replication mapping at the bloodstream expression sites (BES).  
The BES sequenced by (Hertz-Fowler et al., 2008) and annotated as contigs to the Lister 427 
genome (available on TriTrypDB), were used to map the MFA-seq data. Each BES is numbered 
according to (Hertz-Fowler et al., 2008), and as shown in Figure 4.22; note that two contigs, 
referring to two independently sequenced TAR clones (shown in Figure 4.22) (Hertz-Fowler et al., 
2008), are duplicates of two BES: BES 7 (ϕ – TAR 65; ϕϕ – TAR 153) and BES 17 (ϕ – TAR 51; ϕϕ 
– TAR 59). Like in Figure 4.20, the ratio between the coverage (read-depth) in early S phase and 
G2 phase samples, or late S phase and G2 phase samples, is plotted, where each point represents 
the median S/G2 ratio (y-axis) per 2.5 Kbp section across the BES (x-axis). The size of each BES 
is shown on each x-axis in 10 Kbp intervals. The y-axis scale is the same for all graphs, but the 
legend is only shown on the ones at the far left. All graphs are scaled according to each BES size, 
in which each x-axis gap represents 10 Kbp intervals. Graphs are represented by order of size. 
BSF early S data is represented as light red, BSF late S as dark red, PCF early S as light green, 
and PCF late S as dark green. The red dashed box highlights BES 1. Individual graphs were 
generated in GraphPad v6.0.  
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Figure 4.24. Anti-VSG 221 and anti-procyclin immunofluorescence.  
A) Immunofluorescence of PCF strain Lister 427 cells (left panels) and BSF strain Lister 427 cells 
(right panels) with anti-VSG 221 antiserum (middle panel, red), for the detection of the expression, 
at the cell surface, of VSG 221 (as described in Glover et al., 2013a). B) Immunofluorescence of 
PCF strain Lister 427 cells (left panels) and BSF strain Lister 427 cells (right panels) with anti-
procyclin antiserum (central panel, green), for the detection of the expression, at the cell surface, of 
EP procyclin (as described in Richardson et al., 1988). In both A) and B), top panels show the cells 
stained with DAPI, while the bottom panel shows the cells outline by DIC. Images were acquired 
with the Axioskop 2 imaging system. Scale bar represents 5 μm. 
 
It is possible that the above result might be an artefact due to the small size of 
the BES sequences, of between 10 Kbp (BES 8) and 58 Kbp (BES1) (Figure 4.22 
and Figure 4.23), with limited numbers of sequence bins mapping within them. 
In addition, mapping may be compromised by the relative sequence similarity 
between BES. In order to test this, mapping simulations are being carried out, by 
analysing read mapping in random sections of the parasite’s genome of similar 
sizes to the various BES. So far, analysis performed by Samantha Campbell (PhD 
student, supervision by Dr Nicholas J. Dickens) suggests that the only other sites 
with the S/G2 ratio pattern seen for BES1 in BSF cells correspond with sections 
localising to origins mapped in the core regions of the chromosomes (data not 
shown). This supports the idea that the BES 1 region is being replicated in BSF 
cells, though it is not clear whether an origin is present in BES 1 or whether this 
region is being passively replicated from an adjacent origin in BSF cells but not 
in PCF cells, and further analysis is needed. In order to subject the BES mapping 
data to further scrutiny, the S/G2 ratio in each mapped bin was compared for 
each BES and in each set of MFA-seq data: BSF early S, BSF late S, PCF early S 
A) B) 
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and PCF late S (Figure 4.25). The median values and distributions were then 
compared between each other using the non-parametric Kruskal-Wallis test (un-
matched), and p-value threshold of 0.05. A non-parametric test was preferred 
because the data distributions failed to pass normality tests (D’Agostino and 
Pearson normality test, Shapiro-Wilk normality test, and the Kolmogorov-
Smirnov normality test). Although the analysis was performed by comparing the 
medians of all groups with one another, statistical significance is only 
represented in Figure 4.25 for the differences between BSF early S and PCF early 
S, and BSF late S and PCF late S, as the aim of this analysis was to assess 
differences between the two life cycle stages and not differences between early 
S and late S phases. These data confirm that BES1 S/G2 ratios in BSF early S 
significantly differ from PCF early S, as do BSF late S and PCF late S samples 
(both with a p-value < 0.0001; Figure 4.25, A). The median values of the 
combined S/G2 ratios also confirmed S-phase enrichment in BSF cells (ratios of 
1.25 and 1.3 in early and late S, respectively), but no such enrichment in PCF 
cells (median G/2 ratios for both S phase samples <1.0). For no other BES was 
the same BSF S/G2 enrichment seen, and indeed in all cases the median S/G2 
ratios for both BSF and PCF cells (both early and late S) were noticeably closer 
to 1.0 than for BES 1 BSF. Some significant differences were observed between 
the BSF and PCF median S/G2 values in five other BES (BES 7ϕ, BES 7ϕϕ, BES 15, 
BES 5 and BES 3), though in all cases with less significance than seen for BES1 
(with the exception of BES15, and here only in the late S phase samples; Figure 
4.25, A and B).  
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Figure 4.25. Median and scatter of MFA-seq S/G2 values in each individual BES.  
The S/G2 values used to generate the graphs in Figure 4.24 were plotted per sample (BSF early S 
– light red, BSF late S – dark red, PCF early S – light green, and PCF late S – dark green), rather 
than by genomic location, for each BES (numbered as before). Horizontal bars (black) represent 
the median of the S/G2 values, and error bars the interquartile range. In order to infer statistical 
significance, the values were analysed with the non-parametric, unmatched, Kruskal-Wallis test. 
Statistical significance is only shown for differences between the BSF and PCF samples. 
Differences between early S and late S samples are not shown. (**) p-value < 0.01; (***) p-value < 
0.001; (****) p-value < 0.0001. A) BES 17ϕϕ, BES 7ϕϕ and BES 15 are shown alongside BES 1, 
because these four BES are of roughly the same size. B) Shows all other BES.  
 
 
 
A) 
B) 
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To ask if locus-specific, stage-specific replication initiation differences are 
limited to the BES, the MFA-seq data around the two loci encoding the surface 
proteins in PCF cells, the procyclins, as well as the procyclin-associated genes 
(PAGs), was also examined. These loci are localised in chromosome 6 (from 
around 200 to 240 Kbp, including the EP procyclin 3 (EP3) and GPEET genes) and 
in chromosome 10 (from about 2505 to 2532 Kbp, including the EP1 and EP2 
genes) (Haenni et al., 2009; Haenni et al., 2006). In both chromosomes, each 
locus is located in the slope of a strong origin peak (Figure 4.26, A). Zooming in 
on these regions did not reveal any clear differences between BSF and PCF cells, 
and analysis of the medians of the S/G2 ratios in the ~40 Kbp around the two 
loci (again comparing BSF early S, BSF late S, PCF early S and PCF late S) did not 
reveal any statistically significant differences (Figure 4.26, B), though visually 
the PCF late S/G2 ratio at the chromosome 10 locus might indicate enrichment, 
perhaps indicative of earlier replication in PCF cells (Figure 4.26, B). The 
expression of procyclin is apparently regulated (Acosta-Serrano et al., 2001; 
Jensen et al., 2009) via transcription attenuation and life cycle stage-dependent 
changes in mRNA stability due to properties of their 3’ UTR sequences 
(Vanhamme et al., 1995; Vassella et al., 2001; Vassella et al., 2000; Urwyler et 
al., 2005). Whether this is comparable with the full activity of a singular BES in 
BSF cells, where one promoter may be more active than all others, is unclear. 
Nevertheless, it seems most likely that the two procyclin loci are passively 
replicated from an origin at a nearby SSR in PCF and BSF cells (Figure 4.26, A, 
and Figure 4.20), rather than facilitating DNA replication through acting as 
origins (Figure 4.23).  
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Figure 4.26. DNA replication at the EP procyclin loci.  
The two EP procyclin loci are shown: chromosome 6 on the left, and chromosome 10 on the right. 
A) Chromosomes 6 and 10, containing the overlapped MFA-seq data from BSF early S, BSF late 
S, PCF early S and PCF late S. The dashed boxes mark the region of the chromosome where 
these loci are localised. Below, a magnified view is shown of these loci, with each x-axis interval 
representing 10 Kbp. B) The S/G2 values within the EP procyclin loci, “zoomed in” in A) were 
plotted per sample (BSF early S – light red, BSF late S – dark red, PCF early S – light green, and 
PCF late S – dark green), rather than by genomic location. Horizontal bars (black) represent the 
median of the values, and error bars the interquartile range. In order to infer statistical significance, 
the values were analysed with the non-parametric, unmatched, Kruskal-Wallis test. No statistically 
significant differences were observed. 
 
4.6 Discussion 
Most of the knowledge on nuclear DNA replication in T. brucei has been obtained 
from studies on the replicative midgut insect stage of the parasite’s life cycle 
(Tiengwe et al., 2012b; Tiengwe et al., 2012a; Godoy et al., 2009; Benmerzouga 
et al., 2013). The few data available from studies in the replicative mammal 
stage of the parasite’s life cycle, the BSF cells, suggest that the effects of 
TbORC1/CDC6 and some of its interacting factors depletion are distinct from the 
A) 
B) 
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ones observed in PCF cells (Benmerzouga et al., 2013; Tiengwe et al., 2012b). 
Although no differences are expected between the insect and the mammal life 
cycle stages, as the replication of nuclear DNA is a fundamental cellular process, 
it is possible that minor differences, perhaps related to non-replication roles, 
might exist between these two distinct life cycle stages of T. brucei, in which 
differences in cell cycle control have been described previously (reviewed in 
Hammarton, 2007; Li, 2012). In this chapter, the roles of TbORC1/CDC6 and 
interacting factors in DNA replication, as well as their cell cycle dynamics, were 
investigated in BSF cells. Moreover, the origins of DNA replication were mapped 
in BSF cells, as reports in other eukaryotes suggest that the cohort of origins 
activated is cell type-dependent, changing according to the cell’s developmental 
differentiation program (reviewed in Mechali, 2010; Masai et al., 2010; Leonard 
and Mechali, 2013; Jackson et al., 2012; Rhind and Gilbert, 2013). Below, these 
results are discussed and compared to the findings obtained in PCF studies 
shown in Chapter 3. 
4.6.1 TbORC1/CDC6, TbORC1B and TbORC4 are involved in 
nuclear DNA replication in BSF cells, while all factors 
localisation and cell cycle dynamics in BSF cells mimic the 
ones observed in PCF cells 
To date, the reports on the effects of TbORC1/CDC6 downregulation by RNAi in 
BSF cells have shown that the resulting phenotype is distinct from the one 
obtained in PCF cells: multi-nucleated and multi-kinetoplast cells are generated, 
in contrast with the clear accumulation of enucleated cells (zoids) in PCF 
TbORC1/CDC6 RNAi-induced cells (Godoy et al., 2009; Tiengwe et al., 2012b; 
Benmerzouga et al., 2013). As already discussed in Chapter 3, PCF cells appear 
to lack the mitosis to cytokinesis cell cycle checkpoint, which allows cell cycle 
progression to cytokinesis in the event of DNA replication or mitosis impairment, 
resulting in the generation of zoid cells (Ploubidou et al., 1999; Hammarton et 
al., 2003). As a result, it has been assumed that it is the lack of this checkpoint 
that results in the generation and accumulation of zoids when silencing of 
TbORC1/CDC6 is induced in PCF cells (Godoy et al., 2009; Tiengwe et al., 2012b; 
Benmerzouga et al., 2013). In BSF cells, however, it has been shown that defects 
in mitosis, induced for example, through the depletion, by RNAi, of the mitotic 
cyclin TbCYC6 (Hammarton et al., 2003), the mitotic CDK TbCRK3 (Tu and Wang, 
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2004), or aurora-like kinase TbAUK1 (Li and Wang, 2006), results in cytokinesis 
inhibition, with a consequent generation and accumulation of cells with an 
enlarged nucleus and multiple kinetoplasts that re-replicate their nuclear DNA 
without nuclear division, suggesting that this life cycle stage of the parasite 
possesses the mitosis to cytokinesis checkpoint (reviewed in Hammarton, 2007; 
Li, 2012).  
Published reports on the effect of TbORC1/CDC6 silencing in BSF cells have not 
been corroborative (Tiengwe et al., 2012b; Benmerzouga et al., 2013). For 
instance, the timing of phenotype appearance and progression was different, 
although both studies reported the appearance and accumulation of the same 
type of cells with multiple nucleus and kinetoplasts. More strikingly, analysis of 
these cells by flow cytometry revealed very different results: while in (Tiengwe 
et al., 2012b) these cells appeared to have the double of the amount of DNA 
than G2/M cells, in (Benmerzouga et al., 2013) this was not observed, with these 
cells apparently arresting in G2/M phase instead. Therefore, these results 
suggest that somehow, the cells are still able to replicate their nuclear DNA in 
the absence of TbORC1/CDC6. Unfortunately, in (Tiengwe et al., 2012b) it was 
not possible to assess the effect of TbORC1/CDC6 RNAi on DNA replication 
levels, but data from (Benmerzouga et al., 2013) confirmed that, like in PCF 
cells, TbORC1/CDC6 RNAi in BSF cells resulted in a decrease of replicating cells. 
It is perhaps worth mentioning that in (Benmerzouga et al., 2013), in order to 
assess the impact of TbORC1/CDC6 on DNA replication, the cells were incubated 
with BrdU, a thymidine analogue (already detailed in Chapter 3), for 24 h before 
analysis. It has been reported in mammalian cells that prolonged exposure to 
thymidine analogues results in cytotoxic effects, induction of DNA damage 
signals and perturbation of cell cycle progression, with an accumulation of cells 
in G2 phase (Zhao et al., 2013; Fujii et al., 2002; Duque and Rakic, 2011). 
Especially in kinetoplastids, assays involving thymidine analogues must be 
interpreted with care, as these parasites possess the hypermodified base J (Borst 
and Sabatini, 2008), which has been shown to be involved in transcription 
termination in Leishmania promastigotes (insect stage) and T. brucei BSF cells 
(van Luenen et al., 2012; Reynolds et al., 2014), and is known to be replaced by 
thymidine analogues during DNA replication. However, it was recently shown 
that incorporation of the thymidine analogue BrdU per se into the genome, and 
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not just the replacement of base J, is toxic for Leishmania cells (Reynolds et al., 
2014), while prolonged, as well as high dose, incubation of T. brucei BSF cells 
with EdU appears to result in a pronounced S phase arrest (Dr Daniel Paape, 
unpublished). It is therefore possible that the extended exposure (24 h) of the 
cells to BrdU in (Benmerzouga et al., 2013) might have resulted in side effects of 
BrdU incorporation into the genome, and thus possibly obfuscates the 
interpretation of the effects of TbORC1/CDC6 depletion. 
In an attempt to clarify the phenotype of TbORC1/CDC6 depletion by RNAi in BSF 
cells, a new cell line was generated and analysed here for cell growth, cell cycle 
effects and DNA replication. RNAi induction resulted in a similar overall 
phenotype to the ones reported (Tiengwe et al., 2012b; Benmerzouga et al., 
2013), and analysis of EdU incorporation, with minimal incubation period, clearly 
showed that the loss of TbORC1/CDC6 impairs DNA replication in BSF cells. 
Nonetheless, the phenotypes here obtained did not mimic either of the ones 
previously reported (Tiengwe et al., 2012b; Benmerzouga et al., 2013). For 
instance, the growth and cell cycle defects observed were slower to arise and 
less severe than reported by (Tiengwe et al., 2012b), although a large amount of 
unclassifiable cells was also detected. It is not clear whether the results here 
presented are more similar to the ones reported by (Benmerzouga et al., 2013), 
as the analyses were represented differently. Nevertheless, both appear to 
detect a growth defect at 24 h post induction, which is aggravated in later time 
points, although cells continued to grow in (Benmerzouga et al., 2013), while 
here the cells started to die. In addition, in (Benmerzouga et al., 2013) no clear 
cell cycle defects were observed from the cell cycle analysis from DAPI-stained 
cells, although some abnormal cells were observed, and flow cytometry analysis 
showed an increase in cells with G2/M phase DNA content (Benmerzouga et al., 
2013). How these observations fit with the observed decrease in DNA replication 
is not explained (Benmerzouga et al., 2013). Unfortunately, in the present study 
it was not possible to perform flow cytometry analysis on the cells’ DNA content, 
and would have been of great value to attempt to unify these three studies.  
In (Tiengwe et al., 2012b), individual silencing of TbORC4 and Tb7980 by RNAi 
resulted in a strikingly similar phenotype to the one described for TbORC1/CDC6 
depletion, but direct evidence for their role in DNA replication was lacking. 
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Silencing of TbORC4 resulted in a mild and delayed growth and cell cycle 
phenotype in the BSF, though ultimately similar to the one obtained for 
TbORC1/CDC6 RNAi. Nevertheless, a considerable reduction of EdU-incorporation 
at 48 h post-induction strongly supports the involvement of TbORC4 in DNA 
replication in BSF cells. Unfortunately, in the present study induction of Tb7980 
silencing by RNAi was not successful. Indeed, it proved impossible to generate 
stem-loop RNAi cells in PCF T. brucei also (Chapter 3). Whether these 
experimental difficulties are related, perhaps indicating considerable 
importance for this factor, and selection against even a small amount of ‘leaky’ 
RNAi, though this is unclear. Therefore, any role for Tb7980 in T. brucei 
replication currently remains limited to its interaction with TbORC1/CDC6 in PCF 
cells (Tiengwe et al., 2012b).  
The effects of Tb3120 depletion have not been investigated in BSF cells before 
(Tiengwe et al., 2012b). Although here a decrease in protein levels was detected 
48 h post RNAi induction, no clear effects were observed on cell growth, the cell 
cycle, or levels of DNA replication. Tb3120 RNAi phenotypes emerged in PCF 
cells only at late time points (72 h onwards, Chapter 3) after induction, and so it 
is possible that a similar delayed phenotype is seen in BSF cells, and remains to 
be tested. The basis for this delay remains unclear, though the relatively low 
levels of Tb312012myc protein loss seen by western blot in BSF cells (when 
compared with the apparent abrogation of TbORC1/CDC612myc and TbORC1B12myc 
24 h after induction of TbORC1/CDC6 and TbORC1B RNAi, respectively) may 
suggest that this protein is relatively stable, possibly accounting for the delay in 
phenotype appearance, as had been suggested in Chapter 3.  
Taken together, though the PCF and BSF RNAi data for Tb3120 and TbORC4 do 
not entirely overlap and are less compelling than for TbORC1/CDC6 and 
TbORC1B, it seems likely that these factors can be considered components of 
the replication initiation machinery.  
Like in PCF cells, silencing of TbORC1B by RNAi had not been examined in BSF 
cells. Here we show that TbORC1B RNAi induction in BSF cells resulted in a more 
severe phenotype than RNAi of any of the other factors, mirroring the data 
obtaining in PCF cells (Chapter 3, section 3.3.2.5). The growth and cell cycle 
consequences of TbORC1B depletion were very comparable with those of 
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TbORC1/CDC6 RNAi-induction, though the reduction in the number of replicating 
cells (by 90% after 24 h) was more rapid. Two independent experiments have 
shown that the rapidity and nature of these phenotypes is highly reproducible. 
Thus, TbORC1B appears to be a central factor in T. brucei DNA replication in 
both BSF and PCF cells, despite the difficulties we have reported in detecting 
TbORC1B’s interaction with TbORC1/CDC6, or other putative ORC factors, as 
discussed in Chapter 3. Indeed, localisation of myc-tagged TbORC1B suggests 
that its role in BSF cells is the same as in PCF cells: here it was shown that 
TbORC1B12myc, uniquely amongst all the other 12myc-tagged putative Orc-like 
proteins, displays cell cycle dependent sub-nuclear localisation in BSF cells. The 
timing and punctate nature of this localisation, which is limited to late G1, S 
phase and early G2 phase cells, suggests that in both life cycle stages TbORC1B 
performs a regulatory role. Likewise, localisation and dynamics of TbORC1/CDC6 
and interacting factors mimic the results obtained in PCF cells (Chapter 3, 
section 3.5.2): TbORC1/CDC612myc, TbORC412myc, 12mycTb7980, Tb312012myc and 
Tb112012myc localise to the nucleus of the BSF cell throughout the cell cycle, as 
punctate. 
4.6.2 DNA replication dynamics T. brucei BSF cells 
Origins of DNA replication in the eleven megabase chromosomes have been 
mapped to date only in T. brucei PCF cells of strain TREU 927 (Tiengwe et al., 
2012a). As in other eukaryotes, the number of initiator binding sites 
(TbORC1/CDC6 in this case) outnumbered the origins that were activated, which 
co-localised with a subset of TbORC1/CDC6 binding sites in the highly 
transcribed core of the chromosomes (Tiengwe et al., 2012a). No consensus 
sequence was identified at the origins or TbORC1/CDC6-binding sites, although 
these localised to the boundaries of the polycistronic transcriptions units, most 
frequently transcription initiation sites enriched for histone H4K10ac (Siegel et 
al., 2009), thus suggesting an intimate relationship between DNA replication and 
transcription (Tiengwe et al., 2012a), as seen in other eukaryotes (reviewed in 
Leonard and Mechali, 2013; Mechali, 2010; Barlow and Nussenzweig, 2014; 
Helmrich et al., 2013). Nevertheless, the estimated number of active origins (42) 
was smaller than it might have been predicted for a eukaryotic organism; for 
instance, ~280 origins have been mapped by Sort-seq in the genome of S. 
cerevisiae (Muller et al., 2014), which is approximately half the size of the 
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megabase genome of T. brucei. Indeed, with a density of only about one origin 
per ~600 Kbp, origins in T. brucei appear to be much more dispersed than in 
other analysed eukaryotes (Tiengwe et al., 2012a). Recently, the rate of nuclear 
DNA replication has been calculated in T. brucei PCF and BSF cells to be of 3.7 
Kbp.min-1 and 4.4 Kbp.min-1, respectively (Calderano et al., 2015), thus being 
marginally faster than rates described in other eukaryotes (2-3 Kbp.min-1), 
where replication rate, the number of activated origins and genome size are 
assumed to be interconnected (reviewed in Mechali, 2010; Masai et al., 2010). In 
other eukaryotes, it has been reported that the location of origins used 
(reviewed in DePamphilis, 2005), or the timing of origin activation, can differ 
between cell types (Ryba et al., 2010) (and reviewed in Jackson et al., 2012; 
Leonard and Mechali, 2013; Masai et al., 2010; Mechali, 2010). BSF and PCF cells 
are two distinct life cycle stages of T. brucei, differing in many aspects of their 
biology, which prompted us to compare the origins usage between these two cell 
types. To allow direct comparison between life cycle stages, BSF and PCF cells 
of strain Lister 427 were used, therefore also providing a further strain 
comparison with the analysis made in (Tiengwe et al., 2012a). 
Mapping origins in Lister 427 T. brucei PCF and BSF cells revealed considerable 
inflexibility in replication dynamics. Virtually all origins localised to the 
chromosome core regions, and there were no clear differences between BSF and 
PCF cells: the locations of all origins appeared the same in both life cycle 
stages. Although at two locations two origins could be detected in PCF cells, 
while only a single MFA-seq peak was seen in BSF cells, the two PCF origins were 
closely spaced. These minor differences may therefore merely reflect the 
limitations of FACS sorting and mapping resolution by MFA-seq. Even more 
striking than origin location conservation was the finding that the pattern of 
replication timing, as judged by variable MFA-seq peak height and width, was 
strongly comparable between BSF and PCF cells. The only, minor differences 
were where some origins mapped in BSF early S samples had lower amplitude 
peaks than the same peaks in the PCF early S data. Though it is possible that this 
difference reflects some origins firing later in BSF cell S phase, which may be 
possible if the replication rate in BSF cells is 15% faster than in PCF cells 
(Calderano et al., 2015), it is equally likely that these differences may just 
reflect FACS sampling differences. Taken together, these data suggest that in 
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both life cycle stages not only are the same SSRs chosen to act as origins, but 
the timing of their firing during S phase is maintained. This is remarkable, for 
two reasons. First, the active origins represent only ~12% of the mapped 
TbORC1/CDC6 binding sites in the core region of the chromosomes (Tiengwe et 
al., 2012a), and no sequence feature has been described that distinguishes most 
T. brucei origin-active SSRs from inactive SSRs. Second, whereas in other 
eukaryotes origins might be distinguished from potential origins by levels of 
transcription (e.g. promoter strength) (reviewed in Helmrich et al., 2013; 
Leonard and Mechali, 2013; Mechali, 2010; Masai et al., 2010), there is no 
evidence to suggest any regulated activity of the RNA Pol II polycistrons, and it is 
very possible that transcription at each ‘promoter’ is constitutive and initiates 
at equal levels (given the most gene expression control is post-transcriptional) 
(Jensen et al., 2009; Siegel et al., 2010; Kramer, 2012; Clayton, 2013; Clayton, 
2002). What, then, marks the origin-active sites for selective use and maintains 
this during differentiation? It is increasingly clear that centromeres are very 
early replicating features in most eukaryotes, and in chromosomes 1-8 of T. 
brucei, where centromeres have been mapped (Obado et al., 2007), the MFA-seq 
data appears to confirm that this is also true in T. brucei, since these represent 
the highest mapped peaks (Tiengwe et al., 2012a). However, this cannot explain 
all the data, since the centromeres represent only ~20% of the mapped T. brucei 
origins, and the timing of the remaining ~80% also appears to be invariant.  
The origins mapped in BSF and PCF Lister 427 cells not only match each other, 
but also very closely match the origins mapped previously in PCF cells from 
strain TREU 927 (Tiengwe et al., 2012a). Virtually all 42 previously predicted 
origins were seen, with only one origin, in chromosome 2, not being identified. 
However, as for the BSF to PCF differences, this may simply be because in TREU 
927 this origin locus was detected as two very closely separated origins. Within 
the 41-42 conserved origins, MFA-seq peak height was reasonably conserved, 
further reinforcing the suggestion that the profile of replication timing is 
relatively fixed. Five new potential origins were detected in the BSF and PCF 
Lister 427 samples, which had not been previously noticed (Tiengwe et al., 
2012a). Like all other origins, these localised to TbORC1/CDC6 (Tiengwe et al., 
2012a) and histone H4K10ac (Siegel et al., 2009) binding sites, at SSRs.  
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Perhaps more importantly, the work here showed mapped origin usage late in T. 
brucei S phase, which had not been attempted previously (Tiengwe et al., 
2012a). These data may suggest that the 41-45 origins mapped in early S phase 
represent the whole repertoire, as no further MFA-seq peaks were clearly 
discernible. If so, the megabase genome is, as suspected (Tiengwe et al., 
2012a), replicated from a remarkably small number of origins. Very recently, 
single molecule analysis of replicated DNA (SMARD), limited to chromosome 1, 
confirmed origin activity at the centromere and, furthermore, suggested that 
there may be further initiation sites towards at least one of the telomeres in this 
chromosome (Calderano et al., 2015). MFA-seq data generated to date has not 
shown clear peaks in any telomeres or subtelomeres, with the exception of the 
main origin in chromosome 6, which co-localised with the centromere, very 
close to the subtelomeric region of the chromosome (Tiengwe et al., 2012a). 
However, it is possible that this reflects the limitations of the MFA-seq strategy, 
and mapping in these regions is confounded by repetitive sequences and limited 
annotation of VSG location. More work will be needed to localise the origins’ 
initiation site(s) and to ask if such telomere-proximal initiation is seen in all the 
chromosomes. 
As discussed above, DNA replication and transcription are intimately connected, 
(reviewed in Helmrich et al., 2013; Barlow and Nussenzweig, 2014), including in 
T. brucei (Tiengwe et al., 2012a; Benmerzouga et al., 2013). In other 
eukaryotes, it has been proposed that differences in origin usage and timing are 
interconnected with divergences in the transcription programmes employed by 
different cell types of the organism (reviewed in Jackson et al., 2012; Leonard 
and Mechali, 2013; Masai et al., 2010; Mechali, 2010). In T. brucei and related 
kinetoplastids however, gene expression is controlled mainly at the post-
transcriptional level (Jensen et al., 2009; Siegel et al., 2010; Kramer, 2012), 
with few genes being regulated directly at the transcriptional level (Reynolds et 
al., 2014; Maree and Patterton, 2014). The most prominent exceptions to this 
general trend are the genes encoding surface proteins, which are transcribed by 
RNA Pol I, and expressed in a tightly life cycle stage-regulated fashion (Gunzl et 
al., 2003; Gunzl et al., 2014): while the surface of PCF cells is marked by 
abundant procyclins (reviewed in Dyer et al., 2013), the BSF cell surface is 
covered by ~107 copies of a single VSG (reviewed in McCulloch et al., 2014; 
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Glover et al., 2013b). Fourteen VSG BES have been annotated in the Lister 427 
genome (Hertz-Fowler et al., 2008), within which strict expression regulation is 
seen: only one VSG BES is fully transcribed in a single BSF cell at a given time 
(active expression site), with all other sites being transcriptionally silenced, 
while all VSG BES are silenced in the PCF cell (reviewed in McCulloch et al., 
2014; Glover et al., 2013b). MFA-seq mapping in the 14 Lister 427 BES shows that 
this part of the genome provides the only clear example of life cycle stage-
specific transcription-associated replication, and perhaps replication dynamism 
that contrasts with the rigid replication programme seen in the rest of the 
genome. Mapping replication in the BES suggests that virtually all of these 
telomeric sites are very late replicating in both BSF and PCF cells, with a single 
exception: BES 1, the active expression site in Lister 427 BSF cells that 
transcribes VSG 221. MFA-seq mapping in BES 1 was striking in that it too was 
late replicating in PCF cells, where it is not transcribed, but was the single BES 
that showed evidence for early replication in BSF cells. Thus, BES 1 represents 
the single region of the genome in which active transcription can be shown to 
dictate replication timing. It will be important to validate this observation 
further, for instance repeating the same experiment using a cell line actively 
expressing another BES. Nonetheless, this observation raises a number of 
questions. Foremost amongst these, is where is the origin that dictates BES 1-
specific early replication? Most BES have not been linked to specific megabase 
chromosome telomeres, and therefore it remains possible that BES 1 replication 
emerges from within the subtelomere, perhaps as suggested by (Calderano et 
al., 2015). In several works, it is mentioned that BES 1 is localised to the right-
hand side of chromosome 6a (Glover and Horn, 2014; Hertz-Fowler et al., 2008), 
although this would have to be confirmed in the cell lines (both BSF and PCF) 
used in this study. Both data presented here and in (Tiengwe et al., 2012a) do 
not suggest the presence of an origin being activated at that end of chromosome 
6, though a weak origin is detectable just upstream of that end’s subtelomeric 
region, which could passively replicate BES 1. However, this origin is detected 
both in BSF and PCF cells, and thus it seems unlikely that BES 1 is being 
replicated via this origin, since no replication was seen in the PCF sample. A 
perhaps more likely explanation for early BSF replication of BES1 is that this is 
driven by active transcription of the site. If so, mapping the location of the 
origin is needed to understand the mechanism that drives this. For instance, the 
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origin may localise to the VSG RNA Pol I promoter, and perhaps TbORC1/CDC6 is 
recruited there by the transcription machinery or chromatin status, both which 
have been shown to differ between the active and silent BES (reviewed in Horn 
and McCulloch, 2010; McCulloch et al., 2014; Glover et al., 2013b). 
Alternatively, the origin may be at the telomere, with replication being directed 
towards the BES promoter. This is also possible, as TbORC1/CDC6 has been 
documented to interact with telomere repeats (Benmerzouga et al., 2013), and 
origin activity has been detected at telomeres in other eukaryotes (Kurth and 
Gautier, 2010; Drosopoulos et al., 2012). It will be valuable to map 
TbORC1/CDC6-binding sites at the BES to infer whether these include potential 
origins. Moreover, if TbORC1/CDC6 and origins can be found at the telomere, 
selectivity for the active BES needs to be further explored. 
The observation of BSF-specific early replication at the active VSG BES raises a 
wider question regarding T. brucei biology: is it possible that DNA replication 
might be involved in antigenic variation, the mechanism by which the cells 
change their expressed VSG (reviewed in McCulloch et al., 2014; Glover et al., 
2013b)? Some indications of this relationship can be detected in published work 
(Tiengwe et al., 2012a; Benmerzouga et al., 2013; Gassen et al., 2012; Glover et 
al., 2013a), but a direct link between replication dynamics and VSG switching 
has not been reported. Depletion of TbORC1/CDC6 by RNAi has been shown to 
result in the de-repression of silent VSGs and lead to an increase in VSG 
switching (Tiengwe et al., 2012a; Benmerzouga et al., 2013). However, whether 
this is a direct consequence of TbORC1/CDC6 function is not clear, as 
TbORC1/CDC6 depletion by RNAi results in a widespread effect on transcription 
and subsequent cell death (Tiengwe et al., 2012a). In other studies it has been 
shown that the BES of T. brucei are ‘fragile’ sites, with evidence of DNA breaks 
in the vicinity of the VSG gene (Glover et al., 2013a; Boothroyd et al., 2009); 
indeed, it has been proposed that it is this telomere fragility that can generate 
DNA double strand breaks (DSBs) that trigger antigenic variation by DNA repair 
(Glover et al., 2013a; Glover et al., 2013b; McCulloch et al., 2014). However, 
though it was originally suggested that such breaks are found specifically in the 
active BES (Boothroyd et al., 2009), later studies found no difference in break 
distribution between silent and actively transcribed BES (Jehi et al., 2014; 
Glover et al., 2013a). Thus, whether BES telomeric fragility results from 
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transcription or DNA replication, or clashes between them, remains unclear. 
Nonetheless, telomeric DNA has a complex secondary and chromatin structure, 
which can render it prone to replicative stress and subsequent replication fork 
stall or collapse, and potentially result in DSBs (reviewed in Pfeiffer and Lingner, 
2013; Giardini et al., 2014). Finally, a model for replication-dependent initiation 
of VSG switching has been proposed (Kim and Cross, 2010; Kim and Cross, 2011). 
Though the data here may offer some support for this model, it is based on 
untested assumptions about replication direction in the BES (as discussed 
above).  
Like with other eukaryotic ORC subunits (reviewed in Barlow and Nussenzweig, 
2014), most of TbORC1/CDC6 has been shown to accumulate at the subtelomeres 
of the T. brucei megabase chromosomes (Tiengwe et al., 2012a). However, it is 
not clear whether DNA replication is initiated from these TbORC1/CDC6-binding 
sites (Tiengwe et al., 2012a). In addition, TbORC1/CDC6 binding at these 
locations was mapped in TREU 927 PCF cells, and thus it is not known whether it 
also localises to the BES (Tiengwe et al., 2012a) or if this localisation is 
conserved in BSF cells. It will be of great interest to map TbORC1/CDC6 binding 
sites in both Lister 427 PCF and BSF cells to ask whether it binds to sites within 
the BES, and if there are differences between PCF and BSF cells, or specific 
localisation within the active BES. Moreover, it would theoretically allow the 
identification of potential origins within the BES, if any exist. In all cells, 
because DNA replication and transcription are intimately related, it is crucial 
that the cell is able to tightly coordinate both processes, limiting the risk of 
subsequent genomic instability (reviewed in Barlow and Nussenzweig, 2014; 
Helmrich et al., 2013). It is well established that when transcription and DNA 
replication machineries collide, replication fork stalling occurs with consequent 
collapse, and generation of DNA breaks (reviewed in Helmrich et al., 2013). 
Normally such instances are avoided, and so it would be of considerable interest 
to investigate whether T. brucei has evolved to promote such interactions in the 
BES of BSF cells, allowing DNA replication to trigger antigenic variation.  
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5 Origins of DNA replication in Leishmania 
Chapter 5  318 
 
 
5.1 Introduction 
5.1.1 The Leishmania parasites and leishmaniasis 
Like T. brucei, Leishmania spp. parasites belong to the order Trypanosomatida 
(Moreira et al., 2004; Adl et al., 2012; Lukes et al., 2014), and possess a 
complex life cycle in which the parasite has to go through drastic developmental 
changes (Figure 5.1), including stages in the insect vector (sand fly) and the 
mammalian host. Unlike T. brucei, however, Leishmania parasites are 
intracellular in the mammalian host, with a tropism to phagocytic cells, such as 
macrophages (reviewed in Kaye and Scott, 2011). The infection of the 
mammalian host results in leishmaniasis, whose pathology, separated into 
visceral leishmaniasis (VL) or cutaneous leishmaniasis (CL), appears to depend on 
both the Leishmania species and the mammalian host immune response 
(reviewed in Kaye and Scott, 2011). For instance, L. major and L. mexicana 
species are associated with CL, while L. donovani and L. infantum cause VL 
(reviewed in Kaye and Scott, 2011). Recently, it has been estimated that, every 
year, there are between 700,000 and 1,200,000 cases of CL, and between 
200,000-400,000 cases of VL in 98 affected countries (Alvar et al., 2012).  
 
Figure 5.1. Life cycle of Leishmania spp. parasites.  
Generic diagram of the Leishmania parasite life cycle. During its blood meal, the sand fly 
regurgitates into the mammalian host infective, non-dividing metacyclic promastigotes, which are 
phagocytosed by a phagocytic cell present in the bite environment. Once inside the phagocytic cell, 
metacyclic promastigotes differentiate into aflagellate amastigotes, which then divide within the 
host cell. Once the cell is full with amastigotes, it ruptures, releasing the parasites that will infect 
another phagocytes. Upon taking a blood meal from an infected mammal, the sand fly ingests 
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amastigotes, which will then develop within the fly midgut into procyclic promastigotes, and later 
metacyclic promastigotes, that can be transmitted to a new mammalian host. Several 
developmental stages occur inside the sand fly, but are not here distinguished from the procyclic 
promastigotes for simplicity. Reproduced from (Kaye and Scott, 2011), with permission (license 
number 3586541268882).  
 
5.1.2 Leishmania genome organisation and ploidy 
The genomes of the so-called TriTryps, T. brucei, T. cruzi, and L. major, were 
sequenced 10 years ago (Berriman et al., 2005; El-Sayed et al., 2005a; El-Sayed 
et al., 2005b; Ivens et al., 2005). This has allowed many genome-wide studies to 
be carried out, including (Tiengwe et al., 2012a; Siegel et al., 2009; Siegel et 
al., 2010; Jensen et al., 2009; Rogers et al., 2011; Jones et al., 2014; Alsford et 
al., 2011). The main, common characteristic of the TriTryp genomes is the 
organisation of their genes into large polycistronic gene clusters, also known as 
polycistronic transcription units or directional gene clusters (DGCs) (El-Sayed et 
al., 2005b; Jackson, 2014; Stuart and Myler, 2006), which are delimited by 
divergent, convergent or head-to-tail strand-switch regions (SSRs). While the T. 
brucei genome is composed of 11 diploid megabase chromosomes (0.9 to 6 Mbp), 
as well as variable numbers of aneuploid intermediate (150 to 900 Kbp) and mini 
chromosomes (50 to 150 Kbp) (Melville et al., 1998; Turner et al., 1997; 
Berriman et al., 2005), the Leishmania genome is comprised of 34 to 36 
chromosomes, depending on the species (reviewed in Stuart and Myler, 2006), 
which display variable ploidy (below). For instance, the old world Leishmania 
species L. major has 36 chromosomes (0.28 to 2.8 Mbp) (Ivens et al., 2005; Ravel 
et al., 1998), while the new world Leishmania L. mexicana, has only 34. This 
may have arisen by fusion of two pairs of L. major chromosomes (8 and 29, and 
20 and 36) (Ivens et al., 2005; Britto et al., 1998) to form two larger L. mexicana 
chromosomes (8 and 20). However, it is also possible that it occurred by fission 
of the two L. mexicana chromosomes, resulting in the four L. major 
chromosomes. 
Despite being estimated to have diverged around 250 million years ago (Lukes et 
al., 2014), comparison of the T. brucei and L. major genomes revealed a high 
level of gene conservation and synteny, with 68% of the T. brucei, and 75% of 
the L. major, genes localising to the same genomic context (El-Sayed et al., 
2005b). Indeed, 20 of the 36 L. major chromosomes appear to be almost 
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completely syntenic within the core regions of the larger T. brucei 
chromosomes, as represented in Figure 5.2, suggesting that the T. brucei 
chromosomes might have resulted from the fusion of the smaller L. major ones 
(Figure 5.2). It was also observed that around 43% of the synteny breakpoints in 
T. brucei and L. major localised with, or are very close to, SSRs separating two 
DGCs, and it is here that species-specific gene families, retroelements and RNA 
genes localise (El-Sayed et al., 2005b; Stuart and Myler, 2006). The main 
difference in gene content between the two genomes appears to lie on the 
telomeres and subtelomeric regions, which are short in L. major, but long in T. 
brucei (Berriman et al., 2005; El-Sayed et al., 2005b; Ivens et al., 2005). The 
increased size of the T. brucei subtelomeres is due to the evolution of a huge 
archive of VSG genes, found in expression sites and VSG arrays, which are 
necessary for immune evasion via antigenic variation (reviewed in McCulloch et 
al., 2014). Another difference between the two genomes is based on genome 
stability. While the 11 T. brucei megabase chromosomes are stably diploid, it 
has been shown that aneuploidy is frequent in Leishmania, with the parasites 
appearing to tolerate considerable variations in chromosome copy number 
(ranging from haploid to >tetraploid) (Rogers et al., 2011; Sterkers et al., 2011). 
The chromosomes that display aneuploidy vary between different species, as 
well as within a species and even during growth (Rogers et al., 2011; Sterkers et 
al., 2011; Lachaud et al., 2014; Downing et al., 2011). It is not known how this 
aneuploidy originates in Leishmania parasites, though it has been suggested that 
it might be related to nuclear DNA replication (Rogers et al., 2011; Sterkers et 
al., 2012; Lachaud et al., 2014). In addition, it is unclear if chromosome and 
gene copy number variation within chromosomes may be related to the 
extensive gene amplification events that are found in Leishmania, and may 
relate to mechanisms for gene expression variation, such as in response to drug 
selection (reviewed in Leprohon et al., 2014; Mannaert et al., 2012; Sterkers et 
al., 2012). 
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Figure 5.2. Synteny maps of T. brucei and L. major chromosomes.  
The eleven megabase chromosomes of T. brucei are shown on the left. To each T. brucei 
chromosome, the syntenic regions in each of L. major chromosomes are shown, so that each 
colour corresponds to each of the 36 L. major chromosomes. The inverse is shown on the panel on 
the right. Here, the 36 chromosomes of L. major are coloured according to the T. brucei eleven 
chromosomes, each individually coloured. The syntenic regions are labelled with the chromosome 
number they belong to. Tb1 refers to T. brucei chromosome 1, while Lm1 refers to L. major 
chromosome 1, for instance. Chromosomes are designed to scale, which is shown in Mbp. 
Reproduced from (El-Sayed et al., 2005b), with permission (license number 3586570186594). 
 
5.1.3 Nuclear DNA replication in Leishmania 
Very little is known about nuclear DNA replication in Leishmania parasites, with 
the few data available focusing on the TbORC1/CDC6 orthologues in L. major 
and L. donovani, LmTbORC1/CDC6 and LdTbORC1/CDC6, respectively (Kumar et 
al., 2008; Kumar et al., 2012). In both cases, the protein localised to the nucleus 
of the cell throughout the cell cycle, similar to TbORC1/CDC6 and TcORC1/CDC6 
(Godoy et al., 2009). However, both LmORC1/CDC6 and LdORC1/CDC6 were 
expressed from an episomal plasmid, and thus, the levels of expression might 
have not been the ones naturally occurring in the cell (Kumar et al., 2008; 
Kumar et al., 2012). No functional data on these proteins or analysis of 
replication coordination in Leishmania has been described, though several 
attempts have been made to map replication origins and centromeres by 
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chromosome fragmentation and directed cloning of sequences into bacterial 
plasmids (Dubessay et al., 2001; Dubessay et al., 2002; Tamar and 
Papadopoulou, 2001).  
As already mentioned in the previous chapters, the origins of replication have 
been recently mapped in T. brucei procyclic form (PCF, insect stage) cells 
(Tiengwe et al., 2012a). Although T. brucei and L. major are distinct organisms, 
in eukaryotes it is assumed that origins of replication are not defined by a 
consensus sequence, but by chromatin status, chromatin environment and 
context (reviewed in Leonard and Mechali, 2013); therefore, the high level of 
synteny between the two parasites’ genomes may enable the identification of 
common characteristics or features defining origins of replication in these 
organisms. In addition, origins of replication appear to be highly conserved 
between T. brucei PCF and bloodstream form (BSF) cells, as well as between two 
strains of the parasite (Chapter 4).  
Given the profound genome synteny between Leishmania and T. brucei, albeit 
within the context of considerable differences in genome architecture and 
stability, this chapter describes the mapping of the origins of replication in both 
L. major and L. mexicana promastigote cells (insect stage). One motivation for 
this was to enable comparison with the previously mapped origins of replication 
in T. brucei cells (Tiengwe et al., 2012a), perhaps revealing features that define 
an origin of replication in kinetoplastids.  
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5.2 Origins of DNA replication in Leishmania major 
5.2.1 Mapping the origins of replication in L. major 
To investigate the origins of replication in L. major, promastigote cells from L. 
major strain Friedlin, used for the assembly of the reference genome (Ivens et 
al., 2005), were used. The cell line was maintained and cell cultures were 
prepared by Dr Amy Goundry (Jeremy Mottram’s laboratory). Around 109 cells 
were harvested (from cultures at around 5 x 106 cells.ml-1), fixed in 70% 
methanol and stained with propidium iodide (PI). The cells were then sorted into 
early S, late S and G2 phases by FACS using a BD FACSAria I™ cell sorter system 
(BD Biosciences), according to their DNA content, as detailed in the materials 
and methods Chapter 2, section 2.7.3. The gates used for the isolation of the 
different cell cycle stages are represented in Figure 5.3. Each sample was 
collected directly into lysis solution, and the gDNA was purified and sent for 
sequencing at Glasgow Polyomics (University of Glasgow; samples processed by 
Ms Julie Galbraith). Here, the DNA libraries were generated using the Nextera® 
XT DNA Sample Preparation kit (Illumina), and sequenced using the Illumina 
MiSeq paired-end 250 bp sequencing system (Illumina). Like in Chapter 4, the 
samples were multiplexed, with each of the early S, late S, and G2 phase 
samples library DNA being processed in the same run, for direct comparison. The 
resulting data was analysed by marker frequency analysis (MFA) as described in 
(Tiengwe et al., 2012a), with a few adaptations, as already detailed in Chapter 
4, section 4.5.1 for the mapping of the origins of replication in T. brucei BSF 
cells. Here, the L. major strain Friedlin reference genome available on 
TriTrypDB version 6.0 was used. A simplified diagram is shown in Chapter 4, 
Figure 4.19, and the basic coding script can be found in the appendices, section 
7.8. In this case, Dr Nicholas J. Dickens conducted all the mapping (WTCMP 
Bioinformatics team, University of Glasgow), and generated the output graphs 
for each chromosome using ggplot2 and the R package (R Development Core 
Team, 2010). The early S to G2 ratio for each of the 36 chromosomes is shown in 
Figure 5.4, while the late S to G2 ratios are shown in Figure 5.5. For better 
interpretation of the results, and to allow comparisons to the origins mapped in 
T. brucei PCF cells (Tiengwe et al., 2012a), the S to G2 ratios are shown relative 
to the genes for each chromosome, as well as sites of acetylated histone H3 
(H3ac) binding, which were mapped previously (Thomas et al., 2009), and 
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demarcate the start sites of polycistronic transcription in L. major, similar to 
histone H4 acetylated at K10 (H4K10ac) in T. brucei (Siegel et al., 2009).  
 
Figure 5.3. Sorting of L. major asynchronous cultures into early S, late S and G2/M phases 
by FACS.  
Histogram depicting the cell cycle profile of a mid-log phase L. major promastigote cell culture, 
reflecting the fluorescent signal emitted by the staining of DNA with propidium iodide (PI). The 
different sections (dashed rectangles) represent the gates defined to purify the different cell cycle 
populations using a BD FACSAria I sorting flow cytometry machine. The same gates were used for 
the sorting of L. mexicana cells, discussed in section 5.3.  
 
Surprisingly, only a single MFA-seq peak was detected per chromosome in early S 
L. major cells (Figure 5.4), suggesting that a single origin of replication is 
present in each chromosome. MFA-seq from late S cells, also compared with G2, 
did not reveal any further peaks per chromosome (Figure 5.5), even in the 
largest chromosomes, suggesting that no extra origins are activated in later 
stages of S phase. Nevertheless, analysis of the late S data showed that all peaks 
widened, suggesting that DNA replication had proceeded further from each 
single origin per chromosome from early S to late S (Figure 5.4 and Figure 5.5): 
on average the width of the early S/G2 peaks were ~0.33 to 0.46 Mbp, but were 
~0.5 to 0.83 Mbp in late S/G2.  
Replication from a single origin per chromosome is unprecedented in a 
eukaryote, and contrasts with what was observed in T. brucei, where multiple 
origins of different strength were detected per chromosome (Tiengwe et al., 
2012a). Analysis of the late S data suggests that a single origin may suffice for 
the replication of the smaller chromosomes (chromosomes 1 to 24, between 0.28 
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and 0.84 Mbp), as here discrete MFA-seq peaks are unclear (Figure 5.5), 
compared with the pronounced peak for most chromosomes in the early S/G2 
data (Figure 5.4). Thus, these chromosomes appear to have completed 
replication in the late S sampled cells (Figure 5.5). For example, in small-mid 
sized chromosomes, such as 15 (0.63 Mbp), 18 (0.74 Mbp) and 24 (0.84 Mbp), 
early S peaks had a width of ~0.33 Mbp to 0.375 Mbp (Figure 5.4), while in late S 
phase these were of ~0.5 Mbp to 0.625 Mbp (Figure 5.5), the latter 
corresponding to 74-79% of the chromosomes’ size. This was not true for the 
larger chromosomes (25-36), where a discrete late S/G2 MFA-seq peak could be 
seen. 
All MFA-seq peaks in early S, as well as in lase S phase, appeared to have similar 
widths, independent of chromosome size. Measurement of peak width in the 
largest chromosomes, 30-36, suggest a width of 0.37 Mb to 0.46 Mbp in early S 
phase (Figure 5.4), and 0.54 Mbp to 0.83 Mbp in late S phase (Figure 5.5), very 
similar to the values obtained for the smaller chromosomes. These 
measurements suggest that each origin is of similar ‘strength’, in that 
replication has proceeded to a similar distance in the same time frame. As a 
result, data suggests that all origins are fired at the same time, and thus there is 
no order of origin activation, unlike in T. brucei, where some origins appear to 
be activated earlier than others (Tiengwe et al., 2012a).  
It is therefore not clear how the larger chromosomes are able to complete DNA 
replication successfully per cell cycle, as in many of the chromosomes the single 
detectable late S/G2 peak was not wide enough to suggest that these 
chromosomes are completely replicated from each single origin (Figure 5.5): 
conversely to the smaller chromosomes such as 15 and 18, the widths in late 
S/G2 peaks of chromosomes 30 to 36 suggest that only 28-56% of the 
chromosomes’ length were replicated in the cells collected as late S phase. 
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Figure 5.4. Origins of replication in early S phase L. major promastigote cells.  
Graphs represent the distribution of active origins of replication per L. major chromosome (numbered 1 to 36), assessed by MFA-seq. Each graph shows the ratio of 
the coverage (read-depth) between early S phase and G2 phase samples, where each point (blue) represents the median S/G2 ratio (y-axis) per 2.5 Kbp section 
across the chromosome (x-axis). Each x-axis gap represents a 250 Kbp interval. The y-axis scale is the same for all graphs, but the legend is only shown in the ones in 
the far left. All graphs are made to scale according to each chromosome size. At the top of each graph a track is represented with the different genes in the 
chromosome, in blue the open reading frames (ORF) that are transcribed from the left to the right, and in red the genes transcribed from right to left. Below the MFA-
 
 
327 
seq profiles, a track is shown of histone H3ac-enriched sites (Thomas et al., 2009), demarcating the different polycistronic transcription start sites. Each individual 
graph was generated by Dr Nicholas J. Dickens as described in the materials and methods Chapter 2.  
 
 
Figure 5.5. Origins of replication in late S phase L. major promastigote cells.  
Description as in Figure 5.4, with the exception that the MFA-seq data shows the ratio between late S and G2 phases.  
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Recently, replication rates have been calculated for T. brucei PCF cells, to be of 
3.7 Kbp.min-1 (Calderano et al., 2015), relatively similar but still slightly faster 
than the rates reported for other eukaryotes (2-3 Kbp.min-1) (reviewed in Masai 
et al., 2010; Mechali, 2010). The replication rate in L. major or other 
Leishmania species has not been calculated to date. Nevertheless, in L. major 
promastigotes it was estimated that G1, S and G2 phases comprise 7.7 h of the 
10.2 h cell cycle (Ambit et al., 2011), while in L. mexicana it was possible to 
estimate the S phase as lasting 2.9 h (40%) of the 7.1 h cell cycle (Wheeler et 
al., 2011). This measurements suggest a longer S phase than in T. brucei PCF 
cells, where S phase is estimated to last 1.5 h (17.6%) of a cell cycle of 8.5 h 
(Woodward and Gull, 1990). One possibility, then, is that Leishmania replication 
rates might be slower than in T. brucei, and it will be invaluable to make this 
measurement in the future. Assuming that in L. major, mirroring the data 
available for L. mexicana (Wheeler et al., 2011), S phase occupies around 40% of 
the cell cycle (total of 10.2 h) (Ambit et al., 2011), it would take about 4 h to 
complete. At a replication rate of 2 Kbp.min-1, a bi-directional replication fork 
would be able to replicate about 0.96 Mbp, while at a 3.7 Kbp.min-1 rate it 
would replicate 1.77 Mbp. In either case, such rates would not be sufficient to 
allow complete replication of all chromosomes: for example, chromosomes 34, 
35 and 36, of 1.86 Mbp, 2.09 Mbp and 2.68 Mbp, respectively, would not be 
replicated at the faster rate of 3.7 Kbp.min-1, while chromosomes 26 to 36 would 
not be fully replicated at a fork rate of 2 Kbp.min-1. Therefore, it seems very 
unlikely that a single origin drives the complete replication of the large 
chromosomes in L. major. Analysis of L. mexicana (below), where a firmer 
estimate of S phase has been made, confirms this dichotomy between the MFA-
seq data and prediction.  
Besides the very similar peak width (described above) between the 36 
chromosomes, all of the MFA-seq peaks appeared to have the same height, of 
around 1.5 S/G2 ratio in the early S phase samples (Figure 5.4). This contrasts 
with the observations made in T. brucei, where MFA-seq peaks of variable 
heights (1.1 to 1.8) were detected within the same and between chromosomes, 
thus suggesting a replication timing program in T. brucei, with some origins 
firing earlier (higher peaks) than others (lower peaks) during S phase (Tiengwe 
et al., 2012a). This further supports the absence of a temporal order of origin 
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usage in L. major, suggesting that DNA synthesis from the single origin in each 
chromosome is activated at the same time in S phase.  
Like in T. brucei, almost all L. major origins co-localised to SSRs, at the 
boundaries between two polycistronic transcription units (Figure 5.4). The single 
exception was the origin in chromosome 1, which localises to the right end of 
the chromosome, where co-localisation with the telomere or the end of the 50-
gene polycistron (McDonagh et al., 2000; Myler et al., 1999) cannot be 
distinguished. It is worth noting that the location of the origin predicted here by 
MFA-seq does not correspond with sequence-based predictions of L. major 
chromosome 1, which suggested localisation to the central SSR (McDonagh et al., 
2000). Of the remaining 35 origins (Figure 5.4), 30 (83.3%) co-localised with 
histone H3ac-binding sites, at divergent SSRs (dSSRs, 47.2%) or head-to-tail SSRs 
(h-t SSRs, 36.1%), while 5 localised to convergent SSRs (cSSRs, 13.9%), deemed 
transcription termination sites. These percentages are similar to the ones 
obtained for T. brucei: 85% of the origins co-localised with histone H4K10ac-
binding sites (Siegel et al., 2009), 42.9% at dSSRs, 31% at the h-t SSRs, and 4.7% 
at the cSSRs, while the localisation of 9 origins was either at the centromeres or 
unclear (21.4%) (Figure 5.7) (Tiengwe et al., 2012a). To date, the centromeres 
in the L. major chromosomes have not been mapped. Consequently, it is not 
possible to localise the origins of replication to these regions, which in other 
eukaryotes (reviewed in Rhind and Gilbert, 2013; Masai et al., 2010), as well as 
in T. brucei (Tiengwe et al., 2012a), appear to replicate early in S phase. 
Nevertheless, this overlap with initiation transcription sites suggests that, like in 
other eukaryotes (reviewed in Barlow and Nussenzweig, 2014; Helmrich et al., 
2013) and T. brucei (Tiengwe et al., 2012a), DNA replication is intimately 
interconnected with transcription in L. major. Origin conservation between L. 
major and T. brucei is investigated and discussed in a dedicated section below 
(section 5.2.3).  
5.2.2 Confirmation of an origin of replication by MFA-qPCR 
To complement the above MFA-seq data in L. major, MFA analysis by qPCR was 
performed for one chromosome, similar to what was done in T. brucei (Tiengwe 
et al., 2012a). For this analysis, chromosome 34 was chosen, as it is one of the 
large chromosomes (1.86 Mbp). For this analysis, the chromosome was separated 
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into several sections (A-L), covering most of its length: sections A-C were 
designed to cover the origin, section L as an origin-proximal region that was not 
replicated in the early S phase sample, sections D-H covering a large early S non-
replicated, central region, J-K as an early S non-replicated region towards the 
end of the chromosome, and I as an early S non-replicated region to serve as 
endogenous control (“reference gene”) in the qPCR reaction and further analysis 
(Figure 5.6, A). Primers were designed targeting genes from each of the A-L 
sections, according to the MIQE guidelines for qPCR primer design (Alvarez-
Fernandez, 2013; Dymond, 2013; Bustin et al., 2009). All primer sequences are 
shown in the materials and methods Chapter 2, Table 2-10. Primer efficiency 
and specificity was assessed for all pairs of primers through, respectively, the 
analysis of calibration curves and melting profiles, which resulted in efficiencies 
of approximately 100%, all within a 8% interval (data not shown). The same 
amount of gDNA (0.01 ng) from early S and G2 samples, from two independent 
sorting experiments, was used for the qPCR reaction, and the resultant 
fluorescence intensity data was analysed by relative quantification using the 
ΔΔCt method (Livak and Schmittgen, 2001). For each pair of primers, 
corresponding to each section, primers in I were used as “reference gene” for 
normalisation, and the G2 phase sample as calibrator, as its frequency per 
marker (pair of primers) should be the same throughout the chromosome (fully 
replicated), and was therefore set at 1. The relative ratios between early S and 
G2 phase were then plotted on a graph relative to position in the chromosome. 
To allow comparison with the MFA-seq data, the qPCR data is shown overlapping 
with the MFA-seq profile (Figure 5.6, B). A pronounced enrichment in S phase 
relative to G2 was seen only for A, B, C and L, corresponding with the MFA-seq 
peak. Thus, the qPCR analysis also suggests that only one origin can be detected, 
corroborating the data obtained by sequencing (Figure 5.6, A and B). 
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Figure 5.6. L. major chromosome 34 analysed by MFA-qPCR.  
A) MFA-seq graph (early S/G2) of L. major chromosome 34, as shown in Figure 5.4. Dashed lines 
demark the regions (loci A-L) chosen for the design of primers for MFA analysis by qPCR. Primers 
pair I2 (within I locus) was used as the “endogenous gene” in the qPCR analysis by the ΔΔCt 
method (Livak and Schmittgen, 2001). B) Validation of the replication origin in L. major 
chromosome 34, by MFA-qPCR the specific loci shown in A). At each loci (A1 to K1 refer to the 
primers used for each loci), the values from the G2 sample (red) are set as 1 (completely replicated 
DNA), while the relative amount of the early S phase over G2 is shown (black). Each data point 
(black) represents the mean of two qPCR runs of two independently obtained samples (gDNA from 
two independent sorting experiments) (n = 4), with each qPCR run performed with three 
experimental replicates. The error bars depict the standard error of the mean of the two 
independent qPCR runs for the two different samples. For ease of comparison, the MFA-seq data 
was plotted in the background (light blue). All data is represented to their position in the 
chromosome, with the x-axis represented to scale, depicting the chromosome length in bp. 
 
A) 
B) 
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5.2.3 Origin conservation between L. major and T. brucei 
The initial aim of the investigation of the origins of replication in L. major was 
to explore whether there are common characteristics defining origins between 
two distinct kinetoplastid organisms. Although the results above show that there 
are clear differences in replication coordination between L. major and T. brucei, 
they also indicate that both organisms have a similar number of origins (36 and 
42, respectively), with virtually all localising to SSRs. To allow direct comparison 
between origins mapped in L. major and T. brucei, and to confirm the results 
published (Tiengwe et al., 2012a), T. brucei PCF cells of strain TREU 927 were 
sorted again, sequenced (together with the L. major samples, as described in 
section 5.2.1) and the MFA-seq mapping repeated. The results of this analysis 
are shown in Figure 5.7, and coincide entirely with the origins previously 
mapped in PCF TREU 927 cells, showing that origin location does not vary as the 
cell line is cultured (Tiengwe et al., 2012a).  
As shown in Figure 5.2, the high level of synteny between the two genomes 
allowed the construction of a diagram in which the T. brucei chromosomes are 
represented as blocks of synteny with the L. major chromosomes, thus allowing 
direct comparison of large syntenic regions between the two species’ 
chromosomes (Figure 5.8). Origin location conservation between L. major and T. 
brucei was then analysed by comparing the presence of origins in the syntenic 
regions between the two genomes (Figure 5.8). Of the T. brucei SSR loci 
conserved in location in L. major, 41% (light-dark blue) coincided with active 
origins in L. major, while 36% (orange-red) represented sites lacking origin 
activity in L. major (Figure 5.8, pie chart). Fourteen (33%) of the T. brucei 
origins localised to sites of chromosome fusion (or fission) of L. major 
chromosome synteny blocks, meaning sites of re-arrangement or synteny break 
points. In five of these cases (13% of the 42 T. brucei origins), origin activity was 
not detected in the L. major chromosomes. At the other 9 sites, origin activity 
was conserved in the L. major chromosomes; indeed, in two of these cases, one 
T. brucei origin was present in two different L. major chromosomes: a T. brucei 
chromosome 7 origin, at around 2 Mbp was retained in both L. major 
chromosomes 17 and 5 (Figure 5.8 and Figure 5.9), while the strongest origin in 
T. brucei chromosome 5 (around 0.25 Mbp) was conserved in both chromosomes 
5 and 35 of L. major (Figure 5.8). In 8% of the T. brucei origins, conservation was 
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not clear. Finally, only a single origin appeared to be T. brucei-specific, 
localising to the subtelomeric region of chromosome 6, to which there is no 
corresponding syntenic region in the L. major genome (Figure 5.8).  
Specific examples of origins conservation, non-conservation and complex 
patterns of origin conservation are shown in more detail in Figure 5.9. For 
instance, in Figure 5.9, A), an example is shown of an origin that is active in L. 
major chromosome 30, but is not active in the corresponding syntenic region in 
T. brucei chromosome 6. In contrast, in Figure 5.9, B), an active origin in T. 
brucei chromosome 10 is not conserved in L. major chromosome 33, though the 
same origin is, instead, conserved in L. major chromosome 36, as the T. brucei 
region is duplicated in the two L. major chromosomes. In Figure 5.9, C), an 
example is given in which a T. brucei origin, localising at a region of a synteny 
break point between two L. major chromosomes, is present in the two L. major 
chromosomes. A further example, depicting the complexity of origin 
conservation, is shown in Figure 5.9, D): in T. brucei chromosome 8, four of its 6 
origins, all of various strengths, were also found in, respectively, syntenic 
regions of L. major chromosomes 7, 23, 10 and 31. However, in each case the L. 
major origins were of equal strength. Furthermore, L. major chromosome 31, 
which is >diploid in all species (Rogers et al., 2011), is duplicated in the T. 
brucei genome on chromosomes 8 and 4, and the origin detected in L. major 
chromosome 31 is found in both these T. brucei chromosomes. However, the 
origin in T. brucei chromosome 8 is strong and co-localises with the centromere, 
while its counterpart in chromosome 4 is non-centromeric and weak (Figure 5.9). 
These data suggest that a single L. major origin has adapted to be activated 
differently in two genomic locations in T. brucei. Moreover, whereas in L. major 
all origins appear to have the same strength, the ones conserved, regarding 
location, have been adapted to differing strengths in T. brucei. 
Like in T. brucei (Tiengwe et al., 2012a), no specific sequence motifs (analysis 
by Dr Nicholas J. Dickens, not shown) were found that could define an origin in 
L. major, and no common sequence motifs or patterns were found in origins 
conserved between the two parasites. This is further explored in in section 5.4. 
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Figure 5.7. Origins of replication in early S phase T. brucei procyclic form cells.  
Graphs represent the distribution of active origins of replication per T. brucei megabase chromosome (1 to 11), assessed by MFA-seq. Each graph shows the ratio of 
the coverage (read-depth) between early S phase and G2 phase samples, where each point (orange) represents the median S/G2 ratio (y-axis) per 2.5 Kbp section 
across the chromosome (x-axis). Each x-axis gap represents a 250 Kbp interval. The y-axis scale is the same for all graphs, but the legend is only shown in the ones in 
the far left. All graphs are made to scale according to each chromosome size. At the top of each graph a track is represented with the different genes in the 
chromosome, in blue the open reading frames (ORF) that are transcribed from the left to the right, and in red the genes transcribed from right to left. Below the MFA-
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seq profiles, a track is shown with the histone H4K10ac-enriched sites (Siegel et al., 2009) (represented simply as H4ac), demarking the different polycistronic 
transcription units. Each individual graph was generated by Dr Nicholas J. Dickens as described in the materials and methods Chapter 2. 
 
 
Figure 5.8. T. brucei origin conservation in L. major.  
 
 
336 
A synteny block diagram based on the one in (El-Sayed et al., 2005b), and reproduced in Figure 5.2, is shown. Here, the 11 megabase chromosomes of T. brucei are 
represented by the ORF track (genes transcribed from left to right are shown in blue, and genes transcribed right to left are shown in red) and histone H4K10ac-binding 
sites (shown in black) (Siegel et al., 2009). The sizes of the chromosomes are represented by intervals of 0.5 Mbp. T. brucei chromosomes are labelled as Tbr1 to 
Tbr11. Regions of synteny between the T. brucei 11 chromosomes and the 36 L. major chromosomes (Lmj1 to Lmj36) are represented by rectangles containing the L. 
major chromosome number below the T. brucei chromosome. In some cases, the whole L. major chromosome is syntenic with a region of a T. brucei chromosome, 
while others are fragmented. For simplicity, the orientation of the synteny blocks is not shown. Conservation of replication origins throughout syntenic regions is shown 
as follows (and summarised in the pie chart, inside dashed box): blue dot localises T. brucei origins conserved in L. major, while red/orange dots highlight non-
conserved origins; grey dots localise T. brucei origins at rearrangement sites (L. major synteny blocks break point) that were lost in L. major; white/black dots depict 
regions where conservation is unclear; and the single black dot represents the only T. brucei origin that is specific to T. brucei, as it localises to the subtelomere of 
chromosome 6, that shows no synteny with L. major. Light pink dots show origins that appear to be L. major specific. The green boxes highlight the centromeres that 
have been mapped in T. brucei (Obado et al., 2007).  
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Figure 5.9. Examples of origin conservation between T. brucei and L. major.  
Diagrams of some examples of origin conservation, or not, between the two parasites. All 
represented data is from early S samples. The MFA-seq graphs used have already been shown 
and described in Figure 5.4 (early S L. major) and Figure 5.7 (early S T. brucei), and the y-axes are 
not shown for simplicity. Syntenic regions are highlighted within the grey boxes, while conserved 
origins are marked with a green line, and non-conserved ones with a red dashed line. Grey dashed 
lines represent the direction of synteny between blocks. A) example of origin non-conservation, in 
which the same syntenic region displays origin activity in L. major chromosome 30 but not in T. 
brucei chromosome 6. B) example in which the same region in T. brucei (chromosome 10) is 
syntenic to two regions in two different L. major chromosomes (chromosomes 33 and 36). The 
origin in T. brucei is conserved in L. major chromosome 36 but not 33. C) one origin in T. brucei 
(chromosome 7), localised at a rearrangement site, is conserved in two L. major chromosomes (17 
and 5). D) a complex example of origin conservation. Four of the origins in T. brucei chromosome 8 
are conserved in L. major. In T. brucei these origins appear to have different strengths, suggesting 
that these are activated at different times during S phase; but the conserved origins in L. major 
appear to all have the same strength, suggesting activation at the same time. All x-axes graphs are 
to scale to chromosome size.  
 
A) 
B) 
C) 
D) 
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5.3 Origins of DNA replication in Leishmania mexicana 
To date, no eukaryote has been reported to have a single origin of replication 
per chromosome, and thus the present dogma states that eukaryotic 
chromosomes are replicated from multiple origins that can be activated at 
different times during S phase (reviewed in Leonard and Mechali, 2013). 
Although all evidence here shown supports the existence of a single origin per 
chromosome in L. major, in contrast with T. brucei where multiple origins are 
detected, we sought to test whether origin singularity is common to other 
Leishmania species. Like L. major, L. mexicana is also a causative agent of 
cutaneous leishmaniasis. The two species, estimated to have diverged around 16 
million years ago (Lukes et al., 2014), have highly syntenic genomes of similar 
sizes (32-33 Mbp), though these differ in composition, since L. mexicana 
possesses 34 chromosomes (Britto et al., 1998; Rogers et al., 2011), in contrast 
with the 36 found in L. major (Ravel et al., 1998; Ivens et al., 2005). Two of the 
L. mexicana chromosomes (8 and 20) appear to have resulted from the fusion of 
two smaller L. major chromosomes (29 plus 8, and 36 plus 20, respectively), or 
the larger L. mexicana chromosomes evolved into the smaller L. major 
molecules by fission. Thus, mapping of replication origins in L. mexicana, in 
particular in chromosomes 8 and 20, provides a test of origin singularity in 
Leishmania. 
5.3.1 Mapping the origins of replication in L. mexicana 
L. mexicana strain U1103 promastigotes were used. The cell line was maintained 
and cell cultures were prepared by Dr Amy Goundry (Jeremy Mottram’s 
laboratory). Cells were prepared, sorted, sequenced, and analysed as described 
for the L. major samples in section 5.2.1. In this case, the reference genome for 
L. mexicana strain U1103 (Rogers et al., 2011), retrieved from TriTrypDB version 
6.0, was used. The results were represented as mentioned, with the exception 
that no histone-binding data was included, as it is not available for this species. 
As for L. major, a single origin was detected in each L. mexicana chromosome in 
early S phase, and no further origins were detected later in S phase (Figure 5.10 
and Figure 5.11, respectively). In all cases, with two exceptions (below), the 
origins detected in L. mexicana localised to the same SSRs to which the origins 
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mapped in L. major, showing that there is an almost complete conservation in 
origin location between these two species (Figure 5.12).  
The two exceptions were chromosomes 8 and 20. In each of these chromosomes, 
a single origin was detected in both early and late S phase samples (Figure 5.10 
and Figure 5.11, red boxes), although each of these chromosomes is syntenic 
with two L. major chromosomes, each with a single origin (Figure 5.12, red 
boxes). In L. mexicana chromosome 8, the origin from chromosome 8 of L. major 
was maintained while the one from 29 was not, and in L. mexicana chromosome 
20, the origin from chromosome 20 of L. major was kept while the one from 36 
was not (Figure 5.12, red boxes). Assuming that these L. mexicana chromosomes 
result from the fusion of the L. major ones, it appears that origin singularity was 
maintained in both cases, with origin activity retained at one SSR and suppressed 
at the other. Alternatively, if the L. mexicana chromosomes split into two 
molecules, an inactive SSR was activated in one of the resulting L. major 
chromosomes. Further analysis of these regions is discussed in sections 5.3.2 and 
5.4.  
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Figure 5.10. Origins of replication in early S phase L. mexicana promastigote cells.  
Graphs represent the distribution of active origins of replication per L. mexicana chromosome (1 to 34), assessed by MFA-seq. Each graph shows the ratio of the 
coverage (read-depth) between early S phase and G2 phase samples, where each point (green) represents the median S/G2 ratio (y-axis) per 2.5 Kbp section across 
the chromosome (x-axis). Each x-axis gap represents a 250 Kbp interval. The y-axis scale is the same for all graphs, but the legend is only shown in the ones in the far 
left. All graphs are made to scale according to each chromosome size. At the top of each graph a track is represented with the different genes in the chromosome, in 
blue the open reading frames (ORF) that are transcribed from the left to the right, and in red the genes transcribed from right to left. Chromosomes 8 and 20 are 
enclosed by a red box as these are the chromosomes each syntenic to two L. major chromosomes (29 and 8, 36 and 20, respectively). Each individual graph was 
generated by Dr Nicholas J. Dickens as described in the materials and methods Chapter 2. 
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Figure 5.11. Origins of replication in late S phase L. mexicana promastigote cells.  
Description as in Figure 5.10, with the exception that the MFA-seq data shows the ratio between late S and G2 phases. 
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Like in L. major, all peaks in L. mexicana appeared to have the same height 
(around 1.5 in early S phase) (Figure 5.10), suggesting again the absence of an 
origin activation timing programme, as seen in T. brucei (Tiengwe et al., 2012a). 
Consistent with this, origin width was similar between L. mexicana origins, 
independent of the chromosome size, and identical to the values observed in L. 
major: peaks in smaller chromosomes such as 15 (0.57 Mbp) and 18 (0.69 Mbp) 
had a width of ~0.36 Mbp in early S phase, and of 0.53-0.6 Mbp in late S phase, 
like in larger chromosomes, such as 29 to 34 (1.32-1.97 Mbp), where peaks had a 
width of 0.36-0.43 Mbp in early S phase and about 0.78-0.89 Mbp in late S phase 
(Figure 5.10 and Figure 5.11). The broad similarity in peak width may suggest 
that both Leishmania species replicate at similar rates, albeit within the 
uncertainty of how comparable the S-phase sampling by FACS was. Nonetheless 
these values again suggest that the smaller chromosomes could be replicated 
from a single origin; for instance, data from late S phase suggest that 
chromosome 15 was already 93% replicated while chromosome 18 was 87%. In 
contrast, a single origin appears insufficient to replicate the larger 
chromosomes, such as chromosomes 29 and 34, which in the late S sample were 
only 59% and 43% replicated, respectively (Figure 5.10 and Figure 5.11). 
Although S phase in L. mexicana (Wheeler et al., 2011) appears to be shorter 
than the one from L. major (Ambit et al., 2011), lasting 2.9 h of its 7.1 h cell 
cycle, at a fork rate similar to the one reported for other eukaryotes, of 2 
Kbp.min-1 (reviewed in Masai et al., 2010; Mechali, 2010), bi-directional 
replication forks would be able to replicate only about 0.69 Mb of DNA, which 
would be enough to completely replicate chromosomes 1 to 19, but would not be 
enough to replicate the larger ones. Even if L. mexicana replicates at a faster 
rate, such as has been described for T. brucei PCF cells (3.7 Kbp.min-1 rate) 
(Calderano et al., 2015), it would still be insufficient, replicating a maximum of 
1.28 Mbp per origin. Again, this would not be enough to completely replicate the 
larger chromosomes, such as 30 to 34 (1.44 to 1.96 Mbp), and chromosome 20 
(3.3 Mbp).  
Together, this suggests that origin usage in L. mexicana is highly similar to L. 
major, and both greatly different from T. brucei, supporting the idea that 
Leishmania parasites may employ a different strategy from T. brucei to ensure 
the complete replication of their genomes.  
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Figure 5.12. Comparison of the origins of replication in L. major and L. mexicana.  
Individual graphs of the MFA-seq data (S/G2 ratio) from early S samples of L. mexicana (green, 
shown in Figure 5.10) and L. major (blue, as shown in Figure 5.4) are shown. Graphs are shown 
according to synteny between the two genomes, with the chromosomes of L. mexicana on top and 
the respective syntenic L. major chromosome below. L. mexicana chromosome 8 (red box) is 
syntenic with both L. major chromosomes 29 and 8, while chromosome 20 (red box) is syntenic 
with L. major chromosomes 26 and 20; the syntenic regions in the L. mexicana chromosomes are 
highlighted by a grey box, and the arrows indicate the respective syntenic chromosome in L. major. 
 
5.3.2 Confirmation of a single origin in L. mexicana chromosomes 
8 and 20 by MFA-qPCR 
In order to test the validity of the MFA-seq data further we tested the prediction 
of a single origin in L. mexicana chromosomes 8 and 20 by MFA-qPCR (Figure 5.). 
Employing the qPCR strategy described in (Tiengwe et al., 2012a), and as 
detailed in section 5.2.2, gDNA from L. major and L. mexicana early S and G2 
samples was analysed by qPCR. In this case, primers were designed in regions 
that covered the origins detected in the L. major chromosomes 8 (primers N3, 
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P2, P3 and Q1) and 29 (primers N1, M2, M4 and O2), 20 (U1, V1 and W1) and 36 
(R2, S1, S3 and T1), and the corresponding syntenic regions in the L. mexicana 
chromosomes 8 (O2, M4, M2, N1, N3, P2, P3 and Q1) and 20 (R2, S1, S3, T1, U1, 
V1 and W1), respectively (Figure 5., A). Primer sequences are shown in the 
materials and methods Chapter 2, Table 2-10. All primers were tested for 
efficiency (data not shown) as described in section 5.2.2, with all pairs being 
close to 100%, and with a maximum difference of 12%. Primers pair R3 was used 
as the “reference gene” for normalisation, and the corresponding G2 phase 
sample as the calibrator for the ΔΔCt analysis (Livak and Schmittgen, 2001). As 
shown in Figure 5., B), only one origin was detected in each of the L. mexicana 
chromosomes, with the MFA-seq and MFA-qPCR S/G2 ratios matching well. In the 
syntenic regions in which MFA-seq predicted origin activity in L. major, but no 
activity in L. mexicana, the MFA-qPCR S/G2 ratios confirmed this prediction. 
Together, these results corroborate the MFA-seq analysis (Figure 5.10), and 
support the existence of a single origin per Leishmania chromosome.  
 
 
Figure 5.13. L. mexicana and L. major fusion/fission chromosomes.  
A) MFA-seq graphs of L. mexicana chromosomes 8 (LmxM.08) and 20 (LmxM.20), over the 
corresponding L. major syntenic chromosomes 29 (LmjF.29) and 8 (LmjF.08), 36 (LmjF.36) and 20 
(LmjF.20), respectively, as shown in Figure 5.12. The y-axes are not shown for simplicity. The grey 
shaded boxes highlight the synteny blocks, while the dotted lines show their orientation. Dashed 
lines demark the regions (loci O to W) chosen for the design of primers for MFA analysis by qPCR. 
A) 
B) 
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Primers pair R3 (within R locus) was used as the “endogenous gene” in the qPCR analysis by the 
ΔΔCt method (Livak and Schmittgen, 2001). B) Validation of the replication origins in the L. 
mexicana chromosomes 8 and 20, as well as in L. major chromosomes 29, 8, 36 and 20, by MFA-
qPCR at a number of specific loci predicted to display origin activity in L. major. At each loci (O2 to 
W1 refer to the primers pairs used per loci), the values from the G2 sample (red) are set as 1 
(completely replicated DNA), while the relative quantity of the early S phase over G2 is shown 
(black). Each data point (black) represents the mean of three qPCR runs (n = 3) of the same 
sample, each run performed with three experimental replicates. The error bars depict the standard 
error of the mean of the three independent qPCR runs. For ease of comparison, the MFA-seq data 
was plotted in the background. All data is represented to their position in the chromosome, as the 
x-axis is represented to scale, depicting the chromosome’s length in bp. 
 
5.4 Do any sequence features define an origin in 
kinetoplastids? 
Similar to T. brucei (Tiengwe et al., 2012a), analysis of the mapped L. major 
and L. mexicana origins of replication (performed by Dr Nicholas J. Dickens, data 
not shown) failed to find any consensus DNA sequence, motif or pattern, defining 
the sites that become origins of replication, perhaps suggesting that, like other 
eukaryotes, origins of replication in kinetoplastids are defined by chromatin 
structure, context and status (reviewed in Masai et al., 2010; Mechali, 2010; 
Leonard and Mechali, 2013). In line with this, a common feature between T. 
brucei, L. major and L. mexicana origins is their localisation at SSRs, irrespective 
of whether they are divergent (dSSRs) or head-to-tail (h-t SSRs), both 
demarcated by acetylated histones and known RNA polymerase II transcription 
starting sites (Thomas et al., 2009; Siegel et al., 2009), or convergent (cSSRs), 
where transcription terminates. However, origins are not found at all SSRs, and 
thus we asked whether there are differences between origin-active SSRs and 
non-origin SSRs. To answer this, the length of each origin-active SSR was 
assessed by measuring of the distance (in Kbp) between the most proximal gene 
ORFs at the SSR: between the predicted start codons of the genes at a dSSR; the 
two stop codons of the genes at a cSSR; and the stop and start codons of the two 
genes at a h-t SSR. The length of multiple non-origin SSRs was also measured, 
and plotted alongside the origin-active SSR data, in order to infer statistically 
significant differences (Figure 5.14, A). Individual measurements are shown in 
the appendices, section 7.9. Because the distributions of the L. major and L. 
mexicana origin-active and non-origin SSR data sets failed to pass normality tests 
(D’Agostino and Pearson normality test, Shapiro-Wilk normality test, and the 
Kolmogorov-Smirnov normality test), a non-parametric test was preferred. For 
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the three sets of data, T. brucei, L. major and L. mexicana, the two unpaired 
groups (origin-active SSR and non-origin SSR) were compared using the Mann-
Whitney test, one-tailed, with statistical significance defined at a p value < 
0.05. In T. brucei, no difference in length was seen between origin-active and 
non-origin SSRs (Figure 5.14, A), orange graph), suggesting that they could not 
be distinguished by size. In striking contrast, in both Leishmania species there 
was a clear difference (p < 0.0001) between these two types of SSRs: the 
distance between the most proximal genes in SSRs containing an origin was 
significantly larger than the non-origin SSRs (Figure 5.14, A), blue and green 
graphs). Separating the SSRs into the three types (dSSR, cSSR or h-t SSR) and 
repeating the analysis (due to the small number of data points in some groups, 
normality was assumed for the data distribution, and the analysis was performed 
using one-way ANOVA, un-matched, with statistical significance defined at a p 
value < 0.05) showed that the size differences in Leishmania between origin-
active and inactive SSRs are independent from the configuration of transcription 
direction around them (Figure 5.14, B). 
 
 
Figure 5.14. Size of origin and non-origin containing strand switch regions.  
A) Scatter plot showing the lengths of each origin SSR (circles) and of multiple non-origin SSRs 
(squares). The graph on the left represents the data (in orange) from T. brucei; the graph in the 
middle shows the data (in blue) from L. major; while the graph on the right shown the data (in 
green) from L. mexicana. In the L. major and L. mexicana graphs, black points represent the origin-
SSR in L. major chromosomes 29 and 36 that are non-origin SSRs in L. mexicana chromosomes 8 
and 20, respectively. The mean is shown as a black horizontal line, and the error bars represent 
the standard error of the mean. Statistical significance was inferred with the non-parametric Mann-
B) 
A) 
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Whitney test, one tailed, with a p value threshold of < 0.05. (ns) refers to non-significant, while 
(****) refers to a p value < 0.0001. B) Same data as in A) but represented per SSR type: dSSR, 
cSSR and h-t SSR. As in A), the graph on the left shows the data from T. brucei (orange), the one 
in the middle refers to L. major (blue), while the one on the right represents the data from L. 
mexicana (green). The mean is shown as a black horizontal line, and the error bars represent the 
standard error of the mean. Statistical significance was inferred with the parametric one-way 
ANOVA test, un-matched, multiple group comparison, with a p value threshold of < 0.05. (****) 
refers to a p value < 0.0001. 
 
In the previous sections it was shown that in L. mexicana chromosome 8, only 
the origin from the region syntenic with L. major chromosome 8 was kept, while 
the one referring to the region of L. major chromosome 29 was lost; and in L. 
mexicana chromosome 20, the origin from L. major chromosome 20 was kept, 
while the one in L. major chromosome 36 was lost (Figure 5.12). A closer 
analysis of these regions showed that the general SSRs trend was reflected in 
these specific sites: in L. major, the origin-active SSRs have a length of 6.13 Kbp 
(chromosome 29) and 6.4 Kbp (chromosome 36) (Figure 5.14, A, middle graph, 
black points), while the corresponding syntenic, non-origin SSRs in L. mexicana, 
are 3.63 Kbp (chromosome 8) and 3.55 Kbp (chromosome 20) in size (Figure 
5.14, A, far right graph, black points). These differences are shown in more 
detail in Figure 5.15. 
In both T. brucei and Leishmania, origins localise to a subset of SSRs, and appear 
to be maintained during differentiation and prolonged culture (in T. brucei), and 
between strains or species. However, the data above suggests that the origins of 
replication in Leishmania, but not in T. brucei, localise to a specific subset of 
SSRs that can be distinguished by size from non-active SSRs. This lends weight to 
the argument that replication in Leishmania initiates from only a single origin in 
each chromosome, as these are the SSRs in each case whose size differs from all 
others. The observation that the SSRs in L. mexicana chromosomes 8 and 20 that 
do not show origin activity in L. mexicana are smaller than the syntenic SSRs in 
L. major, where origin activity is observed, gives support to the argument that 
SSR features are altered as these loci move from an origin-active to inactive (or 
vice versa) status.  
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Figure 5.15. Syntenic regions and L. mexicana and L. major that display different origin 
activity.  
Diagrams representing the two regions of L. mexicana chromosomes 8 (A) and 20 (B) that do not 
show origin activity but correspond to syntenic regions in L. major chromosomes 29 (A) and 36 (B), 
respectively, that show origin activity. As in Figure 5., the blocks of synteny are highlighted within 
the grey boxes. Dashed boxes identify the syntenic SSR, which are shown in more detail below 
(each gap represents 0.2 Mbp). The distance between the two most proximal ORFs within the SSR 
is highlighted in red. Distances are shown in Kbp. 
 
5.5 Discussion 
Presently, it is universally accepted that eukaryotic chromosomes are invariably 
replicated from multiple origins of replication (reviewed in Costa et al., 2013): 
origin multiplicity in eukaryotic genomes is needed since complete, timely 
duplication of their large linear chromosomes is only possible with the 
establishment of various replication forks at different loci distributed throughout 
the chromosomes (reviewed in Leonard and Mechali, 2013; Mechali, 2010). In 
addition, although all pre-RC-bound sites at the end of G1 phase are deemed 
potential origins, only a small subset of these are activated per cell cycle, with 
A) 
B) 
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the remaining acting as a dormant pool of origins than can be activated during S 
phase if needed (reviewed in Blow et al., 2011; McIntosh and Blow, 2012). 
Nevertheless, the origins that are activated in every cell cycle, the number of 
which appears to be dependent on chromosome size, do not do so at the same 
time, as their activation is governed by a specific timing programme of origin 
activation during the cell cycle, with some origins being activated earlier (early 
firing) than others (late firing) (reviewed in Mechali, 2010; Rhind and Gilbert, 
2013). With the exception of budding yeast, where origins are defined by 
consensus sequences (Bell and Stillman, 1992), eukaryotic origins of replication 
appear to be defined by contextual cues, such as chromatin structure, status and 
environment, including proximity to promoter elements, DNA accessibility and 
nucleosome occupancy (reviewed in Costa et al., 2013). Finally, DNA replication 
and transcription are intimately connected processes (reviewed in Helmrich et 
al., 2013; Barlow and Nussenzweig, 2014). 
Mapping of the origins of replication in T. brucei PCF cells (Tiengwe et al., 
2012a) revealed that this parasite appears to conform to the above ‘universal’ 
features of eukaryotic DNA replication: multiple origins of replication are 
detected per chromosome; origin number relates to chromosome size; the 
number of TbORC1/CDC6-binding sites outnumbers the activated origins, thus 
showing that only a subset of potential origins are activated per cell cycle; the 
detected active origins appear to have different strengths, suggesting that T. 
brucei origins of replication are activated at different times during the cell 
cycle, and thus an activation timing programme is present; and no specific 
sequences were found to define either TbORC1/CDC6-binding sites or active 
origin sites. In addition, and perhaps to an even greater extent than in other 
eukaryotes, origins of replication overlap with regions of transcription initiation 
and termination, suggesting that DNA replication and transcription are 
interconnected in T. brucei. Furthermore, a recent report measured replication 
rate in T. brucei, and provided very preliminary evidence for non-active 
TbORC1/CDC6 binding sites acting as dormant origins, since one such site 
appears to be activated after hydroxyurea (HU) treatment (Calderano et al., 
2015). 
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Though believed to have diverged around 250 million years ago (Lukes et al., 
2014), the genomes of T. brucei and L. major are highly conserved and syntenic, 
and share the same unusual gene expression organisation in large polycistronic 
transcription units (El-Sayed et al., 2005b). As origins of replication in 
eukaryotes appear to be defined by chromatin cues and genomic context, we 
sought to analyse the origins of replication in L. major, since it might be 
predicted that kinetoplastid gene expression constrains the potential location of 
origins (Tiengwe et al., 2012a). The result of origins mapping that was obtained, 
however, was unprecedented: only a single origin could be mapped in each L. 
major chromosome. Further analysis of another Leishmania species, L. 
mexicana, revealed the same pattern: a unique origin per chromosome. If this 
organisation of replication is correct, it overturns the accepted orthodoxy of 
origin multiplicity in eukaryotes, and the suggestion that origin singularity is an 
exclusive feature of prokaryotic genomes, which are small enough to be 
replicated from a single origin (reviewed in Masai et al., 2010; Costa et al., 
2013). Moreover, analyses of L. major and L. mexicana replication patterns by 
MFA-seq around the mapped origins, suggests that all origins are activated at the 
same time and replicate at the same rate in every chromosome. As a result, 
these findings indicate that an origin activation timing program is absent in 
Leishmania, in contrast to T. brucei (Tiengwe et al., 2012a) and all 
characterised eukaryotes to date (reviewed in Rhind and Gilbert, 2013). Like in 
T. brucei (Tiengwe et al., 2012a), all Leishmania origins co-localised with SSRs. 
Indeed, a remarkably high level of origin location conservation was seen: 40% of 
origins were conserved between the two parasites, in contrast with only 12-21% 
between S. cerevisiae and Lachancea waltii, two yeasts believed to have 
diverged from each other at a similar time to T. brucei and L. major (Di Rienzi 
et al., 2012). However, analysis comparing the size of origin-active and inactive 
SSRs revealed a striking difference between Leishmania and T. brucei. In the 
latter, there is no difference between origin-active and inactive SSRs, and thus 
SSR size in itself is not defining which origins are activated. In contrast, in both 
L. major and L. mexicana it is clear that the origin-containing SSRs are 
considerably larger than the ones with no origin activity. Indeed, SSRs with 
origin activity in L. major are considerably larger than syntenic SSRs in L. 
mexicana that do not display any origin activity. These data suggest that in 
Leishmania, origins of replication are activated only at specific SSRs that, most 
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likely amongst other features, are larger. How this is reflected in factor 
recruitment to the SSRs is unknown; for instance, does the Leishmania pre-RC 
machinery bind to all SSRs or only to the distinctive origin-active SSRs? 
Nonetheless, the fact that SSRs size is equivalent at origin-active and inactive 
SSRs in T. brucei is consistent with TbORC1/CDC6 binding to all these sites, and 
the potential that some act as dormant origins. In Leishmania, this flexibility 
may be absent, with no possibility to initiate replication via an origin of 
replication at any other discrete sites than the single mapped SSRs in each 
chromosome. In T. brucei, gene density is higher than in L. major, where the 
average length between polycistronic transcription units has been shown to be 
almost twice the size than in T. brucei (El-Sayed et al., 2005b). Perhaps this 
difference in gene density may account for the possibility of Leishmania 
parasites to use the length of SSRs as an origin-defining feature, but not T. 
brucei, which might have developed origin-activating mechanisms common to 
other eukaryotes. 
The observation of a single origin per chromosome in Leishmania raises an 
important question: how is the parasite capable of replicating its genome within 
S phase? Data from late S samples suggest that it is, most likely, not possible to 
complete the replication of all chromosomes from one site. In L. major and L. 
mexicana, chromosomes size rages from 0.27-2.7 Mbp and 0.27-3.3 Mbp, 
respectively. Data from late S phase samples suggest that a single L. major 
origin replicated between 0.5 and 0.83 Mbp of DNA, while in L. mexicana 0.5 to 
0.89 Mbp had been replicated. Although the replication rate has not been 
measured for any Leishmania species, the assumption that these might have a 
similar rate to other eukaryotes and T. brucei (2-3.7 Kbp.min-1), and a 3-4 h S 
phase (Ambit et al., 2011; Wheeler et al., 2011), suggests that L. major and L. 
mexicana origins would only be able to replicate a maximum of 0.7-0.96 Mbp 
(rate of 2 Kbp.min-1), similar to the observations made for the late S phase data, 
or 1.28-1.77 Mbp (rate of 3.7 Kbp.min-1). In making these estimates, it should be 
noted that this assumes that replication fork movement is unperturbed, and that 
origin location is central in the chromosome. The former assumption is unlikely, 
as all organisms use recombination and by-pass mechanisms to overcome lesions. 
The latter is demonstrably incorrect, with the most striking example of a non-
central origin seen in L. mexicana chromosome 20; here, the single mapped 
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origin is close one telomere and therefore replication needs to traverse most of 
the ~3.3 Mb molecule. It seems very likely that although a single origin is most 
likely able to efficiently direct the complete replication of the smaller 
chromosomes of L. major and L. mexicana, a unique origin is not sufficient to 
allow the replication of the larger chromosomes. In fact, in T. brucei PCF cells 
the chromosomes can only be completely replicated because various origins are 
activated per chromosome and the replication rate of 3.7 Kbp.min-1 is slightly 
faster than other eukaryotes (Calderano et al., 2015), as each origin is only able 
to replicate around 0.66 Mbp per S phase, which lasts 1.5 h (Woodward and Gull, 
1990). Therefore, the main question arising from this study is: how do 
Leishmania parasites completely replicate their larger chromosomes? 
One hypothesis is that there are other origins of replication per chromosome, 
but that the MFA-seq approach is not sensitive enough to detect them, as it 
maps predominant origins in a population. For instance, if a dominant origin is 
activated in every cell per cell cycle (constitutive origins), but others are 
activated randomly throughout the chromosome in different cells (flexible 
origins), these origins will not be identified by MFA analysis, as these are not 
activated in a large proportion of the cell population. It will be crucial to map 
the binding sites of Leishmania ORC1/CDC6 throughout the genome in order to 
address this. This will answer whether there are more potential origins in the 
Leishmania chromosomes, and if so, whether these can be activated. Moreover, 
mapping L. mexicana ORC1/CDC6 to the fusion chromosomes, 8 and 20, could be 
informative, as these molecules possess SSRs that may have recently lost origin 
activity. Nonetheless, indirect data from various studies on chromosome stability 
support the existence of a single origin of replication per Leishmania 
chromosome (Figure 5.16). Fragmentation of chromosome 5 of L. donovani and 
of chromosome 23 of L. tarantolae by telomere-associated chromosome 
fragmentation into two fragments each, showed that in both cases one fragment 
was stably maintained while the other was lost after several generations (Tamar 
and Papadopoulou, 2001). This suggested that there were elements, most likely 
centromere-like, in these two maintained fragments that conferred mitotic 
stability, thus allowing their retention and segregation during cell divisions, 
while these were absent from the fragments that were lost during growth 
(Tamar and Papadopoulou, 2001). However, unlike in T. cruzi (in which similar 
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fragmentation assays (Obado et al., 2005; Obado et al., 2007) led to the 
functional mapping of the centromeres in chromosomes 1 and 3) and T. brucei, 
where the mapping of topoisomerase II activity after etoposide treatment 
allowed the biochemical mapping of centromere location , the implementation 
of such approach failed to identify L. major centromeres (Obado et al., 2007). It 
therefore remains unknown where centromeres are localised in the Leishmania 
genome. Data from the mapping of the origins of replication in T. brucei, 
however, suggest that the strongest origins co-localise with the mapped 
centromeres in chromosomes 1 to 8 (Tiengwe et al., 2012a), similarly to other 
eukaryotes, in which the centromeres have been shown to be the earliest 
replicating regions in the genome (reviewed in Rhind and Gilbert, 2013; Masai et 
al., 2010). It is thus possible that the elements conferring mitotic stability in the 
chromosome fragments highlighted above (Tamar and Papadopoulou, 2001) 
include not just a potential centromere-like region, but also the origin of 
replication of that chromosome. Assuming that the origins of replication here 
mapped are conserved in other Leishmania species (L. major and L. mexicana 
genomes are highly syntenic with the L. donovani and L. tarantolae ones; data 
available on TriTrypDB), comparison of the chromosome fragmentation data 
from L. donovani and L. tarantolae with the origins mapped in both L. major and 
L. mexicana show that the stable chromosome fragments enclosed the region of 
the chromosomes containing the origin, whereas the unstable fragments did not, 
thus supporting the results of a single origin at least in chromosomes 5 and 23. 
Fragmentation of a duplicated region of chromosome 19 in L. donovani retrieved 
similar results (Dubessay et al., 2001), as the fragment stably maintained by the 
parasites contained the syntenic region of the L. major and L. mexicana mapped 
origins, while the non-origin containing fragment was lost with growth. It was 
also shown that the “right end” of chromosome 1 of L. major is stably 
maintained, a region that corresponds with the origin here mapped (Dubessay et 
al., 2002). It will be of interest to explore this further in L. major and L. 
mexicana, now that origin locations are known, either by chromosome 
fragmentation, as described in the abovementioned studies, or by cloning origin-
active and non-origin SSRs into plasmids and asking whether these are 
maintained by the parasites in the absence of drug selection (already being 
performed in L. major by Dr Daniel Paape using a vector system from (Roy et al., 
2000). It will be perhaps of value to explore the L. mexicana origin-active and 
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non-active SSRs from the “fusion” chromosomes. Indeed, if it was possible, it 
would be interesting to artificially fuse two single origin L. major chromosomes, 
such as 8 and 29, recapitulating the proposed evolutionary history, and ask what 
effect the imposition of two origin-active SSRs has on their usage and on 
chromosome stability.  
 
Figure 5.16. Summary of fragmentation assays.  
Diagrams summarising data published from chromosome fragmentation stability in Leishmania. 
Green dashed box represents the section of the L. major chromosome syntenic to the fragments 
showed to be maintained in various Leishmania species. Chromosome 1 represents the data from 
(Dubessay et al., 2002), study performed in L. major. Chromosome 5 summarises the finding in L. 
donovani and chromosome 23 from L. tarantolae, both from (Tamar and Papadopoulou, 2001). 
Chromosome 19 depicts the data from (Dubessay et al., 2001), in L. donovani. The L. major plots 
are the same as in Figure 5.5, showing the origins detected by MFA-seq in early S. The reader is 
referred there for the legend in Figure 5.5 for more detail.  
 
The evidence outlined above supports the existence of a single origin per 
Leishmania chromosome, although it is very unlikely that the parasites are able 
to completely replicate their larger chromosomes within S phase, at least by 
origin-dependent DNA replication. A plausible alternative hypothesis relies on 
the parasite finishing DNA replication, of perhaps mainly its large chromosomes, 
by origin-independent initiation of DNA replication. Such replication is well 
known to occur by recombination-dependent initiation of DNA replication (also 
known as break-induced DNA replication, BIR), which is, for example, an 
intrinsic part of the bacteriophage T4 life cycle, wherein early studies allowed 
the study of such process in bacterial and eukaryotic cells (reviewed in Anand et 
al., 2013). Origin-independent initiation can take place when recombination (D-
loops) or transcription (R-loops) intermediates are used to prime replication, 
being converted into replication forks, which are composed of the molecular 
machineries used in normal DNA replication, including the replicative helicase 
MCM2-7, Cdc45 and GINS complex, but excluding ORC (reviewed in Anand et al., 
2013). A recent example of recombination-dependent initiation of DNA 
replication comes from an archaeal organism, Heloferax volcanii (Hawkins et al., 
2013). H. volcanii possesses a main circular chromosome of 2.8 Mbp (similar in 
size to L. major and L. mexicana larger chromosomes), which is normally 
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replicated from 4 different origins, recognised by ORC1/CDC6. However, it was 
possible to generate viable cells in which all four origins were deleted (Hawkins 
et al., 2013). Moreover, these cells grew faster, and presented a similar DNA 
profile to the wild type cells when analysed for DNA content by flow cytometry, 
suggesting that they had successfully replicated their DNA. MFA-seq analysis 
revealed that no defined origins were used, though the largely flat replication 
profile suggested widespread origin-independent initiation of DNA replication 
(Hawkins et al., 2013). Attempts to generate origin-less cells deficient in one of 
the central players of homologous recombination, RadA (homologous to the 
bacterial RecA and the eukaryotic Rad51), showed that in these origin-lacking 
cells, the entire genome was being replicated by recombination-dependent 
initiation alone, apparently with no associated fitness cost. H. volcanii is highly 
polyploid, tolerating variations in genome copy number, and it has been 
suggested that this enables the origin-less cells to grow (Hawkins et al., 2013). 
This contrasts with oriC deletion in bacteria, which though possible, is severely 
detrimental to growth (reviewed in Kogoma, 1997).  
Leishmania species have been shown to be prone to chromosome aneuploidy, 
which appears to arise frequently and to be well tolerated (Rogers et al., 2011; 
Sterkers et al., 2011; Downing et al., 2011; Lachaud et al., 2014). For instance, 
in L. major strain Friedlin (used here) chromosome 31 (1.48 Mbp) is tetraploid, 
while in L. mexicana strain U1103 (used here) several chromosomes are triploid, 
or intermediate between monoploid and tetraploid (Rogers et al., 2011). It is 
possible that Leishmania species’ tendency to chromosome aneuploidy might be 
necessary to ensure complete replication of their genomes. In addition, 
Leishmania parasites are known to resort to gene amplification of specific loci as 
a response to the environment, through the generation of extra-chromosomal 
circular (episomes) or linear DNA molecules by homologous recombination 
between direct or inverted repeated sequences, respectively, which were 
recently shown to be widespread throughout the L. major, L. infantum, and L. 
braziliensis genomes (Ubeda et al., 2014). These repeats are mostly non-coding 
sequences and present in low-copy number, being used as a platform for the 
amplification of segments of the parasite genome, and as a consequence, 
allowing the Leishmania genome to be continuously subjected to gene 
rearrangements, thus conferring high plasticity to the genome (Ubeda et al., 
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2014; Rogers et al., 2011). Leishmania parasites are able to replicate and 
maintain these extra-chromosomal elements as long as selective pressure is 
present, which also happens with plasmids not containing any Leishmania 
specific sequences (Papadopoulou et al., 1994), suggesting that Leishmania 
parasites are highly permissive to extra-chromosomal elements without 
sequences needed for stability (for e.g. origins of replication) (Ubeda et al., 
2014). Could the genome-wide distribution of these repeated sequences and 
origin-independent replication of extra-chromosomal elements be linked to the 
need for recombination-dependent initiation of DNA replication to facilitate the 
complete replication of the Leishmania genome (or at least the larger 
chromosomes)? Like Leishmania, it was shown that T. brucei also possesses 
repeated sequences where gene rearrangements could take place (Ubeda et al., 
2014). However, no gene amplification has been described in T. brucei, thus 
suggesting that although the parasite has the potential (at the sequence level) 
to generate extra-chromosomal elements, this is not a common event, as the 
parasite is most likely unable to efficiently replicate and maintain them (Ubeda 
et al., 2014). Though apparently uncommon, the presence and maintenance of a 
naturally occurring extra-chromosomal circular DNA element (NR-element) has 
nevertheless been reported in T. brucei Lister 427 and field strains (but not in 
the TREU 927 strain) (Alsford et al., 2003). Could this difference in generating 
and maintaining extra-chromosomal elements between Leishmania and T. brucei 
result from them employing different strategies of DNA replication initiation, in 
which a replication origin is required for T. brucei to replicate and maintain any 
extra-chromosomal element, while in Leishmania these elements will be 
replicated completely via recombination-dependent initiation of replication? 
Null mutants of RAD51, a key player in homologous recombination, in L. 
infantum promastigotes were not reported to have a growth defect, besides 
being more sensitive to double strand break-inducing agents (Ubeda et al., 
2014). However, growth is a weak measure of genome stability, and it will be 
interesting to analyse DNA replication dynamics in these mutants as well as in 
other mutants, deficient in other factors involved in DNA recombination.  
Another question arising from the results here presented is: how do Leishmania 
parasites cope with replicative stress if they only have one origin? As already 
suggested, it will be of importance to map the ORC1/CDC6-binding sites in 
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Leishmania in order to reveal whether there are other potential origins in the 
chromosomes that can be activated under replicative stress, such as dormant 
origins. Indeed, it will be interesting to generate ORC1/CDC6 mutants in 
Leishmania. In T. brucei, TbORC1/CDC6 is essential for parasite survival, and it 
was not possible to generate null mutants of the gene (Tiengwe et al., 2012b), 
in principle because the parasite depends on TbORC1/CDC6 for origin of 
replication recognition and activation. If DNA replication can be initiated in 
Leishmania parasites independently of origins of replication, ORC1/CDC6 may 
not be as essential in these parasites. Nonetheless, one prediction of the single 
origin hypothesis is that in conditions of replicative stress no further discrete 
origins are present to restart replication. If so, it might be predicted that 
replicative stress must be overcome by recombination-dependent replication, 
perhaps leading to increased chromosome copy variation. Whole genome 
sequencing could be used to test this. 
In T. brucei the strongest origins co-localised with the mapped centromeres 
(Tiengwe et al., 2012a). It is thus possible that L. major and L. mexicana origins 
localise to the centromere of each chromosome. Although centromeres have not 
been successfully mapped in Leishmania, the kinetochore proteins of T. brucei 
have been recently identified and shown to localise to the centromeres, and 
orthologues for all of these were also shown be present in L. mexicana (Akiyoshi 
and Gull, 2014), and potentially in L. major. Logically, the next step would be to 
localise these proteins in L. major or L. mexicana to map centromere location 
and test whether these overlap with origins of replication. 
In summary, mapping of the origins of replication in Leishmania has revealed an 
unprecedented case of origin usage in a eukaryote, in which a single origin is 
used per chromosome. Whether this feature is unique to the Leishmania genus or 
whether it is a common feature among early-diverged unicellular organisms it is 
not known, and only the analysis of a broader spectrum of eukaryotes will 
answer this question. Nevertheless, it appears that initiation of DNA replication 
in Leishmania is considerably different from T. brucei, though there is a high 
conservation of origin location. Moreover, it appears that origins of replication in 
Leishmania, but not T. brucei, are associated with specific genomic loci that 
differ from others that do not possess origin activity at least in one specific 
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aspect: the distance between the first two genes at strand switch regions. 
Further understanding of Leishmania DNA replication will be essential to provide 
insight into the evolution of the eukaryotic initiation of DNA replication 
machinery (apparently highly diverged in both Leishmania and T. brucei, see 
Chapter 3), as well as the evolution of the mechanisms behind co-ordination of 
initiation of DNA replication in eukaryotes. 
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6 Concluding Remarks & Future Perspectives 
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Since the T. brucei genome was sequenced in 2005 (Berriman et al., 2005), it 
has become clear that the process of DNA replication in T. brucei, as well as in 
the related kinetoplastids T. cruzi and L. major (El-Sayed et al., 2005b), may 
differ from that described in most of the eukaryotes studied so far (reviewed in 
Tiengwe et al., 2013). In eukaryotes, the process of DNA replication has been 
mostly studied in a limited group of organisms, all of which belong to the 
Opisthokonta supergroup of the eukaryotic tree. Consequently, this focus might 
have led to the idea that this essential process is highly conserved among all 
eukaryotes, not just functionally, but also in terms of the molecular machineries 
involved. With the recent availability of sequenced genomes from a wider range 
of eukaryotes, belonging to the various eukaryotic supergroups, it has become 
clear that, most likely, there is a great variability between eukaryotes, 
especially regarding the factors involved in the first steps of DNA replication, 
such as the members of the pre-replication complex (pre-RC) (Aves et al., 2012). 
For example, in the Excavata supergroup, to which T. brucei belongs, no 
sequence orthologues have been found for the Orc3 and Orc6 subunits of ORC, or 
for Cdc6 or Cdt1, suggesting that in these organisms these factors are either 
absent, present but so diverged that they cannot be identified bioinformatically, 
or non-homologous proteins perform their roles (Aves et al., 2012). In addition, 
the Orc2, Orc4 and Orc5 subunits could not be found in all species analysed from 
this supergroup (Aves et al., 2012). It is therefore not surprising that it has been 
a cumbersome task to identify the pre-RC components in T. brucei, T. cruzi or L. 
major (El-Sayed et al., 2005a). The results presented in this thesis appear to 
suggest that a mix of the above scenarios may be present in T. brucei: there is 
evidence for the existence of a multi-subunit complex, but this might be 
composed of a combination of well-conserved Orc-like factors, some highly 
diverged Orc-like factors, and some non-homologous factors. To date, no 
evidence supports the existence of the key mediators Cdc6 and Cdt1, and it 
remains possible that these may be absent, with their functions/regulatory roles 
being performed by other factors.  
At the start of this work, it was suggested that TbORC1/CDC6 interacts with 
TbORC1B (Dang and Li, 2011), TbORC4, Tb7980, and Tb3120 (Tiengwe et al., 
2012b), and also potentially with Tb1120 (Tiengwe, 2010). It was not known, 
however, if these interacted with TbORC1/CDC6 in an ORC-like complex, 
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whether these factors were involved in DNA replication, or if these were 
functionally replacing any of the ORC subunits still not identified at the time 
(reviewed in Tiengwe et al., 2013). Presently, it is clear that TbORC1/CDC6 and 
TbORC4 are Orc-like subunits (Tiengwe et al., 2012b; Godoy et al., 2009), and 
both have been confirmed to be involved in DNA replication in PCF and BSF cells. 
Though initially identified as being most likely kinetoplastid-specific factors 
(Tiengwe et al., 2012b), a re-analysis of Tb7980 and Tb3120 protein sequences 
tentatively suggests that these are, respectively, highly diverged Orc5-like and 
Orc2-like subunits. However, it was not possible to confirm the role of Tb7980 in 
DNA replication in either PCF or BSF cells, and therefore it remains premature to 
firmly re-label it as TbORC5. It will thus be essential, in the future, to associate 
it with DNA replication in T. brucei. In the case of Tb3120, evidence from PCF 
cells confirm its role in DNA replication, and protein sequence re-analysis was 
able to identify diverged Walker A and Walker B motifs defined by signature 
sequences present in Orc2 subunits, strongly suggesting that Tb3120 is, most 
likely, TbORC2. However, analysis of Tb3120 and corresponding orthologues in T. 
cruzi and L. major revealed that these proteins are considerably larger than 
other Orc2 proteins; when comparing these with other eukaryotes Orc2 subunits, 
it is clear that the kinetoplastid Orc2-like factors have an enlarged N-terminus, 
especially in L. major. It will be of interest, in the future, to try and explore 
what function this enlargement might provide: for instance, it may be that this 
domain provides an key activity or conformation to the putative kinetoplastid 
ORC, or even provide non-replication functions. It has not to date proved 
possible to infer homology with any other factors, replication-related or not, 
when analysing Tb1120. Though it was here confirmed that Tb1120 interacts 
with TbORC1/CDC6, it was not possible to show that it is involved in DNA 
replication, and thus it remains inconclusive whether it is part of, or not, an 
ORC-like complex. Very recently, the crystal structure of D. melanogaster ORC 
has been published (Bleichert et al., 2015). It will be of value to repeat the 
structure prediction analysis (using RaptorX and I-Tasser), in order to infer 
whether any of these subunits would be used as templates for modelling some of 
the T. brucei Orc-like proteins. Moreover, it would be also interesting to predict 
the T. brucei factors’ structures and try to model these into the D. melanogaster 
ORC structure (Bleichert et al., 2015; Bleichert et al., 2013), in order to infer 
putative interactions between the various factors.  
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Overall, if Tb7980 and Tb3120 are confirmed to be T. brucei TbORC5 and 
TbORC2, respectively, one can argue that T. brucei has orthologues for Orc1, 
Orc4, Orc5 and Orc2 subunits of ORC (Figure 6.1), which were the ones predicted 
to be present in the organisms from the Excavata supergroup (Aves et al., 2012), 
while Orc3 and Orc6 are still missing, together with Cdc6 and Cdt1. 
TbORC1/CDC6 has been shown to complement functionally Cdc6 in yeast (Godoy 
et al., 2009), so it is possible that in T. brucei, TbORC1/CDC6 might have a dual 
role, functioning both as Orc1 and Cdc6, and thus not requiring a independent 
Cdc6 factor. In yeast, for instance, Orc6 has two Cdt1-binding sites, and allows 
the recruitment and loading of the MCM2-7 helicase via Cdt1 (Takara and Bell, 
2011). If Orc6 is truly absent in kinetoplastids, it may then make sense that Cdt1 
is also absent, and it is thus possible that in the absence of both, the TbMCM2-7 
helicase is recruited and loaded to the origin-bound ORC-like complex via other 
factors. It was shown that both TbORC1/CDC6 and TbORC1B interact with, at 
least, TbMCM3 (Dang and Li, 2011), but whether these interactions are enough 
to recruit and load the helicase onto the origins of replication (Figure 6.1), is not 
known and requires further investigation. 
The gel filtration assay presented here suggests the existence of TbORC1/CDC6 
in a complex, or various complexes of different sizes. Though this must be 
repeated, and the presence of the various TbORC1/CDC6-interacting factors in 
these complexes still require testing, these preliminary results support the 
existence of an ORC-like complex in T. brucei, which had not been shown before 
(reviewed in Tiengwe et al., 2013). As already explored in the dedicated 
discussion section, TbORC1/CDC6 was detected in fractions suggesting 
complexes large enough to include TbORC1/CDC6, TbORC4, Tb7980, Tb3120 and 
Tb1120 as members of an ORC-like complex, but also other factors, which might 
have not been yet identified (potential model in Figure 6.1). Nevertheless, the 
most predominant putative complexes are too big to just harbour a putative 
ORC-like complex, and are large enough to include, in addition to the 
abovementioned factors, the six subunits of the TbMCM2-7 helicase, which would 
make up the pre-RC complex (if Cdc6 and Cdt1 are indeed lacking). Even larger 
complexes were also observed, that could in addition include the four subunits 
of TbGINS and TbCDC45, making up the pre-IC complex, and even TbMCM10. This 
all, of course, requires testing, which could be done by performing the same 
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assay using the PCF cell lines containing both TbORC1/CDC6 tagged 
endogenously with 12myc and each of the other factors tagged with 6HA, or 
performing an immunoprecipitation assay of the isolated gel filtration fractions, 
using TbORC1/CDC612myc as bait, followed by mass spectrometry analysis. 
Immunoprecipitation of TbORC412myc followed by mass spectrometry analysis, 
suggests that TbORC4 interacts not only with TbORC1/CDC6 but also with Tb3120 
and Tb1120, and it will be essential to confirm these interactions by directed co-
Immunoprecipitation. Nevertheless, these results offer further support for the 
existence of an ORC-like complex in T. brucei, in which, at least, TbORC1/CDC6, 
TbORC4, Tb3120 (possibly as TbORC2) and Tb1120, interact. Furthermore, the 
Immunoprecipitation of TbORC1/CDC6, TbORC4, and TbORC1B tagged with 
12myc followed by mass spectrometry analysis retrieved a common hit, 
Tb927.10.2240 (Tb2240), which had not previously been examined. It will be 
important to investigate this new factor and test whether it is also another 
member of the ORC-like complex and if it is involved in DNA replication.  
Immunolocalisation of the TbORC1/CDC6, TbORC4, Tb7980, Tb3120 and Tb1120 
12myc-tagged versions revealed that all these factors localise to the nucleus of 
both PCF and BSF cells as punctate throughout the cell cycle, during which all 
showed identical localisation dynamics, perhaps supporting the idea that these 
are interacting in a complex. In the future, it will be important to co-localise 
these factors, perhaps by super resolution imaging. Though it requires further 
validation, it appears that TbORC1/CDC6 co-localises with newly replicated DNA 
during S phase; it has been described in other eukaryotes that ORC binds to 
newly synthesised origins of replication as S phase progresses, so it is possible 
that as the DNA is replicated, TbORC1/CDC6 recognises and binds to newly 
replicated origins of replication, a hypothesis that is somehow supported by the 
previous report that TbORC1/CDC6 is bound to the DNA throughout the cell cycle 
(Godoy et al., 2009). Whether this is also true for the other factors requires 
testing.  
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Figure 6.1. Models of pre-RC and pre-IC formation.  
Simplified models of pre-RC and pre-IC formation in model eukaryotes (left), and T. brucei (right); 
both not to scale. In model eukaryotes, ORC binds to the origin of replication; next, Cdc6 binds, 
leading to conformational changes in ORC, exposing the Cdt1-binding domains in Orc6; Cdt1, 
bound to the MCM2-7 helicase, is recruited to the origin, where it binds to ORC via Orc6; Cdc6 and 
Orc1 undergo ATP hydrolysis, and this releases both Cdc6 and Cdt1 from the origins; at the onset 
of S phase, the GINS complex and Cdc45 are recruited, and form the CMG complex with MCM2-7, 
activating it, and unwinding the origin DNA, allowing the recruitment of the components of the 
replication fork. In T. brucei, TbORC1/CDC6 is known to bind to the origins of replication, and has 
been shown to interact with TbORC4, Tb7980 (potential TbORC5), Tb3120 (potential TbORC2), 
and Tb1120, possibly as a divergent ORC-like complex. There’s indication that TbORC4 interacts 
with both Tb3120 and Tb1120, though this requires further validation. It is not known whether other 
factors are members of this ORC-like complex (represented in grey). It is not known if a factor such 
as Cdc6 binds to the ORC-like complex, or if the helicase is recruited to it directly or via a loader, in 
place of Cdt1. At the end of G1 and onset of S phase, TbORC1B is expressed and potentially binds 
to the ORC-like complex, at least via TbORC1/CDC6, and also to the TbMCM2-7 helicase at least 
via TbMCM3. Whether TbORC1B is recruited together with the TbGINS complex and TbCDC45, or 
if it interacts with them at all at the origin, it is not known. Supposedly, the helicase is then 
activated, the origin DNA is unwind, and DNA replication starts. Question marks represent the 
speculative steps in process of initiation of DNA replication in T. brucei, which must be further 
investigated in the near future. Diagrams adapted from (Tiengwe et al., 2013), with permission.  
Chapter 6  365 
 
 
Unlike all the other analysed factors, TbORC1B, both in PCF and BSF cells, 
localised to the nucleus of cells from late G1 phase/start of S phase to late S 
phase/early G2 phase. Further analysis revealed that TbORC1B is mainly 
expressed in S phase cells and is completely absent from G1 phase cells, strongly 
suggesting that TbORC1B expression is cell cycle dependent, though how its 
expression is controlled is not known, and requires further investigation. 
Together with the strikingly rapid phenotype following its silencing by inducible 
RNAi, which results in the virtual abolishment of DNA replication, the results 
herein presented suggest that, more than being a potential member of a ORC-
like complex (indeed, the data suggest it is not a static member of such a 
complex), TbORC1B appears to be, instead, a regulatory factor. However, how it 
provides a regulatory function is presently unknown, as it does not seem to 
follow the pattern of either Cdc6 or Cdt1 localisation dynamics described in 
other organisms (Delmolino et al., 2001; Petersen et al., 1999; Piatti et al., 
1995; Luo et al., 2003; Borlado and Mendez, 2008; Diffley, 2010; Li and Jin, 
2010; Tanaka and Diffley, 2002; Nishitani et al., 2000; Nishitani et al., 2001; 
Wohlschlegel et al., 2000). The evidence to date suggests that it might be a 
positive regulatory factor whose expression or nuclear localisation coincides with 
the onset of S phase and its presence continues to the late stages of S phase 
(and perhaps early G2 phase), but is removed when the cells have committed 
into mitosis. It remains possible then, that TbORC1B acts in a truly novel 
strategy in the control of nuclear DNA replication, and deserves further 
investigation. 
Unlike TbORC1/CDC6, the preliminary localisation data suggest that TbORC1B 
does not appear to bind to newly synthesised DNA. If TbORC1B is acting from the 
beginning of S phase up to G2 phase as a regulator of DNA replication initiation, 
it is logical that it would not associate with newly replicated DNA, but instead 
with origins that are activated during the S phase. This would accord with the 
observations that TbORC1B signal is more intense in the nucleus of cells that are 
in the beginning and during S phase (1N1K and 1N1eK cells), decreasing as the 
cells progress into G2 phase (1N2K cells): at the start of S phase, TbORC1B would 
be present at the origins of DNA replication; as S phase progresses, less origins 
would remain to be activated, and thus TbORC1B signal would decrease as the 
cells progress into the end of S phase and beginning of the G2 phase. Once all 
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origins have been used, TbORC1B would no longer be needed, and therefore 
would no longer be detected in the nucleus. The complete absence of TbORC1B 
in G1 phase cells may suggest that it is important for the start of DNA replication 
and, therefore, acts as the factor that directs the activation of origins from the 
larger pool of TbORC1/CDC6 (and potentially ORC) binding sites. These 
suggestions require further investigation, and it will be of great value to perform 
a chromatin-immunoprecipitation using TbORC1B as bait, and ask whether this 
binds to all potential origins, like TbORC1/CDC6, or whether it only binds to the 
origins that are activated during S phase, which were detected by the MFA-seq 
analysis (Tiengwe et al., 2012b). 
Initially proposed as another Orc1-like factor devoid of ATPase activity, TbORC1B 
was shown to interact with both TbORC1/CDC6 and TbMCM3 (Dang and Li, 2011). 
Though various attempts were made in this study to confirm that TbORC1B 
interacts with TbORC1/CDC6, this proved unsuccessful. This would be consistent 
with TbORC1B acting as a regulatory factor: if it interacts with the ORC-like 
complex at the origins of replication, such interaction may be rather transient, 
taking place between late G1/early S and late S/early G2 phase, and thus might 
be difficult to detect. The interaction between TbORC1B and TbORC1/CDC6, or 
any other ORC and pre-RC factors should be further analysed (perhaps via 
immunoprecipitation assays coupled with cross-linking, if the interaction is 
transient) to probe in detail how it might influence replication initiation.  
In order to better understand DNA replication in T. brucei, the origins of 
replication were also a focus of attention in the present work. Previously, the 
origins of replication have been mapped in T. brucei PCF cells, revealing a small 
number of active origins, all localising to the SSR boundaries of the polycistronic 
transcription units, and the existence of an origin activation timing programme 
(Tiengwe et al., 2012a). Though all the analysed factors’ subcellular localisation 
dynamics was identical in PCF and BSF cells, we sought to map, using the same 
strategy as before (MFA-seq) (Tiengwe et al., 2012a), the activated origins of 
replication in BSF cells, driven by reports that in other eukaryotes origin usage 
differs between cell types (reviewed in Leonard and Mechali, 2013; Rhind and 
Gilbert, 2013). Perhaps not surprisingly, though the two life cycle stages of the 
parasite differ in many biological aspects (detailed in the introduction and in 
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Chapter 4), the same activated origins were detected, and appear to follow the 
same, or very similar, activation programme in BSF cells as in PCF cells. This 
reveals that the programme of origin usage is rather inflexible in T. brucei, 
which might be related to the fact that, unlike other eukaryotes, gene 
expression (of housekeeping genes, by RNA pol II) in T. brucei, and related 
kinetoplastids, is not mainly controlled at the transcription level but at the post-
transcriptional level (reviewed in Clayton, 2002; Clayton, 2013; Kramer, 2012; 
Siegel et al., 2011). Thus, pronounced differences in chromatin status, structure 
and composition that may underlie replication variation in different 
developmental stages in other eukaryotes may be absent between PCF and BSF 
cells. Nonetheless, if there is no variation in transcription initiation or 
termination at any SSR in T. brucei, it remains unclear what features determine 
the relatively rigid pattern of origin firing (as seen in varying MFA-seq peak 
heights), which is also maintained between BSF and PCF cells. The main 
difference in transcription patterns between PCF and BSF cells lies on the 
expression of their surface antigens: procyclins in PCF cells and VSGs in BSF 
cells, both expressed in a life cycle-dependent fashion by RNA Pol I (Gunzl et 
al., 2003). Indeed, the only apparent difference between origin mapping in PCF 
and BSF cells lies in the region from where the single VSG is being expressed in 
the analysed BSF cells (VSG 221), the active bloodstream expression site (BES 1). 
This genome feature appeared to be replicated early during S phase in BSF cells 
(where it is transcribed), but be late replicating in PCF cells (where it is 
silenced). All other analysed BES, whose expression is silenced in both life cycle 
stages, were replicated late in both BSF and PCF cells. In order to validate these 
observations, it will be necessary to analyse BSF cell lines in which another BES 
is active and BES 1 is inactive, and ask whether the distinct, active BES is 
replicated early in BSF cells while BES 1 is replicated late. Nevertheless, these 
data support previous findings (Tiengwe et al., 2012a; Benmerzouga et al., 
2013) in which DNA replication and transcription appear to be intimately 
connected in T. brucei, and that DNA replication might be involved in antigenic 
variation.  
With the initial intention to better understand origins of replication in T. brucei, 
and in an attempt to identify origin-defining features, origins were also mapped 
in Leishmania major and L. mexicana, taking advantage of their genomes being 
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highly syntenic between each other as well as with the genome of T. brucei (El-
Sayed et al., 2005b). Surprisingly, only one origin of replication could be 
identified per chromosome in both Leishmania species. More strikingly, in two L. 
mexicana chromosomes, each of which is syntenic with two L. major 
chromosomes (each with a single detectable origin), only one origin was 
detected, suggesting that a single origin per chromosome is preferred in 
Leishmania. This is unprecedented in eukaryotes, which are assumed to have 
multiple origins per chromosome (reviewed in Masai et al., 2010; Mechali, 2010; 
Leonard and Mechali, 2013), and contrasts with what has been consistently 
observed in T. brucei (Tiengwe et al., 2012a; and shown in Chapter 4). In 
addition, all detected origins appeared to be of the same strength, suggesting 
that, again in contrast to T. brucei, Leishmania does not possess an origin 
activation timing programme, and instead all origins are activated at the same 
time. The analysis of some chromosomes by MFA coupled with qPCR (MFA-qPCR) 
supports the existence of a single origin per Leishmania chromosome, but it will 
be crucial to confirm this, as it goes against the orthodoxy established in the 
field: eukaryotic chromosomes are replicated from multiple origins of 
replication. One option would be to perform single molecule analysis of 
replicated DNA (SMARD). However, if DNA replication can be initiated via other 
mechanisms that are independent from origins of replication, such as 
recombination-dependent DNA replication (below), these events will be 
detected by SMARD, and will be difficult to distinguish from the existence of 
‘extra’ origins. Another option would be to perform MFA-seq on a single cell 
basis, although how feasible single cell sequencing (Nawy, 2014; Eberwine et al., 
2014) would be in Leishmania is not clear at present. Therefore, confirmation of 
a single origin per Leishmania chromosome by other experimental procedures 
beyond MFA-seq will have to be planned carefully, in order to exclude 
replication-initiation events that are not dependent on origins of replication. 
Although the rate of replication fork movement has been recently calculated in 
both T. brucei PCF and BSF cells (Calderano et al., 2015), and appears to be 
slightly faster than in other eukaryotes (reviewed in Mechali, 2010), the same 
has not been done in Leishmania. Even if it were predicted that Leishmania 
replication fork rate is similar to the one of T. brucei, this would not be enough 
to allow full replication of the Leishmania larger chromosomes within S phase; it 
would be enough to only completely replicate the smaller chromosomes. The 
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MFA-seq approach is able to detect origins that are activated at the population 
level (constitutive origins), and it is thus possible that origins that are activated 
only at the individual cell level (flexible or dormant origins) are below 
detection. It is therefore possible that other origins are present per Leishmania 
chromosome, but these are activated differently from cell to cell and, 
consequently, are not detected by MFA-seq/MFA-qPCR. Nevertheless, even this 
scenario is still completely different from what was observed in T. brucei, 
suggesting that DNA replication dynamics in these two closely related organisms 
differ. Whether this is because the machineries involved in replication differ is 
unknown, but may be hinted at by our observation of differences in what 
features define what SSR acts as an origin relative to those SSRs that do not.  
Like in T. brucei, no specific sequence was detected that defines what an origin 
is in Leishmania. Furthermore, Leishmania origins localised to SSRs. However, 
analysis of the size of origin and non-origin SSRs revealed that there is a 
significant difference between the two SSR classes in Leishmania, but not in T. 
brucei. Besides, in the two unique syntenic regions which are origin-active SSRs 
in L. major but non-origin SSRs in L. mexicana, a difference in size was also 
observed, suggesting that SSR size might be an origin-defining feature in 
Leishmania. What feature of origin designation SSR size in Leishmania dictates is 
unknown, but may relate to a requirement for the binding of specific factors or 
the generation of specific chromatin structures. Given the likely absence of such 
SSR differences in T. brucei, comparison of the machinery that localises to SSRs 
in the two parasites may be revealing.  
If indeed there is only one origin per chromosome, Leishmania must have 
developed a strategy to achieve complete replication of each chromosome 
within S phase. One strategy could be to initiate DNA replication independently 
from origins of replication, via recombination-dependent DNA replication, as 
suggested and discussed in Chapter 5, which could also explain the variation in 
and tolerance of chromosome ploidy changes in Leishmania, but not T. brucei. It 
will be essential to test this hypothesis by, for instance, mapping the origins of 
replication in cell lines deficient for recombination factors such as Rad51. If 
Leishmania is indeed able to initiate DNA replication in a non-origin dependent 
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fashion, it will also be of value to investigate the DNA replication and cell cycle 
effects of Leishmania ORC1/CDC6 depletion.  
Origin singularity in Leishmania, besides raising the question on how the parasite 
fully replicates its larger chromosomes within S phase, also raises the question 
on how the parasite copes with replicative stress. Although recombination-
dependent DNA replication could be the answer for both of these, it will be of 
importance to map the Leishmania ORC1/CDC6-binding sites at the genome-wide 
level by chromatin-immunoprecipitation followed by sequencing, in order to 
infer whether the initiator only binds to the origins that are activated or if it 
also bind to the other SSRs, potentially allowing them to act as origins under 
stress. It will also be interesting to map the origins of replication in cells in 
which DNA replication stress has been induced (e.g. hydroxyurea). In other 
eukaryotes (Leonard and Mechali, 2013; Rhind and Gilbert, 2013), including in T. 
brucei (Tiengwe et al., 2012a), the centromeres are one of the earliest regions 
of the genome to be replicated. Unfortunately, to date, the centromeres have 
not been mapped in Leishmania. Recently, however, the kinetochore subunits 
have been identified in T. brucei and appear to be conserved in Leishmania 
(Akiyoshi and Gull, 2014). It will, therefore, be of interest to map, as for 
ORC1/CDC6, the kinetochore-binding sites, and ask whether these localise to the 
single origins detected per Leishmania chromosome.  
In conclusion, much still has to be done in the field of DNA replication in T. 
brucei and related kinetoplastids, and it will be a very exciting area of research 
in the next years. Whether the divergences, both in the initiation machinery and 
in the dynamics of replication, relative to mammals are sufficient to warrant 
investigation as routes towards drug development is unclear and requires further 
fundamental studies. 
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